ID   ZN593_HUMAN             Reviewed;         134 AA.
AC   O00488; B2R4S0; Q5T2H7;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   22-FEB-2023, entry version 182.
DE   RecName: Full=Zinc finger protein 593;
DE   AltName: Full=Zinc finger protein T86;
GN   Name=ZNF593; Synonyms=ZT86;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-134, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=T-cell lymphoma;
RX   PubMed=9115366; DOI=10.1093/nar/25.10.1984;
RA   Terunuma A., Shiba K., Noda T.;
RT   "A novel genetic system to isolate a dominant negative effector on DNA-
RT   binding activity of Oct-2.";
RL   Nucleic Acids Res. 25:1984-1990(1997).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   STRUCTURE BY NMR OF 20-134 IN COMPLEX WITH ZINC IONS, AND DOMAIN.
RX   PubMed=18287285; DOI=10.1110/ps.073290408;
RA   Hayes P.L., Lytle B.L., Volkman B.F., Peterson F.C.;
RT   "The solution structure of ZNF593 from Homo sapiens reveals a zinc finger
RT   in a predominantly unstructured protein.";
RL   Protein Sci. 17:571-576(2008).
RN   [14] {ECO:0007744|PDB:6LSS, ECO:0007744|PDB:6LU8}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.13 ANGSTROMS) IN COMPLEX WITH PRE-60S
RP   RIBOSOMAL PARTICLES, FUNCTION, AND INTERACTION WITH PRE-60S RIBOSOMAL
RP   PARTICLES.
RX   PubMed=32669547; DOI=10.1038/s41467-020-17237-x;
RA   Liang X., Zuo M.Q., Zhang Y., Li N., Ma C., Dong M.Q., Gao N.;
RT   "Structural snapshots of human pre-60S ribosomal particles before and after
RT   nuclear export.";
RL   Nat. Commun. 11:3542-3542(2020).
CC   -!- FUNCTION: Involved in pre-60S ribosomal particles maturation by
CC       promoting the nuclear export of the 60S ribosome (PubMed:32669547).
CC       Negatively modulates the DNA binding activity of Oct-2 and therefore
CC       its transcriptional regulatory activity (PubMed:9115366).
CC       {ECO:0000269|PubMed:9115366, ECO:0000305|PubMed:32669547}.
CC   -!- SUBUNIT: Associates with pre-60S ribosomal particles.
CC       {ECO:0000269|PubMed:32669547}.
CC   -!- INTERACTION:
CC       O00488; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-726769, EBI-742054;
CC       O00488; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-726769, EBI-739832;
CC       O00488; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-726769, EBI-79165;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q08004}. Note=Shuttles between the
CC       nucleus and the cytoplasm. {ECO:0000250|UniProtKB:Q08004}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected in spleen, prostate, testis,
CC       small intestine, colon and to a minor level in thymus and peripheral
CC       blood leukocytes. {ECO:0000269|PubMed:9115366}.
CC   -!- DOMAIN: The protein is largely disordered, with the exception of the
CC       zinc finger domain. {ECO:0000269|PubMed:18287285}.
CC   -!- SIMILARITY: Belongs to the ZNF593/BUD20 C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02580.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH19267.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA20369.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG34867.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK311926; BAG34867.1; ALT_INIT; mRNA.
DR   EMBL; AL391650; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07843.1; -; Genomic_DNA.
DR   EMBL; BC002580; AAH02580.1; ALT_INIT; mRNA.
DR   EMBL; BC019267; AAH19267.1; ALT_INIT; mRNA.
DR   EMBL; D45213; BAA20369.1; ALT_INIT; mRNA.
DR   CCDS; CCDS275.2; -.
DR   RefSeq; NP_056955.2; NM_015871.4.
DR   PDB; 1ZR9; NMR; -; A=20-134.
DR   PDB; 6LSS; EM; 3.23 A; 9=1-134.
DR   PDB; 6LU8; EM; 3.13 A; 9=1-134.
DR   PDBsum; 1ZR9; -.
DR   PDBsum; 6LSS; -.
DR   PDBsum; 6LU8; -.
DR   AlphaFoldDB; O00488; -.
DR   SMR; O00488; -.
DR   BioGRID; 119241; 60.
DR   IntAct; O00488; 22.
DR   MINT; O00488; -.
DR   STRING; 9606.ENSP00000363384; -.
DR   iPTMnet; O00488; -.
DR   PhosphoSitePlus; O00488; -.
DR   BioMuta; ZNF593; -.
DR   SWISS-2DPAGE; O00488; -.
DR   EPD; O00488; -.
DR   jPOST; O00488; -.
DR   MassIVE; O00488; -.
DR   MaxQB; O00488; -.
DR   PaxDb; O00488; -.
DR   PeptideAtlas; O00488; -.
DR   ProteomicsDB; 47933; -.
DR   Antibodypedia; 30564; 74 antibodies from 19 providers.
DR   DNASU; 51042; -.
DR   Ensembl; ENST00000374266.7; ENSP00000363384.5; ENSG00000142684.9.
DR   GeneID; 51042; -.
DR   KEGG; hsa:51042; -.
DR   MANE-Select; ENST00000374266.7; ENSP00000363384.5; NM_015871.5; NP_056955.2.
DR   UCSC; uc001bll.5; human.
DR   AGR; HGNC:30943; -.
DR   CTD; 51042; -.
DR   DisGeNET; 51042; -.
DR   GeneCards; ZNF593; -.
DR   HGNC; HGNC:30943; ZNF593.
DR   HPA; ENSG00000142684; Low tissue specificity.
DR   MIM; 616698; gene.
DR   neXtProt; NX_O00488; -.
DR   OpenTargets; ENSG00000142684; -.
DR   PharmGKB; PA134962156; -.
DR   VEuPathDB; HostDB:ENSG00000142684; -.
DR   eggNOG; KOG3408; Eukaryota.
DR   GeneTree; ENSGT00390000004173; -.
DR   HOGENOM; CLU_117291_1_2_1; -.
DR   InParanoid; O00488; -.
DR   OMA; TECAKWF; -.
DR   OrthoDB; 230013at2759; -.
DR   PhylomeDB; O00488; -.
DR   TreeFam; TF315114; -.
DR   PathwayCommons; O00488; -.
DR   SignaLink; O00488; -.
DR   BioGRID-ORCS; 51042; 187 hits in 1177 CRISPR screens.
DR   ChiTaRS; ZNF593; human.
DR   EvolutionaryTrace; O00488; -.
DR   GeneWiki; ZNF593; -.
DR   GenomeRNAi; 51042; -.
DR   Pharos; O00488; Tbio.
DR   PRO; PR:O00488; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O00488; protein.
DR   Bgee; ENSG00000142684; Expressed in gastrocnemius and 173 other tissues.
DR   ExpressionAtlas; O00488; baseline and differential.
DR   Genevisible; O00488; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:1990275; F:preribosome binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IMP:CAFA.
DR   GO; GO:1903026; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; IGI:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IGI:GO_Central.
DR   GO; GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW.
DR   DisProt; DP00549; -.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR022755; Znf_C2H2_jaz.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR46095; ZINC FINGER PROTEIN 593; 1.
DR   PANTHER; PTHR46095:SF1; ZINC FINGER PROTEIN 593; 1.
DR   Pfam; PF12171; zf-C2H2_jaz; 1.
DR   SMART; SM00451; ZnF_U1; 1.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; DNA-binding; Metal-binding; Nucleus;
KW   Reference proteome; Ribosome biogenesis; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..134
FT                   /note="Zinc finger protein 593"
FT                   /id="PRO_0000047684"
FT   ZN_FING         61..85
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          82..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..20
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        21..39
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         6
FT                   /note="R -> Q (in dbSNP:rs2232649)"
FT                   /id="VAR_059924"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:1ZR9"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:1ZR9"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:1ZR9"
FT   HELIX           73..79
FT                   /evidence="ECO:0007829|PDB:1ZR9"
FT   HELIX           83..92
FT                   /evidence="ECO:0007829|PDB:1ZR9"
FT   TURN            99..101
FT                   /evidence="ECO:0007829|PDB:1ZR9"
SQ   SEQUENCE   134 AA;  15199 MW;  883BCE4F72459818 CRC64;
     MGRSRRTGAH RAHSLARQMK AKRRRPDLDE IHRELRPQGS ARPQPDPNAE FDPDLPGGGL
     HRCLACARYF IDSTNLKTHF RSKDHKKRLK QLSVEPYSQE EAERAAGMGS YVPPRRLAVP
     TEVSTEVPEM DTST
//
ID   ZNHI1_HUMAN             Reviewed;         154 AA.
AC   O43257; Q6IB12;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   22-FEB-2023, entry version 156.
DE   RecName: Full=Zinc finger HIT domain-containing protein 1;
DE   AltName: Full=Cyclin-G1-binding protein 1;
DE   AltName: Full=Zinc finger protein subfamily 4A member 1;
DE   AltName: Full=p18 Hamlet {ECO:0000303|PubMed:17380123};
GN   Name=ZNHIT1; Synonyms=CGBP1, ZNFN4A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wang Y., Underwood L.J., Tanimoto H., Shigemasa K., O'Brien T.J.;
RT   "Molecular cloning and characterization of cyclin G1 binding protein 1
RT   (CGBP1).";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Xu F., Hall F.L., Starnes V., Wu L.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION IN THE SRCAP COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15647280; DOI=10.1074/jbc.m500001200;
RA   Cai Y., Jin J., Florens L., Swanson S.K., Kusch T., Li B., Workman J.L.,
RA   Washburn M.P., Conaway R.C., Conaway J.W.;
RT   "The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone
RT   acetyltransferase and SRCAP complexes.";
RL   J. Biol. Chem. 280:13665-13670(2005).
RN   [8]
RP   FUNCTION.
RX   PubMed=17700068; DOI=10.4161/cc.6.19.4741;
RA   Lafarga V., Cuadrado A., Nebreda A.R.;
RT   "p18(Hamlet) mediates different p53-dependent responses to DNA-damage
RT   inducing agents.";
RL   Cell Cycle 6:2319-2322(2007).
RN   [9]
RP   FUNCTION, INTERACTION WITH MAPK11 AND MAPK14, PHOSPHORYLATION AT THR-103 BY
RP   MAPK11 AND MAPK14, INDUCTION BY DNA DAMAGE, AND MUTAGENESIS OF THR-103.
RX   PubMed=17380123; DOI=10.1038/sj.emboj.7601657;
RA   Cuadrado A., Lafarga V., Cheung P.C., Dolado I., Llanos S., Cohen P.,
RA   Nebreda A.R.;
RT   "A new p38 MAP kinase-regulated transcriptional coactivator that stimulates
RT   p53-dependent apoptosis.";
RL   EMBO J. 26:2115-2126(2007).
RN   [10]
RP   FUNCTION, INTERACTION WITH NR1D1 AND NR1D2, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=17892483; DOI=10.1111/j.1742-4658.2007.06062.x;
RA   Wang J., Li Y., Zhang M., Liu Z., Wu C., Yuan H., Li Y.Y., Zhao X., Lu H.;
RT   "A zinc finger HIT domain-containing protein, ZNHIT-1, interacts with
RT   orphan nuclear hormone receptor Rev-erbbeta and removes Rev-erbbeta-induced
RT   inhibition of apoCIII transcription.";
RL   FEBS J. 274:5370-5381(2007).
RN   [11]
RP   FUNCTION, IDENTIFICATION IN THE SRCAP COMPLEX, INTERACTION WITH H2AZ1, AND
RP   PHOSPHORYLATION.
RX   PubMed=20473270; DOI=10.1038/emboj.2010.85;
RA   Cuadrado A., Corrado N., Perdiguero E., Lafarga V., Munoz-Canoves P.,
RA   Nebreda A.R.;
RT   "Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin
RT   incorporation in muscle differentiation.";
RL   EMBO J. 29:2014-2025(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   INTERACTION WITH RUVBL1/RUVBL2 COMPLEX.
RX   PubMed=28561026; DOI=10.1038/ncomms15615;
RA   Cloutier P., Poitras C., Durand M., Hekmat O., Fiola-Masson E.,
RA   Bouchard A., Faubert D., Chabot B., Coulombe B.;
RT   "R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2
RT   to regulate assembly of U5 small nuclear ribonucleoprotein.";
RL   Nat. Commun. 8:15615-15615(2017).
RN   [14]
RP   FUNCTION.
RX   PubMed=35175558; DOI=10.1007/s12035-022-02768-9;
RA   McCarthy E., Barron A., Morales-Prieto N., Mazzocchi M., McCarthy C.M.,
RA   Collins L.M., Sullivan A.M., O'Keeffe G.W.;
RT   "Gene Co-expression Analysis of the Human Substantia Nigra Identifies
RT   ZNHIT1 as an SNCA Co-expressed Gene that Protects Against alpha-Synuclein-
RT   Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-
RT   SY5Y Cells.";
RL   Mol. Neurobiol. 59:2745-2757(2022).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-134.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Plays a role in chromatin remodeling by promoting the
CC       incorporation of histone variant H2AZ1/H2A.Z into the genome to
CC       regulate gene expression (PubMed:20473270, PubMed:35175558). Promotes
CC       SRCAP complex-mediated deposition of histone variant H2AZ1 to lymphoid
CC       fate regulator genes, enhancing lymphoid lineage commitment (By
CC       similarity). Recruited to the promoter of the transcriptional activator
CC       MYOG at the early stages of muscle differentiation where it mediates
CC       binding of histone H2AZ1 to chromatin and induces muscle-specific gene
CC       expression (PubMed:20473270). Maintains hematopoietic stem cell (HSC)
CC       quiescence by determining the chromatin accessibility at distal
CC       enhancers of HSC quiescence genes such as PTEN, FSTL1 and KLF4,
CC       enhancing deposition of H2AZ1 to promote their sustained transcription
CC       and restricting PI3K-AKT signaling inhibition (By similarity). Plays a
CC       role in intestinal stem cell maintenance by promoting H2AZ1 deposition
CC       at the transcription start sites of genes involved in intestinal stem
CC       cell fate determination including LGR5, TGFB1 and TGFBR2, thereby
CC       contributing to gene transcription (By similarity). Promotes
CC       phosphorylation of the H2AZ1 chaperone VPS72/YL1 which enhances the
CC       interaction between HZAZ1 and VPS72 (By similarity). Regulates the
CC       entry of male germ cells into meiosis by controlling histone H2AZ1
CC       deposition which facilitates the expression of meiotic genes such as
CC       MEIOSIN, leading to the initiation of meiosis (By similarity). Required
CC       for postnatal heart function through its role in maintenance of cardiac
CC       Ca(2+) homeostasis by modulating the expression of Ca(2+)-regulating
CC       proteins CASQ1 and ATP2A2/SERCA2A via deposition of histone H2AZ1 at
CC       their promoters (By similarity). During embryonic heart development,
CC       required for mitochondrial maturation and oxidative metabolism by
CC       functioning through H2AZ1 deposition to activate transcription of
CC       metabolic genes and is also required to maintain the stability of the
CC       respiratory complex (By similarity). In neural cells, increases
CC       deposition of the H2AZ1 histone variant and promotes neurite growth
CC       (PubMed:35175558). Plays a role in TP53/p53-mediated apoptosis
CC       induction by stimulating the transcriptional activation of several
CC       proapoptotic p53 target genes such as PMAIP1/NOXA and BBC3/PUMA
CC       (PubMed:17380123). Mediates cell cycle arrest induced in response to
CC       gamma-irradiation by enhancing recruitment of TP53/p53 to the promoter
CC       of the cell cycle inhibitor CDKN1A, leading to its transcriptional
CC       activation (PubMed:17700068). Recruited to the promoter of cyclin-
CC       dependent kinase CDK6 and inhibits its transcription, possibly by
CC       decreasing the acetylation level of histone H4, leading to cell cycle
CC       arrest at the G1 phase (By similarity). Plays a role in lens fiber cell
CC       differentiation by regulating the expression of cell cycle regulator
CC       CDKN1A/p21Cip1 (By similarity). Binds to transcriptional repressor
CC       NR1D2 and relieves it of its inhibitory effect on the transcription of
CC       apolipoprotein APOC3 without affecting its DNA-binding activity
CC       (PubMed:17892483). {ECO:0000250|UniProtKB:Q8R331,
CC       ECO:0000269|PubMed:17380123, ECO:0000269|PubMed:17700068,
CC       ECO:0000269|PubMed:17892483, ECO:0000269|PubMed:20473270,
CC       ECO:0000269|PubMed:35175558}.
CC   -!- SUBUNIT: Component of the chromatin-remodeling SRCAP complex composed
CC       of at least SRCAP, DMAP1, RUVBL1, RUVBL2, ACTL6A, YEATS4, ACTR6 and
CC       ZNHIT1 (PubMed:15647280, PubMed:20473270). Interacts with MAPK11 and
CC       MAPK14 (PubMed:17380123). Interacts with NR1D1 and NR2D2
CC       (PubMed:17892483). Interacts (via HIT-type zinc finger) with the
CC       RUVBL1/RUVBL2 complex in the presence of ADP (PubMed:28561026).
CC       Interacts with histone deacetylase HDAC1 (By similarity). Interacts
CC       with histone H2AZ1; the interaction results in recruitment of H2AZ1 to
CC       the MYOG promoter region (PubMed:20473270). Interacts with PCID2; the
CC       interaction results in inhibition of SRCAP complex activity, preventing
CC       the deposition of histone variant H2AZ1 to lymphoid fate regulator
CC       genes and restricting lymphoid lineage commitment (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R331, ECO:0000269|PubMed:15647280,
CC       ECO:0000269|PubMed:17380123, ECO:0000269|PubMed:17892483,
CC       ECO:0000269|PubMed:20473270, ECO:0000269|PubMed:28561026}.
CC   -!- INTERACTION:
CC       O43257; Q9GZN1: ACTR6; NbExp=5; IntAct=EBI-347522, EBI-769329;
CC       O43257; Q92870-2: APBB2; NbExp=3; IntAct=EBI-347522, EBI-21535880;
CC       O43257; P41182: BCL6; NbExp=3; IntAct=EBI-347522, EBI-765407;
CC       O43257; Q8WUW1: BRK1; NbExp=3; IntAct=EBI-347522, EBI-2837444;
CC       O43257; P27658: COL8A1; NbExp=3; IntAct=EBI-347522, EBI-747133;
CC       O43257; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-347522, EBI-3867333;
CC       O43257; O00429-3: DNM1L; NbExp=3; IntAct=EBI-347522, EBI-6896746;
CC       O43257; P29692-2: EEF1D; NbExp=3; IntAct=EBI-347522, EBI-5280572;
CC       O43257; Q5TD97: FHL5; NbExp=3; IntAct=EBI-347522, EBI-750641;
CC       O43257; Q06787-7: FMR1; NbExp=3; IntAct=EBI-347522, EBI-25856644;
CC       O43257; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-347522, EBI-5916454;
CC       O43257; P0C0S5: H2AZ1; NbExp=5; IntAct=EBI-347522, EBI-1199859;
CC       O43257; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-347522, EBI-2556193;
CC       O43257; P60371: KRTAP10-6; NbExp=3; IntAct=EBI-347522, EBI-12012928;
CC       O43257; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-347522, EBI-10172290;
CC       O43257; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-347522, EBI-10176379;
CC       O43257; Q15759: MAPK11; NbExp=2; IntAct=EBI-347522, EBI-298304;
CC       O43257; Q16539: MAPK14; NbExp=7; IntAct=EBI-347522, EBI-73946;
CC       O43257; P45984: MAPK9; NbExp=3; IntAct=EBI-347522, EBI-713568;
CC       O43257; Q99750: MDFI; NbExp=3; IntAct=EBI-347522, EBI-724076;
CC       O43257; Q9ULV0-2: MYO5B; NbExp=3; IntAct=EBI-347522, EBI-14093244;
CC       O43257; P32243-2: OTX2; NbExp=3; IntAct=EBI-347522, EBI-9087860;
CC       O43257; D3DTS7: PMP22; NbExp=3; IntAct=EBI-347522, EBI-25882629;
CC       O43257; Q15025: TNIP1; NbExp=3; IntAct=EBI-347522, EBI-357849;
CC       O43257; Q12888: TP53BP1; NbExp=2; IntAct=EBI-347522, EBI-396540;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17892483}.
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in liver, but weakly in
CC       skeletal muscle, ovary and small intestine.
CC       {ECO:0000269|PubMed:17892483}.
CC   -!- INDUCTION: Induced by DNA damage. {ECO:0000269|PubMed:17380123}.
CC   -!- PTM: Phosphorylated on Thr by MAPK11 or MAPK14 (PubMed:17380123).
CC       Phosphorylation is required for MYOG induction, for deposition of
CC       histone H2AZ1 at the MYOG promoter and for SRCAP complex integrity
CC       (PubMed:20473270). {ECO:0000269|PubMed:17380123,
CC       ECO:0000269|PubMed:20473270}.
CC   -!- SIMILARITY: Belongs to the ZNHIT1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF093571; AAF03558.1; -; mRNA.
DR   EMBL; U61837; AAB88578.1; -; mRNA.
DR   EMBL; CR456992; CAG33273.1; -; mRNA.
DR   EMBL; AC004876; AAD45833.1; -; Genomic_DNA.
DR   EMBL; CH471197; EAW50209.1; -; Genomic_DNA.
DR   EMBL; BC017333; AAH17333.1; -; mRNA.
DR   CCDS; CCDS5716.1; -.
DR   RefSeq; NP_006340.1; NM_006349.2.
DR   AlphaFoldDB; O43257; -.
DR   BioGRID; 115730; 59.
DR   ComplexPortal; CPX-974; SRCAP chromatin remodeling complex.
DR   CORUM; O43257; -.
DR   IntAct; O43257; 50.
DR   MINT; O43257; -.
DR   STRING; 9606.ENSP00000304593; -.
DR   iPTMnet; O43257; -.
DR   PhosphoSitePlus; O43257; -.
DR   BioMuta; ZNHIT1; -.
DR   EPD; O43257; -.
DR   jPOST; O43257; -.
DR   MassIVE; O43257; -.
DR   MaxQB; O43257; -.
DR   PaxDb; O43257; -.
DR   PeptideAtlas; O43257; -.
DR   ProteomicsDB; 48839; -.
DR   Antibodypedia; 16743; 135 antibodies from 28 providers.
DR   DNASU; 10467; -.
DR   Ensembl; ENST00000305105.3; ENSP00000304593.2; ENSG00000106400.12.
DR   GeneID; 10467; -.
DR   KEGG; hsa:10467; -.
DR   MANE-Select; ENST00000305105.3; ENSP00000304593.2; NM_006349.3; NP_006340.1.
DR   UCSC; uc003uye.4; human.
DR   AGR; HGNC:21688; -.
DR   CTD; 10467; -.
DR   DisGeNET; 10467; -.
DR   GeneCards; ZNHIT1; -.
DR   HGNC; HGNC:21688; ZNHIT1.
DR   HPA; ENSG00000106400; Low tissue specificity.
DR   MIM; 618617; gene.
DR   neXtProt; NX_O43257; -.
DR   OpenTargets; ENSG00000106400; -.
DR   PharmGKB; PA134947251; -.
DR   VEuPathDB; HostDB:ENSG00000106400; -.
DR   eggNOG; KOG3362; Eukaryota.
DR   GeneTree; ENSGT00390000018426; -.
DR   HOGENOM; CLU_106918_2_1_1; -.
DR   InParanoid; O43257; -.
DR   OMA; PCGARYC; -.
DR   OrthoDB; 2029831at2759; -.
DR   PhylomeDB; O43257; -.
DR   TreeFam; TF314330; -.
DR   PathwayCommons; O43257; -.
DR   SignaLink; O43257; -.
DR   SIGNOR; O43257; -.
DR   BioGRID-ORCS; 10467; 171 hits in 1175 CRISPR screens.
DR   ChiTaRS; ZNHIT1; human.
DR   GenomeRNAi; 10467; -.
DR   Pharos; O43257; Tbio.
DR   PRO; PR:O43257; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; O43257; protein.
DR   Bgee; ENSG00000106400; Expressed in right lobe of liver and 199 other tissues.
DR   Genevisible; O43257; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000812; C:Swr1 complex; IBA:GO_Central.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:InterPro.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031491; F:nucleosome binding; IBA:GO_Central.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0003015; P:heart process; ISS:UniProtKB.
DR   GO; GO:0036335; P:intestinal stem cell homeostasis; ISS:UniProtKB.
DR   GO; GO:0042692; P:muscle cell differentiation; IMP:UniProtKB.
DR   GO; GO:1902164; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB.
DR   GO; GO:1905458; P:positive regulation of lymphoid progenitor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060261; P:positive regulation of transcription initiation by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:ComplexPortal.
DR   Gene3D; 3.30.60.190; -; 1.
DR   InterPro; IPR039723; Vps71/ZNHIT1.
DR   InterPro; IPR007529; Znf_HIT.
DR   PANTHER; PTHR13093; ZINC FINGER HIT DOMAIN CONTAINING PROTEIN 1; 1.
DR   PANTHER; PTHR13093:SF0; ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF04438; zf-HIT; 1.
DR   SUPFAM; SSF144232; HIT/MYND zinc finger-like; 1.
DR   PROSITE; PS51083; ZF_HIT; 1.
PE   1: Evidence at protein level;
KW   Chromatin regulator; Coiled coil; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..154
FT                   /note="Zinc finger HIT domain-containing protein 1"
FT                   /id="PRO_0000173546"
FT   ZN_FING         117..149
FT                   /note="HIT-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   REGION          1..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          72..110
FT                   /note="Interaction with NR1D2"
FT                   /evidence="ECO:0000269|PubMed:17892483"
FT   COILED          23..39
FT                   /evidence="ECO:0000255"
FT   MOTIF           38..47
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:17892483"
FT   COMPBIAS        1..40
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         117
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         120
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         128
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         131
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         136
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         140
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         144
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         149
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   MOD_RES         103
FT                   /note="Phosphothreonine; by MAPK11 and MAPK14"
FT                   /evidence="ECO:0000269|PubMed:17380123"
FT   VARIANT         134
FT                   /note="R -> W (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs369664812)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035719"
FT   MUTAGEN         103
FT                   /note="T->A: Impairs the p38 MAPK-mediated phosphorylation
FT                   of ZNHIT1."
FT                   /evidence="ECO:0000269|PubMed:17380123"
FT   MUTAGEN         124
FT                   /note="S->A: No change in the in vitro
FT                   MAPK14/MAPK11-induced phosphorylation level of ZNHIT1."
SQ   SEQUENCE   154 AA;  17536 MW;  6A45F05249DC07A6 CRC64;
     MVEKKTSVRS QDPGQRRVLD RAARQRRINR QLEALENDNF QDDPHAGLPQ LGKRLPQFDD
     DADTGKKKKK TRGDHFKLRF RKNFQALLEE QNLSVAEGPN YLTACAGPPS RPQRPFCAVC
     GFPSPYTCVS CGARYCTVRC LGTHQETRCL KWTV
//
ID   RU1C_HUMAN              Reviewed;         159 AA.
AC   P09234; Q5TAL3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   22-FEB-2023, entry version 199.
DE   RecName: Full=U1 small nuclear ribonucleoprotein C {ECO:0000255|HAMAP-Rule:MF_03153};
DE            Short=U1 snRNP C {ECO:0000255|HAMAP-Rule:MF_03153};
DE            Short=U1-C {ECO:0000255|HAMAP-Rule:MF_03153};
DE            Short=U1C {ECO:0000255|HAMAP-Rule:MF_03153};
GN   Name=SNRPC {ECO:0000255|HAMAP-Rule:MF_03153};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2971157; DOI=10.1093/nar/16.17.8307;
RA   Sillekens P.T.G., Beijer R.P., Habets W.J., van Venrooij W.J.;
RT   "Human U1 snRNP-specific C protein: complete cDNA and protein sequence and
RT   identification of a multigene family in mammals.";
RL   Nucleic Acids Res. 16:8307-8321(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-131.
RX   PubMed=2961811;
RA   Yamamoto K., Miura H., Moroi Y., Yoshinoya S., Goto M., Nishioka K.,
RA   Miyamoto T.;
RT   "Isolation and characterization of a complementary DNA expressing human U1
RT   small nuclear ribonucleoprotein C polypeptide.";
RL   J. Immunol. 140:311-317(1988).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=2136774; DOI=10.1126/science.2136774;
RA   Heinrichs V., Bach M., Winkelmann G., Luehrmann R.;
RT   "U1-specific protein C needed for efficient complex formation of U1 snRNP
RT   with a 5' splice site.";
RL   Science 247:69-72(1990).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF CYS-6; CYS-9; HIS-24; CYS-25 AND HIS-30.
RX   PubMed=1826349; DOI=10.1093/nar/19.3.449;
RA   Nelissen R.L.H., Heinrichs V., Habets W.J., Simons F., Luehrmann R.,
RA   van Venrooij W.J.;
RT   "Zinc finger-like structure in U1-specific protein C is essential for
RT   specific binding to U1 snRNP.";
RL   Nucleic Acids Res. 19:449-454(1991).
RN   [6]
RP   FUNCTION.
RX   PubMed=8798632; DOI=10.1074/jbc.271.39.23985;
RA   Rossi F., Forne T., Antoine E., Tazi J., Brunel C., Cathala G.;
RT   "Involvement of U1 small nuclear ribonucleoproteins (snRNP) in 5' splice
RT   site-U1 snRNP interaction.";
RL   J. Biol. Chem. 271:23985-23991(1996).
RN   [7]
RP   INTERACTION WITH TIA1.
RX   PubMed=12486009; DOI=10.1093/emboj/cdf668;
RA   Foerch P., Puig O., Martinez C., Seraphin B., Valcarcel J.;
RT   "The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP
RT   recruitment to 5' splice sites.";
RL   EMBO J. 21:6882-6892(2002).
RN   [8]
RP   IDENTIFICATION IN THE U1 SNRNP COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15525645; DOI=10.1074/jbc.m409587200;
RA   Hochleitner E.O., Kastner B., Froehlich T., Schmidt A., Luehrmann R.,
RA   Arnold G., Lottspeich F.;
RT   "Protein stoichiometry of a multiprotein complex, the human spliceosomal U1
RT   small nuclear ribonucleoprotein: absolute quantification using isotope-
RT   coded tags and mass spectrometry.";
RL   J. Biol. Chem. 280:2536-2542(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-8, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 1-61, SUBUNIT, AND DOMAIN ZINC-FINGER.
RX   PubMed=15312772; DOI=10.1016/j.jmb.2004.04.078;
RA   Muto Y., Pomeranz Krummel D., Oubridge C., Hernandez H., Robinson C.V.,
RA   Neuhaus D., Nagai K.;
RT   "The structure and biochemical properties of the human spliceosomal protein
RT   U1C.";
RL   J. Mol. Biol. 341:185-198(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (5.49 ANGSTROMS) OF 1-77 IN SPLICEOSOMAL U1 SNRNP,
RP   SUBUNIT, AND FUNCTION.
RX   PubMed=19325628; DOI=10.1038/nature07851;
RA   Pomeranz Krummel D.A., Oubridge C., Leung A.K., Li J., Nagai K.;
RT   "Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution.";
RL   Nature 458:475-480(2009).
RN   [18] {ECO:0007744|PDB:4PJO}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 1-61 IN COMPLEX WITH ZINC, AND
RP   SUBUNIT.
RX   PubMed=25555158; DOI=10.7554/elife.04986;
RA   Kondo Y., Oubridge C., van Roon A.M., Nagai K.;
RT   "Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein
RT   particle, reveals the mechanism of 5' splice site recognition.";
RL   Elife 4:0-0(2015).
CC   -!- FUNCTION: Component of the spliceosomal U1 snRNP, which is essential
CC       for recognition of the pre-mRNA 5' splice-site and the subsequent
CC       assembly of the spliceosome. SNRPC/U1-C is directly involved in initial
CC       5' splice-site recognition for both constitutive and regulated
CC       alternative splicing. The interaction with the 5' splice-site seems to
CC       precede base-pairing between the pre-mRNA and the U1 snRNA. Stimulates
CC       commitment or early (E) complex formation by stabilizing the base
CC       pairing of the 5' end of the U1 snRNA and the 5' splice-site region.
CC       {ECO:0000255|HAMAP-Rule:MF_03153, ECO:0000269|PubMed:1826349,
CC       ECO:0000269|PubMed:19325628, ECO:0000269|PubMed:2136774,
CC       ECO:0000269|PubMed:8798632}.
CC   -!- SUBUNIT: Component of the U1 snRNP (PubMed:2136774). The U1 snRNP is
CC       composed of the U1 snRNA and the 7 core Sm proteins SNRPB, SNRPD1,
CC       SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric
CC       protein ring on the Sm site of the small nuclear RNA to form the core
CC       snRNP, and at least 3 U1 snRNP-specific proteins SNRNP70/U1-70K,
CC       SNRPA/U1-A and SNRPC/U1-C. SNRPC/U1-C interacts with U1 snRNA and the
CC       5' splice-site region of the pre-mRNA. Interacts (via N-terminus) with
CC       TIA1 (via C-terminus); thereby promoting spliceosomal U1 snRNP
CC       recruitment to 5' splice sites (PubMed:12486009). {ECO:0000255|HAMAP-
CC       Rule:MF_03153, ECO:0000269|PubMed:12486009,
CC       ECO:0000269|PubMed:15312772, ECO:0000269|PubMed:15525645,
CC       ECO:0000269|PubMed:19325628, ECO:0000269|PubMed:2136774,
CC       ECO:0000269|PubMed:25555158}.
CC   -!- INTERACTION:
CC       P09234; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-766589, EBI-357530;
CC       P09234; Q9NXR5-2: ANKRD10; NbExp=3; IntAct=EBI-766589, EBI-12102070;
CC       P09234; Q9BRR9: ARHGAP9; NbExp=3; IntAct=EBI-766589, EBI-750254;
CC       P09234; O95429: BAG4; NbExp=3; IntAct=EBI-766589, EBI-2949658;
CC       P09234; O75934: BCAS2; NbExp=3; IntAct=EBI-766589, EBI-1050106;
CC       P09234; Q8N9W6-4: BOLL; NbExp=3; IntAct=EBI-766589, EBI-11983447;
CC       P09234; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-766589, EBI-11976299;
CC       P09234; Q03060-25: CREM; NbExp=3; IntAct=EBI-766589, EBI-12884642;
CC       P09234; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-766589, EBI-3867333;
CC       P09234; Q15038: DAZAP2; NbExp=3; IntAct=EBI-766589, EBI-724310;
CC       P09234; Q16610: ECM1; NbExp=3; IntAct=EBI-766589, EBI-947964;
CC       P09234; Q96B26: EXOSC8; NbExp=3; IntAct=EBI-766589, EBI-371922;
CC       P09234; O00167-2: EYA2; NbExp=3; IntAct=EBI-766589, EBI-12807776;
CC       P09234; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-766589, EBI-12193763;
CC       P09234; Q13643: FHL3; NbExp=3; IntAct=EBI-766589, EBI-741101;
CC       P09234; Q96AE4-2: FUBP1; NbExp=3; IntAct=EBI-766589, EBI-12121668;
CC       P09234; O75420: GIGYF1; NbExp=3; IntAct=EBI-766589, EBI-947774;
CC       P09234; O14979: HNRNPDL; NbExp=3; IntAct=EBI-766589, EBI-299727;
CC       P09234; P31943: HNRNPH1; NbExp=3; IntAct=EBI-766589, EBI-351590;
CC       P09234; P49639: HOXA1; NbExp=5; IntAct=EBI-766589, EBI-740785;
CC       P09234; Q9BPX1: HSD17B14; NbExp=3; IntAct=EBI-766589, EBI-742664;
CC       P09234; Q5TA45: INTS11; NbExp=3; IntAct=EBI-766589, EBI-748258;
CC       P09234; P0C870: JMJD7; NbExp=5; IntAct=EBI-766589, EBI-9090173;
CC       P09234; Q13351: KLF1; NbExp=3; IntAct=EBI-766589, EBI-8284732;
CC       P09234; Q8IUC1: KRTAP11-1; NbExp=3; IntAct=EBI-766589, EBI-1052037;
CC       P09234; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-766589, EBI-11953846;
CC       P09234; Q3LHN2: KRTAP19-2; NbExp=3; IntAct=EBI-766589, EBI-12196745;
CC       P09234; Q3LI72: KRTAP19-5; NbExp=3; IntAct=EBI-766589, EBI-1048945;
CC       P09234; Q3LI70: KRTAP19-6; NbExp=3; IntAct=EBI-766589, EBI-12805508;
CC       P09234; Q3LI59: KRTAP21-2; NbExp=3; IntAct=EBI-766589, EBI-18395721;
CC       P09234; Q3LI66: KRTAP6-2; NbExp=5; IntAct=EBI-766589, EBI-11962084;
CC       P09234; Q8IUC3: KRTAP7-1; NbExp=3; IntAct=EBI-766589, EBI-18394498;
CC       P09234; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-766589, EBI-10261141;
CC       P09234; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-766589, EBI-716006;
CC       P09234; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-766589, EBI-8487781;
CC       P09234; Q13064: MKRN3; NbExp=3; IntAct=EBI-766589, EBI-2340269;
CC       P09234; Q9NZQ3-3: NCKIPSD; NbExp=3; IntAct=EBI-766589, EBI-10963850;
CC       P09234; A1E959: ODAM; NbExp=3; IntAct=EBI-766589, EBI-5774125;
CC       P09234; O15496: PLA2G10; NbExp=3; IntAct=EBI-766589, EBI-726466;
CC       P09234; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-766589, EBI-3957793;
CC       P09234; P86480: PRR20D; NbExp=3; IntAct=EBI-766589, EBI-12754095;
CC       P09234; Q9BTL3: RAMAC; NbExp=3; IntAct=EBI-766589, EBI-744023;
CC       P09234; P98175: RBM10; NbExp=2; IntAct=EBI-766589, EBI-721525;
CC       P09234; Q93062-3: RBPMS; NbExp=3; IntAct=EBI-766589, EBI-740343;
CC       P09234; Q9P2R6: RERE; NbExp=3; IntAct=EBI-766589, EBI-948076;
CC       P09234; Q01196-8: RUNX1; NbExp=3; IntAct=EBI-766589, EBI-12001422;
CC       P09234; Q15437: SEC23B; NbExp=3; IntAct=EBI-766589, EBI-742673;
CC       P09234; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-766589, EBI-11959123;
CC       P09234; Q8IWL8: STH; NbExp=3; IntAct=EBI-766589, EBI-12843506;
CC       P09234; P31483: TIA1; NbExp=6; IntAct=EBI-766589, EBI-1387216;
CC       P09234; Q08117-2: TLE5; NbExp=3; IntAct=EBI-766589, EBI-11741437;
CC       P09234; Q96RU7: TRIB3; NbExp=3; IntAct=EBI-766589, EBI-492476;
CC       P09234; Q6NVU6: UFSP1; NbExp=3; IntAct=EBI-766589, EBI-12068150;
CC       P09234; Q9BRX9: WDR83; NbExp=2; IntAct=EBI-766589, EBI-7705033;
CC       P09234; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-766589, EBI-12040603;
CC       P09234; O00308: WWP2; NbExp=3; IntAct=EBI-766589, EBI-743923;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03153,
CC       ECO:0000269|PubMed:2136774}.
CC   -!- SIMILARITY: Belongs to the U1 small nuclear ribonucleoprotein C family.
CC       {ECO:0000255|HAMAP-Rule:MF_03153}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X12517; CAA31037.1; -; mRNA.
DR   EMBL; AL139100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M18465; AAA36618.1; -; mRNA.
DR   CCDS; CCDS34436.1; -.
DR   PIR; S01387; S01387.
DR   RefSeq; NP_003084.1; NM_003093.2.
DR   PDB; 2VRD; NMR; -; A=1-61.
DR   PDB; 3CW1; X-ray; 5.49 A; 0/9/L/l=1-77.
DR   PDB; 4PJO; X-ray; 3.30 A; L/M/l/m=1-61.
DR   PDB; 6ELD; X-ray; 2.48 A; A=30-61.
DR   PDB; 6QX9; EM; 3.28 A; 1C=1-159.
DR   PDBsum; 2VRD; -.
DR   PDBsum; 3CW1; -.
DR   PDBsum; 4PJO; -.
DR   PDBsum; 6ELD; -.
DR   PDBsum; 6QX9; -.
DR   AlphaFoldDB; P09234; -.
DR   SMR; P09234; -.
DR   BioGRID; 112515; 409.
DR   ComplexPortal; CPX-2392; U1 small nuclear ribonucleoprotein complex.
DR   CORUM; P09234; -.
DR   DIP; DIP-34235N; -.
DR   IntAct; P09234; 113.
DR   MINT; P09234; -.
DR   STRING; 9606.ENSP00000244520; -.
DR   GlyGen; P09234; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P09234; -.
DR   PhosphoSitePlus; P09234; -.
DR   SwissPalm; P09234; -.
DR   BioMuta; SNRPC; -.
DR   DMDM; 134093; -.
DR   CPTAC; CPTAC-947; -.
DR   EPD; P09234; -.
DR   jPOST; P09234; -.
DR   MassIVE; P09234; -.
DR   PaxDb; P09234; -.
DR   PeptideAtlas; P09234; -.
DR   ProteomicsDB; 52209; -.
DR   Antibodypedia; 45711; 72 antibodies from 21 providers.
DR   DNASU; 6631; -.
DR   Ensembl; ENST00000244520.10; ENSP00000244520.5; ENSG00000124562.10.
DR   GeneID; 6631; -.
DR   KEGG; hsa:6631; -.
DR   MANE-Select; ENST00000244520.10; ENSP00000244520.5; NM_003093.3; NP_003084.1.
DR   AGR; HGNC:11157; -.
DR   CTD; 6631; -.
DR   DisGeNET; 6631; -.
DR   GeneCards; SNRPC; -.
DR   HGNC; HGNC:11157; SNRPC.
DR   HPA; ENSG00000124562; Low tissue specificity.
DR   MIM; 603522; gene.
DR   neXtProt; NX_P09234; -.
DR   OpenTargets; ENSG00000124562; -.
DR   PharmGKB; PA35998; -.
DR   VEuPathDB; HostDB:ENSG00000124562; -.
DR   eggNOG; KOG3454; Eukaryota.
DR   GeneTree; ENSGT00730000110997; -.
DR   HOGENOM; CLU_079697_3_0_1; -.
DR   InParanoid; P09234; -.
DR   OMA; FLTHDST; -.
DR   OrthoDB; 5490378at2759; -.
DR   TreeFam; TF313578; -.
DR   PathwayCommons; P09234; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SignaLink; P09234; -.
DR   SIGNOR; P09234; -.
DR   BioGRID-ORCS; 6631; 590 hits in 1161 CRISPR screens.
DR   ChiTaRS; SNRPC; human.
DR   EvolutionaryTrace; P09234; -.
DR   GeneWiki; Small_nuclear_ribonucleoprotein_polypeptide_C; -.
DR   GenomeRNAi; 6631; -.
DR   Pharos; P09234; Tbio.
DR   PRO; PR:P09234; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P09234; protein.
DR   Bgee; ENSG00000124562; Expressed in apex of heart and 208 other tissues.
DR   ExpressionAtlas; P09234; baseline and differential.
DR   Genevisible; P09234; HS.
DR   GO; GO:0015030; C:Cajal body; IDA:UniProtKB.
DR   GO; GO:0000243; C:commitment complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:ComplexPortal.
DR   GO; GO:0005681; C:spliceosomal complex; IPI:ComplexPortal.
DR   GO; GO:0005685; C:U1 snRNP; IDA:UniProtKB.
DR   GO; GO:0071004; C:U2-type prespliceosome; IEA:UniProtKB-UniRule.
DR   GO; GO:0003729; F:mRNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0030627; F:pre-mRNA 5'-splice site binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0000395; P:mRNA 5'-splice site recognition; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   HAMAP; MF_03153; U1_C; 1.
DR   IDEAL; IID00139; -.
DR   InterPro; IPR000690; Matrin/U1-C_Znf_C2H2.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR013085; U1-CZ_Znf_C2H2.
DR   InterPro; IPR017340; U1_snRNP-C.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   PANTHER; PTHR31148; U1 SMALL NUCLEAR RIBONUCLEOPROTEIN C; 1.
DR   PANTHER; PTHR31148:SF1; U1 SMALL NUCLEAR RIBONUCLEOPROTEIN C; 1.
DR   Pfam; PF06220; zf-U1; 1.
DR   PIRSF; PIRSF037969; U1_snRNP-C; 1.
DR   SMART; SM00451; ZnF_U1; 1.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
DR   PROSITE; PS50171; ZF_MATRIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..159
FT                   /note="U1 small nuclear ribonucleoprotein C"
FT                   /id="PRO_0000097525"
FT   ZN_FING         4..36
FT                   /note="Matrin-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03153"
FT   REGION          62..96
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..159
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        64..96
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         8
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MUTAGEN         6
FT                   /note="C->S: Abolishes the binding to U1 snRNP."
FT                   /evidence="ECO:0000269|PubMed:1826349"
FT   MUTAGEN         9
FT                   /note="C->S: Abolishes the binding to U1 snRNP."
FT                   /evidence="ECO:0000269|PubMed:1826349"
FT   MUTAGEN         24
FT                   /note="H->Q: Abolishes the binding to U1 snRNP."
FT                   /evidence="ECO:0000269|PubMed:1826349"
FT   MUTAGEN         25
FT                   /note="C->S: No effect."
FT                   /evidence="ECO:0000269|PubMed:1826349"
FT   MUTAGEN         30
FT                   /note="H->Q: Abolishes the binding to U1 snRNP."
FT                   /evidence="ECO:0000269|PubMed:1826349"
FT   CONFLICT        25..27
FT                   /note="CSG -> RSR (in Ref. 3; AAA36618)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94..98
FT                   /note="APHMG -> TPIW (in Ref. 3; AAA36618)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="P -> S (in Ref. 3; AAA36618)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129..131
FT                   /note="HMP -> ICQ (in Ref. 3; AAA36618)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..6
FT                   /evidence="ECO:0007829|PDB:4PJO"
FT   TURN            7..10
FT                   /evidence="ECO:0007829|PDB:4PJO"
FT   STRAND          11..15
FT                   /evidence="ECO:0007829|PDB:4PJO"
FT   HELIX           18..25
FT                   /evidence="ECO:0007829|PDB:4PJO"
FT   HELIX           36..58
FT                   /evidence="ECO:0007829|PDB:6ELD"
SQ   SEQUENCE   159 AA;  17394 MW;  EC313A57DEC79D95 CRC64;
     MPKFYCDYCD TYLTHDSPSV RKTHCSGRKH KENVKDYYQK WMEEQAQSLI DKTTAAFQQG
     KIPPTPFSAP PPAGAMIPPP PSLPGPPRPG MMPAPHMGGP PMMPMMGPPP PGMMPVGPAP
     GMRPPMGGHM PMMPGPPMMR PPARPMMVPT RPGMTRPDR
//
ID   RPB9_HUMAN              Reviewed;         125 AA.
AC   P36954; B2R5J2; Q6NW05;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   22-FEB-2023, entry version 207.
DE   RecName: Full=DNA-directed RNA polymerase II subunit RPB9;
DE            Short=RNA polymerase II subunit B9;
DE   AltName: Full=DNA-directed RNA polymerase II subunit I;
DE   AltName: Full=RNA polymerase II 14.5 kDa subunit;
DE            Short=RPB14.5;
GN   Name=POLR2I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8265347; DOI=10.1093/nar/21.23.5345;
RA   Acker J., Wintzerith M., Vigneron M., Kedinger C.;
RT   "Structure of the gene encoding the 14.5 kDa subunit of human RNA
RT   polymerase II.";
RL   Nucleic Acids Res. 21:5345-5350(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, IDENTIFICATION IN THE RNA POLYMERASE II CORE-COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9852112; DOI=10.1074/jbc.273.51.34444;
RA   Kershnar E., Wu S.-Y., Chiang C.-M.;
RT   "Immunoaffinity purification and functional characterization of human
RT   transcription factor IIH and RNA polymerase II from clonal cell lines that
RT   conditionally express epitope-tagged subunits of the multiprotein
RT   complexes.";
RL   J. Biol. Chem. 273:34444-34453(1998).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of
CC       DNA into RNA using the four ribonucleoside triphosphates as substrates.
CC       Component of RNA polymerase II which synthesizes mRNA precursors and
CC       many functional non-coding RNAs. Pol II is the central component of the
CC       basal RNA polymerase II transcription machinery. It is composed of
CC       mobile elements that move relative to each other. RPB9 is part of the
CC       upper jaw surrounding the central large cleft and thought to grab the
CC       incoming DNA template (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:9852112}.
CC   -!- SUBUNIT: Component of the RNA polymerase II (Pol II) complex consisting
CC       of 12 subunits. {ECO:0000269|PubMed:9852112}.
CC   -!- INTERACTION:
CC       P36954; P55212: CASP6; NbExp=3; IntAct=EBI-395202, EBI-718729;
CC       P36954; P30519: HMOX2; NbExp=3; IntAct=EBI-395202, EBI-712096;
CC       P36954; P13473-2: LAMP2; NbExp=3; IntAct=EBI-395202, EBI-21591415;
CC       P36954; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-395202, EBI-5280197;
CC       P36954; P62826: RAN; NbExp=3; IntAct=EBI-395202, EBI-286642;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:9852112}.
CC   -!- SIMILARITY: Belongs to the archaeal RpoM/eukaryotic RPA12/RPB9/RPC11
CC       RNA polymerase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z23102; CAA80649.1; -; Genomic_DNA.
DR   EMBL; AK312206; BAG35139.1; -; mRNA.
DR   EMBL; AD001527; AAB51181.1; -; Genomic_DNA.
DR   EMBL; BC017112; AAH17112.1; -; mRNA.
DR   EMBL; BC067794; AAH67794.1; -; mRNA.
DR   CCDS; CCDS12487.1; -.
DR   PIR; S41621; S41621.
DR   RefSeq; NP_006224.1; NM_006233.4.
DR   PDB; 5IY6; EM; 7.20 A; I=1-125.
DR   PDB; 5IY7; EM; 8.60 A; I=1-125.
DR   PDB; 5IY8; EM; 7.90 A; I=1-125.
DR   PDB; 5IY9; EM; 6.30 A; I=1-125.
DR   PDB; 5IYA; EM; 5.40 A; I=1-125.
DR   PDB; 5IYB; EM; 3.90 A; I=1-125.
DR   PDB; 5IYC; EM; 3.90 A; I=1-125.
DR   PDB; 5IYD; EM; 3.90 A; I=1-125.
DR   PDB; 6DRD; EM; 3.90 A; I=1-125.
DR   PDB; 6O9L; EM; 7.20 A; I=1-125.
DR   PDB; 6XRE; EM; 4.60 A; I=1-125.
DR   PDB; 7LBM; EM; 4.80 A; I=1-125.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IY9; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   PDBsum; 5IYD; -.
DR   PDBsum; 6DRD; -.
DR   PDBsum; 6O9L; -.
DR   PDBsum; 6XRE; -.
DR   PDBsum; 7LBM; -.
DR   AlphaFoldDB; P36954; -.
DR   SMR; P36954; -.
DR   BioGRID; 111434; 132.
DR   CORUM; P36954; -.
DR   DIP; DIP-32917N; -.
DR   IntAct; P36954; 47.
DR   MINT; P36954; -.
DR   STRING; 9606.ENSP00000221859; -.
DR   iPTMnet; P36954; -.
DR   PhosphoSitePlus; P36954; -.
DR   BioMuta; POLR2I; -.
DR   DMDM; 548702; -.
DR   EPD; P36954; -.
DR   jPOST; P36954; -.
DR   MassIVE; P36954; -.
DR   MaxQB; P36954; -.
DR   PaxDb; P36954; -.
DR   PeptideAtlas; P36954; -.
DR   ProteomicsDB; 55242; -.
DR   Antibodypedia; 29696; 193 antibodies from 28 providers.
DR   DNASU; 5438; -.
DR   Ensembl; ENST00000221859.9; ENSP00000221859.3; ENSG00000105258.9.
DR   GeneID; 5438; -.
DR   KEGG; hsa:5438; -.
DR   MANE-Select; ENST00000221859.9; ENSP00000221859.3; NM_006233.5; NP_006224.1.
DR   UCSC; uc002ode.4; human.
DR   AGR; HGNC:9196; -.
DR   CTD; 5438; -.
DR   GeneCards; POLR2I; -.
DR   HGNC; HGNC:9196; POLR2I.
DR   HPA; ENSG00000105258; Low tissue specificity.
DR   MIM; 180662; gene.
DR   neXtProt; NX_P36954; -.
DR   OpenTargets; ENSG00000105258; -.
DR   PharmGKB; PA33516; -.
DR   VEuPathDB; HostDB:ENSG00000105258; -.
DR   eggNOG; KOG2691; Eukaryota.
DR   GeneTree; ENSGT00550000075063; -.
DR   HOGENOM; CLU_093932_0_1_1; -.
DR   InParanoid; P36954; -.
DR   OMA; CRDCNNM; -.
DR   OrthoDB; 19808at2759; -.
DR   PhylomeDB; P36954; -.
DR   TreeFam; TF103032; -.
DR   PathwayCommons; P36954; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-167161; HIV Transcription Initiation.
DR   Reactome; R-HSA-167162; RNA Polymerase II HIV Promoter Escape.
DR   Reactome; R-HSA-167172; Transcription of the HIV genome.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-HSA-73776; RNA Polymerase II Promoter Escape.
DR   Reactome; R-HSA-73779; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening.
DR   Reactome; R-HSA-75953; RNA Polymerase II Transcription Initiation.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   Reactome; R-HSA-76042; RNA Polymerase II Transcription Initiation And Promoter Clearance.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   Reactome; R-HSA-8851708; Signaling by FGFR2 IIIa TM.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9670095; Inhibition of DNA recombination at telomere.
DR   SignaLink; P36954; -.
DR   SIGNOR; P36954; -.
DR   BioGRID-ORCS; 5438; 831 hits in 1172 CRISPR screens.
DR   ChiTaRS; POLR2I; human.
DR   GeneWiki; POLR2I; -.
DR   GenomeRNAi; 5438; -.
DR   Pharos; P36954; Tbio.
DR   PRO; PR:P36954; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P36954; protein.
DR   Bgee; ENSG00000105258; Expressed in left testis and 203 other tissues.
DR   ExpressionAtlas; P36954; baseline and differential.
DR   Genevisible; P36954; HS.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005665; C:RNA polymerase II, core complex; IDA:UniProtKB.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0001193; P:maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006379; P:mRNA cleavage; IEA:InterPro.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006367; P:transcription initiation at RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; IBA:GO_Central.
DR   CDD; cd10508; Zn-ribbon_RPB9; 1.
DR   Gene3D; 2.20.25.10; -; 2.
DR   InterPro; IPR019761; DNA-dir_RNA_pol-M_15_CS.
DR   InterPro; IPR001529; DNA-dir_RNA_pol_M/15kDasu.
DR   InterPro; IPR012164; Rpa12/Rpb9/Rpc10/TFS.
DR   InterPro; IPR034012; Zn_ribbon_RPB9_C.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   PANTHER; PTHR11239; DNA-DIRECTED RNA POLYMERASE; 1.
DR   PANTHER; PTHR11239:SF1; DNA-DIRECTED RNA POLYMERASE II SUBUNIT RPB9; 1.
DR   Pfam; PF02150; RNA_POL_M_15KD; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   PIRSF; PIRSF005586; RNApol_RpoM; 1.
DR   SMART; SM00661; RPOL9; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF57783; Zinc beta-ribbon; 2.
DR   PROSITE; PS01030; RNA_POL_M_15KD; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; DNA-directed RNA polymerase; Metal-binding;
KW   Nucleus; Reference proteome; Transcription; Zinc; Zinc-finger.
FT   CHAIN           1..125
FT                   /note="DNA-directed RNA polymerase II subunit RPB9"
FT                   /id="PRO_0000121467"
FT   ZN_FING         17..42
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         82..124
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         17
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P27999"
FT   BINDING         20
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P27999"
FT   BINDING         39
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P27999"
FT   BINDING         42
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P27999"
FT   BINDING         86
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         89
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         114
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         119
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
SQ   SEQUENCE   125 AA;  14523 MW;  6520687BB57EE018 CRC64;
     MEPDGTYEPG FVGIRFCQEC NNMLYPKEDK ENRILLYACR NCDYQQEADN SCIYVNKITH
     EVDELTQIIA DVSQDPTLPR TEDHPCQKCG HKEAVFFQSH SARAEDAMRL YYVCTAPHCG
     HRWTE
//
ID   CDN1A_HUMAN             Reviewed;         164 AA.
AC   P38936; Q14010; Q6FI05; Q9BUT4;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-FEB-2023, entry version 239.
DE   RecName: Full=Cyclin-dependent kinase inhibitor 1;
DE   AltName: Full=CDK-interacting protein 1;
DE   AltName: Full=Melanoma differentiation-associated protein 6;
DE            Short=MDA-6;
DE   AltName: Full=p21;
GN   Name=CDKN1A; Synonyms=CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INDUCTION.
RX   PubMed=8242751; DOI=10.1016/0092-8674(93)90499-g;
RA   Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J.;
RT   "The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-
RT   dependent kinases.";
RL   Cell 75:805-816(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=8242752; DOI=10.1016/0092-8674(93)90500-p;
RA   El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R.,
RA   Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B.;
RT   "WAF1, a potential mediator of p53 tumor suppression.";
RL   Cell 75:817-825(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8259214; DOI=10.1038/366701a0;
RA   Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D.;
RT   "p21 is a universal inhibitor of cyclin kinases.";
RL   Nature 366:701-704(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jiang H., Fisher P.B.;
RT   "Use of a sensitive and efficient subtraction hybridization protocol for
RT   the identification of genes differentially regulated during the induction
RT   of differentiation in human melanoma cells.";
RL   Mol. Cell. Differ. 1:285-299(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7753561;
RA   Jiang H., Lin J., Su Z.Z., Herlyn M., Kerbel R.S., Weissman B.E.,
RA   Welch D.R., Fisher P.B.;
RT   "The melanoma differentiation-associated gene mda-6, which encodes the
RT   cyclin-dependent kinase inhibitor p21, is differentially expressed during
RT   growth, differentiation and progression in human melanoma cells.";
RL   Oncogene 10:1855-1864(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8125163; DOI=10.1006/excr.1994.1063;
RA   Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R.;
RT   "Cloning of senescent cell-derived inhibitors of DNA synthesis using an
RT   expression screen.";
RL   Exp. Cell Res. 211:90-98(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-31.
RX   PubMed=7655464; DOI=10.1093/hmg/4.6.1089;
RA   Mousses S., Oezcelik H., Lee P.D., Malkin D., Bull S.B., Andrulis I.L.;
RT   "Two variants of the CIP1/WAF1 gene occur together and are associated with
RT   human cancer.";
RL   Hum. Mol. Genet. 4:1089-1092(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-31.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-31.
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 2-16, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15574338; DOI=10.1016/j.molcel.2004.11.011;
RA   Chen X., Chi Y., Bloecher A., Aebersold R., Clurman B.E., Roberts J.M.;
RT   "N-acetylation and ubiquitin-independent proteasomal degradation of
RT   p21(Cip1).";
RL   Mol. Cell 16:839-847(2004).
RN   [16]
RP   PROTEIN SEQUENCE OF 136-148, PHOSPHORYLATION AT THR-145; SER-146 AND
RP   SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10753973; DOI=10.1074/jbc.275.15.11529;
RA   Scott M.T., Morrice N., Ball K.L.;
RT   "Reversible phosphorylation at the C-terminal regulatory domain of
RT   p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.";
RL   J. Biol. Chem. 275:11529-11537(2000).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CDK4 AND CCND1 IN THE
RP   CYCLIN D-CDK4-CDKN1A COMPLEX.
RX   PubMed=9106657; DOI=10.1101/gad.11.7.847;
RA   LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C.,
RA   Chou H.S., Fattaey A., Harlow E.;
RT   "New functional activities for the p21 family of CDK inhibitors.";
RL   Genes Dev. 11:847-862(1997).
RN   [18]
RP   INTERACTION WITH PSMA3.
RX   PubMed=11350925; DOI=10.1093/emboj/20.10.2367;
RA   Touitou R., Richardson J., Bose S., Nakanishi M., Rivett J., Allday M.J.;
RT   "A degradation signal located in the C-terminus of p21WAF1/CIP1 is a
RT   binding site for the C8 alpha-subunit of the 20S proteasome.";
RL   EMBO J. 20:2367-2375(2001).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH PCNA.
RX   PubMed=11595739; DOI=10.1074/jbc.m106990200;
RA   Ducoux M., Urbach S., Baldacci G., Huebscher U., Koundrioukoff S.,
RA   Christensen J., Hughes P.;
RT   "Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA
RT   replication through a conserved p21(Cip1)-like PCNA-binding motif present
RT   in the third subunit of human DNA polymerase delta.";
RL   J. Biol. Chem. 276:49258-49266(2001).
RN   [20]
RP   PHOSPHORYLATION AT THR-145, MUTAGENESIS OF THR-145 AND SER-146, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11463845; DOI=10.1128/mcb.21.16.5644-5657.2001;
RA   Roessig L., Jadidi A.S., Urbich C., Badorff C., Zeiher A.M., Dimmeler S.;
RT   "Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and
RT   proliferation of endothelial cells.";
RL   Mol. Cell. Biol. 21:5644-5657(2001).
RN   [21]
RP   PHOSPHORYLATION AT THR-145 BY PIM1, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH PIM1.
RX   PubMed=12431783; DOI=10.1016/s0167-4889(02)00347-6;
RA   Wang Z., Bhattacharya N., Mixter P.F., Wei W., Sedivy J., Magnuson N.S.;
RT   "Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1
RT   kinase.";
RL   Biochim. Biophys. Acta 1593:45-55(2002).
RN   [22]
RP   UBIQUITINATION AT SER-2.
RX   PubMed=15226418; DOI=10.1128/mcb.24.14.6140-6150.2004;
RA   Coulombe P., Rodier G., Bonneil E., Thibault P., Meloche S.;
RT   "N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and
RT   p21 directs their degradation by the proteasome.";
RL   Mol. Cell. Biol. 24:6140-6150(2004).
RN   [23]
RP   PHOSPHORYLATION AT THR-145.
RX   PubMed=16982699; DOI=10.1128/mcb.00201-06;
RA   Heron-Milhavet L., Franckhauser C., Rana V., Berthenet C., Fisher D.,
RA   Hemmings B.A., Fernandez A., Lamb N.J.;
RT   "Only Akt1 is required for proliferation, while Akt2 promotes cell cycle
RT   exit through p21 binding.";
RL   Mol. Cell. Biol. 26:8267-8280(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [25]
RP   UBIQUITINATION, DOMAIN PIP-BOX K+4 MOTIF, INTERACTION WITH PCNA,
RP   MUTAGENESIS OF SER-114 AND 144-GLN--PHE-150, AND PHOSPHORYLATION AT
RP   SER-114.
RX   PubMed=18794347; DOI=10.1101/gad.1676108;
RA   Abbas T., Sivaprasad U., Terai K., Amador V., Pagano M., Dutta A.;
RT   "PCNA-dependent regulation of p21 ubiquitylation and degradation via the
RT   CRL4Cdt2 ubiquitin ligase complex.";
RL   Genes Dev. 22:2496-2506(2008).
RN   [26]
RP   UBIQUITINATION.
RX   PubMed=18794348; DOI=10.1101/gad.1703708;
RA   Kim Y., Starostina N.G., Kipreos E.T.;
RT   "The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to
RT   control replication licensing.";
RL   Genes Dev. 22:2507-2519(2008).
RN   [27]
RP   UBIQUITINATION, DOMAIN PIP-BOX K+4 MOTIF, MUTAGENESIS OF 147-MET--TYR-151
RP   AND 154-LYS--ARG-156, AND INTERACTION WITH PCNA.
RX   PubMed=18703516; DOI=10.1074/jbc.m806045200;
RA   Nishitani H., Shiomi Y., Iida H., Michishita M., Takami T., Tsurimoto T.;
RT   "CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-
RT   coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.";
RL   J. Biol. Chem. 283:29045-29052(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   REVIEW ON DNA REPAIR, AND INTERACTION WITH CDK2.
RX   PubMed=19445729; DOI=10.1186/1747-1028-4-9;
RA   Satyanarayana A., Kaldis P.;
RT   "A dual role of Cdk2 in DNA damage response.";
RL   Cell Div. 4:9-9(2009).
RN   [30]
RP   UBIQUITINATION, AND INTERACTION WITH MKRN1.
RX   PubMed=19536131; DOI=10.1038/emboj.2009.164;
RA   Lee E.-W., Lee M.-S., Camus S., Ghim J., Yang M.-R., Oh W., Ha N.-C.,
RA   Lane D.P., Song J.;
RT   "Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell
RT   cycle arrest and apoptosis.";
RL   EMBO J. 28:2100-2113(2009).
RN   [31]
RP   UBIQUITINATION.
RX   PubMed=19332548; DOI=10.1074/jbc.m808810200;
RA   Stuart S.A., Wang J.Y.;
RT   "Ionizing radiation induces ATM-independent degradation of p21Cip1 in
RT   transformed cells.";
RL   J. Biol. Chem. 284:15061-15070(2009).
RN   [32]
RP   PHOSPHORYLATION AT THR-145 BY PIM2.
RX   PubMed=20307683; DOI=10.1016/j.biocel.2010.03.012;
RA   Wang Z., Zhang Y., Gu J.J., Davitt C., Reeves R., Magnuson N.S.;
RT   "Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and
RT   inhibits cell proliferation in HCT116 cells.";
RL   Int. J. Biochem. Cell Biol. 42:1030-1038(2010).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [34]
RP   FUNCTION, INTERACTION WITH TRIM39 AND DTL, SUBCELLULAR LOCATION,
RP   UBIQUITINATION, PROTEASOMAL DEGRADATION, AND MUTAGENESIS OF LYS-154.
RX   PubMed=23213251; DOI=10.1073/pnas.1214156110;
RA   Zhang L., Mei Y., Fu N.Y., Guan L., Xie W., Liu H.H., Yu C.D., Yin Z.,
RA   Yu V.C., You H.;
RT   "TRIM39 regulates cell cycle progression and DNA damage responses via
RT   stabilizing p21.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:20937-20942(2012).
RN   [35]
RP   UBIQUITINATION BY RNF114.
RX   PubMed=23645206; DOI=10.1038/cdd.2013.33;
RA   Han J., Kim Y.L., Lee K.W., Her N.G., Ha T.K., Yoon S., Jeong S.I.,
RA   Lee J.H., Kang M.J., Lee M.G., Ryu B.K., Baik J.H., Chi S.G.;
RT   "ZNF313 is a novel cell cycle activator with an E3 ligase activity
RT   inhibiting cellular senescence by destabilizing p21(WAF1.).";
RL   Cell Death Differ. 20:1055-1067(2013).
RN   [36]
RP   FUNCTION, INTERACTION WITH STK11 AND NUAK1, PHOSPHORYLATION AT THR-80 AND
RP   SER-146, AND MUTAGENESIS OF THR-80 AND SER-146.
RX   PubMed=25329316; DOI=10.1371/journal.pgen.1004721;
RA   Esteve-Puig R., Gil R., Gonzalez-Sanchez E., Bech-Serra J.J., Grueso J.,
RA   Hernandez-Losa J., Moline T., Canals F., Ferrer B., Cortes J., Bastian B.,
RA   Cajal S.R.Y., Martin-Caballero J., Flores J.M., Vivancos A.,
RA   Garcia-Patos V., Recio J.A.;
RT   "A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating
RT   CDKN1A (p21WAF1/CIP1) degradation.";
RL   PLoS Genet. 10:E1004721-E1004721(2014).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 139-160 IN COMPLEX WITH PCNA.
RX   PubMed=8861913; DOI=10.1016/s0092-8674(00)81347-1;
RA   Gulbis J.M., Kelman Z., Hurwitz J., O'Donnell M., Kuriyan J.;
RT   "Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human
RT   PCNA.";
RL   Cell 87:297-306(1996).
CC   -!- FUNCTION: May be involved in p53/TP53 mediated inhibition of cellular
CC       proliferation in response to DNA damage. Binds to and inhibits cyclin-
CC       dependent kinase activity, preventing phosphorylation of critical
CC       cyclin-dependent kinase substrates and blocking cell cycle progression.
CC       Functions in the nuclear localization and assembly of cyclin D-CDK4
CC       complex and promotes its kinase activity towards RB1. At higher
CC       stoichiometric ratios, inhibits the kinase activity of the cyclin D-
CC       CDK4 complex. Inhibits DNA synthesis by DNA polymerase delta by
CC       competing with POLD3 for PCNA binding (PubMed:11595739). Plays an
CC       important role in controlling cell cycle progression and DNA damage-
CC       induced G2 arrest (PubMed:9106657). {ECO:0000269|PubMed:11595739,
CC       ECO:0000269|PubMed:8242751, ECO:0000269|PubMed:9106657}.
CC   -!- SUBUNIT: Interacts with HDAC1; the interaction is prevented by
CC       competitive binding of C10orf90/FATS to HDAC1 facilitating acetylation
CC       and protein stabilization of CDKN1A/p21 (By similarity). Interacts with
CC       MKRN1 (PubMed:19536131). Interacts with PSMA3 (PubMed:11350925).
CC       Interacts with PCNA (PubMed:11595739, PubMed:18794347, PubMed:18703516,
CC       PubMed:8861913). Component of the ternary complex, cyclin D-CDK4-
CC       CDKN1A. Interacts (via its N-terminal domain) with CDK4; the
CC       interaction promotes the assembly of the cyclin D-CDK4 complex, its
CC       nuclear translocation and promotes the cyclin D-dependent enzyme
CC       activity of CDK4 (PubMed:9106657). Binding to CDK2 leads to CDK2/cyclin
CC       E inactivation at the G1-S phase DNA damage checkpoint, thereby
CC       arresting cells at the G1-S transition during DNA repair
CC       (PubMed:19445729). Interacts with PIM1 (PubMed:12431783). Interacts
CC       with STK11 and NUAK1 (PubMed:25329316). Interacts wih DTL
CC       (PubMed:23213251). Interacts with isoform 1 and isoform 2 of TRIM39
CC       (PubMed:23213251). {ECO:0000250|UniProtKB:P39689,
CC       ECO:0000269|PubMed:11350925, ECO:0000269|PubMed:11595739,
CC       ECO:0000269|PubMed:12431783, ECO:0000269|PubMed:18703516,
CC       ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:19445729,
CC       ECO:0000269|PubMed:19536131, ECO:0000269|PubMed:23213251,
CC       ECO:0000269|PubMed:25329316, ECO:0000269|PubMed:8861913,
CC       ECO:0000269|PubMed:9106657}.
CC   -!- INTERACTION:
CC       P38936; P78396: CCNA1; NbExp=8; IntAct=EBI-375077, EBI-375065;
CC       P38936; P20248: CCNA2; NbExp=5; IntAct=EBI-375077, EBI-457097;
CC       P38936; P24385: CCND1; NbExp=20; IntAct=EBI-375077, EBI-375001;
CC       P38936; P30279: CCND2; NbExp=17; IntAct=EBI-375077, EBI-748789;
CC       P38936; P30281: CCND3; NbExp=26; IntAct=EBI-375077, EBI-375013;
CC       P38936; P24864: CCNE1; NbExp=9; IntAct=EBI-375077, EBI-519526;
CC       P38936; O96020: CCNE2; NbExp=6; IntAct=EBI-375077, EBI-375033;
CC       P38936; O75419: CDC45; NbExp=2; IntAct=EBI-375077, EBI-374969;
CC       P38936; Q99741: CDC6; NbExp=2; IntAct=EBI-375077, EBI-374862;
CC       P38936; P06493: CDK1; NbExp=7; IntAct=EBI-375077, EBI-444308;
CC       P38936; O94921: CDK14; NbExp=8; IntAct=EBI-375077, EBI-1043945;
CC       P38936; P24941: CDK2; NbExp=28; IntAct=EBI-375077, EBI-375096;
CC       P38936; Q00526: CDK3; NbExp=6; IntAct=EBI-375077, EBI-1245761;
CC       P38936; P11802: CDK4; NbExp=8; IntAct=EBI-375077, EBI-295644;
CC       P38936; Q00535: CDK5; NbExp=5; IntAct=EBI-375077, EBI-1041567;
CC       P38936; Q00534: CDK6; NbExp=2; IntAct=EBI-375077, EBI-295663;
CC       P38936; G5E9A7: DMWD; NbExp=3; IntAct=EBI-375077, EBI-10976677;
CC       P38936; P41091: EIF2S3; NbExp=3; IntAct=EBI-375077, EBI-1054228;
CC       P38936; O75460-2: ERN1; NbExp=3; IntAct=EBI-375077, EBI-25852368;
CC       P38936; P22607: FGFR3; NbExp=3; IntAct=EBI-375077, EBI-348399;
CC       P38936; Q0VDC6: FKBP1A; NbExp=3; IntAct=EBI-375077, EBI-10226858;
CC       P38936; Q9BVV2: FNDC11; NbExp=3; IntAct=EBI-375077, EBI-744935;
CC       P38936; Q08379: GOLGA2; NbExp=3; IntAct=EBI-375077, EBI-618309;
CC       P38936; P06396: GSN; NbExp=3; IntAct=EBI-375077, EBI-351506;
CC       P38936; Q96ED9-2: HOOK2; NbExp=3; IntAct=EBI-375077, EBI-10961706;
CC       P38936; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-375077, EBI-747204;
CC       P38936; Q0VD86: INCA1; NbExp=3; IntAct=EBI-375077, EBI-6509505;
CC       P38936; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-375077, EBI-14069005;
CC       P38936; Q15323: KRT31; NbExp=6; IntAct=EBI-375077, EBI-948001;
CC       P38936; Q9BYR8: KRTAP3-1; NbExp=3; IntAct=EBI-375077, EBI-9996449;
CC       P38936; Q9P2M1: LRP2BP; NbExp=3; IntAct=EBI-375077, EBI-18273118;
CC       P38936; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-375077, EBI-741037;
CC       P38936; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-375077, EBI-16439278;
CC       P38936; Q9UHC7: MKRN1; NbExp=5; IntAct=EBI-375077, EBI-373524;
CC       P38936; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-375077, EBI-11522433;
CC       P38936; Q9BQ15: NABP2; NbExp=7; IntAct=EBI-375077, EBI-2120336;
CC       P38936; P12004: PCNA; NbExp=37; IntAct=EBI-375077, EBI-358311;
CC       P38936; Q6FI35: PCNA; NbExp=2; IntAct=EBI-375077, EBI-8469539;
CC       P38936; P31321: PRKAR1B; NbExp=3; IntAct=EBI-375077, EBI-2805516;
CC       P38936; Q04864-2: REL; NbExp=3; IntAct=EBI-375077, EBI-10829018;
CC       P38936; P49591: SARS1; NbExp=3; IntAct=EBI-375077, EBI-1053431;
CC       P38936; Q9UQR0-1: SCML2; NbExp=3; IntAct=EBI-375077, EBI-16087037;
CC       P38936; Q6ZSJ9: SHISA6; NbExp=3; IntAct=EBI-375077, EBI-12037847;
CC       P38936; Q96FS4: SIPA1; NbExp=2; IntAct=EBI-375077, EBI-1054981;
CC       P38936; P63208: SKP1; NbExp=3; IntAct=EBI-375077, EBI-307486;
CC       P38936; Q13309: SKP2; NbExp=3; IntAct=EBI-375077, EBI-456291;
CC       P38936; Q7Z699: SPRED1; NbExp=4; IntAct=EBI-375077, EBI-5235340;
CC       P38936; P51692: STAT5B; NbExp=3; IntAct=EBI-375077, EBI-1186119;
CC       P38936; P15884: TCF4; NbExp=3; IntAct=EBI-375077, EBI-533224;
CC       P38936; Q8IYF3: TEX11; NbExp=4; IntAct=EBI-375077, EBI-742397;
CC       P38936; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-375077, EBI-1105213;
CC       P38936; P04637: TP53; NbExp=4; IntAct=EBI-375077, EBI-366083;
CC       P38936; Q13077: TRAF1; NbExp=3; IntAct=EBI-375077, EBI-359224;
CC       P38936; Q9BYV2: TRIM54; NbExp=6; IntAct=EBI-375077, EBI-2130429;
CC       P38936; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-375077, EBI-741480;
CC       P38936; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-375077, EBI-739895;
CC       P38936; Q9Y649; NbExp=3; IntAct=EBI-375077, EBI-25900580;
CC       P38936; PRO_0000037566 [P27958]; Xeno; NbExp=3; IntAct=EBI-375077, EBI-6377335;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11463845}. Nucleus
CC       {ECO:0000269|PubMed:11463845, ECO:0000269|PubMed:23213251}.
CC   -!- TISSUE SPECIFICITY: Expressed in all adult tissues, with 5-fold lower
CC       levels observed in the brain.
CC   -!- INDUCTION: Activated by p53/TP53, mezerein (antileukemic compound) and
CC       IFNB1. Repressed by HDAC1. {ECO:0000269|PubMed:8242751,
CC       ECO:0000269|PubMed:8242752}.
CC   -!- DOMAIN: The PIP-box K+4 motif mediates both the interaction with PCNA
CC       and the recruitment of the DCX(DTL) complex: while the PIP-box
CC       interacts with PCNA, the presence of the K+4 submotif, recruits the
CC       DCX(DTL) complex, leading to its ubiquitination.
CC   -!- DOMAIN: The C-terminal is required for nuclear localization of the
CC       cyclin D-CDK4 complex.
CC   -!- PTM: Phosphorylation of Thr-145 by Akt or of Ser-146 by PKC impairs
CC       binding to PCNA. Phosphorylation at Ser-114 by GSK3-beta enhances
CC       ubiquitination by the DCX(DTL) complex. Phosphorylation of Thr-145 by
CC       PIM2 enhances CDKN1A stability and inhibits cell proliferation.
CC       Phosphorylation of Thr-145 by PIM1 results in the relocation of CDKN1A
CC       to the cytoplasm and enhanced CDKN1A protein stability. UV radiation-
CC       induced phosphorylation at Thr-80 by LKB1 and at Ser-146 by NUAK1 leads
CC       to its degradation. {ECO:0000269|PubMed:10753973,
CC       ECO:0000269|PubMed:11463845, ECO:0000269|PubMed:12431783,
CC       ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:18794347,
CC       ECO:0000269|PubMed:20307683, ECO:0000269|PubMed:25329316}.
CC   -!- PTM: Ubiquitinated by MKRN1; leading to polyubiquitination and 26S
CC       proteasome-dependent degradation. Ubiquitinated by the DCX(DTL)
CC       complex, also named CRL4(CDT2) complex, leading to its degradation
CC       during S phase or following UV irradiation. Ubiquitination by the
CC       DCX(DTL) complex is essential to control replication licensing and is
CC       PCNA-dependent: interacts with PCNA via its PIP-box, while the presence
CC       of the containing the 'K+4' motif in the PIP box, recruit the DCX(DTL)
CC       complex, leading to its degradation. Ubiquitination at Ser-2 leads to
CC       degradation by the proteasome pathway. Ubiquitinated by RNF114; leading
CC       to proteasomal degradation. {ECO:0000269|PubMed:15226418,
CC       ECO:0000269|PubMed:23213251}.
CC   -!- PTM: Acetylation leads to protein stability. Acetylated in vitro on
CC       Lys-141, Lys-154, Lys-161 and Lys-163. Deacetylation by HDAC1 is
CC       prevented by competitive binding of C10orf90/FATS to HDAC1 (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the CDI family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB59559.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB59560.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/139/CDKN1A";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdkn1a/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L25610; AAA16109.1; -; mRNA.
DR   EMBL; S67388; AAB29246.1; -; mRNA.
DR   EMBL; U09579; AAA85641.1; -; mRNA.
DR   EMBL; U03106; AAC04313.1; -; mRNA.
DR   EMBL; L26165; AAA19811.1; -; mRNA.
DR   EMBL; L47232; AAB59559.1; ALT_INIT; mRNA.
DR   EMBL; L47233; AAB59560.1; ALT_INIT; mRNA.
DR   EMBL; AF497972; AAM11787.1; -; Genomic_DNA.
DR   EMBL; BT006719; AAP35365.1; -; mRNA.
DR   EMBL; AB451290; BAG70104.1; -; mRNA.
DR   EMBL; AB451422; BAG70236.1; -; mRNA.
DR   EMBL; CR536533; CAG38770.1; -; mRNA.
DR   EMBL; Z85996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03904.1; -; Genomic_DNA.
DR   EMBL; BC000275; AAH00275.1; -; mRNA.
DR   EMBL; BC000312; AAH00312.1; -; mRNA.
DR   EMBL; BC001935; AAH01935.1; -; mRNA.
DR   EMBL; BC013967; AAH13967.1; -; mRNA.
DR   CCDS; CCDS4824.1; -.
DR   PIR; I54380; I54380.
DR   PIR; I68674; I68674.
DR   RefSeq; NP_000380.1; NM_000389.4.
DR   RefSeq; NP_001207706.1; NM_001220777.1.
DR   RefSeq; NP_001207707.1; NM_001220778.1.
DR   RefSeq; NP_001278478.1; NM_001291549.1.
DR   RefSeq; NP_510867.1; NM_078467.2.
DR   PDB; 1AXC; X-ray; 2.60 A; B/D/F=139-160.
DR   PDB; 2ZVV; X-ray; 2.00 A; X/Y=139-160.
DR   PDB; 2ZVW; X-ray; 2.50 A; I/J/K/L/M/N/O/P=139-160.
DR   PDB; 4RJF; X-ray; 2.01 A; B/D/F=139-160.
DR   PDB; 5E0U; X-ray; 1.93 A; D/E/F=139-160.
DR   PDB; 6CBI; X-ray; 2.75 A; H/I/J/K=139-152.
DR   PDB; 6CEJ; NMR; -; A=139-152.
DR   PDB; 6CIV; NMR; -; C=139-152.
DR   PDB; 6CIX; NMR; -; B=139-152.
DR   PDB; 6P8H; X-ray; 3.19 A; C=9-85.
DR   PDB; 7KQ0; X-ray; 2.40 A; B/D/F=141-155.
DR   PDB; 7KQ1; X-ray; 3.30 A; B/D/F=141-155.
DR   PDBsum; 1AXC; -.
DR   PDBsum; 2ZVV; -.
DR   PDBsum; 2ZVW; -.
DR   PDBsum; 4RJF; -.
DR   PDBsum; 5E0U; -.
DR   PDBsum; 6CBI; -.
DR   PDBsum; 6CEJ; -.
DR   PDBsum; 6CIV; -.
DR   PDBsum; 6CIX; -.
DR   PDBsum; 6P8H; -.
DR   PDBsum; 7KQ0; -.
DR   PDBsum; 7KQ1; -.
DR   AlphaFoldDB; P38936; -.
DR   BMRB; P38936; -.
DR   SMR; P38936; -.
DR   BioGRID; 107460; 357.
DR   CORUM; P38936; -.
DR   DIP; DIP-246N; -.
DR   IntAct; P38936; 218.
DR   MINT; P38936; -.
DR   STRING; 9606.ENSP00000384849; -.
DR   BindingDB; P38936; -.
DR   ChEMBL; CHEMBL5021; -.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   MoonDB; P38936; Predicted.
DR   GlyGen; P38936; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P38936; -.
DR   PhosphoSitePlus; P38936; -.
DR   BioMuta; CDKN1A; -.
DR   DMDM; 729143; -.
DR   SWISS-2DPAGE; P38936; -.
DR   EPD; P38936; -.
DR   jPOST; P38936; -.
DR   MassIVE; P38936; -.
DR   PaxDb; P38936; -.
DR   PeptideAtlas; P38936; -.
DR   ProteomicsDB; 55307; -.
DR   Antibodypedia; 3757; 2465 antibodies from 47 providers.
DR   DNASU; 1026; -.
DR   Ensembl; ENST00000244741.10; ENSP00000244741.6; ENSG00000124762.14.
DR   Ensembl; ENST00000373711.3; ENSP00000362815.1; ENSG00000124762.14.
DR   Ensembl; ENST00000405375.5; ENSP00000384849.1; ENSG00000124762.14.
DR   Ensembl; ENST00000448526.6; ENSP00000409259.3; ENSG00000124762.14.
DR   Ensembl; ENST00000615513.4; ENSP00000482768.1; ENSG00000124762.14.
DR   GeneID; 1026; -.
DR   KEGG; hsa:1026; -.
DR   MANE-Select; ENST00000244741.10; ENSP00000244741.6; NM_000389.5; NP_000380.1.
DR   UCSC; uc003omm.5; human.
DR   AGR; HGNC:1784; -.
DR   CTD; 1026; -.
DR   DisGeNET; 1026; -.
DR   GeneCards; CDKN1A; -.
DR   HGNC; HGNC:1784; CDKN1A.
DR   HPA; ENSG00000124762; Low tissue specificity.
DR   MalaCards; CDKN1A; -.
DR   MIM; 116899; gene.
DR   neXtProt; NX_P38936; -.
DR   OpenTargets; ENSG00000124762; -.
DR   Orphanet; 652; Multiple endocrine neoplasia type 1.
DR   PharmGKB; PA104; -.
DR   VEuPathDB; HostDB:ENSG00000124762; -.
DR   eggNOG; KOG4743; Eukaryota.
DR   GeneTree; ENSGT00940000159918; -.
DR   HOGENOM; CLU_077692_1_1_1; -.
DR   InParanoid; P38936; -.
DR   OMA; KVCRRLF; -.
DR   OrthoDB; 692679at2759; -.
DR   PhylomeDB; P38936; -.
DR   TreeFam; TF101038; -.
DR   PathwayCommons; P38936; -.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-198323; AKT phosphorylates targets in the cytosol.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-5674400; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-6804116; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest.
DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-69563; p53-Dependent G1 DNA Damage Response.
DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-HSA-69895; Transcriptional activation of cell cycle inhibitor p21.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8866911; TFAP2 (AP-2) family regulates transcription of cell cycle factors.
DR   Reactome; R-HSA-8878166; Transcriptional regulation by RUNX2.
DR   Reactome; R-HSA-8941855; RUNX3 regulates CDKN1A transcription.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-9617828; FOXO-mediated transcription of cell cycle genes.
DR   Reactome; R-HSA-9661069; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3).
DR   Reactome; R-HSA-9702518; STAT5 activation downstream of FLT3 ITD mutants.
DR   Reactome; R-HSA-9703465; Signaling by FLT3 fusion proteins.
DR   SignaLink; P38936; -.
DR   SIGNOR; P38936; -.
DR   BioGRID-ORCS; 1026; 36 hits in 1197 CRISPR screens.
DR   ChiTaRS; CDKN1A; human.
DR   EvolutionaryTrace; P38936; -.
DR   GeneWiki; P21; -.
DR   GenomeRNAi; 1026; -.
DR   Pharos; P38936; Tchem.
DR   PRO; PR:P38936; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P38936; protein.
DR   Bgee; ENSG00000124762; Expressed in stromal cell of endometrium and 200 other tissues.
DR   ExpressionAtlas; P38936; baseline and differential.
DR   Genevisible; P38936; HS.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070557; C:PCNA-p21 complex; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0030332; F:cyclin binding; ISS:BHF-UCL.
DR   GO; GO:0019912; F:cyclin-dependent protein kinase activating kinase activity; IDA:UniProtKB.
DR   GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; TAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0140677; F:molecular function activator activity; IMP:DisProt.
DR   GO; GO:0140678; F:molecular function inhibitor activity; IDA:DisProt.
DR   GO; GO:0019901; F:protein kinase binding; IPI:CAFA.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IMP:CAFA.
DR   GO; GO:0140311; F:protein sequestering activity; IMP:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:CAFA.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IMP:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:BHF-UCL.
DR   GO; GO:0031668; P:cellular response to extracellular stimulus; IMP:BHF-UCL.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL.
DR   GO; GO:0071493; P:cellular response to UV-B; ISS:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; IMP:BHF-UCL.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007507; P:heart development; ISS:BHF-UCL.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; IMP:UniProtKB.
DR   GO; GO:1905179; P:negative regulation of cardiac muscle tissue regeneration; ISS:BHF-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:BHF-UCL.
DR   GO; GO:1904030; P:negative regulation of cyclin-dependent protein kinase activity; IMP:CAFA.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:UniProtKB.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IGI:MGI.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; IMP:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEP:DisProt.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; IEA:Ensembl.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IDA:MGI.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IEP:DisProt.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IDA:BHF-UCL.
DR   GO; GO:1902806; P:regulation of cell cycle G1/S phase transition; IMP:UniProtKB.
DR   GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0090399; P:replicative senescence; IEA:Ensembl.
DR   GO; GO:0090400; P:stress-induced premature senescence; TAS:BHF-UCL.
DR   GO; GO:0042246; P:tissue regeneration; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   DisProt; DP00016; -.
DR   Gene3D; 4.10.365.10; p27; 1.
DR   IDEAL; IID00043; -.
DR   InterPro; IPR003175; CDI_dom.
DR   InterPro; IPR044898; CDI_dom_sf.
DR   InterPro; IPR029841; CDKN1A.
DR   PANTHER; PTHR46778:SF1; CYCLIN-DEPENDENT KINASE INHIBITOR 1; 1.
DR   PANTHER; PTHR46778; CYCLIN-DEPENDENT KINASE INHIBITOR 1-RELATED; 1.
DR   Pfam; PF02234; CDI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell cycle; Cytoplasm;
KW   Direct protein sequencing; Metal-binding; Nucleus; Phosphoprotein;
KW   Protein kinase inhibitor; Reference proteome; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15574338"
FT   CHAIN           2..164
FT                   /note="Cyclin-dependent kinase inhibitor 1"
FT                   /id="PRO_0000190079"
FT   ZN_FING         13..41
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   REGION          17..24
FT                   /note="Required for binding cyclins"
FT   REGION          53..58
FT                   /note="Required for binding CDKs"
FT   REGION          76..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          152..164
FT                   /note="Interaction with TRIM39"
FT                   /evidence="ECO:0000269|PubMed:23213251"
FT   MOTIF           140..164
FT                   /note="PIP-box K+4 motif"
FT   MOTIF           141..156
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15574338"
FT   MOD_RES         80
FT                   /note="Phosphothreonine; by LKB1"
FT                   /evidence="ECO:0000269|PubMed:25329316"
FT   MOD_RES         114
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:18794347"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         145
FT                   /note="Phosphothreonine; by PKA, PKB/AKT1, PIM1 and PIM2"
FT                   /evidence="ECO:0000269|PubMed:10753973,
FT                   ECO:0000269|PubMed:11463845, ECO:0000269|PubMed:12431783,
FT                   ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:20307683"
FT   MOD_RES         146
FT                   /note="Phosphoserine; by PKC and NUAK1"
FT                   /evidence="ECO:0000269|PubMed:10753973,
FT                   ECO:0000269|PubMed:25329316"
FT   MOD_RES         160
FT                   /note="Phosphoserine; by PKC; in vitro"
FT                   /evidence="ECO:0000269|PubMed:10753973"
FT   CROSSLNK        2
FT                   /note="Glycyl serine ester (Ser-Gly) (interchain with G-
FT                   Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:15226418"
FT   VARIANT         4
FT                   /note="P -> L (in dbSNP:rs4986866)"
FT                   /id="VAR_048686"
FT   VARIANT         31
FT                   /note="S -> R (in dbSNP:rs1801270)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:7655464, ECO:0000269|Ref.8"
FT                   /id="VAR_011870"
FT   VARIANT         63
FT                   /note="F -> L (in dbSNP:rs4986867)"
FT                   /id="VAR_048687"
FT   MUTAGEN         80
FT                   /note="T->A: Abolishes UV radiation-induced phosphorylation
FT                   and subsequent degradation."
FT                   /evidence="ECO:0000269|PubMed:25329316"
FT   MUTAGEN         114
FT                   /note="S->E: Phosphomimetic mutant, increases
FT                   ubiquitination by the DCX(DTL) complex."
FT                   /evidence="ECO:0000269|PubMed:18794347"
FT   MUTAGEN         144..150
FT                   /note="QTSMTDF->ATSATDA: Abolishes interaction with PCNA
FT                   and subsequent degradation by the proteasome."
FT                   /evidence="ECO:0000269|PubMed:18794347"
FT   MUTAGEN         145
FT                   /note="T->A: Reduces phosphorylation by Akt; no change in
FT                   interaction with PCNA, CDK2 or CDK4; no change in
FT                   subcellular location."
FT                   /evidence="ECO:0000269|PubMed:11463845"
FT   MUTAGEN         145
FT                   /note="T->D: No interaction with PCNA; 59% inhibition of
FT                   CDK2 binding; modest inhibition of CDK4 binding; no change
FT                   in subcellular location."
FT                   /evidence="ECO:0000269|PubMed:11463845"
FT   MUTAGEN         146
FT                   /note="S->A: No change in interaction with PCNA. Abolishes
FT                   UV radiation-induced phosphorylation and subsequent
FT                   degradation."
FT                   /evidence="ECO:0000269|PubMed:11463845,
FT                   ECO:0000269|PubMed:25329316"
FT   MUTAGEN         146
FT                   /note="S->D: Reduces interaction with PCNA."
FT                   /evidence="ECO:0000269|PubMed:11463845"
FT   MUTAGEN         147..151
FT                   /note="MTDFY->ATDAAA: Abolishes interaction with PCNA and
FT                   subsequent degradation by the proteasome."
FT                   /evidence="ECO:0000269|PubMed:18703516"
FT   MUTAGEN         154..156
FT                   /note="KRR->AAA: Abolishes degradation by the proteasome
FT                   without affecting the interaction with PCNA."
FT                   /evidence="ECO:0000269|PubMed:18703516"
FT   MUTAGEN         154
FT                   /note="K->A: Loss of interaction with TRIM39."
FT                   /evidence="ECO:0000269|PubMed:23213251"
FT   STRAND          21..23
FT                   /evidence="ECO:0007829|PDB:6P8H"
FT   HELIX           27..46
FT                   /evidence="ECO:0007829|PDB:6P8H"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:6P8H"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:6P8H"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:7KQ1"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:5E0U"
FT   STRAND          153..158
FT                   /evidence="ECO:0007829|PDB:5E0U"
SQ   SEQUENCE   164 AA;  18119 MW;  98D1E7C519ADFCA9 CRC64;
     MSEPAGDVRQ NPCGSKACRR LFGPVDSEQL SRDCDALMAG CIQEARERWN FDFVTETPLE
     GDFAWERVRG LGLPKLYLPT GPRRGRDELG GGRRPGTSPA LLQGTAEEDH VDLSLSCTLV
     PRSGEQAEGS PGGPGDSQGR KRRQTSMTDF YHSKRRLIFS KRKP
//
ID   RS27_HUMAN              Reviewed;          84 AA.
AC   P42677; Q5T4L6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-FEB-2023, entry version 224.
DE   RecName: Full=40S ribosomal protein S27;
DE   AltName: Full=Metallopan-stimulin 1;
DE            Short=MPS-1;
DE   AltName: Full=Small ribosomal subunit protein eS27 {ECO:0000303|PubMed:24524803};
GN   Name=RPS27; Synonyms=MPS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=8407955; DOI=10.1016/s0021-9258(19)36910-8;
RA   Fernandez-Pol J.A., Klos D.J., Hamilton P.D.;
RT   "A growth factor-inducible gene encodes a novel nuclear protein with zinc
RT   finger structure.";
RL   J. Biol. Chem. 268:21198-21204(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=8908372; DOI=10.1080/15216549600201203;
RA   Tsui S.K.W., Lee S.M.Y., Fung K.P., Waye M.M.Y., Lee C.Y.;
RT   "Primary structures and sequence analysis of human ribosomal proteins L39
RT   and S27.";
RL   Biochem. Mol. Biol. Int. 40:611-616(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11875025; DOI=10.1101/gr.214202;
RA   Yoshihama M., Uechi T., Asakawa S., Kawasaki K., Kato S., Higa S.,
RA   Maeda N., Minoshima S., Tanaka T., Shimizu N., Kenmochi N.;
RT   "The human ribosomal protein genes: sequencing and comparative analysis of
RT   73 genes.";
RL   Genome Res. 12:379-390(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-11, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   FUNCTION.
RX   PubMed=8706699; DOI=10.1111/j.1432-1033.1996.0144u.x;
RA   Vladimirov S.N., Ivanov A.V., Karpova G.G., Musolyamov A.K., Egorov T.A.,
RA   Thiede B., Wittmann-Liebold B., Otto A.;
RT   "Characterization of the human small-ribosomal-subunit proteins by N-
RT   terminal and internal sequencing, and mass spectrometry.";
RL   Eur. J. Biochem. 239:144-149(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 6-74.
RX   PubMed=9582194; DOI=10.1101/gr.8.5.509;
RA   Kenmochi N., Kawaguchi T., Rozen S., Davis E., Goodman N., Hudson T.J.,
RA   Tanaka T., Page D.C.;
RT   "A map of 75 human ribosomal protein genes.";
RL   Genome Res. 8:509-523(1998).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   FUNCTION, AND INVOLVEMENT IN DBA17.
RX   PubMed=25424902; DOI=10.1111/bjh.13229;
RA   Wang R., Yoshida K., Toki T., Sawada T., Uechi T., Okuno Y.,
RA   Sato-Otsubo A., Kudo K., Kamimaki I., Kanezaki R., Shiraishi Y., Chiba K.,
RA   Tanaka H., Terui K., Sato T., Iribe Y., Ohga S., Kuramitsu M.,
RA   Hamaguchi I., Ohara A., Hara J., Goi K., Matsubara K., Koike K.,
RA   Ishiguro A., Okamoto Y., Watanabe K., Kanno H., Kojima S., Miyano S.,
RA   Kenmochi N., Ogawa S., Ito E.;
RT   "Loss of function mutations in RPL27 and RPS27 identified by whole-exome
RT   sequencing in Diamond-Blackfan anaemia.";
RL   Br. J. Haematol. 168:854-864(2015).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS).
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
CC   -!- FUNCTION: Component of the small ribosomal subunit (PubMed:8706699).
CC       Required for proper rRNA processing and maturation of 18S rRNAs
CC       (PubMed:25424902). {ECO:0000269|PubMed:25424902,
CC       ECO:0000305|PubMed:8706699}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000305};
CC   -!- SUBUNIT: Component of the small ribosomal subunit.
CC       {ECO:0000305|PubMed:8706699}.
CC   -!- INTERACTION:
CC       P42677; P54132: BLM; NbExp=4; IntAct=EBI-356336, EBI-621372;
CC       P42677; Q5S007: LRRK2; NbExp=4; IntAct=EBI-356336, EBI-5323863;
CC       P42677; Q00987: MDM2; NbExp=5; IntAct=EBI-356336, EBI-389668;
CC       P42677; P61289: PSME3; NbExp=3; IntAct=EBI-356336, EBI-355546;
CC   -!- TISSUE SPECIFICITY: Expressed in a wide variety of actively
CC       proliferating cells and tumor tissues.
CC   -!- DISEASE: Diamond-Blackfan anemia 17 (DBA17) [MIM:617409]: A form of
CC       Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic
CC       anemia that usually presents early in infancy. Diamond-Blackfan anemia
CC       is characterized by a moderate to severe macrocytic anemia,
CC       erythroblastopenia, and an increased risk of malignancy. 30 to 40% of
CC       Diamond-Blackfan anemia patients present with short stature and
CC       congenital anomalies, the most frequent being craniofacial (Pierre-
CC       Robin syndrome and cleft palate), thumb and urogenital anomalies.
CC       {ECO:0000269|PubMed:25424902}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eS27 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally (PubMed:8407955) thought to be a protein that
CC       could have played a role as a potentially important mediator of
CC       cellular proliferative responses to various growth factors and other
CC       environmental signals. Capable of specific binding to a cAMP response
CC       element in DNA. {ECO:0000305|PubMed:8407955}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/45550/RPS27";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L19739; AAA59867.1; -; mRNA.
DR   EMBL; U57847; AAB02266.1; -; mRNA.
DR   EMBL; AB061845; BAB79483.1; -; Genomic_DNA.
DR   EMBL; AK312070; BAG35006.1; -; mRNA.
DR   EMBL; AL358472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53239.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64624.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88871.1; -; Genomic_DNA.
DR   EMBL; BC002658; AAH02658.1; -; mRNA.
DR   EMBL; BC070219; AAH70219.1; -; mRNA.
DR   EMBL; AB007162; BAA25825.1; -; Genomic_DNA.
DR   CCDS; CCDS1059.1; -.
DR   PIR; A48045; A48045.
DR   RefSeq; NP_001021.1; NM_001030.4.
DR   PDB; 4UG0; EM; -; Sb=1-84.
DR   PDB; 4V6X; EM; 5.00 A; Ab=1-84.
DR   PDB; 5A2Q; EM; 3.90 A; b=2-83.
DR   PDB; 5AJ0; EM; 3.50 A; Bb=1-84.
DR   PDB; 5FLX; EM; 3.90 A; b=1-84.
DR   PDB; 5LKS; EM; 3.60 A; Sb=1-84.
DR   PDB; 5OA3; EM; 4.30 A; b=2-83.
DR   PDB; 5T2C; EM; 3.60 A; AV=1-84.
DR   PDB; 5VYC; X-ray; 6.00 A; b1/b2/b3/b4/b5/b6=1-84.
DR   PDB; 6FEC; EM; 6.30 A; Y=1-84.
DR   PDB; 6G18; EM; 3.60 A; b=1-84.
DR   PDB; 6G4S; EM; 4.00 A; b=1-84.
DR   PDB; 6G4W; EM; 4.50 A; b=1-84.
DR   PDB; 6G51; EM; 4.10 A; b=1-84.
DR   PDB; 6G53; EM; 4.50 A; b=1-84.
DR   PDB; 6G5H; EM; 3.60 A; b=1-84.
DR   PDB; 6G5I; EM; 3.50 A; b=1-84.
DR   PDB; 6IP5; EM; 3.90 A; 3P=1-84.
DR   PDB; 6IP6; EM; 4.50 A; 3P=1-84.
DR   PDB; 6IP8; EM; 3.90 A; 3P=1-84.
DR   PDB; 6OLE; EM; 3.10 A; Sb=2-83.
DR   PDB; 6OLF; EM; 3.90 A; Sb=2-83.
DR   PDB; 6OLG; EM; 3.40 A; Bb=4-83.
DR   PDB; 6OLI; EM; 3.50 A; Sb=2-83.
DR   PDB; 6OLZ; EM; 3.90 A; Bb=4-83.
DR   PDB; 6OM0; EM; 3.10 A; Sb=2-83.
DR   PDB; 6OM7; EM; 3.70 A; Sb=2-83.
DR   PDB; 6QZP; EM; 2.90 A; Sb=2-84.
DR   PDB; 6XA1; EM; 2.80 A; Sb=2-83.
DR   PDB; 6Y0G; EM; 3.20 A; Sb=1-84.
DR   PDB; 6Y2L; EM; 3.00 A; Sb=1-84.
DR   PDB; 6Y57; EM; 3.50 A; Sb=1-84.
DR   PDB; 6YBD; EM; 3.30 A; H=1-84.
DR   PDB; 6YBW; EM; 3.10 A; H=1-84.
DR   PDB; 6Z6L; EM; 3.00 A; Sb=1-84.
DR   PDB; 6Z6M; EM; 3.10 A; Sb=1-84.
DR   PDB; 6Z6N; EM; 2.90 A; Sb=1-84.
DR   PDB; 6ZLW; EM; 2.60 A; b=1-84.
DR   PDB; 6ZM7; EM; 2.70 A; Sb=1-84.
DR   PDB; 6ZME; EM; 3.00 A; Sb=1-84.
DR   PDB; 6ZMI; EM; 2.60 A; Sb=1-84.
DR   PDB; 6ZMO; EM; 3.10 A; Sb=1-84.
DR   PDB; 6ZMT; EM; 3.00 A; b=1-84.
DR   PDB; 6ZMW; EM; 3.70 A; H=1-84.
DR   PDB; 6ZN5; EM; 3.20 A; b=2-83.
DR   PDB; 6ZOJ; EM; 2.80 A; b=2-83.
DR   PDB; 6ZOK; EM; 2.80 A; b=2-83.
DR   PDB; 6ZON; EM; 3.00 A; R=1-84.
DR   PDB; 6ZP4; EM; 2.90 A; R=1-84.
DR   PDB; 6ZUO; EM; 3.10 A; b=1-84.
DR   PDB; 6ZV6; EM; 2.90 A; b=1-84.
DR   PDB; 6ZVH; EM; 2.90 A; b=2-84.
DR   PDB; 6ZVJ; EM; 3.80 A; R=2-83.
DR   PDB; 6ZXD; EM; 3.20 A; b=1-84.
DR   PDB; 6ZXE; EM; 3.00 A; b=1-84.
DR   PDB; 6ZXF; EM; 3.70 A; b=1-84.
DR   PDB; 6ZXG; EM; 2.60 A; b=1-84.
DR   PDB; 6ZXH; EM; 2.70 A; b=1-84.
DR   PDB; 7A09; EM; 3.50 A; R=1-84.
DR   PDB; 7K5I; EM; 2.90 A; b=1-84.
DR   PDB; 7MQ8; EM; 3.60 A; NQ=1-84.
DR   PDB; 7MQ9; EM; 3.87 A; NQ=1-84.
DR   PDB; 7MQA; EM; 2.70 A; NQ=1-84.
DR   PDB; 7QP6; EM; 4.70 A; H=1-84.
DR   PDB; 7QP7; EM; 3.70 A; H=1-84.
DR   PDB; 7TQL; EM; 3.40 A; b=2-83.
DR   PDB; 7WTS; EM; 3.20 A; b=1-84.
DR   PDB; 7WTT; EM; 3.10 A; b=1-84.
DR   PDB; 7WTU; EM; 3.00 A; b=1-84.
DR   PDB; 7WTV; EM; 3.50 A; b=1-84.
DR   PDB; 7WTW; EM; 3.20 A; b=1-84.
DR   PDB; 7WTX; EM; 3.10 A; b=1-84.
DR   PDB; 7WTZ; EM; 3.00 A; b=1-84.
DR   PDB; 7WU0; EM; 3.30 A; b=1-84.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5A2Q; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5FLX; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5OA3; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 5VYC; -.
DR   PDBsum; 6FEC; -.
DR   PDBsum; 6G18; -.
DR   PDBsum; 6G4S; -.
DR   PDBsum; 6G4W; -.
DR   PDBsum; 6G51; -.
DR   PDBsum; 6G53; -.
DR   PDBsum; 6G5H; -.
DR   PDBsum; 6G5I; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   PDBsum; 6XA1; -.
DR   PDBsum; 6Y0G; -.
DR   PDBsum; 6Y2L; -.
DR   PDBsum; 6Y57; -.
DR   PDBsum; 6YBD; -.
DR   PDBsum; 6YBW; -.
DR   PDBsum; 6Z6L; -.
DR   PDBsum; 6Z6M; -.
DR   PDBsum; 6Z6N; -.
DR   PDBsum; 6ZLW; -.
DR   PDBsum; 6ZM7; -.
DR   PDBsum; 6ZME; -.
DR   PDBsum; 6ZMI; -.
DR   PDBsum; 6ZMO; -.
DR   PDBsum; 6ZMT; -.
DR   PDBsum; 6ZMW; -.
DR   PDBsum; 6ZN5; -.
DR   PDBsum; 6ZOJ; -.
DR   PDBsum; 6ZOK; -.
DR   PDBsum; 6ZON; -.
DR   PDBsum; 6ZP4; -.
DR   PDBsum; 6ZUO; -.
DR   PDBsum; 6ZV6; -.
DR   PDBsum; 6ZVH; -.
DR   PDBsum; 6ZVJ; -.
DR   PDBsum; 6ZXD; -.
DR   PDBsum; 6ZXE; -.
DR   PDBsum; 6ZXF; -.
DR   PDBsum; 6ZXG; -.
DR   PDBsum; 6ZXH; -.
DR   PDBsum; 7A09; -.
DR   PDBsum; 7K5I; -.
DR   PDBsum; 7MQ8; -.
DR   PDBsum; 7MQ9; -.
DR   PDBsum; 7MQA; -.
DR   PDBsum; 7QP6; -.
DR   PDBsum; 7QP7; -.
DR   PDBsum; 7TQL; -.
DR   PDBsum; 7WTS; -.
DR   PDBsum; 7WTT; -.
DR   PDBsum; 7WTU; -.
DR   PDBsum; 7WTV; -.
DR   PDBsum; 7WTW; -.
DR   PDBsum; 7WTX; -.
DR   PDBsum; 7WTZ; -.
DR   PDBsum; 7WU0; -.
DR   AlphaFoldDB; P42677; -.
DR   SMR; P42677; -.
DR   BioGRID; 112146; 317.
DR   CORUM; P42677; -.
DR   DIP; DIP-44182N; -.
DR   IntAct; P42677; 101.
DR   MINT; P42677; -.
DR   STRING; 9606.ENSP00000357555; -.
DR   BindingDB; P42677; -.
DR   ChEMBL; CHEMBL1932893; -.
DR   GlyGen; P42677; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P42677; -.
DR   MetOSite; P42677; -.
DR   PhosphoSitePlus; P42677; -.
DR   SwissPalm; P42677; -.
DR   BioMuta; RPS27; -.
DR   DMDM; 1171014; -.
DR   EPD; P42677; -.
DR   jPOST; P42677; -.
DR   MassIVE; P42677; -.
DR   PaxDb; P42677; -.
DR   PeptideAtlas; P42677; -.
DR   ProteomicsDB; 55523; -.
DR   TopDownProteomics; P42677; -.
DR   Antibodypedia; 20391; 263 antibodies from 33 providers.
DR   DNASU; 6232; -.
DR   Ensembl; ENST00000651669.1; ENSP00000499044.1; ENSG00000177954.14.
DR   GeneID; 6232; -.
DR   KEGG; hsa:6232; -.
DR   MANE-Select; ENST00000651669.1; ENSP00000499044.1; NM_001030.6; NP_001021.1.
DR   UCSC; uc001fdv.4; human.
DR   AGR; HGNC:10416; -.
DR   CTD; 6232; -.
DR   DisGeNET; 6232; -.
DR   GeneCards; RPS27; -.
DR   GeneReviews; RPS27; -.
DR   HGNC; HGNC:10416; RPS27.
DR   HPA; ENSG00000177954; Low tissue specificity.
DR   MalaCards; RPS27; -.
DR   MIM; 603702; gene.
DR   MIM; 617409; phenotype.
DR   neXtProt; NX_P42677; -.
DR   OpenTargets; ENSG00000177954; -.
DR   Orphanet; 124; Blackfan-Diamond anemia.
DR   PharmGKB; PA34820; -.
DR   VEuPathDB; HostDB:ENSG00000177954; -.
DR   eggNOG; KOG1779; Eukaryota.
DR   GeneTree; ENSGT00950000182891; -.
DR   HOGENOM; CLU_130128_3_0_1; -.
DR   InParanoid; P42677; -.
DR   OMA; VYSHANT; -.
DR   OrthoDB; 5470875at2759; -.
DR   PhylomeDB; P42677; -.
DR   TreeFam; TF300265; -.
DR   PathwayCommons; P42677; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   Reactome; R-HSA-9735869; SARS-CoV-1 modulates host translation machinery.
DR   Reactome; R-HSA-9754678; SARS-CoV-2 modulates host translation machinery.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; P42677; -.
DR   SIGNOR; P42677; -.
DR   BioGRID-ORCS; 6232; 448 hits in 705 CRISPR screens.
DR   ChiTaRS; RPS27; human.
DR   GeneWiki; RPS27; -.
DR   GenomeRNAi; 6232; -.
DR   Pharos; P42677; Tchem.
DR   PRO; PR:P42677; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P42677; protein.
DR   Bgee; ENSG00000177954; Expressed in ganglionic eminence and 94 other tissues.
DR   ExpressionAtlas; P42677; baseline and differential.
DR   Genevisible; P42677; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022626; C:cytosolic ribosome; IDA:FlyBase.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0005840; C:ribosome; NAS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0002181; P:cytoplasmic translation; IC:FlyBase.
DR   GO; GO:0000028; P:ribosomal small subunit assembly; IBA:GO_Central.
DR   GO; GO:0006364; P:rRNA processing; IMP:UniProtKB.
DR   GO; GO:0006412; P:translation; NAS:UniProtKB.
DR   Gene3D; 2.20.25.100; Zn-binding ribosomal proteins; 1.
DR   HAMAP; MF_00371; Ribosomal_S27e; 1.
DR   InterPro; IPR000592; Ribosomal_S27.
DR   InterPro; IPR023407; Ribosomal_S27_Zn-bd_dom_sf.
DR   InterPro; IPR011332; Ribosomal_zn-bd.
DR   PANTHER; PTHR11594; 40S RIBOSOMAL PROTEIN S27; 1.
DR   PANTHER; PTHR11594:SF1; 40S RIBOSOMAL PROTEIN S27; 1.
DR   Pfam; PF01667; Ribosomal_S27e; 1.
DR   SUPFAM; SSF57829; Zn-binding ribosomal proteins; 1.
DR   PROSITE; PS01168; RIBOSOMAL_S27E; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Diamond-Blackfan anemia; Direct protein sequencing;
KW   Metal-binding; Phosphoprotein; Reference proteome; Ribonucleoprotein;
KW   Ribosomal protein; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:8706699"
FT   CHAIN           2..84
FT                   /note="40S ribosomal protein S27"
FT                   /id="PRO_0000149051"
FT   ZN_FING         37..59
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   CONFLICT        5
FT                   /note="K -> R (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          7..9
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   HELIX           12..17
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          20..25
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          32..36
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          38..41
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   STRAND          43..47
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:6ZMT"
FT   TURN            57..59
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          78..82
FT                   /evidence="ECO:0007829|PDB:6ZLW"
SQ   SEQUENCE   84 AA;  9461 MW;  242C4466AC8A8900 CRC64;
     MPLAKDLLHP SPEEEKRKHK KKRLVQSPNS YFMDVKCPGC YKITTVFSHA QTVVLCVGCS
     TVLCQPTGGK ARLTEGCSFR RKQH
//
ID   RPAB4_HUMAN             Reviewed;          58 AA.
AC   P53803; Q6IBD4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-FEB-2023, entry version 195.
DE   RecName: Full=DNA-directed RNA polymerases I, II, and III subunit RPABC4;
DE            Short=RNA polymerases I, II, and III subunit ABC4;
DE   AltName: Full=ABC10-alpha;
DE   AltName: Full=DNA-directed RNA polymerase II subunit K;
DE   AltName: Full=RNA polymerase II 7.0 kDa subunit;
DE            Short=RPB7.0;
DE   AltName: Full=RPB10alpha;
GN   Name=POLR2K;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7651387; DOI=10.1128/mcb.15.9.4702;
RA   Shpakovski G.V., Acker J., Wintzerith M., Lacroix J.F., Thuriaux P.,
RA   Vigneron M.;
RT   "Four subunits that are shared by the three classes of RNA polymerase are
RT   functionally interchangeable between Homo sapiens and Saccharomyces
RT   cerevisiae.";
RL   Mol. Cell. Biol. 15:4702-4710(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RA   Shpakovski G.V., Lebedenko E.N., Grandemange S., Schaller S., Vigneron M.,
RA   Kedinger C.;
RT   "Organization of genes encoding subunits of eucaryotic nuclear RNA
RT   polymerases shows non random intron distribution and correlates with the
RT   subunit modular structure.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of
CC       DNA into RNA using the four ribonucleoside triphosphates as substrates.
CC       Common component of RNA polymerases I, II and III which synthesize
CC       ribosomal RNA precursors, mRNA precursors and many functional non-
CC       coding RNAs, and a small RNAs, such as 5S rRNA and tRNAs, respectively.
CC   -!- SUBUNIT: Component of the RNA polymerase I (Pol I), RNA polymerase II
CC       (Pol II) and RNA polymerase III (Pol III) complexes consisting of at
CC       least 13, 12 and 17 subunits, respectively. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P53803; Q96B97: SH3KBP1; NbExp=3; IntAct=EBI-395357, EBI-346595;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the archaeal Rpo12/eukaryotic RPC10 RNA
CC       polymerase subunit family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z47727; CAA87656.1; -; mRNA.
DR   EMBL; AJ252078; CAB91873.1; -; Genomic_DNA.
DR   EMBL; CR456870; CAG33151.1; -; mRNA.
DR   EMBL; CH471060; EAW91798.1; -; Genomic_DNA.
DR   EMBL; BC000806; AAH00806.1; -; mRNA.
DR   EMBL; BC018157; AAH18157.1; -; mRNA.
DR   CCDS; CCDS6285.1; -.
DR   PIR; I37558; I37558.
DR   RefSeq; NP_005025.1; NM_005034.3.
DR   PDB; 5IY6; EM; 7.20 A; L=1-58.
DR   PDB; 5IY7; EM; 8.60 A; L=1-58.
DR   PDB; 5IY8; EM; 7.90 A; L=1-58.
DR   PDB; 5IY9; EM; 6.30 A; L=1-58.
DR   PDB; 5IYA; EM; 5.40 A; L=1-58.
DR   PDB; 5IYB; EM; 3.90 A; L=1-58.
DR   PDB; 5IYC; EM; 3.90 A; L=1-58.
DR   PDB; 5IYD; EM; 3.90 A; L=1-58.
DR   PDB; 6DRD; EM; 3.90 A; L=1-58.
DR   PDB; 6O9L; EM; 7.20 A; L=1-58.
DR   PDB; 6XRE; EM; 4.60 A; L=1-58.
DR   PDB; 7A6H; EM; 3.30 A; L=1-58.
DR   PDB; 7AE1; EM; 2.80 A; L=1-58.
DR   PDB; 7AE3; EM; 3.10 A; L=1-58.
DR   PDB; 7AEA; EM; 3.40 A; L=1-58.
DR   PDB; 7AST; EM; 4.00 A; C=1-58.
DR   PDB; 7D58; EM; 2.90 A; L=1-58.
DR   PDB; 7D59; EM; 3.10 A; L=1-58.
DR   PDB; 7DN3; EM; 3.50 A; L=1-58.
DR   PDB; 7DU2; EM; 3.35 A; L=1-58.
DR   PDB; 7FJI; EM; 3.60 A; L=1-58.
DR   PDB; 7FJJ; EM; 3.60 A; L=1-58.
DR   PDB; 7LBM; EM; 4.80 A; L=1-58.
DR   PDB; 7OB9; EM; 2.70 A; L=1-58.
DR   PDB; 7OBA; EM; 3.10 A; L=1-58.
DR   PDB; 7OBB; EM; 3.30 A; L=1-58.
DR   PDB; 7VBA; EM; 2.89 A; L=1-58.
DR   PDB; 7VBB; EM; 2.81 A; L=1-58.
DR   PDB; 7VBC; EM; 3.01 A; L=1-58.
DR   PDB; 8A43; EM; 4.09 A; L=1-58.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IY9; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   PDBsum; 5IYD; -.
DR   PDBsum; 6DRD; -.
DR   PDBsum; 6O9L; -.
DR   PDBsum; 6XRE; -.
DR   PDBsum; 7A6H; -.
DR   PDBsum; 7AE1; -.
DR   PDBsum; 7AE3; -.
DR   PDBsum; 7AEA; -.
DR   PDBsum; 7AST; -.
DR   PDBsum; 7D58; -.
DR   PDBsum; 7D59; -.
DR   PDBsum; 7DN3; -.
DR   PDBsum; 7DU2; -.
DR   PDBsum; 7FJI; -.
DR   PDBsum; 7FJJ; -.
DR   PDBsum; 7LBM; -.
DR   PDBsum; 7OB9; -.
DR   PDBsum; 7OBA; -.
DR   PDBsum; 7OBB; -.
DR   PDBsum; 7VBA; -.
DR   PDBsum; 7VBB; -.
DR   PDBsum; 7VBC; -.
DR   PDBsum; 8A43; -.
DR   AlphaFoldDB; P53803; -.
DR   SMR; P53803; -.
DR   BioGRID; 111436; 153.
DR   CORUM; P53803; -.
DR   DIP; DIP-32968N; -.
DR   IntAct; P53803; 15.
DR   MINT; P53803; -.
DR   STRING; 9606.ENSP00000342889; -.
DR   iPTMnet; P53803; -.
DR   PhosphoSitePlus; P53803; -.
DR   BioMuta; POLR2K; -.
DR   DMDM; 1710664; -.
DR   EPD; P53803; -.
DR   jPOST; P53803; -.
DR   MassIVE; P53803; -.
DR   MaxQB; P53803; -.
DR   PaxDb; P53803; -.
DR   PeptideAtlas; P53803; -.
DR   ProteomicsDB; 56622; -.
DR   TopDownProteomics; P53803; -.
DR   Antibodypedia; 26170; 107 antibodies from 21 providers.
DR   DNASU; 5440; -.
DR   Ensembl; ENST00000353107.8; ENSP00000342889.3; ENSG00000147669.11.
DR   GeneID; 5440; -.
DR   KEGG; hsa:5440; -.
DR   MANE-Select; ENST00000353107.8; ENSP00000342889.3; NM_005034.4; NP_005025.1.
DR   UCSC; uc003yjf.4; human.
DR   AGR; HGNC:9198; -.
DR   CTD; 5440; -.
DR   DisGeNET; 5440; -.
DR   GeneCards; POLR2K; -.
DR   HGNC; HGNC:9198; POLR2K.
DR   HPA; ENSG00000147669; Low tissue specificity.
DR   MIM; 606033; gene.
DR   neXtProt; NX_P53803; -.
DR   OpenTargets; ENSG00000147669; -.
DR   PharmGKB; PA33518; -.
DR   VEuPathDB; HostDB:ENSG00000147669; -.
DR   eggNOG; KOG3507; Eukaryota.
DR   GeneTree; ENSGT00390000008918; -.
DR   HOGENOM; CLU_179456_1_0_1; -.
DR   InParanoid; P53803; -.
DR   OMA; VIRCREC; -.
DR   OrthoDB; 5489148at2759; -.
DR   PhylomeDB; P53803; -.
DR   TreeFam; TF103045; -.
DR   PathwayCommons; P53803; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-167161; HIV Transcription Initiation.
DR   Reactome; R-HSA-167162; RNA Polymerase II HIV Promoter Escape.
DR   Reactome; R-HSA-167172; Transcription of the HIV genome.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-73776; RNA Polymerase II Promoter Escape.
DR   Reactome; R-HSA-73779; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-75953; RNA Polymerase II Transcription Initiation.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   Reactome; R-HSA-76042; RNA Polymerase II Transcription Initiation And Promoter Clearance.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   Reactome; R-HSA-8851708; Signaling by FGFR2 IIIa TM.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9670095; Inhibition of DNA recombination at telomere.
DR   SignaLink; P53803; -.
DR   SIGNOR; P53803; -.
DR   BioGRID-ORCS; 5440; 734 hits in 1073 CRISPR screens.
DR   ChiTaRS; POLR2K; human.
DR   GeneWiki; POLR2K; -.
DR   GenomeRNAi; 5440; -.
DR   Pharos; P53803; Tbio.
DR   PRO; PR:P53803; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P53803; protein.
DR   Bgee; ENSG00000147669; Expressed in islet of Langerhans and 210 other tissues.
DR   ExpressionAtlas; P53803; baseline and differential.
DR   Genevisible; P53803; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005736; C:RNA polymerase I complex; IBA:GO_Central.
DR   GO; GO:0005665; C:RNA polymerase II, core complex; IDA:UniProtKB.
DR   GO; GO:0005666; C:RNA polymerase III complex; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0006356; P:regulation of transcription by RNA polymerase I; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006383; P:transcription by RNA polymerase III; TAS:ProtInc.
DR   Gene3D; 2.20.28.30; RNA polymerase ii, chain L; 1.
DR   InterPro; IPR006591; RNAP_P/RPABC4.
DR   InterPro; IPR039747; RPABC4.
DR   InterPro; IPR029040; RPABC4/Spt4.
DR   PANTHER; PTHR12056; DNA-DIRECTED RNA POLYMERASES I, II, AND III; 1.
DR   PANTHER; PTHR12056:SF2; DNA-DIRECTED RNA POLYMERASES I, II, AND III SUBUNIT RPABC4; 1.
DR   Pfam; PF03604; DNA_RNApol_7kD; 1.
DR   SMART; SM00659; RPOLCX; 1.
DR   SUPFAM; SSF63393; RNA polymerase subunits; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-directed RNA polymerase; Metal-binding; Nucleus;
KW   Reference proteome; Transcription; Zinc; Zinc-finger.
FT   CHAIN           1..58
FT                   /note="DNA-directed RNA polymerases I, II, and III subunit
FT                   RPABC4"
FT                   /id="PRO_0000159750"
FT   ZN_FING         19..39
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   BINDING         19
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         22
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         36
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         39
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   STRAND          16..22
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          25..27
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          30..32
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   TURN            37..39
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          53..56
FT                   /evidence="ECO:0007829|PDB:7OB9"
SQ   SEQUENCE   58 AA;  7004 MW;  239BA3A67416F02C CRC64;
     MDTQKDVQPP KQQPMIYICG ECHTENEIKS RDPIRCRECG YRIMYKKRTK RLVVFDAR
//
ID   NANO2_HUMAN             Reviewed;         138 AA.
AC   P60321; Q17R30; Q4G0P8;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 1.
DT   22-FEB-2023, entry version 137.
DE   RecName: Full=Nanos homolog 2;
DE            Short=NOS-2;
GN   Name=NANOS2; Synonyms=NOS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND VARIANT
RP   GLN-68.
RX   PubMed=19168545; DOI=10.1093/molehr/gap003;
RA   Kusz K.M., Tomczyk L., Sajek M., Spik A., Latos-Bielenska A.,
RA   Jedrzejczak P., Pawelczyk L., Jaruzelska J.;
RT   "The highly conserved NANOS2 protein: testis-specific expression and
RT   significance for the human male reproduction.";
RL   Mol. Hum. Reprod. 15:165-171(2009).
RN   [3]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=21421998; DOI=10.1093/hmg/ddr114;
RA   Julaton V.T., Reijo Pera R.A.;
RT   "NANOS3 function in human germ cell development.";
RL   Hum. Mol. Genet. 20:2238-2250(2011).
CC   -!- FUNCTION: Plays a key role in the sexual differentiation of germ cells
CC       by promoting the male fate but suppressing the female fate. Represses
CC       the female fate pathways by suppressing meiosis, which in turn results
CC       in the promotion of the male fate. Maintains the suppression of meiosis
CC       by preventing STRA8 expression, which is required for premeiotic DNA
CC       replication, after CYP26B1 is decreased. Regulates the localization of
CC       the CCR4-NOT deadenylation complex to P-bodies and plays a role in
CC       recruiting the complex to trigger the degradation of mRNAs involved in
CC       meiosis. Required for the maintenance of the spermatogonial stem cell
CC       population. Not essential for the assembly of P-bodies but is required
CC       for the maintenance of their normal state (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CNOT1, CNOT3, CNOT6L, CNOT7 and CNOT9.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P60321; O95273: CCNDBP1; NbExp=5; IntAct=EBI-10216569, EBI-748961;
CC       P60321; P43365: MAGEA12; NbExp=7; IntAct=EBI-10216569, EBI-749530;
CC       P60321; P60903: S100A10; NbExp=3; IntAct=EBI-10216569, EBI-717048;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19168545}.
CC       Cytoplasm, P-body {ECO:0000250}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:19168545}. Note=Localizes at P-bodies during
CC       gonocyte development (By similarity). More abundant in perinuclear
CC       region of the cytoplasm of the germ cells of the adult testis.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Testis and ovary. Expression found in several
CC       spermatogenic stages: in cells on the periphery of the tubules which
CC       could correspond to spermatogonia, in spermatocytes and in round
CC       spermatids (at protein level). {ECO:0000269|PubMed:19168545,
CC       ECO:0000269|PubMed:21421998}.
CC   -!- DEVELOPMENTAL STAGE: Fetal ovary and fetal testis. Present in all germ
CC       cells of seminiferous tubules of the 24-week fetus (at protein level).
CC       {ECO:0000269|PubMed:19168545, ECO:0000269|PubMed:21421998}.
CC   -!- DOMAIN: The Nanos-type zinc finger is composed of two C2HC motifs, each
CC       motif binding one molecule of zinc. It is essential for the translation
CC       repression activity of the protein. {ECO:0000255|PROSITE-
CC       ProRule:PRU00855}.
CC   -!- SIMILARITY: Belongs to the nanos family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00855}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC042883; AAH42883.1; -; mRNA.
DR   EMBL; BC117484; AAI17485.1; -; mRNA.
DR   EMBL; BC117486; AAI17487.1; -; mRNA.
DR   CCDS; CCDS33056.1; -.
DR   RefSeq; NP_001025032.1; NM_001029861.2.
DR   AlphaFoldDB; P60321; -.
DR   SMR; P60321; -.
DR   BioGRID; 130871; 28.
DR   ELM; P60321; -.
DR   IntAct; P60321; 23.
DR   MINT; P60321; -.
DR   STRING; 9606.ENSP00000341021; -.
DR   BioMuta; NANOS2; -.
DR   DMDM; 41688561; -.
DR   MassIVE; P60321; -.
DR   PaxDb; P60321; -.
DR   PeptideAtlas; P60321; -.
DR   ProteomicsDB; 57191; -.
DR   Antibodypedia; 31412; 260 antibodies from 30 providers.
DR   DNASU; 339345; -.
DR   Ensembl; ENST00000341294.4; ENSP00000341021.2; ENSG00000188425.4.
DR   GeneID; 339345; -.
DR   KEGG; hsa:339345; -.
DR   MANE-Select; ENST00000341294.4; ENSP00000341021.2; NM_001029861.3; NP_001025032.1.
DR   UCSC; uc002pdu.4; human.
DR   AGR; HGNC:23292; -.
DR   CTD; 339345; -.
DR   DisGeNET; 339345; -.
DR   GeneCards; NANOS2; -.
DR   HGNC; HGNC:23292; NANOS2.
DR   HPA; ENSG00000188425; Tissue enriched (testis).
DR   MIM; 608228; gene.
DR   neXtProt; NX_P60321; -.
DR   OpenTargets; ENSG00000188425; -.
DR   PharmGKB; PA134909776; -.
DR   VEuPathDB; HostDB:ENSG00000188425; -.
DR   eggNOG; KOG4602; Eukaryota.
DR   GeneTree; ENSGT00950000183135; -.
DR   HOGENOM; CLU_094055_1_0_1; -.
DR   InParanoid; P60321; -.
DR   OMA; RHVYASH; -.
DR   OrthoDB; 5360339at2759; -.
DR   PhylomeDB; P60321; -.
DR   TreeFam; TF326882; -.
DR   PathwayCommons; P60321; -.
DR   SignaLink; P60321; -.
DR   SIGNOR; P60321; -.
DR   BioGRID-ORCS; 339345; 13 hits in 1145 CRISPR screens.
DR   GenomeRNAi; 339345; -.
DR   Pharos; P60321; Tbio.
DR   PRO; PR:P60321; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P60321; protein.
DR   Bgee; ENSG00000188425; Expressed in right testis and 24 other tissues.
DR   Genevisible; P60321; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:0045835; P:negative regulation of meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:BHF-UCL.
DR   GO; GO:0048477; P:oogenesis; IBA:GO_Central.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:BHF-UCL.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   Gene3D; 4.10.60.30; Nanos, RNA-binding domain; 1.
DR   InterPro; IPR008705; Nanos/Xcar2.
DR   InterPro; IPR038129; Nanos_sf.
DR   InterPro; IPR024161; Znf_nanos-typ.
DR   PANTHER; PTHR12887:SF14; NANOS HOMOLOG 2; 1.
DR   PANTHER; PTHR12887; NANOS PROTEIN; 1.
DR   Pfam; PF05741; zf-nanos; 1.
DR   PROSITE; PS51522; ZF_NANOS; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Developmental protein; Differentiation; Metal-binding;
KW   Reference proteome; RNA-binding; Spermatogenesis; Translation regulation;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..138
FT                   /note="Nanos homolog 2"
FT                   /id="PRO_0000207687"
FT   ZN_FING         62..116
FT                   /note="Nanos-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   REGION          31..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           63..90
FT                   /note="C2HC 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   MOTIF           98..114
FT                   /note="C2HC 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         63
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         66
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         79
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         90
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         98
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         101
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         109
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         114
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   VARIANT         68
FT                   /note="H -> Q (in dbSNP:rs148451980)"
FT                   /evidence="ECO:0000269|PubMed:19168545"
FT                   /id="VAR_065246"
SQ   SEQUENCE   138 AA;  15132 MW;  98469E0F1AA6BC11 CRC64;
     MQLPPFDMWK DYFNLSQVVW ALIASRGQRL ETQEIEEPSP GPPLGQDQGL GAPGANGGLG
     TLCNFCKHNG ESRHVYSSHQ LKTPDGVVVC PILRHYVCPV CGATGDQAHT LKYCPLNGGQ
     QSLYRRSGRN SAGRRVKR
//
ID   NANO3_HUMAN             Reviewed;         173 AA.
AC   P60323; Q495E5;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 1.
DT   22-FEB-2023, entry version 143.
DE   RecName: Full=Nanos homolog 3;
DE            Short=NOS-3;
GN   Name=NANOS3; Synonyms=NOS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 122-173 (ISOFORMS 1/2).
RX   PubMed=8889548; DOI=10.1101/gr.6.9.791;
RA   Bonaldo M.F., Lennon G., Soares M.B.;
RT   "Normalization and subtraction: two approaches to facilitate gene
RT   discovery.";
RL   Genome Res. 6:791-806(1996).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=21421998; DOI=10.1093/hmg/ddr114;
RA   Julaton V.T., Reijo Pera R.A.;
RT   "NANOS3 function in human germ cell development.";
RL   Hum. Mol. Genet. 20:2238-2250(2011).
CC   -!- FUNCTION: Plays a role in the maintenance of the undifferentiated state
CC       of germ cells regulating the spermatogonia cell cycle and inducing a
CC       prolonged transit in G1 phase. Affects cell proliferation probably by
CC       repressing translation of specific mRNAs. Maintains the germ cell
CC       lineage by suppressing both Bax-dependent and -independent apoptotic
CC       pathways. Essential in the early stage embryo to protect the migrating
CC       primordial germ cells (PGCs) from apoptosis.
CC       {ECO:0000269|PubMed:21421998}.
CC   -!- SUBUNIT: Binds mRNA from germ cells. Interacts with PUM2 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P60323-2; Q96Q77: CIB3; NbExp=3; IntAct=EBI-18012223, EBI-10292696;
CC       P60323-2; Q9NV31: IMP3; NbExp=3; IntAct=EBI-18012223, EBI-747481;
CC       P60323-2; P40692: MLH1; NbExp=3; IntAct=EBI-18012223, EBI-744248;
CC       P60323-2; P20618: PSMB1; NbExp=3; IntAct=EBI-18012223, EBI-372273;
CC       P60323-2; Q8WW24: TEKT4; NbExp=3; IntAct=EBI-18012223, EBI-750487;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21421998}. Cytoplasm
CC       {ECO:0000269|PubMed:21421998}. Cytoplasm, Stress granule
CC       {ECO:0000250|UniProtKB:P60324}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:P60324}. Note=Co-localizes with PUM2, EIF2S1 and
CC       TIAL1 in the stress granules. Co-localizes with DCP1A in the P-body.
CC       {ECO:0000250|UniProtKB:P60324}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P60323-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P60323-2; Sequence=VSP_038695;
CC   -!- TISSUE SPECIFICITY: Ovary, testis and brain (at protein level). In the
CC       ovaries, expressed during multiple stages of oogenesis, including
CC       primordial, primary, secondary and antral follicles with the highest
CC       expression in the oocytes. In the testis, expressed in germ cells, type
CC       A spermatogonia (SA), primary spermatocytes (S1), round spermatids (S3)
CC       and elongated spermatids. {ECO:0000269|PubMed:21421998}.
CC   -!- DEVELOPMENTAL STAGE: Fetal ovary and fetal testis (at protein level).
CC       {ECO:0000269|PubMed:21421998}.
CC   -!- DOMAIN: The Nanos-type zinc finger is composed of two C2HC motifs, each
CC       motif binding one molecule of zinc. It is essential for the translation
CC       repression activity of the protein. {ECO:0000255|PROSITE-
CC       ProRule:PRU00855}.
CC   -!- SIMILARITY: Belongs to the nanos family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00855}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC020916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101209; AAI01210.1; -; mRNA.
DR   EMBL; BC101210; AAI01211.1; -; mRNA.
DR   EMBL; BM702754; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS42511.1; -. [P60323-2]
DR   RefSeq; NP_001092092.1; NM_001098622.2. [P60323-2]
DR   AlphaFoldDB; P60323; -.
DR   SMR; P60323; -.
DR   BioGRID; 131219; 16.
DR   ELM; P60323; -.
DR   IntAct; P60323; 5.
DR   iPTMnet; P60323; -.
DR   PhosphoSitePlus; P60323; -.
DR   SwissPalm; P60323; -.
DR   BioMuta; NANOS3; -.
DR   MassIVE; P60323; -.
DR   PeptideAtlas; P60323; -.
DR   ProteomicsDB; 57192; -. [P60323-1]
DR   ProteomicsDB; 57193; -. [P60323-2]
DR   Antibodypedia; 26509; 132 antibodies from 29 providers.
DR   DNASU; 342977; -.
DR   Ensembl; ENST00000339133.6; ENSP00000341992.4; ENSG00000187556.8. [P60323-2]
DR   Ensembl; ENST00000397555.3; ENSP00000380687.2; ENSG00000187556.8. [P60323-1]
DR   Ensembl; ENST00000672749.1; ENSP00000500080.1; ENSG00000288505.1. [P60323-1]
DR   Ensembl; ENST00000673200.1; ENSP00000500242.1; ENSG00000288505.1. [P60323-2]
DR   GeneID; 342977; -.
DR   KEGG; hsa:342977; -.
DR   MANE-Select; ENST00000339133.6; ENSP00000341992.4; NM_001098622.3; NP_001092092.1. [P60323-2]
DR   UCSC; uc002mxj.5; human. [P60323-1]
DR   AGR; HGNC:22048; -.
DR   CTD; 342977; -.
DR   DisGeNET; 342977; -.
DR   GeneCards; NANOS3; -.
DR   HGNC; HGNC:22048; NANOS3.
DR   HPA; ENSG00000187556; Group enriched (brain, testis).
DR   MIM; 608229; gene.
DR   neXtProt; NX_P60323; -.
DR   OpenTargets; ENSG00000187556; -.
DR   PharmGKB; PA134867615; -.
DR   VEuPathDB; HostDB:ENSG00000187556; -.
DR   eggNOG; KOG4602; Eukaryota.
DR   GeneTree; ENSGT00950000183135; -.
DR   HOGENOM; CLU_094055_1_0_1; -.
DR   InParanoid; P60323; -.
DR   OMA; GYMSVYS; -.
DR   OrthoDB; 5360339at2759; -.
DR   PhylomeDB; P60323; -.
DR   TreeFam; TF326882; -.
DR   PathwayCommons; P60323; -.
DR   SignaLink; P60323; -.
DR   SIGNOR; P60323; -.
DR   BioGRID-ORCS; 342977; 18 hits in 1140 CRISPR screens.
DR   GenomeRNAi; 342977; -.
DR   Pharos; P60323; Tbio.
DR   PRO; PR:P60323; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P60323; protein.
DR   Bgee; ENSG00000187556; Expressed in prefrontal cortex and 95 other tissues.
DR   Genevisible; P60323; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0007281; P:germ cell development; IMP:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:BHF-UCL.
DR   GO; GO:0048477; P:oogenesis; IBA:GO_Central.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:BHF-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   Gene3D; 4.10.60.30; Nanos, RNA-binding domain; 1.
DR   InterPro; IPR008705; Nanos/Xcar2.
DR   InterPro; IPR038129; Nanos_sf.
DR   InterPro; IPR024161; Znf_nanos-typ.
DR   PANTHER; PTHR12887:SF12; NANOS HOMOLOG 3; 1.
DR   PANTHER; PTHR12887; NANOS PROTEIN; 1.
DR   Pfam; PF05741; zf-nanos; 1.
DR   PROSITE; PS51522; ZF_NANOS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Developmental protein; Differentiation;
KW   Metal-binding; Nucleus; Oogenesis; Reference proteome; RNA-binding;
KW   Spermatogenesis; Translation regulation; Zinc; Zinc-finger.
FT   CHAIN           1..173
FT                   /note="Nanos homolog 3"
FT                   /id="PRO_0000207689"
FT   ZN_FING         57..111
FT                   /note="Nanos-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   REGION          23..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          123..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           58..85
FT                   /note="C2HC 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   MOTIF           93..109
FT                   /note="C2HC 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   COMPBIAS        129..144
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         58
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         61
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         74
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         85
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         96
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         104
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   BINDING         109
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00855"
FT   SITE            62
FT                   /note="Involved in RNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q90WW1"
FT   SITE            77
FT                   /note="Involved in RNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q90WW1"
FT   SITE            89
FT                   /note="Involved in RNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q90WW1"
FT   SITE            107
FT                   /note="Involved in RNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q90WW1"
FT   VAR_SEQ         42
FT                   /note="P -> PVSALEPMPAPESVPVPGPK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038695"
SQ   SEQUENCE   173 AA;  18844 MW;  14C18866070795D9 CRC64;
     MGTFDLWTDY LGLAHLVRAL SGKEGPETRL SPQPEPEPML EPDQKRSLES SPAPERLCSF
     CKHNGESRAI YQSHVLKDEA GRVLCPILRD YVCPQCGATR ERAHTRRFCP LTGQGYTSVY
     SHTTRNSAGK KLVRPDKAKT QDTGHRRGGG GGAGFRGAGK SEPSPSCSPS MST
//
ID   RL37A_HUMAN             Reviewed;          92 AA.
AC   P61513; P12751; Q6FGF5;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-FEB-2023, entry version 173.
DE   RecName: Full=60S ribosomal protein L37a;
DE   AltName: Full=Large ribosomal subunit protein eL43 {ECO:0000303|PubMed:24524803};
GN   Name=RPL37A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Nasal polyp;
RX   PubMed=1437567; DOI=10.1093/nar/20.20.5475;
RA   Hoof T., Fislage R., Tuemmler B.;
RT   "Primary sequence of the human ribosomal protein L37a.";
RL   Nucleic Acids Res. 20:5475-5475(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8479924; DOI=10.1093/nar/21.7.1672;
RA   Chu W., Presky D.H., Swerlick R.A., Burns D.K.;
RT   "Human ribosomal protein S20 cDNA sequence.";
RL   Nucleic Acids Res. 21:1672-1672(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8224875; DOI=10.1016/0378-1119(93)90209-l;
RA   Saha D.P., Tirumalai P.S., Scala L.A., Howells R.D.;
RT   "Human ribosomal protein L37a: cloning of the cDNA and analysis of
RT   differential gene expression in tissues and cell lines.";
RL   Gene 132:285-289(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell, Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
RN   [13] {ECO:0007744|PDB:6LQM, ECO:0007744|PDB:6LSR, ECO:0007744|PDB:6LSS, ECO:0007744|PDB:6LU8}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.09 ANGSTROMS), FUNCTION, AND SUBUNIT.
RX   PubMed=32669547; DOI=10.1038/s41467-020-17237-x;
RA   Liang X., Zuo M.Q., Zhang Y., Li N., Ma C., Dong M.Q., Gao N.;
RT   "Structural snapshots of human pre-60S ribosomal particles before and after
RT   nuclear export.";
RL   Nat. Commun. 11:3542-3542(2020).
CC   -!- FUNCTION: Component of the large ribosomal subunit. The ribosome is a
CC       large ribonucleoprotein complex responsible for the synthesis of
CC       proteins in the cell. {ECO:0000269|PubMed:23636399,
CC       ECO:0000269|PubMed:32669547}.
CC   -!- SUBUNIT: Component of the large ribosomal subunit.
CC       {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547}.
CC   -!- INTERACTION:
CC       P61513; P43360: MAGEA6; NbExp=6; IntAct=EBI-356793, EBI-1045155;
CC       P61513; P16284: PECAM1; NbExp=3; IntAct=EBI-356793, EBI-716404;
CC       P61513; P17612: PRKACA; NbExp=3; IntAct=EBI-356793, EBI-476586;
CC       P61513; P50454: SERPINH1; NbExp=3; IntAct=EBI-356793, EBI-350723;
CC       P61513; P37173: TGFBR2; NbExp=3; IntAct=EBI-356793, EBI-296151;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23636399}.
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eL43 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L06499; AAA60280.1; -; mRNA.
DR   EMBL; X66699; CAA47244.1; -; mRNA.
DR   EMBL; L22154; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK289472; BAF82161.1; -; mRNA.
DR   EMBL; CR542152; CAG46949.1; -; mRNA.
DR   EMBL; AC073321; AAY15078.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70569.1; -; Genomic_DNA.
DR   EMBL; BC000555; AAH00555.2; -; mRNA.
DR   EMBL; BC014262; AAH14262.1; -; mRNA.
DR   EMBL; BC016748; AAH16748.1; -; mRNA.
DR   EMBL; BC067789; AAH67789.1; -; mRNA.
DR   EMBL; BC082239; AAH82239.1; -; mRNA.
DR   CCDS; CCDS2404.1; -.
DR   PIR; JN0875; JN0875.
DR   RefSeq; NP_000989.1; NM_000998.4.
DR   PDB; 4UG0; EM; -; Lp=1-92.
DR   PDB; 4V6X; EM; 5.00 A; Cp=1-92.
DR   PDB; 5AJ0; EM; 3.50 A; Ap=1-92.
DR   PDB; 5LKS; EM; 3.60 A; Lp=1-92.
DR   PDB; 5T2C; EM; 3.60 A; j=1-92.
DR   PDB; 6IP5; EM; 3.90 A; 2j=1-92.
DR   PDB; 6IP6; EM; 4.50 A; 2j=1-92.
DR   PDB; 6IP8; EM; 3.90 A; 2j=1-92.
DR   PDB; 6LQM; EM; 3.09 A; X=1-92.
DR   PDB; 6LSR; EM; 3.13 A; X=1-92.
DR   PDB; 6LSS; EM; 3.23 A; X=1-92.
DR   PDB; 6LU8; EM; 3.13 A; X=1-92.
DR   PDB; 6OLE; EM; 3.10 A; q=2-92.
DR   PDB; 6OLF; EM; 3.90 A; q=2-92.
DR   PDB; 6OLG; EM; 3.40 A; Ap=2-92.
DR   PDB; 6OLI; EM; 3.50 A; q=2-92.
DR   PDB; 6OLZ; EM; 3.90 A; Ap=2-92.
DR   PDB; 6OM0; EM; 3.10 A; q=2-92.
DR   PDB; 6OM7; EM; 3.70 A; q=2-92.
DR   PDB; 6QZP; EM; 2.90 A; Lp=2-92.
DR   PDB; 6W6L; EM; 3.84 A; q=1-92.
DR   PDB; 6XA1; EM; 2.80 A; Lp=2-92.
DR   PDB; 6Y0G; EM; 3.20 A; Lp=1-92.
DR   PDB; 6Y2L; EM; 3.00 A; Lp=1-92.
DR   PDB; 6Y57; EM; 3.50 A; Lp=1-92.
DR   PDB; 6Y6X; EM; 2.80 A; Lp=2-92.
DR   PDB; 6Z6L; EM; 3.00 A; Lp=1-92.
DR   PDB; 6Z6M; EM; 3.10 A; Lp=1-92.
DR   PDB; 6Z6N; EM; 2.90 A; Lp=1-92.
DR   PDB; 6ZM7; EM; 2.70 A; Lp=1-92.
DR   PDB; 6ZME; EM; 3.00 A; Lp=1-92.
DR   PDB; 6ZMI; EM; 2.60 A; Lp=1-92.
DR   PDB; 6ZMO; EM; 3.10 A; Lp=1-92.
DR   PDB; 7BHP; EM; 3.30 A; Lp=1-92.
DR   PDB; 7F5S; EM; 2.72 A; Lp=1-92.
DR   PDB; 7OW7; EM; 2.20 A; j=1-92.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6LQM; -.
DR   PDBsum; 6LSR; -.
DR   PDBsum; 6LSS; -.
DR   PDBsum; 6LU8; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   PDBsum; 6W6L; -.
DR   PDBsum; 6XA1; -.
DR   PDBsum; 6Y0G; -.
DR   PDBsum; 6Y2L; -.
DR   PDBsum; 6Y57; -.
DR   PDBsum; 6Y6X; -.
DR   PDBsum; 6Z6L; -.
DR   PDBsum; 6Z6M; -.
DR   PDBsum; 6Z6N; -.
DR   PDBsum; 6ZM7; -.
DR   PDBsum; 6ZME; -.
DR   PDBsum; 6ZMI; -.
DR   PDBsum; 6ZMO; -.
DR   PDBsum; 7BHP; -.
DR   PDBsum; 7F5S; -.
DR   PDBsum; 7OW7; -.
DR   AlphaFoldDB; P61513; -.
DR   SMR; P61513; -.
DR   BioGRID; 112087; 372.
DR   ComplexPortal; CPX-5183; 60S cytosolic large ribosomal subunit.
DR   CORUM; P61513; -.
DR   IntAct; P61513; 163.
DR   MINT; P61513; -.
DR   STRING; 9606.ENSP00000418082; -.
DR   GlyGen; P61513; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P61513; -.
DR   MetOSite; P61513; -.
DR   PhosphoSitePlus; P61513; -.
DR   SwissPalm; P61513; -.
DR   BioMuta; RPL37A; -.
DR   DMDM; 47606455; -.
DR   EPD; P61513; -.
DR   jPOST; P61513; -.
DR   MassIVE; P61513; -.
DR   MaxQB; P61513; -.
DR   PaxDb; P61513; -.
DR   PeptideAtlas; P61513; -.
DR   ProteomicsDB; 57302; -.
DR   TopDownProteomics; P61513; -.
DR   Antibodypedia; 35073; 97 antibodies from 24 providers.
DR   DNASU; 6168; -.
DR   Ensembl; ENST00000491306.6; ENSP00000418082.1; ENSG00000197756.10.
DR   GeneID; 6168; -.
DR   KEGG; hsa:6168; -.
DR   MANE-Select; ENST00000491306.6; ENSP00000418082.1; NM_000998.5; NP_000989.1.
DR   UCSC; uc002vgf.4; human.
DR   AGR; HGNC:10348; -.
DR   CTD; 6168; -.
DR   DisGeNET; 6168; -.
DR   GeneCards; RPL37A; -.
DR   HGNC; HGNC:10348; RPL37A.
DR   HPA; ENSG00000197756; Low tissue specificity.
DR   MIM; 613314; gene.
DR   neXtProt; NX_P61513; -.
DR   OpenTargets; ENSG00000197756; -.
DR   PharmGKB; PA34737; -.
DR   VEuPathDB; HostDB:ENSG00000197756; -.
DR   eggNOG; KOG0402; Eukaryota.
DR   GeneTree; ENSGT00390000016988; -.
DR   HOGENOM; CLU_141199_1_0_1; -.
DR   InParanoid; P61513; -.
DR   OMA; ISTGIWQ; -.
DR   OrthoDB; 5245971at2759; -.
DR   PhylomeDB; P61513; -.
DR   TreeFam; TF313068; -.
DR   PathwayCommons; P61513; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; P61513; -.
DR   SIGNOR; P61513; -.
DR   BioGRID-ORCS; 6168; 839 hits in 1138 CRISPR screens.
DR   ChiTaRS; RPL37A; human.
DR   GeneWiki; RPL37A; -.
DR   GenomeRNAi; 6168; -.
DR   Pharos; P61513; Tbio.
DR   PRO; PR:P61513; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P61513; protein.
DR   Bgee; ENSG00000197756; Expressed in upper leg skin and 207 other tissues.
DR   ExpressionAtlas; P61513; baseline and differential.
DR   Genevisible; P61513; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:ComplexPortal.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0022626; C:cytosolic ribosome; IDA:FlyBase.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB.
DR   GO; GO:0002181; P:cytoplasmic translation; NAS:ComplexPortal.
DR   GO; GO:0006412; P:translation; NAS:UniProtKB.
DR   Gene3D; 2.20.25.30; -; 1.
DR   HAMAP; MF_00327; Ribosomal_L37Ae; 1.
DR   InterPro; IPR002674; Ribosomal_L37ae.
DR   InterPro; IPR011331; Ribosomal_L37ae/L37e.
DR   InterPro; IPR011332; Ribosomal_zn-bd.
DR   PANTHER; PTHR48188:SF2; 60S RIBOSOMAL PROTEIN L37A-LIKE PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48188; 60S RIBOSOMAL PROTEIN L43; 1.
DR   Pfam; PF01780; Ribosomal_L37ae; 1.
DR   SUPFAM; SSF57829; Zn-binding ribosomal proteins; 1.
DR   TIGRFAMs; TIGR00280; eL43_euk_arch; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Metal-binding; Reference proteome;
KW   Ribonucleoprotein; Ribosomal protein; Zinc; Zinc-finger.
FT   CHAIN           1..92
FT                   /note="60S ribosomal protein L37a"
FT                   /id="PRO_0000139817"
FT   ZN_FING         39..60
FT                   /note="C4-type"
FT   BINDING         39
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         42
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         57
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         60
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
SQ   SEQUENCE   92 AA;  10275 MW;  7122AF87B0E24CF6 CRC64;
     MAKRTKKVGI VGKYGTRYGA SLRKMVKKIE ISQHAKYTCS FCGKTKMKRR AVGIWHCGSC
     MKTVAGGAWT YNTTSAVTVK SAIRRLKELK DQ
//
ID   RL37_HUMAN              Reviewed;          97 AA.
AC   P61927; B2R4H2; P02403; Q6IBB4; Q99883;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-FEB-2023, entry version 167.
DE   RecName: Full=60S ribosomal protein L37;
DE   AltName: Full=G1.16;
DE   AltName: Full=Large ribosomal subunit protein eL37 {ECO:0000303|PubMed:24524803};
GN   Name=RPL37;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lymphoma;
RA   Kato S.;
RT   "Cloning of human ribosomal protein L37 cDNA.";
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Colon;
RX   PubMed=7545944; DOI=10.1016/0167-4781(94)90197-x;
RA   Barnard G.F., Staniunas R.J., Puder M., Steele G.D. Jr., Chen L.B.;
RT   "Human ribosomal protein L37 has motifs predicting serine/threonine
RT   phosphorylation and a zinc-finger domain.";
RL   Biochim. Biophys. Acta 1218:425-428(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7588717; DOI=10.1111/j.1432-1033.1995.tb20874.x;
RA   Su S., Bird R.C.;
RT   "Cell cycle, differentiation and tissue-independent expression of ribosomal
RT   protein L37.";
RL   Eur. J. Biochem. 232:789-797(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11875025; DOI=10.1101/gr.214202;
RA   Yoshihama M., Uechi T., Asakawa S., Kawasaki K., Kato S., Higa S.,
RA   Maeda N., Minoshima S., Tanaka T., Shimizu N., Kenmochi N.;
RT   "The human ribosomal protein genes: sequencing and comparative analysis of
RT   73 genes.";
RL   Genome Res. 12:379-390(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 48-74 AND 76-97.
RX   PubMed=9582194; DOI=10.1101/gr.8.5.509;
RA   Kenmochi N., Kawaguchi T., Rozen S., Davis E., Goodman N., Hudson T.J.,
RA   Tanaka T., Page D.C.;
RT   "A map of 75 human ribosomal protein genes.";
RL   Genome Res. 8:509-523(1998).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-10, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND SER-97, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
RN   [18] {ECO:0007744|PDB:6LQM, ECO:0007744|PDB:6LSR, ECO:0007744|PDB:6LSS, ECO:0007744|PDB:6LU8}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.09 ANGSTROMS), FUNCTION, AND SUBUNIT.
RX   PubMed=32669547; DOI=10.1038/s41467-020-17237-x;
RA   Liang X., Zuo M.Q., Zhang Y., Li N., Ma C., Dong M.Q., Gao N.;
RT   "Structural snapshots of human pre-60S ribosomal particles before and after
RT   nuclear export.";
RL   Nat. Commun. 11:3542-3542(2020).
CC   -!- FUNCTION: Component of the large ribosomal subunit (PubMed:23636399,
CC       PubMed:32669547). The ribosome is a large ribonucleoprotein complex
CC       responsible for the synthesis of proteins in the cell (PubMed:23636399,
CC       PubMed:32669547). {ECO:0000269|PubMed:23636399,
CC       ECO:0000269|PubMed:32669547}.
CC   -!- SUBUNIT: Component of the large ribosomal subunit.
CC       {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23636399}.
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eL37 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D23661; BAA04888.1; -; mRNA.
DR   EMBL; L11567; AAA62148.1; -; mRNA.
DR   EMBL; S79979; AAB47039.2; -; mRNA.
DR   EMBL; AB061834; BAB79472.1; -; Genomic_DNA.
DR   EMBL; CR456890; CAG33171.1; -; mRNA.
DR   EMBL; AK311827; BAG34769.1; -; mRNA.
DR   EMBL; BC079477; AAH79477.1; -; mRNA.
DR   EMBL; BC084576; AAH84576.1; -; mRNA.
DR   EMBL; AB007184; BAA25843.1; -; Genomic_DNA.
DR   EMBL; AB007183; BAA25842.1; -; Genomic_DNA.
DR   CCDS; CCDS3934.1; -.
DR   PIR; S47646; S47646.
DR   RefSeq; NP_000988.1; NM_000997.4.
DR   PDB; 4UG0; EM; -; Lj=1-97.
DR   PDB; 4V6X; EM; 5.00 A; Cj=1-97.
DR   PDB; 5AJ0; EM; 3.50 A; Aj=1-97.
DR   PDB; 5LKS; EM; 3.60 A; Lj=1-97.
DR   PDB; 5T2C; EM; 3.60 A; d=1-97.
DR   PDB; 6IP5; EM; 3.90 A; 2d=1-97.
DR   PDB; 6IP6; EM; 4.50 A; 2d=1-97.
DR   PDB; 6IP8; EM; 3.90 A; 2d=1-97.
DR   PDB; 6LQM; EM; 3.09 A; M=1-97.
DR   PDB; 6LSR; EM; 3.13 A; M=1-97.
DR   PDB; 6LSS; EM; 3.23 A; M=1-97.
DR   PDB; 6LU8; EM; 3.13 A; M=1-97.
DR   PDB; 6OLE; EM; 3.10 A; k=2-85.
DR   PDB; 6OLF; EM; 3.90 A; k=2-85.
DR   PDB; 6OLG; EM; 3.40 A; Aj=2-85.
DR   PDB; 6OLI; EM; 3.50 A; k=2-85.
DR   PDB; 6OLZ; EM; 3.90 A; Aj=2-85.
DR   PDB; 6OM0; EM; 3.10 A; k=2-85.
DR   PDB; 6OM7; EM; 3.70 A; k=2-85.
DR   PDB; 6QZP; EM; 2.90 A; Lj=2-87.
DR   PDB; 6W6L; EM; 3.84 A; k=1-97.
DR   PDB; 6XA1; EM; 2.80 A; Lj=2-87.
DR   PDB; 6Y0G; EM; 3.20 A; Lj=1-97.
DR   PDB; 6Y2L; EM; 3.00 A; Lj=1-97.
DR   PDB; 6Y57; EM; 3.50 A; Lj=1-97.
DR   PDB; 6Y6X; EM; 2.80 A; Lj=2-87.
DR   PDB; 6Z6L; EM; 3.00 A; Lj=1-97.
DR   PDB; 6Z6M; EM; 3.10 A; Lj=1-97.
DR   PDB; 6Z6N; EM; 2.90 A; Lj=1-97.
DR   PDB; 6ZM7; EM; 2.70 A; Lj=1-97.
DR   PDB; 6ZME; EM; 3.00 A; Lj=1-97.
DR   PDB; 6ZMI; EM; 2.60 A; Lj=1-97.
DR   PDB; 6ZMO; EM; 3.10 A; Lj=1-97.
DR   PDB; 7BHP; EM; 3.30 A; Lj=1-97.
DR   PDB; 7F5S; EM; 2.72 A; Lj=1-97.
DR   PDB; 7OW7; EM; 2.20 A; d=1-97.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6LQM; -.
DR   PDBsum; 6LSR; -.
DR   PDBsum; 6LSS; -.
DR   PDBsum; 6LU8; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   PDBsum; 6W6L; -.
DR   PDBsum; 6XA1; -.
DR   PDBsum; 6Y0G; -.
DR   PDBsum; 6Y2L; -.
DR   PDBsum; 6Y57; -.
DR   PDBsum; 6Y6X; -.
DR   PDBsum; 6Z6L; -.
DR   PDBsum; 6Z6M; -.
DR   PDBsum; 6Z6N; -.
DR   PDBsum; 6ZM7; -.
DR   PDBsum; 6ZME; -.
DR   PDBsum; 6ZMI; -.
DR   PDBsum; 6ZMO; -.
DR   PDBsum; 7BHP; -.
DR   PDBsum; 7F5S; -.
DR   PDBsum; 7OW7; -.
DR   AlphaFoldDB; P61927; -.
DR   SMR; P61927; -.
DR   BioGRID; 112086; 289.
DR   ComplexPortal; CPX-5183; 60S cytosolic large ribosomal subunit.
DR   CORUM; P61927; -.
DR   IntAct; P61927; 27.
DR   MINT; P61927; -.
DR   STRING; 9606.ENSP00000274242; -.
DR   DrugBank; DB02494; (S)-3-phenyllactic acid.
DR   DrugBank; DB07374; Anisomycin.
DR   DrugBank; DB08437; Puromycin.
DR   DrugBank; DB04602; PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE.
DR   DrugBank; DB04805; Virginiamycin S1.
DR   GlyCosmos; P61927; 1 site, 1 glycan.
DR   GlyGen; P61927; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P61927; -.
DR   PhosphoSitePlus; P61927; -.
DR   BioMuta; RPL37; -.
DR   DMDM; 48429090; -.
DR   EPD; P61927; -.
DR   jPOST; P61927; -.
DR   MassIVE; P61927; -.
DR   MaxQB; P61927; -.
DR   PaxDb; P61927; -.
DR   PeptideAtlas; P61927; -.
DR   ProteomicsDB; 57340; -.
DR   TopDownProteomics; P61927; -.
DR   Antibodypedia; 23151; 139 antibodies from 23 providers.
DR   DNASU; 6167; -.
DR   Ensembl; ENST00000274242.10; ENSP00000274242.5; ENSG00000145592.14.
DR   GeneID; 6167; -.
DR   KEGG; hsa:6167; -.
DR   MANE-Select; ENST00000274242.10; ENSP00000274242.5; NM_000997.5; NP_000988.1.
DR   UCSC; uc021xxr.2; human.
DR   AGR; HGNC:10347; -.
DR   CTD; 6167; -.
DR   DisGeNET; 6167; -.
DR   GeneCards; RPL37; -.
DR   HGNC; HGNC:10347; RPL37.
DR   HPA; ENSG00000145592; Low tissue specificity.
DR   MIM; 604181; gene.
DR   neXtProt; NX_P61927; -.
DR   OpenTargets; ENSG00000145592; -.
DR   PharmGKB; PA34736; -.
DR   VEuPathDB; HostDB:ENSG00000145592; -.
DR   eggNOG; KOG3475; Eukaryota.
DR   GeneTree; ENSGT00390000005254; -.
DR   HOGENOM; CLU_150908_0_0_1; -.
DR   InParanoid; P61927; -.
DR   OrthoDB; 5471297at2759; -.
DR   PhylomeDB; P61927; -.
DR   TreeFam; TF300260; -.
DR   PathwayCommons; P61927; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; P61927; -.
DR   SIGNOR; P61927; -.
DR   BioGRID-ORCS; 6167; 650 hits in 1128 CRISPR screens.
DR   ChiTaRS; RPL37; human.
DR   GeneWiki; RPL37; -.
DR   GenomeRNAi; 6167; -.
DR   Pharos; P61927; Tbio.
DR   PRO; PR:P61927; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P61927; protein.
DR   Bgee; ENSG00000145592; Expressed in germinal epithelium of ovary and 211 other tissues.
DR   ExpressionAtlas; P61927; baseline and differential.
DR   Genevisible; P61927; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:ComplexPortal.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0022626; C:cytosolic ribosome; IDA:FlyBase.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; IPI:FlyBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0019843; F:rRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB.
DR   GO; GO:1990948; F:ubiquitin ligase inhibitor activity; IDA:FlyBase.
DR   GO; GO:0002181; P:cytoplasmic translation; NAS:ComplexPortal.
DR   GO; GO:1901798; P:positive regulation of signal transduction by p53 class mediator; IDA:FlyBase.
DR   GO; GO:0006412; P:translation; TAS:UniProtKB.
DR   Gene3D; 2.20.25.30; -; 1.
DR   HAMAP; MF_00547; Ribosomal_L37e; 1.
DR   InterPro; IPR011331; Ribosomal_L37ae/L37e.
DR   InterPro; IPR001569; Ribosomal_L37e.
DR   InterPro; IPR018267; Ribosomal_L37e_CS.
DR   InterPro; IPR011332; Ribosomal_zn-bd.
DR   PANTHER; PTHR10768; 60S RIBOSOMAL PROTEIN L37; 1.
DR   PANTHER; PTHR10768:SF22; 60S RIBOSOMAL PROTEIN L37; 1.
DR   Pfam; PF01907; Ribosomal_L37e; 1.
DR   SUPFAM; SSF57829; Zn-binding ribosomal proteins; 1.
DR   PROSITE; PS01077; RIBOSOMAL_L37E; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Metal-binding; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; Ribosomal protein; RNA-binding;
KW   rRNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..97
FT                   /note="60S ribosomal protein L37"
FT                   /id="PRO_0000139705"
FT   ZN_FING         19..37
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   BINDING         19
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         22
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         34
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   BINDING         37
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P49166"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   CONFLICT        65
FT                   /note="R -> S (in Ref. 3; AAB47039)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   97 AA;  11078 MW;  F565A11E983027C9 CRC64;
     MTKGTSSFGK RRNKTHTLCR RCGSKAYHLQ KSTCGKCGYP AKRKRKYNWS AKAKRRNTTG
     TGRMRHLKIV YRRFRHGFRE GTTPKPKRAA VAASSSS
//
ID   CNBP_HUMAN              Reviewed;         177 AA.
AC   P62633; A8K7V4; B2RAV9; B4DP17; D3DNB9; D3DNC0; D3DNC1; E9PDR7; P20694;
AC   Q4JGY0; Q4JGY1; Q5QJR0; Q5U0E9; Q6PJI7; Q96NV3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   22-FEB-2023, entry version 174.
DE   RecName: Full=CCHC-type zinc finger nucleic acid binding protein {ECO:0000312|HGNC:HGNC:13164};
DE   AltName: Full=Cellular nucleic acid-binding protein {ECO:0000305};
DE            Short=CNBP {ECO:0000305};
DE   AltName: Full=Zinc finger protein 9;
GN   Name=CNBP {ECO:0000312|HGNC:HGNC:13164}; Synonyms=RNF163, ZNF9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   INDUCTION BY STEROL.
RX   PubMed=2562787; DOI=10.1126/science.2562787;
RA   Rajavashisth T.B., Taylor A.K., Andalibi A., Svenson K.L., Lusis A.J.;
RT   "Identification of a zinc finger protein that binds to the sterol
RT   regulatory element.";
RL   Science 245:640-643(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7590281; DOI=10.1016/0378-1119(95)00421-2;
RA   Flink I.L., Morkin E.;
RT   "Organization of the gene encoding cellular nucleic acid-binding protein.";
RL   Gene 163:279-282(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND DISEASE.
RX   PubMed=11486088; DOI=10.1126/science.1062125;
RA   Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W.,
RA   Naylor S.L., Day J.W., Ranum L.P.;
RT   "Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of
RT   ZNF9.";
RL   Science 293:864-867(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5 AND 8).
RA   Yang F., Yan H., Zhang S.;
RT   "Cloning of novel transcript variants of human cellular nucleic acid
RT   binding protein.";
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 6 AND 7).
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   METHYLATION AT ARG-25 AND ARG-27, AND MUTAGENESIS OF ARG-25 AND ARG-27.
RX   PubMed=24726729; DOI=10.1016/j.febslet.2014.03.052;
RA   Wei H.M., Hu H.H., Chang G.Y., Lee Y.J., Li Y.C., Chang H.H., Li C.;
RT   "Arginine methylation of the cellular nucleic acid binding protein does not
RT   affect its subcellular localization but impedes RNA binding.";
RL   FEBS Lett. 588:1542-1548(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-79, METHYLATION [LARGE SCALE
RP   ANALYSIS] AT ARG-32 AND ARG-34 (ISOFORMS 2; 5 AND 8), METHYLATION [LARGE
RP   SCALE ANALYSIS] AT ARG-80 (ISOFORM 4), METHYLATION [LARGE SCALE ANALYSIS]
RP   AT ARG-73 (ISOFORM 8), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   FUNCTION (ISOFORMS 1; 2; 4; 5; 6 AND 8), ASSOCIATION WITH RIBOSOMES AND
RP   POLYSOMES, AND SUBCELLULAR LOCATION (ISOFORMS 1; 2; 4; 5; 6 AND 8).
RX   PubMed=28329689; DOI=10.1016/j.celrep.2017.02.080;
RA   Benhalevy D., Gupta S.K., Danan C.H., Ghosal S., Sun H.W., Kazemier H.G.,
RA   Paeschke K., Hafner M., Juranek S.A.;
RT   "The Human CCHC-type Zinc Finger Nucleic Acid-Binding Protein Binds G-Rich
RT   Elements in Target mRNA Coding Sequences and Promotes Translation.";
RL   Cell Rep. 18:2979-2990(2017).
CC   -!- FUNCTION: Single-stranded DNA-binding protein that preferentially binds
CC       to the sterol regulatory element (SRE) sequence 5'-GTGCGGTG-3', and
CC       thereby mediates transcriptional repression (PubMed:2562787). Has a
CC       role as transactivator of the Myc promoter (By similarity). Binds
CC       single-stranded RNA in a sequence-specific manner (By similarity).
CC       {ECO:0000250|UniProtKB:P53996, ECO:0000250|UniProtKB:P62634,
CC       ECO:0000269|PubMed:2562787}.
CC   -!- FUNCTION: [Isoform 1]: Binds G-rich elements in target mRNA coding
CC       sequences (PubMed:28329689). Prevents G-quadruplex structure formation
CC       in vitro, suggesting a role in supporting translation by resolving
CC       stable structures on mRNAs (PubMed:28329689).
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- FUNCTION: [Isoform 2]: Binds to RNA. {ECO:0000269|PubMed:28329689}.
CC   -!- FUNCTION: [Isoform 4]: Binds to RNA. {ECO:0000269|PubMed:28329689}.
CC   -!- FUNCTION: [Isoform 5]: Binds to RNA. {ECO:0000269|PubMed:28329689}.
CC   -!- FUNCTION: [Isoform 6]: Binds to RNA. {ECO:0000269|PubMed:28329689}.
CC   -!- FUNCTION: [Isoform 8]: Binds to RNA. {ECO:0000269|PubMed:28329689}.
CC   -!- SUBUNIT: Associates with the 40S ribosomal subunit, the 80S ribosome
CC       and with polysomes. {ECO:0000269|PubMed:28329689}.
CC   -!- INTERACTION:
CC       P62633; Q63009: Prmt1; Xeno; NbExp=2; IntAct=EBI-1047529, EBI-78708;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P53996}. Cytoplasm
CC       {ECO:0000269|PubMed:28329689}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P53996}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 6]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 8]: Cytoplasm
CC       {ECO:0000269|PubMed:28329689}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=P62633-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P62633-2; Sequence=VSP_010981;
CC       Name=3;
CC         IsoId=P62633-3; Sequence=VSP_010982;
CC       Name=4;
CC         IsoId=P62633-4; Sequence=VSP_043304;
CC       Name=5;
CC         IsoId=P62633-5; Sequence=VSP_010981, VSP_043424;
CC       Name=6;
CC         IsoId=P62633-6; Sequence=VSP_043424;
CC       Name=7;
CC         IsoId=P62633-7; Sequence=VSP_055084;
CC       Name=8;
CC         IsoId=P62633-8; Sequence=VSP_010981, VSP_043304;
CC   -!- TISSUE SPECIFICITY: Expressed in the liver, kidney, spleen, testis,
CC       lung, muscle and adrenal glands. {ECO:0000269|PubMed:2562787}.
CC   -!- INDUCTION: Transcriptionally up-regulated by sterol treatment.
CC       {ECO:0000269|PubMed:2562787}.
CC   -!- PTM: Arginine methylation by PRMT1 in the Arg/Gly-rich region impedes
CC       RNA binding. {ECO:0000269|PubMed:24726729}.
CC   -!- DISEASE: Dystrophia myotonica 2 (DM2) [MIM:602668]: A multisystem
CC       disease characterized by the association of proximal muscle weakness
CC       with myotonia, cardiac manifestations and cataract. Additional features
CC       can include hyperhidrosis, testicular atrophy, insulin resistance and
CC       diabetes and central nervous system anomalies in rare cases. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. The causative mutation is a CCTG expansion (mean approximately
CC       5000 repeats) located in intron 1 of the CNBP gene.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M28372; AAA61975.1; -; mRNA.
DR   EMBL; U19765; AAA91782.1; -; Genomic_DNA.
DR   EMBL; AY329622; AAR89462.1; -; Genomic_DNA.
DR   EMBL; DQ092366; AAY96754.1; -; mRNA.
DR   EMBL; DQ092367; AAY96755.1; -; mRNA.
DR   EMBL; DQ091187; AAY89856.1; -; mRNA.
DR   EMBL; AK054592; BAB70769.1; -; mRNA.
DR   EMBL; AK298154; BAG60429.1; -; mRNA.
DR   EMBL; AK292119; BAF84808.1; -; mRNA.
DR   EMBL; AK314380; BAG37006.1; -; mRNA.
DR   EMBL; BT019613; AAV38419.1; -; mRNA.
DR   EMBL; AC108673; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79271.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79272.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79273.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79274.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79275.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79277.1; -; Genomic_DNA.
DR   EMBL; BC000288; AAH00288.1; -; mRNA.
DR   EMBL; BC014911; AAH14911.1; -; mRNA.
DR   EMBL; BC093058; AAH93058.1; -; mRNA.
DR   CCDS; CCDS3056.1; -. [P62633-1]
DR   CCDS; CCDS46906.1; -. [P62633-6]
DR   CCDS; CCDS46907.1; -. [P62633-4]
DR   CCDS; CCDS46908.1; -. [P62633-5]
DR   CCDS; CCDS54637.1; -. [P62633-2]
DR   PIR; A32760; A32760.
DR   RefSeq; NP_001120664.1; NM_001127192.1. [P62633-6]
DR   RefSeq; NP_001120665.1; NM_001127193.1. [P62633-4]
DR   RefSeq; NP_001120666.1; NM_001127194.1. [P62633-5]
DR   RefSeq; NP_001120667.1; NM_001127195.1. [P62633-8]
DR   RefSeq; NP_001120668.1; NM_001127196.1. [P62633-2]
DR   RefSeq; NP_003409.1; NM_003418.4. [P62633-1]
DR   AlphaFoldDB; P62633; -.
DR   SASBDB; P62633; -.
DR   BioGRID; 113387; 268.
DR   IntAct; P62633; 135.
DR   MINT; P62633; -.
DR   STRING; 9606.ENSP00000410769; -.
DR   GlyGen; P62633; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P62633; -.
DR   PhosphoSitePlus; P62633; -.
DR   SwissPalm; P62633; -.
DR   BioMuta; CNBP; -.
DR   DMDM; 50401852; -.
DR   CPTAC; CPTAC-480; -.
DR   CPTAC; CPTAC-481; -.
DR   EPD; P62633; -.
DR   jPOST; P62633; -.
DR   MassIVE; P62633; -.
DR   MaxQB; P62633; -.
DR   PaxDb; P62633; -.
DR   PeptideAtlas; P62633; -.
DR   ProteomicsDB; 19732; -.
DR   ProteomicsDB; 4742; -.
DR   ProteomicsDB; 57408; -. [P62633-1]
DR   ProteomicsDB; 57409; -. [P62633-2]
DR   ProteomicsDB; 57410; -. [P62633-3]
DR   ProteomicsDB; 57411; -. [P62633-4]
DR   ProteomicsDB; 57412; -. [P62633-5]
DR   Antibodypedia; 33233; 338 antibodies from 32 providers.
DR   DNASU; 7555; -.
DR   Ensembl; ENST00000422453.7; ENSP00000410619.3; ENSG00000169714.17. [P62633-1]
DR   Ensembl; ENST00000441626.6; ENSP00000410769.2; ENSG00000169714.17. [P62633-6]
DR   Ensembl; ENST00000446936.6; ENSP00000400444.2; ENSG00000169714.17. [P62633-5]
DR   Ensembl; ENST00000451728.6; ENSP00000399488.2; ENSG00000169714.17. [P62633-4]
DR   Ensembl; ENST00000500450.6; ENSP00000426223.1; ENSG00000169714.17. [P62633-7]
DR   Ensembl; ENST00000502976.5; ENSP00000421323.1; ENSG00000169714.17. [P62633-2]
DR   Ensembl; ENST00000504813.5; ENSP00000422110.1; ENSG00000169714.17. [P62633-3]
DR   GeneID; 7555; -.
DR   KEGG; hsa:7555; -.
DR   MANE-Select; ENST00000422453.7; ENSP00000410619.3; NM_003418.5; NP_003409.1.
DR   UCSC; uc003elq.5; human. [P62633-1]
DR   AGR; HGNC:13164; -.
DR   CTD; 7555; -.
DR   DisGeNET; 7555; -.
DR   GeneCards; CNBP; -.
DR   GeneReviews; CNBP; -.
DR   HGNC; HGNC:13164; CNBP.
DR   HPA; ENSG00000169714; Low tissue specificity.
DR   MalaCards; CNBP; -.
DR   MIM; 116955; gene.
DR   MIM; 602668; phenotype.
DR   neXtProt; NX_P62633; -.
DR   OpenTargets; ENSG00000169714; -.
DR   Orphanet; 606; Proximal myotonic myopathy.
DR   PharmGKB; PA37737; -.
DR   VEuPathDB; HostDB:ENSG00000169714; -.
DR   eggNOG; KOG4400; Eukaryota.
DR   GeneTree; ENSGT00950000183041; -.
DR   HOGENOM; CLU_058879_4_0_1; -.
DR   InParanoid; P62633; -.
DR   OMA; SHQARDC; -.
DR   OrthoDB; 147033at2759; -.
DR   PhylomeDB; P62633; -.
DR   TreeFam; TF316974; -.
DR   PathwayCommons; P62633; -.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; P62633; -.
DR   SIGNOR; P62633; -.
DR   BioGRID-ORCS; 7555; 41 hits in 1166 CRISPR screens.
DR   ChiTaRS; CNBP; human.
DR   GeneWiki; CNBP; -.
DR   GenomeRNAi; 7555; -.
DR   Pharos; P62633; Tbio.
DR   PRO; PR:P62633; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P62633; protein.
DR   Bgee; ENSG00000169714; Expressed in skeletal muscle tissue of rectus abdominis and 205 other tissues.
DR   ExpressionAtlas; P62633; baseline and differential.
DR   Genevisible; P62633; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0051880; F:G-quadruplex DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0003727; F:single-stranded RNA binding; IBA:GO_Central.
DR   GO; GO:0045182; F:translation regulator activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0042632; P:cholesterol homeostasis; TAS:GO_Central.
DR   GO; GO:0071919; P:G-quadruplex DNA formation; IDA:ARUK-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:ProtInc.
DR   Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 5.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   PANTHER; PTHR23002:SF67; CELLULAR NUCLEIC ACID-BINDING PROTEIN; 1.
DR   PANTHER; PTHR23002; ZINC FINGER CCHC DOMAIN CONTAINING PROTEIN; 1.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; DNA-binding;
KW   Endoplasmic reticulum; Metal-binding; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..177
FT                   /note="CCHC-type zinc finger nucleic acid binding protein"
FT                   /id="PRO_0000089965"
FT   ZN_FING         4..21
FT                   /note="CCHC-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         52..69
FT                   /note="CCHC-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         72..89
FT                   /note="CCHC-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         96..113
FT                   /note="CCHC-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         117..134
FT                   /note="CCHC-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         135..152
FT                   /note="CCHC-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         156..173
FT                   /note="CCHC-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   REGION          25..38
FT                   /note="RNA-binding Arg/Gly-rich region (RGG-box)"
FT                   /evidence="ECO:0000269|PubMed:28329689"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P53996"
FT   MOD_RES         25
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MOD_RES         27
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53996"
FT   MOD_RES         79
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         35..51
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055084"
FT   VAR_SEQ         36..42
FT                   /note="Missing (in isoform 2, isoform 5 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4"
FT                   /id="VSP_010981"
FT   VAR_SEQ         42..51
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010982"
FT   VAR_SEQ         72
FT                   /note="D -> DE (in isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.6"
FT                   /id="VSP_043304"
FT   VAR_SEQ         72
FT                   /note="D -> DVE (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.4"
FT                   /id="VSP_043424"
FT   MUTAGEN         25
FT                   /note="R->K: Significantly reduces methylation; when
FT                   associated with K-27."
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MUTAGEN         27
FT                   /note="R->K: Significantly reduces methylation; when
FT                   associated with K-25."
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   CONFLICT        6
FT                   /note="C -> R (in Ref. 5; BAF84808)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P62633-2:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-2:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-4:80
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-5:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-5:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-8:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-8:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         P62633-8:73
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
SQ   SEQUENCE   177 AA;  19463 MW;  996F398285F52618 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGGFTSD RGFQFVSSSL PDICYRCGES
     GHLAKDCDLQ EDACYNCGRG GHIAKDCKEP KREREQCCYN CGKPGHLARD CDHADEQKCY
     SCGEFGHIQK DCTKVKCYRC GETGHVAINC SKTSEVNCYR CGESGHLARE CTIEATA
//
ID   RBX1_HUMAN              Reviewed;         108 AA.
AC   P62877; B2RDY1; Q8N6Z8; Q9D1S2; Q9WUK9; Q9Y254;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   22-FEB-2023, entry version 190.
DE   RecName: Full=E3 ubiquitin-protein ligase RBX1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11027288};
DE            EC=2.3.2.32 {ECO:0000269|PubMed:11027288};
DE   AltName: Full=E3 ubiquitin-protein transferase RBX1 {ECO:0000305};
DE   AltName: Full=Protein ZYP;
DE   AltName: Full=RING finger protein 75;
DE   AltName: Full=RING-box protein 1;
DE            Short=Rbx1;
DE   AltName: Full=Regulator of cullins 1;
DE            Short=ROC1 {ECO:0000303|PubMed:10230407};
DE   Contains:
DE     RecName: Full=E3 ubiquitin-protein ligase RBX1, N-terminally processed;
DE     AltName: Full=E3 ubiquitin-protein transferase RBX1, N-terminally processed {ECO:0000305};
GN   Name=RBX1 {ECO:0000312|HGNC:HGNC:9928};
GN   Synonyms=RNF75, ROC1 {ECO:0000303|PubMed:10230407};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, PATHWAY, INTERACTION WITH CULLINS,
RP   DOMAIN, AND MUTAGENESIS OF CYS-53; CYS-56; CYS-75 AND HIS-77.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10230407; DOI=10.1016/s1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with an
RT   associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND IDENTIFICATION IN CBC(VHL) COMPLEX.
RX   PubMed=10213691; DOI=10.1126/science.284.5414.657;
RA   Kamura T., Koepp D.M., Conrad M.N., Skowyra D., Moreland R.J.,
RA   Iliopoulos O., Lane W.S., Kaelin W.G. Jr., Elledge S.J., Conaway R.C.,
RA   Harper J.W., Conaway J.W.;
RT   "Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin
RT   ligase.";
RL   Science 284:657-661(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-20, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 14-108.
RC   TISSUE=Brain;
RX   PubMed=10643962;
RA   Perin J.-P., Seddiqi N., Charbonnier F., Goudou D., Belkadi L., Rieger F.,
RA   Alliel P.M.;
RT   "Genomic organization and expression of the ubiquitin-proteasome complex-
RT   associated protein Rbx1/ROC1/Hrt1.";
RL   Cell. Mol. Biol. 45:1131-1137(1999).
RN   [10]
RP   PROTEIN SEQUENCE OF 92-105, INTERACTION WITH CUL1, AND IDENTIFICATION IN A
RP   COMPLEX WITH CUL1; SKP1 AND SKP2.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10230406; DOI=10.1016/s1097-2765(00)80481-5;
RA   Tan P., Fuchs S.Y., Chen A., Wu K., Gomez C., Ronai Z., Pan Z.-Q.;
RT   "Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze
RT   the ubiquitination of I kappa B alpha.";
RL   Mol. Cell 3:527-533(1999).
RN   [11]
RP   FUNCTION.
RX   PubMed=10579999; DOI=10.1101/gad.13.22.2928;
RA   Kamura T., Conrad M.N., Yan Q., Conaway R.C., Conaway J.W.;
RT   "The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1
RT   modification of cullins Cdc53 and Cul2.";
RL   Genes Dev. 13:2928-2933(1999).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND PATHWAY.
RX   PubMed=11027288; DOI=10.1128/mcb.20.21.8185-8197.2000;
RA   Furukawa M., Zhang Y., McCarville J., Ohta T., Xiong Y.;
RT   "The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear
RT   accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1.";
RL   Mol. Cell. Biol. 20:8185-8197(2000).
RN   [13]
RP   IDENTIFICATION IN E3 UBIQUITIN-PROTEIN LIGASE COMPLEX WITH MUF1, AND
RP   IDENTIFICATION IN COMPLEXES WITH CUL5.
RX   PubMed=11384984; DOI=10.1074/jbc.m103093200;
RA   Kamura T., Burian D., Yan Q., Schmidt S.L., Lane W.S., Querido E.,
RA   Branton P.E., Shilatifard A., Conaway R.C., Conaway J.W.;
RT   "Muf1, a novel elongin BC-interacting leucine-rich repeat protein that can
RT   assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.";
RL   J. Biol. Chem. 276:29748-29753(2001).
RN   [14]
RP   INTERACTION WITH COPS6.
RX   PubMed=11337588; DOI=10.1126/science.1059780;
RA   Lyapina S., Cope G., Shevchenko A., Serino G., Tsuge T., Zhou C.,
RA   Wolf D.A., Wei N., Shevchenko A., Deshaies R.J.;
RT   "Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome.";
RL   Science 292:1382-1385(2001).
RN   [15]
RP   IDENTIFICATION IN E3 UBIQUITIN-PROTEIN LIGASE COMPLEX WITH MED8.
RX   PubMed=12149480; DOI=10.1073/pnas.162424199;
RA   Brower C.S., Sato S., Tomomori-Sato C., Kamura T., Pause A., Stearman R.,
RA   Klausner R.D., Malik S., Lane W.S., Sorokina I., Roeder R.G., Conaway J.W.,
RA   Conaway R.C.;
RT   "Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that
RT   can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:10353-10358(2002).
RN   [16]
RP   IDENTIFICATION IN SCF-LIKE COMPLEX, AND INTERACTION WITH CUL7.
RX   PubMed=12481031; DOI=10.1073/pnas.252646399;
RA   Dias D.C., Dolios G., Wang R., Pan Z.Q.;
RT   "CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form
RT   an SCF-like complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16601-16606(2002).
RN   [17]
RP   IDENTIFICATION IN THE CSA COMPLEX WITH ERCC8; DDB1 AND CUL4A, AND
RP   INTERACTION OF THE CSA COMPLEX WITH RNA POLYMERASE II AND THE COP9
RP   SIGNALOSOME.
RX   PubMed=12732143; DOI=10.1016/s0092-8674(03)00316-7;
RA   Groisman R., Polanowska J., Kuraoka I., Sawada J., Saijo M., Drapkin R.,
RA   Kisselev A.F., Tanaka K., Nakatani Y.;
RT   "The ubiquitin ligase activity in the DDB2 and CSA complexes is
RT   differentially regulated by the COP9 signalosome in response to DNA
RT   damage.";
RL   Cell 113:357-367(2003).
RN   [18]
RP   IDENTIFICATION IN THE DCX DET1-COP1 COMPLEX WITH DDB1; CUL4A; COP1 AND
RP   DET1.
RX   PubMed=14739464; DOI=10.1126/science.1093549;
RA   Wertz I.E., O'Rourke K.M., Zhang Z., Dornan D., Arnott D., Deshaies R.J.,
RA   Dixit V.M.;
RT   "Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin
RT   ligase.";
RL   Science 303:1371-1374(2004).
RN   [19]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL41) COMPLEX, IDENTIFICATION IN THE
RP   BCR(ENC1) COMPLEX, IDENTIFICATION IN THE BCR(KEAP1) COMPLEX, AND
RP   IDENTIFICATION IN THE BCR(GAN) COMPLEX.
RX   PubMed=15983046; DOI=10.1074/jbc.m501279200;
RA   Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M.;
RT   "Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3,
RT   targets Keap1 for degradation by a proteasome-independent pathway.";
RL   J. Biol. Chem. 280:30091-30099(2005).
RN   [20]
RP   FUNCTION.
RX   PubMed=16751180; DOI=10.1101/gad.378206;
RA   Groisman R., Kuraoka I., Chevallier O., Gaye N., Magnaldo T., Tanaka K.,
RA   Kisselev A.F., Harel-Bellan A., Nakatani Y.;
RT   "CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway
RT   establishes a link between complementation factors of the Cockayne
RT   syndrome.";
RL   Genes Dev. 20:1429-1434(2006).
RN   [21]
RP   IDENTIFICATION IN COMPLEX WITH DDB1; DDB2; CUL4A AND CUL4B, IDENTIFICATION
RP   BY MASS SPECTROMETRY, AND FUNCTION.
RX   PubMed=16678110; DOI=10.1016/j.molcel.2006.03.035;
RA   Wang H., Zhai L., Xu J., Joo H.-Y., Jackson S., Erdjument-Bromage H.,
RA   Tempst P., Xiong Y., Zhang Y.;
RT   "Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase
RT   facilitates cellular response to DNA damage.";
RL   Mol. Cell 22:383-394(2006).
RN   [22]
RP   FUNCTION.
RX   PubMed=18397884; DOI=10.1074/jbc.m802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [24]
RP   INTERACTION WITH CUL1; FBXO3; SKP1 AND PML.
RX   PubMed=18809579; DOI=10.1128/mcb.00897-08;
RA   Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P., Kitabayashi I.;
RT   "PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-
RT   mediated degradation.";
RL   Mol. Cell. Biol. 28:7126-7138(2008).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   IDENTIFICATION IN A UBIQUITIN LIGASE COMPLEX WITH HINT1 AND CDC34, AND
RP   FUNCTION.
RX   PubMed=19112177; DOI=10.1074/jbc.m804531200;
RA   Cen B., Li H., Weinstein I.B.;
RT   "Histidine triad nucleotide-binding protein 1 up-regulates cellular levels
RT   of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src.";
RL   J. Biol. Chem. 284:5265-5276(2009).
RN   [27]
RP   INTERACTION WITH UBE2M.
RX   PubMed=19250909; DOI=10.1016/j.molcel.2009.01.011;
RA   Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M., Scott D.C.,
RA   Borg L.A., Neale G., Murray P.J., Roussel M.F., Schulman B.A.;
RT   "E2-RING expansion of the NEDD8 cascade confers specificity to cullin
RT   modification.";
RL   Mol. Cell 33:483-495(2009).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH HADV5 E1A (MICROBIAL INFECTION).
RX   PubMed=19679664; DOI=10.1074/jbc.m109.006809;
RA   Isobe T., Hattori T., Kitagawa K., Uchida C., Kotake Y., Kosugi I., Oda T.,
RA   Kitagawa M.;
RT   "Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.";
RL   J. Biol. Chem. 284:27766-27779(2009).
RN   [29]
RP   FUNCTION, AND IDENTIFICATION IN A UBIQUITIN LIGASE COMPLEX WITH ELONGIN BC;
RP   ELONGIN A/ELOA AND CUL5.
RX   PubMed=19920177; DOI=10.1073/pnas.0907052106;
RA   Harreman M., Taschner M., Sigurdsson S., Anindya R., Reid J., Somesh B.,
RA   Kong S.E., Banks C.A., Conaway R.C., Conaway J.W., Svejstrup J.Q.;
RT   "Distinct ubiquitin ligases act sequentially for RNA polymerase II
RT   polyubiquitylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20705-20710(2009).
RN   [30]
RP   IDENTIFICATION IN THE SCF(CYCLIN F) COMPLEX.
RX   PubMed=20596027; DOI=10.1038/nature09140;
RA   D'Angiolella V., Donato V., Vijayakumar S., Saraf A., Florens L.,
RA   Washburn M.P., Dynlacht B., Pagano M.;
RT   "SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through
RT   CP110 degradation.";
RL   Nature 466:138-142(2010).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND ALA-2, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT THR-9, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [34]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [35]
RP   INTERACTION WITH SESN1 AND SESN2.
RX   PubMed=23274085; DOI=10.1016/j.cmet.2012.12.002;
RA   Bae S.H., Sung S.H., Oh S.Y., Lim J.M., Lee S.K., Park Y.N., Lee H.E.,
RA   Kang D., Rhee S.G.;
RT   "Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation
RT   of Keap1 and prevent oxidative liver damage.";
RL   Cell Metab. 17:73-84(2013).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL22) COMPLEX.
RX   PubMed=23455478; DOI=10.1038/ncb2695;
RA   Beck J., Maerki S., Posch M., Metzger T., Persaud A., Scheel H.,
RA   Hofmann K., Rotin D., Pedrioli P., Swedlow J.R., Peter M., Sumara I.;
RT   "Ubiquitylation-dependent localization of PLK1 in mitosis.";
RL   Nat. Cell Biol. 15:430-439(2013).
RN   [38]
RP   INTERACTION WITH DCUN1D5.
RX   PubMed=24192928; DOI=10.1158/1078-0432.ccr-13-1252;
RA   Bommelje C.C., Weeda V.B., Huang G., Shah K., Bains S., Buss E., Shaha M.,
RA   Goenen M., Ghossein R., Ramanathan S.Y., Singh B.;
RT   "Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity
RT   and nuclear localization.";
RL   Clin. Cancer Res. 20:372-381(2014).
RN   [39]
RP   INTERACTION WITH DCUN1D3.
RX   PubMed=25349211; DOI=10.1074/jbc.m114.585505;
RA   Huang G., Stock C., Bommelje C.C., Weeda V.B., Shah K., Bains S., Buss E.,
RA   Shaha M., Rechler W., Ramanathan S.Y., Singh B.;
RT   "SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of
RT   SCCRO (DCUN1D1).";
RL   J. Biol. Chem. 289:34728-34742(2014).
RN   [40]
RP   SUBUNIT.
RX   PubMed=25684205; DOI=10.1016/j.molcel.2014.12.040;
RA   Genau H.M., Huber J., Baschieri F., Akutsu M., Doetsch V., Farhan H.,
RA   Rogov V., Behrends C.;
RT   "CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to
RT   spatially restrict TIAM1-RAC1 signaling.";
RL   Mol. Cell 57:995-1010(2015).
RN   [41]
RP   FUNCTION.
RX   PubMed=27565346; DOI=10.1016/j.cell.2016.07.027;
RA   Scott D.C., Rhee D.Y., Duda D.M., Kelsall I.R., Olszewski J.L., Paulo J.A.,
RA   de Jong A., Ovaa H., Alpi A.F., Harper J.W., Schulman B.A.;
RT   "Two distinct types of E3 ligases work in unison to regulate substrate
RT   ubiquitylation.";
RL   Cell 166:1198-1214(2016).
RN   [42]
RP   INTERACTION WITH DCUN1D1; DCUN1D2; DCUN1D3; DCUN1D4 AND DCUN1D5.
RX   PubMed=26906416; DOI=10.1242/jcs.181784;
RA   Keuss M.J., Thomas Y., Mcarthur R., Wood N.T., Knebel A., Kurz T.;
RT   "Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.";
RL   J. Cell Sci. 129:1441-1454(2016).
RN   [43]
RP   INTERACTION WITH NOTCH2.
RX   PubMed=29149593; DOI=10.1016/j.molcel.2017.10.018;
RA   Fukushima H., Shimizu K., Watahiki A., Hoshikawa S., Kosho T., Oba D.,
RA   Sakano S., Arakaki M., Yamada A., Nagashima K., Okabe K., Fukumoto S.,
RA   Jimi E., Bigas A., Nakayama K.I., Nakayama K., Aoki Y., Wei W., Inuzuka H.;
RT   "NOTCH2 Hajdu-Cheney mutations escape SCFFBW7-dependent proteolysis to
RT   promote osteoporosis.";
RL   Mol. Cell 68:645-658(2017).
RN   [44]
RP   FUNCTION.
RX   PubMed=29769719; DOI=10.1038/s41586-018-0128-9;
RA   Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y.;
RT   "KLHL22 activates amino-acid-dependent mTORC1 signalling to promote
RT   tumorigenesis and ageing.";
RL   Nature 557:585-589(2018).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 19-108 IN COMPLEX WITH 17-776 OF
RP   CUL1, X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN SCF COMPLEX WITH CUL1; SKP1
RP   AND SKP2, FUNCTION, AND DOMAIN.
RX   PubMed=11961546; DOI=10.1038/416703a;
RA   Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P.,
RA   Chu C., Koepp D.M., Elledge S.J., Pagano M., Conaway R.C., Conaway J.W.,
RA   Harper J.W., Pavletich N.P.;
RT   "Structure of the Cul1-Rbx1-Skp1-F box Skp2 SCF ubiquitin ligase complex.";
RL   Nature 416:703-709(2002).
RN   [46] {ECO:0007744|PDB:4F52}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 5-108 IN COMPLEX WITH CUL1; GLMN
RP   AND ZINC, SUBUNIT, INTERACTION WITH CDC34 AND GLMN, FUNCTION, DOMAIN, AND
RP   PATHWAY.
RX   PubMed=22748924; DOI=10.1016/j.molcel.2012.05.044;
RA   Duda D.M., Olszewski J.L., Tron A.E., Hammel M., Lambert L.J.,
RA   Waddell M.B., Mittag T., DeCaprio J.A., Schulman B.A.;
RT   "Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase
RT   through masking of its E2-binding surface.";
RL   Mol. Cell 47:371-382(2012).
RN   [47] {ECO:0007744|PDB:7PLO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS) IN COMPLEX WITH REPLISOME
RP   AND DNA POLYMERASE EPSILON, AND SUBUNIT.
RX   PubMed=34700328; DOI=10.1038/s41586-021-04145-3;
RA   Jenkyn-Bedford M., Jones M.L., Baris Y., Labib K.P.M., Cannone G.,
RA   Yeeles J.T.P., Deegan T.D.;
RT   "A conserved mechanism for regulating replisome disassembly in
RT   eukaryotes.";
RL   Nature 600:743-747(2021).
CC   -!- FUNCTION: E3 ubiquitin ligase component of multiple cullin-RING-based
CC       E3 ubiquitin-protein ligase (CRLs) complexes which mediate the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins, including proteins involved in cell cycle progression, signal
CC       transduction, transcription and transcription-coupled nucleotide
CC       excision repair (PubMed:10230407, PubMed:10579999, PubMed:15983046,
CC       PubMed:16678110, PubMed:19112177, PubMed:19679664, PubMed:23455478,
CC       PubMed:27565346, PubMed:29769719, PubMed:11961546, PubMed:22748924).
CC       CRLs complexes and ARIH1 collaborate in tandem to mediate
CC       ubiquitination of target proteins, ARIH1 mediating addition of the
CC       first ubiquitin on CRLs targets (PubMed:27565346). The functional
CC       specificity of the E3 ubiquitin-protein ligase complexes depends on the
CC       variable substrate recognition components. As a component of the CSA
CC       complex promotes the ubiquitination of ERCC6 resulting in proteasomal
CC       degradation. Recruits the E2 ubiquitin-conjugating enzyme CDC34 to the
CC       complex and brings it into close proximity to the substrate. Probably
CC       also stimulates CDC34 autoubiquitination. May be required for histone
CC       H3 and histone H4 ubiquitination in response to ultraviolet and for
CC       subsequent DNA repair. Promotes the neddylation of CUL1, CUL2, CUL4 and
CC       CUL4 via its interaction with UBE2M. Involved in the ubiquitination of
CC       KEAP1, ENC1 and KLHL41. In concert with ATF2 and CUL3, promotes
CC       degradation of KAT5 thereby attenuating its ability to acetylate and
CC       activate ATM. As part of a multisubunit complex composed of elongin BC
CC       complex (ELOB and ELOC), elongin A/ELOA, RBX1 and CUL5;
CC       polyubiquitinates monoubiquitinated POLR2A (PubMed:19920177).
CC       {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10579999,
CC       ECO:0000269|PubMed:11027288, ECO:0000269|PubMed:11961546,
CC       ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16678110,
CC       ECO:0000269|PubMed:16751180, ECO:0000269|PubMed:18397884,
CC       ECO:0000269|PubMed:19112177, ECO:0000269|PubMed:19679664,
CC       ECO:0000269|PubMed:19920177, ECO:0000269|PubMed:22748924,
CC       ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:29769719}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:11027288};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-[NEDD8-protein]-yl-[E2 NEDD8-conjugating enzyme]-L-cysteine
CC         + [cullin]-L-lysine = [E2 NEDD8-conjugating enzyme]-L-cysteine +
CC         N(6)-[NEDD8-protein]-yl-[cullin]-L-lysine.; EC=2.3.2.32;
CC         Evidence={ECO:0000269|PubMed:11027288};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:11027288,
CC       ECO:0000269|PubMed:22748924}.
CC   -!- SUBUNIT: Part of a SCF complex consisting of CUL1, RBX1, SKP1 and SKP2
CC       (PubMed:10230406, PubMed:11961546). Part of a SCF-like complex
CC       consisting of CUL7, RBX1, SKP1 and FBXW8. Part of CBC(VHL) complexes
CC       with elongin BC complex (ELOB and ELOC), CUL2 or CUL5 and VHL
CC       (PubMed:10213691). Part of the CSA complex (DCX(ERCC8) complex), a DCX
CC       E3 ubiquitin-protein ligase complex containing ERCC8, RBX1, DDB1 and
CC       CUL4A; the CSA complex interacts with RNA polymerase II; upon UV
CC       irradiation it interacts with the COP9 signalosome and preferentially
CC       with the hyperphosphorylated form of RNA polymerase II
CC       (PubMed:12732143). Part of multisubunit E3 ubiquitin ligase complexes
CC       with elongin BC complex (ELOB and ELOC), CUL2 and MED8; elongin BC
CC       complex (ELOB and ELOC), CUL5 and MUF1 (PubMed:11384984,
CC       PubMed:12149480). Part of multisubunit complexes with elongin BC
CC       complex (ELOB and ELOC), SOCS1 or WSB1 and CUL5. Part of a multisubunit
CC       ubiquitin ligase complex consisting of elongin BC complex (ELOB and
CC       ELOC), elongin A/ELOA, RBX1 and CUL5 (PubMed:19920177). Interacts
CC       directly with CUL1 and probably also with CUL2, CUL3, CUL4A, CUL4B,
CC       CUL5 and CUL7 (PubMed:10230407, PubMed:12481031). Interacts with CDC34
CC       (PubMed:22748924). Interacts with GLMN. GLMN competes for the binding
CC       site of the E2 ubiquitin-conjugating enzyme CDC34 and disrupts CDC34
CC       binding (PubMed:22748924). Interacts with COPS6 (PubMed:11337588).
CC       Component of the DCX DET1-COP1 ubiquitin ligase complex at least
CC       composed of RBX1, DET1, DDB1, CUL4A and COP1 (PubMed:14739464). Part of
CC       an E3 ligase complex composed of RBX1, DDB1, DDB2 and CUL4A or CUL4B
CC       (PubMed:16678110). Interacts with UBE2M (PubMed:19250909). Part of a
CC       SCF complex consisting of CUL1, FBXO3, RBX1 and SKP1; this complex
CC       interacts with PML via FBXO3 (PubMed:18809579). Component of the
CC       SCF(Cyclin F) complex consisting of CUL1, RBX1, SKP1 and CCNF
CC       (PubMed:20596027). Identified in a SCF (SKP1-CUL1-F-box protein) E3
CC       ubiquitin ligase complex together with HINT1 and CDC34
CC       (PubMed:19112177). Component of multiple BCR (BTB-CUL3-RBX1) E3
CC       ubiquitin-protein ligase complexes formed of CUL3, RBX1 and a variable
CC       BTB domain-containing protein (PubMed:15983046). Part of the BCR(ENC1)
CC       complex containing ENC1 (PubMed:15983046). Part of the BCR(GAN) complex
CC       containing GAN (PubMed:15983046). Part of the BCR(KLHL41) complex
CC       containing KLHL41 (PubMed:15983046). Part of the BCR(KEAP1) complex
CC       containing KEAP1 (PubMed:15983046). Interacts with SESN1 and SESN2
CC       (PubMed:23274085). Interacts with NOTCH2 (PubMed:29149593). Component
CC       of the BCR(KLHL22) E3 ubiquitin ligase complex, at least composed of
CC       CUL3, KLHL22 and RBX1 (PubMed:23455478). Interacts with DCUN1D1,
CC       DCUN1D2, DCUN1D3, DCUN1D4 and DCUN1D5 (PubMed:26906416,
CC       PubMed:24192928, PubMed:25349211). Component of a BCR3 (BTB-CUL3-RBX1)
CC       E3 ubiquitin ligase complex, also named Cul3-RING ubiquitin ligase
CC       complex CUL3(KBTBD6/7), composed of CUL3, RBX1, KBTBD6 and KBTBD7
CC       (PubMed:25684205). Component of the ECS(LRR1) complex with the
CC       substrate recognition component LRR1 (PubMed:34700328).
CC       {ECO:0000269|PubMed:10213691, ECO:0000269|PubMed:10230406,
CC       ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:11337588,
CC       ECO:0000269|PubMed:11384984, ECO:0000269|PubMed:11961546,
CC       ECO:0000269|PubMed:12149480, ECO:0000269|PubMed:12481031,
CC       ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:14739464,
CC       ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16678110,
CC       ECO:0000269|PubMed:18809579, ECO:0000269|PubMed:19112177,
CC       ECO:0000269|PubMed:19250909, ECO:0000269|PubMed:20596027,
CC       ECO:0000269|PubMed:22748924, ECO:0000269|PubMed:23274085,
CC       ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:24192928,
CC       ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:25684205,
CC       ECO:0000269|PubMed:26906416, ECO:0000269|PubMed:29149593,
CC       ECO:0000269|PubMed:34700328}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human adenovirus 5
CC       protein E1A; this interaction inhibits RBX1-CUL1-dependent elongation
CC       reaction of ubiquitin chains by the SCF(FBW7) complex.
CC       {ECO:0000269|PubMed:19679664}.
CC   -!- INTERACTION:
CC       P62877; Q13616: CUL1; NbExp=28; IntAct=EBI-398523, EBI-359390;
CC       P62877; Q13617: CUL2; NbExp=8; IntAct=EBI-398523, EBI-456179;
CC       P62877; Q13620: CUL4B; NbExp=7; IntAct=EBI-398523, EBI-456067;
CC       P62877; Q93034: CUL5; NbExp=3; IntAct=EBI-398523, EBI-1057139;
CC       P62877; Q92990: GLMN; NbExp=6; IntAct=EBI-398523, EBI-726150;
CC       P62877; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-398523, EBI-10176379;
CC       P62877; Q9BYU1: PBX4; NbExp=3; IntAct=EBI-398523, EBI-10302990;
CC       P62877; P58004: SESN2; NbExp=3; IntAct=EBI-398523, EBI-3939642;
CC       P62877; Q13309: SKP2; NbExp=3; IntAct=EBI-398523, EBI-456291;
CC       P62877; P61081: UBE2M; NbExp=7; IntAct=EBI-398523, EBI-1041660;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11027288}. Nucleus
CC       {ECO:0000269|PubMed:11027288}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DOMAIN: The RING-type zinc finger domain is essential for ubiquitin
CC       ligase activity (PubMed:10230407). It coordinates an additional third
CC       zinc ion (PubMed:11961546, PubMed:22748924).
CC       {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:11961546,
CC       ECO:0000269|PubMed:22748924}.
CC   -!- SIMILARITY: Belongs to the RING-box family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17370.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42075/RBX1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF142059; AAD30146.1; -; mRNA.
DR   EMBL; AF140598; AAD29715.1; -; mRNA.
DR   EMBL; CR456560; CAG30446.1; -; mRNA.
DR   EMBL; AK315722; BAG38078.1; -; mRNA.
DR   EMBL; AL080242; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60403.1; -; Genomic_DNA.
DR   EMBL; BC001466; AAH01466.1; -; mRNA.
DR   EMBL; BC017370; AAH17370.2; ALT_INIT; mRNA.
DR   EMBL; AY099360; AAM21718.1; -; mRNA.
DR   CCDS; CCDS14009.1; -.
DR   PIR; T51146; T51146.
DR   RefSeq; NP_055063.1; NM_014248.3.
DR   PDB; 1LDJ; X-ray; 3.00 A; B=19-108.
DR   PDB; 1LDK; X-ray; 3.10 A; C=19-108.
DR   PDB; 1U6G; X-ray; 3.10 A; B=1-108.
DR   PDB; 2HYE; X-ray; 3.10 A; D=1-108.
DR   PDB; 2LGV; NMR; -; A=12-108.
DR   PDB; 3DPL; X-ray; 2.60 A; R=5-108.
DR   PDB; 3DQV; X-ray; 3.00 A; R/Y=5-108.
DR   PDB; 3RTR; X-ray; 3.21 A; B/D/F/H=5-108.
DR   PDB; 4F52; X-ray; 3.00 A; B/D=5-108.
DR   PDB; 4P5O; X-ray; 3.11 A; B/D=5-108.
DR   PDB; 5N4W; X-ray; 3.90 A; R=1-102.
DR   PDB; 6R6H; EM; 8.40 A; R=17-102.
DR   PDB; 6R7F; EM; 8.20 A; R=19-108.
DR   PDB; 6R7H; EM; 8.80 A; R=19-108.
DR   PDB; 6R7I; EM; 5.90 A; R=19-102.
DR   PDB; 6R7N; EM; 6.50 A; R=17-102.
DR   PDB; 6TTU; EM; 3.70 A; R=1-108.
DR   PDB; 7B5L; EM; 3.80 A; R=1-108.
DR   PDB; 7B5M; EM; 3.91 A; R=1-108.
DR   PDB; 7B5N; EM; 3.60 A; R=1-108.
DR   PDB; 7B5S; EM; 3.60 A; R=1-108.
DR   PDB; 7OKQ; EM; 8.40 A; D/H/L/P=2-108.
DR   PDB; 7PLO; EM; 2.80 A; T=1-108.
DR   PDB; 7Z8B; EM; 2.80 A; R=1-108.
DR   PDBsum; 1LDJ; -.
DR   PDBsum; 1LDK; -.
DR   PDBsum; 1U6G; -.
DR   PDBsum; 2HYE; -.
DR   PDBsum; 2LGV; -.
DR   PDBsum; 3DPL; -.
DR   PDBsum; 3DQV; -.
DR   PDBsum; 3RTR; -.
DR   PDBsum; 4F52; -.
DR   PDBsum; 4P5O; -.
DR   PDBsum; 5N4W; -.
DR   PDBsum; 6R6H; -.
DR   PDBsum; 6R7F; -.
DR   PDBsum; 6R7H; -.
DR   PDBsum; 6R7I; -.
DR   PDBsum; 6R7N; -.
DR   PDBsum; 6TTU; -.
DR   PDBsum; 7B5L; -.
DR   PDBsum; 7B5M; -.
DR   PDBsum; 7B5N; -.
DR   PDBsum; 7B5S; -.
DR   PDBsum; 7OKQ; -.
DR   PDBsum; 7PLO; -.
DR   PDBsum; 7Z8B; -.
DR   AlphaFoldDB; P62877; -.
DR   SMR; P62877; -.
DR   BioGRID; 115301; 566.
DR   ComplexPortal; CPX-2399; CRL4-DCAF13 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2403; CRL4-DCAF11 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2404; CRL4-DCAF11 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2405; CRL4-DCAF12 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2406; CRL4-DCAF12 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2407; CRL4-DCAF13 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2411; CRL4-DCAF14 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2412; CRL4-DCAF14 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2413; CRL4-DCAF16 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2414; CRL4-DCAF16 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2415; CRL4-DCAF17 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2416; CRL4-DCAF17 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2757; CRL4-ERCC8 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2758; CRL4-ERCC8 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2759; CRL4-CRBN E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2762; CRL4-CRBN E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2765; CRL4-DCAF15 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2766; CRL4-DCAF15 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2769; CRL4-DCAF1 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2770; CRL4-DCAF1 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2777; CRL4-CDT2 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2778; CRL4-AMBRA1 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2782; CRL4-DCAF5 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2783; CRL4-DCAF5 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2784; CRL4-DCAF6 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2785; CRL4-DCAF7 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2786; CRL4-DCAF7 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2787; CRL4-DCAF9 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2795; CRL4-CDT2 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2797; CRL4-AMBRA1 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2799; CRL4-DCAF4 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2804; CRL4-DCAF6 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2809; CRL4-DCAF9 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2816; CRL4-DCAF8 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2817; CRL4-DCAF10 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2818; CRL4-DCAF8 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-2819; CRL4-DCAF10 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-2859; CRL4-DCAF4 E3 ubiquitin ligase complex, CUL4B variant.
DR   ComplexPortal; CPX-477; CRL4-DDB2 E3 ubiquitin ligase complex, CUL4A variant.
DR   ComplexPortal; CPX-648; CRL4-DDB2 E3 ubiquitin ligase complex, CUL4B variant.
DR   CORUM; P62877; -.
DR   DIP; DIP-17014N; -.
DR   IntAct; P62877; 78.
DR   MINT; P62877; -.
DR   STRING; 9606.ENSP00000216225; -.
DR   ChEMBL; CHEMBL3833061; -.
DR   GlyGen; P62877; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P62877; -.
DR   MetOSite; P62877; -.
DR   PhosphoSitePlus; P62877; -.
DR   SwissPalm; P62877; -.
DR   BioMuta; RBX1; -.
DR   DMDM; 51338609; -.
DR   EPD; P62877; -.
DR   jPOST; P62877; -.
DR   MassIVE; P62877; -.
DR   MaxQB; P62877; -.
DR   PaxDb; P62877; -.
DR   PeptideAtlas; P62877; -.
DR   ProteomicsDB; 57443; -.
DR   TopDownProteomics; P62877; -.
DR   Antibodypedia; 295; 354 antibodies from 40 providers.
DR   DNASU; 9978; -.
DR   Ensembl; ENST00000216225.9; ENSP00000216225.8; ENSG00000100387.9.
DR   GeneID; 9978; -.
DR   KEGG; hsa:9978; -.
DR   MANE-Select; ENST00000216225.9; ENSP00000216225.8; NM_014248.4; NP_055063.1.
DR   UCSC; uc003azk.4; human.
DR   AGR; HGNC:9928; -.
DR   CTD; 9978; -.
DR   DisGeNET; 9978; -.
DR   GeneCards; RBX1; -.
DR   HGNC; HGNC:9928; RBX1.
DR   HPA; ENSG00000100387; Low tissue specificity.
DR   MIM; 603814; gene.
DR   neXtProt; NX_P62877; -.
DR   OpenTargets; ENSG00000100387; -.
DR   PharmGKB; PA34299; -.
DR   VEuPathDB; HostDB:ENSG00000100387; -.
DR   eggNOG; KOG2930; Eukaryota.
DR   GeneTree; ENSGT00940000155618; -.
DR   HOGENOM; CLU_115512_2_1_1; -.
DR   InParanoid; P62877; -.
DR   OMA; RFDVKKW; -.
DR   OrthoDB; 3546417at2759; -.
DR   PhylomeDB; P62877; -.
DR   TreeFam; TF105503; -.
DR   BRENDA; 2.3.2.27; 2681.
DR   BRENDA; 2.3.2.32; 2681.
DR   PathwayCommons; P62877; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-1170546; Prolactin receptor signaling.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2644607; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   Reactome; R-HSA-9708530; Regulation of BACH1 activity.
DR   Reactome; R-HSA-9725371; Nuclear events stimulated by ALK signaling in cancer.
DR   Reactome; R-HSA-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-HSA-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P62877; -.
DR   SIGNOR; P62877; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 9978; 663 hits in 1209 CRISPR screens.
DR   ChiTaRS; RBX1; human.
DR   EvolutionaryTrace; P62877; -.
DR   GeneWiki; RBX1; -.
DR   GenomeRNAi; 9978; -.
DR   Pharos; P62877; Tbio.
DR   PRO; PR:P62877; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P62877; protein.
DR   Bgee; ENSG00000100387; Expressed in periodontal ligament and 208 other tissues.
DR   Genevisible; P62877; HS.
DR   GO; GO:0031462; C:Cul2-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031464; C:Cul4A-RING E3 ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031465; C:Cul4B-RING E3 ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031466; C:Cul5-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031467; C:Cul7-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0097602; F:cullin family protein binding; IDA:MGI.
DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.
DR   GO; GO:0061663; F:NEDD8 ligase activity; IDA:UniProtKB.
DR   GO; GO:0019788; F:NEDD8 transferase activity; TAS:Reactome.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0062197; P:cellular response to chemical stress; TAS:Reactome.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; EXP:ComplexPortal.
DR   GO; GO:0034644; P:cellular response to UV; EXP:ComplexPortal.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IPI:UniProtKB.
DR   GO; GO:1902499; P:positive regulation of protein autoubiquitination; IMP:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0045116; P:protein neddylation; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16485; mRING-H2-C3H2C2D_RBX1; 1.
DR   DisProt; DP01750; -.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   IDEAL; IID00059; -.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR024766; Znf_RING_H2.
DR   PANTHER; PTHR11210:SF2; E3 UBIQUITIN-PROTEIN LIGASE RBX1-RELATED; 1.
DR   PANTHER; PTHR11210; RING BOX; 1.
DR   Pfam; PF12678; zf-rbx1; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   DNA damage; DNA repair; Host-virus interaction; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Transferase; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..108
FT                   /note="E3 ubiquitin-protein ligase RBX1"
FT                   /id="PRO_0000423264"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..108
FT                   /note="E3 ubiquitin-protein ligase RBX1, N-terminally
FT                   processed"
FT                   /id="PRO_0000056013"
FT   ZN_FING         53..98
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   BINDING         42
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         45
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         53
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         56
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         68
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         75
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         77
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         80
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         82
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         83
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DQV, ECO:0007744|PDB:3RTR,
FT                   ECO:0007744|PDB:4F52, ECO:0007744|PDB:4P5O"
FT   BINDING         94
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   BINDING         97
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:11961546,
FT                   ECO:0007744|PDB:1LDJ, ECO:0007744|PDB:1LDK,
FT                   ECO:0007744|PDB:1U6G, ECO:0007744|PDB:2HYE,
FT                   ECO:0007744|PDB:3DPL, ECO:0007744|PDB:3DQV,
FT                   ECO:0007744|PDB:3RTR, ECO:0007744|PDB:4F52,
FT                   ECO:0007744|PDB:4P5O"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         2
FT                   /note="N-acetylalanine; in E3 ubiquitin-protein ligase
FT                   RBX1, N-terminally processed"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         9
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MUTAGEN         53
FT                   /note="C->A: Strong reduction in ligase activity; when
FT                   associated with A-56."
FT                   /evidence="ECO:0000269|PubMed:10230407"
FT   MUTAGEN         56
FT                   /note="C->A: Strong reduction in ligase activity; when
FT                   associated with A-53."
FT                   /evidence="ECO:0000269|PubMed:10230407"
FT   MUTAGEN         75
FT                   /note="C->A: Strong reduction in ligase activity; when
FT                   associated with A-77."
FT                   /evidence="ECO:0000269|PubMed:10230407"
FT   MUTAGEN         77
FT                   /note="H->A: Strong reduction in ligase activity; when
FT                   associated with A-75."
FT                   /evidence="ECO:0000269|PubMed:10230407"
FT   CONFLICT        18
FT                   /note="G -> S (in Ref. 9; AAM21718)"
FT                   /evidence="ECO:0000305"
FT   STRAND          21..37
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   STRAND          39..41
FT                   /evidence="ECO:0007829|PDB:1LDJ"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   TURN            49..54
FT                   /evidence="ECO:0007829|PDB:1LDJ"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   TURN            63..67
FT                   /evidence="ECO:0007829|PDB:1LDJ"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:1LDJ"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   HELIX           81..88
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   STRAND          90..93
FT                   /evidence="ECO:0007829|PDB:1LDK"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:3DPL"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:3DPL"
SQ   SEQUENCE   108 AA;  12274 MW;  30FC5ADF66096C0E CRC64;
     MAAAMDVDTP SGTNSGAGKK RFEVKKWNAV ALWAWDIVVD NCAICRNHIM DLCIECQANQ
     ASATSEECTV AWGVCNHAFH FHCISRWLKT RQVCPLDNRE WEFQKYGH
//
ID   RS27A_HUMAN             Reviewed;         156 AA.
AC   P62979; P02248; P02249; P02250; P14798; P62988; Q29120; Q6LBL4; Q6LDU5;
AC   Q8WYN8; Q91887; Q91888; Q9BQ77; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8;
AC   Q9UPK7;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 2.
DT   22-FEB-2023, entry version 180.
DE   RecName: Full=Ubiquitin-40S ribosomal protein S27a;
DE   AltName: Full=Ubiquitin carboxyl extension protein 80;
DE   Contains:
DE     RecName: Full=Ubiquitin;
DE   Contains:
DE     RecName: Full=40S ribosomal protein S27a;
DE     AltName: Full=Small ribosomal subunit protein eS31 {ECO:0000303|PubMed:24524803};
DE   Flags: Precursor;
GN   Name=RPS27A; Synonyms=UBA80, UBCEP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1657614; DOI=10.1002/eji.1830211113;
RA   Pancre V., Pierce R.J., Fournier F., Mehtali M., Delanoye A., Capron A.,
RA   Auriault C.;
RT   "Effect of ubiquitin on platelet functions: possible identity with platelet
RT   activity suppressive lymphokine (PASL).";
RL   Eur. J. Immunol. 21:2735-2741(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1370760; DOI=10.1038/bjc.1992.12;
RA   Adams S.M., Sharp M.G., Walker R.A., Brammar W.J., Varley J.M.;
RT   "Differential expression of translation-associated genes in benign and
RT   malignant human breast tumours.";
RL   Br. J. Cancer 65:65-71(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-98.
RC   TISSUE=Placenta;
RX   PubMed=8706699; DOI=10.1111/j.1432-1033.1996.0144u.x;
RA   Vladimirov S.N., Ivanov A.V., Karpova G.G., Musolyamov A.K., Egorov T.A.,
RA   Thiede B., Wittmann-Liebold B., Otto A.;
RT   "Characterization of the human small-ribosomal-subunit proteins by N-
RT   terminal and internal sequencing, and mass spectrometry.";
RL   Eur. J. Biochem. 239:144-149(1996).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-74.
RX   PubMed=1128706; DOI=10.1038/255423a0;
RA   Schlesinger D.H., Goldstein G.;
RT   "Molecular conservation of 74 amino acid sequence of ubiquitin between
RT   cattle and man.";
RL   Nature 255:423-424(1975).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-27; 30-42 AND 55-72, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 1-27 AND 43-54, UBIQUITINATION AT LYS-6; LYS-11 AND
RP   LYS-48, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16443603; DOI=10.1074/jbc.m512786200;
RA   Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J.;
RT   "Alzheimer disease-specific conformation of hyperphosphorylated paired
RT   helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6
RT   ubiquitin conjugation.";
RL   J. Biol. Chem. 281:10825-10838(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34.
RX   PubMed=11875025; DOI=10.1101/gr.214202;
RA   Yoshihama M., Uechi T., Asakawa S., Kawasaki K., Kato S., Higa S.,
RA   Maeda N., Minoshima S., Tanaka T., Shimizu N., Kenmochi N.;
RT   "The human ribosomal protein genes: sequencing and comparative analysis of
RT   73 genes.";
RL   Genome Res. 12:379-390(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-156.
RX   PubMed=2581967; DOI=10.1016/s0021-9258(17)39652-7;
RA   Lund P.K., Moats-Staats B.M., Simmons J.G., Hoyt E., D'Ercole A.J.,
RA   Martin F., van Wyk J.J.;
RT   "Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals
RT   that ubiquitin is synthesized as a precursor.";
RL   J. Biol. Chem. 260:7609-7613(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 98-148.
RX   PubMed=9582194; DOI=10.1101/gr.8.5.509;
RA   Kenmochi N., Kawaguchi T., Rozen S., Davis E., Goodman N., Hudson T.J.,
RA   Tanaka T., Page D.C.;
RT   "A map of 75 human ribosomal protein genes.";
RL   Genome Res. 8:509-523(1998).
RN   [12]
RP   FUNCTION, UBIQUITINATION AT LYS-11; LYS-29; LYS-48 AND LYS-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and degradation by
RT   multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [13]
RP   UBIQUITINATION AT LYS-27.
RX   PubMed=15466860; DOI=10.1074/jbc.m402916200;
RA   Okumura F., Hatakeyama S., Matsumoto M., Kamura T., Nakayama K.;
RT   "Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B
RT   contributes to neuritogenesis.";
RL   J. Biol. Chem. 279:53533-53543(2004).
RN   [14]
RP   UBIQUITINATION AT LYS-63, AND MUTAGENESIS OF LYS-48 AND LYS-63.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X., Moinova H.,
RA   Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH
RT   prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [15]
RP   REVIEW, AND FUNCTION.
RX   PubMed=19754430; DOI=10.1042/bst0370937;
RA   Komander D.;
RT   "The emerging complexity of protein ubiquitination.";
RL   Biochem. Soc. Trans. 37:937-953(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-104 AND LYS-113, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24660806; DOI=10.1042/bj20140334;
RA   Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G., Ritorto M.S.,
RA   Hofmann K., Alessi D.R., Knebel A., Trost M., Muqit M.M.;
RT   "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at
RT   Ser65.";
RL   Biochem. J. 460:127-139(2014).
RN   [19]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [20]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24751536; DOI=10.1083/jcb.201402104;
RA   Kane L.A., Lazarou M., Fogel A.I., Li Y., Yamano K., Sarraf S.A.,
RA   Banerjee S., Youle R.J.;
RT   "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase
RT   activity.";
RL   J. Cell Biol. 205:143-153(2014).
RN   [21]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24784582; DOI=10.1038/nature13392;
RA   Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M., Kimura Y.,
RA   Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A., Trempe J.F.,
RA   Saeki Y., Tanaka K., Matsuda N.;
RT   "Ubiquitin is phosphorylated by PINK1 to activate parkin.";
RL   Nature 510:162-166(2014).
RN   [22]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=25474007; DOI=10.1371/journal.pgen.1004861;
RA   Shiba-Fukushima K., Arano T., Matsumoto G., Inoshita T., Yoshida S.,
RA   Ishihama Y., Ryu K.Y., Nukina N., Hattori N., Imai Y.;
RT   "Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin
RT   mitochondrial tethering.";
RL   PLoS Genet. 10:e1004861-e1004861(2014).
RN   [23]
RP   PHOSPHORYLATION AT SER-65.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25]
RP   ADP-RIBOSYLATION AT GLY-76, AND MUTAGENESIS OF HIS-68; ARG-72; ARG-74 AND
RP   GLY-76.
RX   PubMed=28525742; DOI=10.1016/j.molcel.2017.04.028;
RA   Yang C.S., Jividen K., Spencer A., Dworak N., Ni L., Oostdyk L.T.,
RA   Chatterjee M., Kusmider B., Reon B., Parlak M., Gorbunova V., Abbas T.,
RA   Jeffery E., Sherman N.E., Paschal B.M.;
RT   "Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase
RT   Dtx3L/Parp9.";
RL   Mol. Cell 66:503-516(2017).
RN   [26]
RP   ADP-RIBOSYLATION AT THR-66 (MICROBIAL INFECTION).
RX   PubMed=32330457; DOI=10.1016/j.molcel.2020.03.016;
RA   Yan F., Huang C., Wang X., Tan J., Cheng S., Wan M., Wang Z., Wang S.,
RA   Luo S., Li A., Guo X., Feng M., Liu X., Zhu Y., Zhou Y.;
RT   "Threonine ADP-ribosylation of ubiquitin by a bacterial effector family
RT   blocks host ubiquitination.";
RL   Mol. Cell 78:641-652(2020).
RN   [27]
RP   FUNCTION (UBIQUITIN), AND UBIQUITINATION AT LYS-29.
RX   PubMed=34239127; DOI=10.1038/s41589-021-00823-5;
RA   Yu Y., Zheng Q., Erramilli S.K., Pan M., Park S., Xie Y., Li J., Fei J.,
RA   Kossiakoff A.A., Liu L., Zhao M.;
RT   "K29-linked ubiquitin signaling regulates proteotoxic stress response and
RT   cell cycle.";
RL   Nat. Chem. Biol. 17:896-905(2021).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 1-76 IN COMPLEX WITH ZRANB1, AND
RP   UBIQUITINATION AT LYS-29.
RX   PubMed=25752573; DOI=10.1016/j.molcel.2015.01.041;
RA   Kristariyanto Y.A., Abdul Rehman S.A., Campbell D.G., Morrice N.A.,
RA   Johnson C., Toth R., Kulathu Y.;
RT   "K29-selective ubiquitin binding domain reveals structural basis of
RT   specificity and heterotypic nature of K29 polyubiquitin.";
RL   Mol. Cell 58:83-94(2015).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) OF 1-76 IN COMPLEX WITH ZRANB1, AND
RP   UBIQUITINATION AT LYS-29 AND LYS-33.
RX   PubMed=25752577; DOI=10.1016/j.molcel.2015.01.042;
RA   Michel M.A., Elliott P.R., Swatek K.N., Simicek M., Pruneda J.N.,
RA   Wagstaff J.L., Freund S.M., Komander D.;
RT   "Assembly and specific recognition of K29- and K33-linked polyubiquitin.";
RL   Mol. Cell 58:95-109(2015).
CC   -!- FUNCTION: [Ubiquitin]: Exists either covalently attached to another
CC       protein, or free (unanchored). When covalently bound, it is conjugated
CC       to target proteins via an isopeptide bond either as a monomer
CC       (monoubiquitin), a polymer linked via different Lys residues of the
CC       ubiquitin (polyubiquitin chains) or a linear polymer linked via the
CC       initiator Met of the ubiquitin (linear polyubiquitin chains).
CC       Polyubiquitin chains, when attached to a target protein, have different
CC       functions depending on the Lys residue of the ubiquitin that is linked:
CC       Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved
CC       in ERAD (endoplasmic reticulum-associated degradation) and in cell-
CC       cycle regulation; Lys-29-linked is involved in proteotoxic stress
CC       response and cell cycle; Lys-33-linked is involved in kinase
CC       modification; Lys-48-linked is involved in protein degradation via the
CC       proteasome; Lys-63-linked is involved in endocytosis, DNA-damage
CC       responses as well as in signaling processes leading to activation of
CC       the transcription factor NF-kappa-B. Linear polymer chains formed via
CC       attachment by the initiator Met lead to cell signaling. Ubiquitin is
CC       usually conjugated to Lys residues of target proteins, however, in rare
CC       cases, conjugation to Cys or Ser residues has been observed. When
CC       polyubiquitin is free (unanchored-polyubiquitin), it also has distinct
CC       roles, such as in activation of protein kinases, and in signaling.
CC       {ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:34239127,
CC       ECO:0000303|PubMed:19754430}.
CC   -!- FUNCTION: [40S ribosomal protein S27a]: Component of the 40S subunit of
CC       the ribosome.
CC   -!- SUBUNIT: Ribosomal protein S27a is part of the 40S ribosomal subunit.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P62979; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-357375, EBI-739580;
CC       P62979; Q15038: DAZAP2; NbExp=9; IntAct=EBI-357375, EBI-724310;
CC       P62979; Q6ICB0: DESI1; NbExp=3; IntAct=EBI-357375, EBI-2806959;
CC       P62979; I6L9I8: EPN3; NbExp=3; IntAct=EBI-357375, EBI-12866582;
CC       P62979; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-357375, EBI-11978259;
CC       P62979; P04792: HSPB1; NbExp=3; IntAct=EBI-357375, EBI-352682;
CC       P62979; P42858: HTT; NbExp=6; IntAct=EBI-357375, EBI-466029;
CC       P62979; Q99732: LITAF; NbExp=3; IntAct=EBI-357375, EBI-725647;
CC       P62979; Q8N3F0: MTURN; NbExp=3; IntAct=EBI-357375, EBI-11980301;
CC       P62979; Q96CS7: PLEKHB2; NbExp=3; IntAct=EBI-357375, EBI-373552;
CC       P62979; Q9NRQ2: PLSCR4; NbExp=3; IntAct=EBI-357375, EBI-769257;
CC       P62979; P54725: RAD23A; NbExp=3; IntAct=EBI-357375, EBI-746453;
CC       P62979; Q9Y3C5: RNF11; NbExp=4; IntAct=EBI-357375, EBI-396669;
CC       P62979; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-357375, EBI-741480;
CC       P62979; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-357375, EBI-947187;
CC       P62979; O76024: WFS1; NbExp=3; IntAct=EBI-357375, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: [Ubiquitin]: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- PTM: [Ubiquitin]: Phosphorylated at Ser-65 by PINK1 during mitophagy
CC       (PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25527291).
CC       Phosphorylated ubiquitin specifically binds and activates parkin
CC       (PRKN), triggering mitophagy (PubMed:24660806, PubMed:24751536,
CC       PubMed:24784582, PubMed:25527291). Phosphorylation does not affect E1-
CC       mediated E2 charging of ubiquitin but affects discharging of E2 enzymes
CC       to form polyubiquitin chains. It also affects deubiquitination by
CC       deubiquitinase enzymes such as USP30 (PubMed:25527291).
CC       {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536,
CC       ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
CC   -!- PTM: [Ubiquitin]: Mono-ADP-ribosylated at the C-terminus by PARP9, a
CC       component of the PPAR9-DTX3L complex. ADP-ribosylation requires
CC       processing by E1 and E2 enzymes and prevents ubiquitin conjugation to
CC       substrates such as histones. {ECO:0000269|PubMed:28525742}.
CC   -!- PTM: [Ubiquitin]: (Microbial infection) Mono-ADP-ribosylated at Thr-66
CC       by the C.violaceum CteC virulence factor. ADP-ribosylation causes the
CC       shutdown of polyubiquitin synthesis and disrupts the recognition and
CC       reversal of polyubiquitin. {ECO:0000269|PubMed:32330457}.
CC   -!- MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. UBA52 and
CC       RPS27A genes code for a single copy of ubiquitin fused to the ribosomal
CC       proteins L40 and S27a, respectively. UBB and UBC genes code for a
CC       polyubiquitin precursor with exact head to tail repeats, the number of
CC       repeats differ between species and strains.
CC   -!- MISCELLANEOUS: For a better understanding, features related to
CC       ubiquitin are only indicated for the first chain.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the ubiquitin family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the eukaryotic
CC       ribosomal protein eS31 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63237; CAA44911.1; -; mRNA.
DR   EMBL; S79522; AAB21188.1; -; mRNA.
DR   EMBL; AC012358; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001392; AAH01392.1; -; mRNA.
DR   EMBL; BC066293; AAH66293.1; -; mRNA.
DR   EMBL; AB062071; BAB79490.1; -; Genomic_DNA.
DR   EMBL; M10939; AAA36788.1; -; mRNA.
DR   EMBL; AB007163; BAA25826.1; -; Genomic_DNA.
DR   CCDS; CCDS33202.1; -.
DR   RefSeq; NP_001129064.1; NM_001135592.2.
DR   RefSeq; NP_001170884.1; NM_001177413.1.
DR   RefSeq; NP_002945.1; NM_002954.5.
DR   PDB; 2KHW; NMR; -; B=1-76.
DR   PDB; 2KOX; NMR; -; A=1-76.
DR   PDB; 2KTF; NMR; -; A=1-76.
DR   PDB; 2KWU; NMR; -; B=1-76.
DR   PDB; 2KWV; NMR; -; B=1-76.
DR   PDB; 2L0F; NMR; -; A=1-76.
DR   PDB; 2L0T; NMR; -; A=1-76.
DR   PDB; 2XK5; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3AXC; X-ray; 2.19 A; A=1-76.
DR   PDB; 3I3T; X-ray; 2.59 A; B/D/F/H=1-75.
DR   PDB; 3K9P; X-ray; 2.80 A; B=1-76.
DR   PDB; 3N30; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3N32; X-ray; 1.80 A; A=1-76.
DR   PDB; 3NHE; X-ray; 1.26 A; B=1-76.
DR   PDB; 3NOB; X-ray; 2.19 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 3NS8; X-ray; 1.71 A; A/B=1-76.
DR   PDB; 3PHD; X-ray; 3.00 A; E/F/G/H=1-76.
DR   PDB; 3PHW; X-ray; 2.00 A; B/D/F/H=1-75.
DR   PDB; 3TBL; X-ray; 2.90 A; D/E=1-76.
DR   PDB; 3VDZ; X-ray; 2.40 A; A/B=1-76.
DR   PDB; 4R62; X-ray; 2.28 A; B=1-76.
DR   PDB; 4UG0; EM; -; Sf=1-156.
DR   PDB; 4V6X; EM; 5.00 A; Af=77-156.
DR   PDB; 5A2Q; EM; 3.90 A; f=78-149.
DR   PDB; 5AJ0; EM; 3.50 A; Bf=1-156.
DR   PDB; 5FLX; EM; 3.90 A; f=1-156.
DR   PDB; 5LKS; EM; 3.60 A; Sf=1-156.
DR   PDB; 5T2C; EM; 3.60 A; AH=1-156.
DR   PDB; 5WVO; X-ray; 2.00 A; A/B=1-76.
DR   PDB; 5YDK; X-ray; 2.50 A; B/E/H/K=1-76, C/D/I/J=1-77.
DR   PDB; 6DC6; X-ray; 3.14 A; B/D=1-76.
DR   PDB; 6FEC; EM; 6.30 A; p=82-152.
DR   PDB; 6G18; EM; 3.60 A; f=1-156.
DR   PDB; 6G51; EM; 4.10 A; f=1-156.
DR   PDB; 6G53; EM; 4.50 A; f=1-156.
DR   PDB; 6G5H; EM; 3.60 A; f=1-156.
DR   PDB; 6G5I; EM; 3.50 A; f=1-156.
DR   PDB; 6IP5; EM; 3.90 A; 3R=1-156.
DR   PDB; 6IP6; EM; 4.50 A; 3R=1-156.
DR   PDB; 6IP8; EM; 3.90 A; 3R=1-156.
DR   PDB; 6J99; EM; 4.10 A; L=1-76.
DR   PDB; 6KFP; X-ray; 2.92 A; D=1-76.
DR   PDB; 6KG6; X-ray; 2.39 A; C=1-76.
DR   PDB; 6KIU; EM; 3.20 A; O=1-76.
DR   PDB; 6KIV; EM; 4.00 A; O=1-76.
DR   PDB; 6KIW; EM; 4.00 A; O=1-76.
DR   PDB; 6OLE; EM; 3.10 A; Sf=85-151.
DR   PDB; 6OLF; EM; 3.90 A; Sf=85-151.
DR   PDB; 6OLG; EM; 3.40 A; Bf=79-151.
DR   PDB; 6OLI; EM; 3.50 A; Sf=85-151.
DR   PDB; 6OLZ; EM; 3.90 A; Bf=79-151.
DR   PDB; 6OM0; EM; 3.10 A; Sf=85-151.
DR   PDB; 6OM7; EM; 3.70 A; Sf=85-151.
DR   PDB; 6QZP; EM; 2.90 A; Sf=85-151.
DR   PDB; 6SQO; X-ray; 1.41 A; C/F=1-76.
DR   PDB; 6SQR; X-ray; 2.18 A; C/F/L=1-76.
DR   PDB; 6SQS; X-ray; 1.83 A; C/F=1-76.
DR   PDB; 6XA1; EM; 2.80 A; Sf=89-151.
DR   PDB; 6Y0G; EM; 3.20 A; Sf=1-156.
DR   PDB; 6Y57; EM; 3.50 A; sh=1-156.
DR   PDB; 6YBS; EM; 3.10 A; k=1-156.
DR   PDB; 6Z6L; EM; 3.00 A; Sf=1-156.
DR   PDB; 6Z6M; EM; 3.10 A; Sf=1-156.
DR   PDB; 6Z6N; EM; 2.90 A; Sf=1-156.
DR   PDB; 6ZLW; EM; 2.60 A; g=1-156.
DR   PDB; 6ZM7; EM; 2.70 A; Sf=1-156.
DR   PDB; 6ZME; EM; 3.00 A; Sf=1-156.
DR   PDB; 6ZMI; EM; 2.60 A; Sf=1-156.
DR   PDB; 6ZMO; EM; 3.10 A; Sf=1-156.
DR   PDB; 6ZMT; EM; 3.00 A; g=1-156.
DR   PDB; 6ZMW; EM; 3.70 A; k=1-156.
DR   PDB; 6ZN5; EM; 3.20 A; g=78-149.
DR   PDB; 6ZOJ; EM; 2.80 A; f=78-149.
DR   PDB; 6ZOL; EM; 2.80 A; f=78-149.
DR   PDB; 6ZON; EM; 3.00 A; U=1-156.
DR   PDB; 6ZP4; EM; 2.90 A; U=1-156.
DR   PDB; 6ZUO; EM; 3.10 A; f=1-156.
DR   PDB; 6ZV6; EM; 2.90 A; f=1-156.
DR   PDB; 6ZVH; EM; 2.90 A; f=85-151.
DR   PDB; 6ZVJ; EM; 3.80 A; U=88-149.
DR   PDB; 6ZXD; EM; 3.20 A; f=1-156.
DR   PDB; 6ZXE; EM; 3.00 A; f=1-156.
DR   PDB; 6ZXF; EM; 3.70 A; f=1-156.
DR   PDB; 6ZXG; EM; 2.60 A; f=1-156.
DR   PDB; 6ZXH; EM; 2.70 A; f=1-156.
DR   PDB; 7A09; EM; 3.50 A; U=1-156.
DR   PDB; 7BWD; EM; 4.32 A; L/M=1-76.
DR   PDB; 7JQB; EM; 2.70 A; g=1-156.
DR   PDB; 7JQC; EM; 3.30 A; g=1-156.
DR   PDB; 7K5I; EM; 2.90 A; f=1-149.
DR   PDB; 7MQ9; EM; 3.87 A; NT=1-156.
DR   PDB; 7MQA; EM; 2.70 A; NT=1-156.
DR   PDB; 7OOJ; X-ray; 2.60 A; A/B=1-76.
DR   PDB; 7QP6; EM; 4.70 A; k=1-156.
DR   PDB; 7QP7; EM; 3.70 A; k=1-156.
DR   PDB; 7TQL; EM; 3.40 A; g=85-149.
DR   PDB; 7WTT; EM; 3.10 A; f=1-156.
DR   PDB; 7WTU; EM; 3.00 A; f=1-156.
DR   PDB; 7WTV; EM; 3.50 A; f=1-156.
DR   PDB; 7WTW; EM; 3.20 A; f=1-156.
DR   PDB; 7WTX; EM; 3.10 A; f=1-156.
DR   PDB; 7WTZ; EM; 3.00 A; f=1-156.
DR   PDB; 7WU0; EM; 3.30 A; f=1-156.
DR   PDBsum; 2KHW; -.
DR   PDBsum; 2KOX; -.
DR   PDBsum; 2KTF; -.
DR   PDBsum; 2KWU; -.
DR   PDBsum; 2KWV; -.
DR   PDBsum; 2L0F; -.
DR   PDBsum; 2L0T; -.
DR   PDBsum; 2XK5; -.
DR   PDBsum; 3AXC; -.
DR   PDBsum; 3I3T; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 3N30; -.
DR   PDBsum; 3N32; -.
DR   PDBsum; 3NHE; -.
DR   PDBsum; 3NOB; -.
DR   PDBsum; 3NS8; -.
DR   PDBsum; 3PHD; -.
DR   PDBsum; 3PHW; -.
DR   PDBsum; 3TBL; -.
DR   PDBsum; 3VDZ; -.
DR   PDBsum; 4R62; -.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5A2Q; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5FLX; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 5WVO; -.
DR   PDBsum; 5YDK; -.
DR   PDBsum; 6DC6; -.
DR   PDBsum; 6FEC; -.
DR   PDBsum; 6G18; -.
DR   PDBsum; 6G51; -.
DR   PDBsum; 6G53; -.
DR   PDBsum; 6G5H; -.
DR   PDBsum; 6G5I; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6J99; -.
DR   PDBsum; 6KFP; -.
DR   PDBsum; 6KG6; -.
DR   PDBsum; 6KIU; -.
DR   PDBsum; 6KIV; -.
DR   PDBsum; 6KIW; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   PDBsum; 6SQO; -.
DR   PDBsum; 6SQR; -.
DR   PDBsum; 6SQS; -.
DR   PDBsum; 6XA1; -.
DR   PDBsum; 6Y0G; -.
DR   PDBsum; 6Y57; -.
DR   PDBsum; 6YBS; -.
DR   PDBsum; 6Z6L; -.
DR   PDBsum; 6Z6M; -.
DR   PDBsum; 6Z6N; -.
DR   PDBsum; 6ZLW; -.
DR   PDBsum; 6ZM7; -.
DR   PDBsum; 6ZME; -.
DR   PDBsum; 6ZMI; -.
DR   PDBsum; 6ZMO; -.
DR   PDBsum; 6ZMT; -.
DR   PDBsum; 6ZMW; -.
DR   PDBsum; 6ZN5; -.
DR   PDBsum; 6ZOJ; -.
DR   PDBsum; 6ZOL; -.
DR   PDBsum; 6ZON; -.
DR   PDBsum; 6ZP4; -.
DR   PDBsum; 6ZUO; -.
DR   PDBsum; 6ZV6; -.
DR   PDBsum; 6ZVH; -.
DR   PDBsum; 6ZVJ; -.
DR   PDBsum; 6ZXD; -.
DR   PDBsum; 6ZXE; -.
DR   PDBsum; 6ZXF; -.
DR   PDBsum; 6ZXG; -.
DR   PDBsum; 6ZXH; -.
DR   PDBsum; 7A09; -.
DR   PDBsum; 7BWD; -.
DR   PDBsum; 7JQB; -.
DR   PDBsum; 7JQC; -.
DR   PDBsum; 7K5I; -.
DR   PDBsum; 7MQ9; -.
DR   PDBsum; 7MQA; -.
DR   PDBsum; 7OOJ; -.
DR   PDBsum; 7QP6; -.
DR   PDBsum; 7QP7; -.
DR   PDBsum; 7TQL; -.
DR   PDBsum; 7WTT; -.
DR   PDBsum; 7WTU; -.
DR   PDBsum; 7WTV; -.
DR   PDBsum; 7WTW; -.
DR   PDBsum; 7WTX; -.
DR   PDBsum; 7WTZ; -.
DR   PDBsum; 7WU0; -.
DR   AlphaFoldDB; P62979; -.
DR   BMRB; P62979; -.
DR   SMR; P62979; -.
DR   BioGRID; 112147; 417.
DR   ComplexPortal; CPX-5223; 40S cytosolic small ribosomal subunit.
DR   CORUM; P62979; -.
DR   IntAct; P62979; 100.
DR   MINT; P62979; -.
DR   STRING; 9606.ENSP00000272317; -.
DR   ChEMBL; CHEMBL4523597; -.
DR   GlyCosmos; P62979; 1 site, 1 glycan.
DR   GlyGen; P62979; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P62979; -.
DR   MetOSite; P62979; -.
DR   PhosphoSitePlus; P62979; -.
DR   SwissPalm; P62979; -.
DR   BioMuta; RPS27A; -.
DR   DMDM; 302393745; -.
DR   EPD; P62979; -.
DR   jPOST; P62979; -.
DR   MassIVE; P62979; -.
DR   MaxQB; P62979; -.
DR   PaxDb; P62979; -.
DR   PeptideAtlas; P62979; -.
DR   ProteomicsDB; 57460; -.
DR   TopDownProteomics; P62979; -.
DR   Antibodypedia; 30320; 223 antibodies from 28 providers.
DR   DNASU; 6233; -.
DR   Ensembl; ENST00000272317.11; ENSP00000272317.6; ENSG00000143947.15.
DR   Ensembl; ENST00000402285.7; ENSP00000383981.3; ENSG00000143947.15.
DR   Ensembl; ENST00000404735.1; ENSP00000385659.1; ENSG00000143947.15.
DR   GeneID; 6233; -.
DR   KEGG; hsa:6233; -.
DR   MANE-Select; ENST00000272317.11; ENSP00000272317.6; NM_002954.6; NP_002945.1.
DR   UCSC; uc002ryk.4; human.
DR   AGR; HGNC:10417; -.
DR   CTD; 6233; -.
DR   DisGeNET; 6233; -.
DR   GeneCards; RPS27A; -.
DR   HGNC; HGNC:10417; RPS27A.
DR   HPA; ENSG00000143947; Low tissue specificity.
DR   MIM; 191343; gene.
DR   neXtProt; NX_P62979; -.
DR   OpenTargets; ENSG00000143947; -.
DR   PharmGKB; PA34821; -.
DR   VEuPathDB; HostDB:ENSG00000143947; -.
DR   eggNOG; KOG0004; Eukaryota.
DR   GeneTree; ENSGT00910000144152; -.
DR   HOGENOM; CLU_010412_2_0_1; -.
DR   InParanoid; P62979; -.
DR   OMA; FMAQHAN; -.
DR   OrthoDB; 312211at2759; -.
DR   PhylomeDB; P62979; -.
DR   TreeFam; TF300036; -.
DR   BioCyc; MetaCyc:ENSG00000180019-MON; -.
DR   PathwayCommons; P62979; -.
DR   Reactome; R-HSA-110312; Translesion synthesis by REV1.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168927; TICAM1, RIP1-mediated IKK complex recruitment.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-174490; Membrane binding and targetting of GAG proteins.
DR   Reactome; R-HSA-175474; Assembly Of The HIV Virion.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-HSA-209560; NF-kB is activated and signals survival.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5205685; PINK1-PRKN Mediated Mitophagy.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-HSA-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-HSA-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-HSA-5655862; Translesion synthesis by POLK.
DR   Reactome; R-HSA-5656121; Translesion synthesis by POLI.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5684264; MAP3K8 (TPL2)-dependent MAPK1/3 activation.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-68867; Assembly of the pre-replicative complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69541; Stabilization of p53.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-HSA-8849469; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   Reactome; R-HSA-8876493; InlA-mediated entry of Listeria monocytogenes into host cells.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013973; TICAM1-dependent activation of IRF3/IRF7.
DR   Reactome; R-HSA-9014325; TICAM1,TRAF6-dependent induction of TAK1 complex.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   Reactome; R-HSA-936964; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; R-HSA-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-HSA-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   Reactome; R-HSA-9615710; Late endosomal microautophagy.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9636383; Prevention of phagosomal-lysosomal fusion.
DR   Reactome; R-HSA-9637628; Modulation by Mtb of host immune system.
DR   Reactome; R-HSA-9645460; Alpha-protein kinase 1 signaling pathway.
DR   Reactome; R-HSA-9646399; Aggrephagy.
DR   Reactome; R-HSA-9648002; RAS processing.
DR   Reactome; R-HSA-9664873; Pexophagy.
DR   Reactome; R-HSA-9683683; Maturation of protein E.
DR   Reactome; R-HSA-9692916; SARS-CoV-1 activates/modulates innate immune responses.
DR   Reactome; R-HSA-9694493; Maturation of protein E.
DR   Reactome; R-HSA-9705462; Inactivation of CSF3 (G-CSF) signaling.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9706369; Negative regulation of FLT3.
DR   Reactome; R-HSA-9706377; FLT3 signaling by CBL mutants.
DR   Reactome; R-HSA-9708530; Regulation of BACH1 activity.
DR   Reactome; R-HSA-9735869; SARS-CoV-1 modulates host translation machinery.
DR   Reactome; R-HSA-975110; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; R-HSA-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-9754678; SARS-CoV-2 modulates host translation machinery.
DR   Reactome; R-HSA-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-HSA-9758274; Regulation of NF-kappa B signaling.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P62979; -.
DR   SIGNOR; P62979; -.
DR   BioGRID-ORCS; 6233; 774 hits in 1103 CRISPR screens.
DR   ChiTaRS; RPS27A; human.
DR   EvolutionaryTrace; P62979; -.
DR   GeneWiki; RPS27A; -.
DR   GenomeRNAi; 6233; -.
DR   Pharos; P62979; Tbio.
DR   PRO; PR:P62979; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P62979; protein.
DR   Bgee; ENSG00000143947; Expressed in left ovary and 162 other tissues.
DR   ExpressionAtlas; P62979; baseline and differential.
DR   Genevisible; P62979; HS.
DR   GO; GO:0005737; C:cytoplasm; HDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022626; C:cytosolic ribosome; IDA:FlyBase.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015935; C:small ribosomal subunit; HDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031386; F:protein tag; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IDA:FlyBase.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0002181; P:cytoplasmic translation; NAS:ComplexPortal.
DR   GO; GO:0019941; P:modification-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0006412; P:translation; IC:UniProtKB.
DR   CDD; cd01803; Ubl_ubiquitin; 1.
DR   Gene3D; 6.20.50.150; -; 1.
DR   InterPro; IPR002906; Ribosomal_S27a.
DR   InterPro; IPR011332; Ribosomal_zn-bd.
DR   InterPro; IPR038582; S27a-like_sf.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR019956; Ubiquitin_dom.
DR   PANTHER; PTHR10666:SF438; GEO12007P1-RELATED; 1.
DR   PANTHER; PTHR10666; UBIQUITIN; 1.
DR   Pfam; PF01599; Ribosomal_S27; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM01402; Ribosomal_S27; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   SUPFAM; SSF57829; Zn-binding ribosomal proteins; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Cytoplasm;
KW   Direct protein sequencing; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Ribonucleoprotein; Ribosomal protein;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..76
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396477"
FT   CHAIN           77..156
FT                   /note="40S ribosomal protein S27a"
FT                   /id="PRO_0000396478"
FT   DOMAIN          1..76
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   ZN_FING         121..144
FT                   /note="C4-type"
FT   REGION          76..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            54
FT                   /note="Interacts with activating enzyme"
FT   SITE            68
FT                   /note="Essential for function"
FT   SITE            72
FT                   /note="Interacts with activating enzyme"
FT   MOD_RES         65
FT                   /note="Phosphoserine; by PINK1"
FT                   /evidence="ECO:0000269|PubMed:24660806,
FT                   ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582,
FT                   ECO:0000269|PubMed:25527291"
FT   MOD_RES         66
FT                   /note="(Microbial infection) ADP-ribosylthreonine"
FT                   /evidence="ECO:0000269|PubMed:32330457"
FT   MOD_RES         76
FT                   /note="ADP-ribosylglycine"
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MOD_RES         104
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         113
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         152
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62983"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603"
FT   CROSSLNK        11
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603,
FT                   ECO:0000269|PubMed:16543144"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:15466860"
FT   CROSSLNK        29
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16543144,
FT                   ECO:0000269|PubMed:25752573, ECO:0000269|PubMed:25752577,
FT                   ECO:0000269|PubMed:34239127"
FT   CROSSLNK        33
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:25752577"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603,
FT                   ECO:0000269|PubMed:16543144"
FT   CROSSLNK        63
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16543144,
FT                   ECO:0000269|PubMed:18719106"
FT   CROSSLNK        76
FT                   /note="Glycyl lysine isopeptide (Gly-Lys) (interchain with
FT                   K-? in acceptor proteins)"
FT   MUTAGEN         48
FT                   /note="K->R: No effect on HLTF-mediated polyubiquitination
FT                   of PCNA."
FT                   /evidence="ECO:0000269|PubMed:18719106"
FT   MUTAGEN         63
FT                   /note="K->R: Abolishes HLTF-mediated polyubiquitination of
FT                   PCNA."
FT                   /evidence="ECO:0000269|PubMed:18719106"
FT   MUTAGEN         65
FT                   /note="S->A: Prevents phosphorylation in case of mitophagy.
FT                   Impaired translocation of PRKN to mitochondria."
FT                   /evidence="ECO:0000269|PubMed:24660806,
FT                   ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25474007"
FT   MUTAGEN         65
FT                   /note="S->D: Phosphomimetic mutant that binds and activates
FT                   PRKN."
FT                   /evidence="ECO:0000269|PubMed:24751536"
FT   MUTAGEN         65
FT                   /note="S->G: Phosphomimetic mutant that can recruit PRKN to
FT                   mitochondria."
FT                   /evidence="ECO:0000269|PubMed:25474007"
FT   MUTAGEN         68
FT                   /note="H->G: Loss of DTX3L-mediated polyubiquitination of
FT                   histone H3 and H4."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         72
FT                   /note="R->G: No effect on ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         72
FT                   /note="R->K: No effect on ADP-ribosylation, when associated
FT                   with K-74."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         74
FT                   /note="R->G: No effect on ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         74
FT                   /note="R->K: No effect on ADP-ribosylation, when associated
FT                   with K-72."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         76
FT                   /note="G->A: Loss of ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   STRAND          2..6
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          8..10
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          12..16
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   HELIX           23..34
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:6SQS"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          66..70
FT                   /evidence="ECO:0007829|PDB:3NHE"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:6ZOJ"
FT   HELIX           101..104
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          106..108
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:7JQB"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   STRAND          123..126
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          131..135
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   TURN            142..144
FT                   /evidence="ECO:0007829|PDB:6ZLW"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:6ZXH"
SQ   SEQUENCE   156 AA;  17965 MW;  617BC63DF3A904F7 CRC64;
     MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ QRLIFAGKQL EDGRTLSDYN
     IQKESTLHLV LRLRGGAKKR KKKSYTTPKK NKHKRKKVKL AVLKYYKVDE NGKISRLRRE
     CPSDECGAGV FMASHFDRHY CGKCCLTYCF NKPEDK
//
ID   SPT4H_HUMAN             Reviewed;         117 AA.
AC   P63272; B2R4X8; D3DTZ4; Q16550; Q62387; Q6ZP89;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   22-FEB-2023, entry version 161.
DE   RecName: Full=Transcription elongation factor SPT4;
DE            Short=hSPT4;
DE   AltName: Full=DRB sensitivity-inducing factor 14 kDa subunit;
DE            Short=DSIF p14;
DE   AltName: Full=DRB sensitivity-inducing factor small subunit;
DE            Short=DSIF small subunit;
GN   Name=SUPT4H1; Synonyms=SPT4H, SUPT4H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=8786137; DOI=10.1006/geno.1996.0299;
RA   Chiang P.-W., Wang S.-Q., Smithivas P., Song W.-J., Crombez E., Akhtar A.,
RA   Im R., Greenfield J., Ramamoorthy S., van Keuren M.L., Blackburn C.C.,
RA   Tsai C.-H., Kurnit D.M.;
RT   "Isolation and characterization of the human and mouse homologues (SUPT4H
RT   and Supt4h) of the yeast SPT4 gene.";
RL   Genomics 34:368-375(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8649394; DOI=10.1128/mcb.16.6.2848;
RA   Hartzog G.A., Basrai M.A., Ricupero-Hovasse S.L., Hieter P., Winston F.;
RT   "Identification and analysis of a functional human homolog of the SPT4 gene
RT   of Saccharomyces cerevisiae.";
RL   Mol. Cell. Biol. 16:2848-2856(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Dermoid cancer, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=9857195; DOI=10.1093/emboj/17.24.7395;
RA   Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa H.;
RT   "Evidence that P-TEFb alleviates the negative effect of DSIF on RNA
RT   polymerase II-dependent transcription in vitro.";
RL   EMBO J. 17:7395-7403(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH SUPT5H.
RX   PubMed=9450929; DOI=10.1101/gad.12.3.343;
RA   Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S.,
RA   Sugimoto S., Yano K., Hartzog G.A., Winston F., Buratowski S., Handa H.;
RT   "DSIF, a novel transcription elongation factor that regulates RNA
RT   polymerase II processivity, is composed of human Spt4 and Spt5 homologs.";
RL   Genes Dev. 12:343-356(1998).
RN   [9]
RP   FUNCTION.
RX   PubMed=10199401; DOI=10.1016/s0092-8674(00)80713-8;
RA   Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S.,
RA   Hasegawa J., Handa H.;
RT   "NELF, a multisubunit complex containing RD, cooperates with DSIF to
RT   repress RNA polymerase II elongation.";
RL   Cell 97:41-51(1999).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SUPT5H.
RX   PubMed=10075709; DOI=10.1074/jbc.274.12.8085;
RA   Yamaguchi Y., Wada T., Watanabe D., Takagi T., Hasegawa J., Handa H.;
RT   "Structure and function of the human transcription elongation factor
RT   DSIF.";
RL   J. Biol. Chem. 274:8085-8092(1999).
RN   [11]
RP   FUNCTION.
RX   PubMed=10454543; DOI=10.1128/mcb.19.9.5960;
RA   Kim J.B., Yamaguchi Y., Wada T., Handa H., Sharp P.A.;
RT   "Tat-SF1 protein associates with RAP30 and human SPT5 proteins.";
RL   Mol. Cell. Biol. 19:5960-5968(1999).
RN   [12]
RP   FUNCTION.
RX   PubMed=10912001; DOI=10.1016/s1097-2765(00)80272-5;
RA   Wada T., Orphanides G., Hasegawa J., Kim D.-K., Shima D., Yamaguchi Y.,
RA   Fukuda A., Hisatake K., Oh S., Reinberg D., Handa H.;
RT   "FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation
RT   and reveals functional differences between P-TEFb and TFIIH.";
RL   Mol. Cell 5:1067-1072(2000).
RN   [13]
RP   INTERACTION WITH SUPT5H.
RX   PubMed=10757782; DOI=10.1128/mcb.20.9.2970-2983.2000;
RA   Ivanov D., Kwak Y.T., Guo J., Gaynor R.B.;
RT   "Domains in the SPT5 protein that modulate its transcriptional regulatory
RT   properties.";
RL   Mol. Cell. Biol. 20:2970-2983(2000).
RN   [14]
RP   FUNCTION.
RX   PubMed=11112772; DOI=10.1074/jbc.m006130200;
RA   Ping Y.-H., Rana T.M.;
RT   "DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1
RT   Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and
RT   DSIF during transcription elongation.";
RL   J. Biol. Chem. 276:12951-12958(2001).
RN   [15]
RP   FUNCTION.
RX   PubMed=11553615; DOI=10.1074/jbc.m104967200;
RA   Renner D.B., Yamaguchi Y., Wada T., Handa H., Price D.H.;
RT   "A highly purified RNA polymerase II elongation control system.";
RL   J. Biol. Chem. 276:42601-42609(2001).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SUPT5H.
RX   PubMed=12653964; DOI=10.1046/j.1365-2443.2003.00638.x;
RA   Kim D.-K., Inukai N., Yamada T., Furuya A., Sato H., Yamaguchi Y., Wada T.,
RA   Handa H.;
RT   "Structure-function analysis of human Spt4: evidence that hSpt4 and hSpt5
RT   exert their roles in transcriptional elongation as parts of the DSIF
RT   complex.";
RL   Genes Cells 8:371-378(2003).
RN   [17]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH SUPT5H.
RX   PubMed=12718890; DOI=10.1016/s1097-2765(03)00101-1;
RA   Kwak Y.T., Guo J., Prajapati S., Park K.-J., Surabhi R.M., Miller B.,
RA   Gehrig P., Gaynor R.B.;
RT   "Methylation of SPT5 regulates its interaction with RNA polymerase II and
RT   transcriptional elongation properties.";
RL   Mol. Cell 11:1055-1066(2003).
RN   [18]
RP   FUNCTION.
RX   PubMed=15380072; DOI=10.1016/j.cub.2004.08.066;
RA   Jennings B.H., Shah S., Yamaguchi Y., Seki M., Phillips R.G., Handa H.,
RA   Ish-Horowicz D.;
RT   "Locus-specific requirements for Spt5 in transcriptional activation and
RT   repression in Drosophila.";
RL   Curr. Biol. 14:1680-1684(2004).
RN   [19]
RP   INTERACTION WITH SUPT5H.
RX   PubMed=15060154; DOI=10.1128/mcb.24.8.3324-3336.2004;
RA   Endoh M., Zhu W., Hasegawa J., Watanabe H., Kim D.-K., Aida M., Inukai N.,
RA   Narita T., Yamada T., Furuya A., Sato H., Yamaguchi Y., Mandal S.S.,
RA   Reinberg D., Wada T., Handa H.;
RT   "Human Spt6 stimulates transcription elongation by RNA polymerase II in
RT   vitro.";
RL   Mol. Cell. Biol. 24:3324-3336(2004).
RN   [20]
RP   FUNCTION.
RX   PubMed=15136722; DOI=10.1073/pnas.0401493101;
RA   Mandal S.S., Chu C., Wada T., Handa H., Shatkin A.J., Reinberg D.;
RT   "Functional interactions of RNA-capping enzyme with factors that positively
RT   and negatively regulate promoter escape by RNA polymerase II.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:7572-7577(2004).
RN   [21]
RP   FUNCTION.
RX   PubMed=16214896; DOI=10.1073/pnas.0409405102;
RA   Palangat M., Renner D.B., Price D.H., Landick R.;
RT   "A negative elongation factor for human RNA polymerase II inhibits the
RT   anti-arrest transcript-cleavage factor TFIIS.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:15036-15041(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 2-117 IN COMPLEX WITH SPT5H.
RX   PubMed=19860741; DOI=10.1042/bj20091422;
RA   Wenzel S., Martins B.M., Rosch P., Wohrl B.M.;
RT   "Crystal structure of the human transcription elongation factor DSIF hSpt4
RT   subunit in complex with the hSpt5 dimerization interface.";
RL   Biochem. J. 425:373-380(2010).
CC   -!- FUNCTION: Component of the DRB sensitivity-inducing factor complex
CC       (DSIF complex), which regulates mRNA processing and transcription
CC       elongation by RNA polymerase II. DSIF positively regulates mRNA capping
CC       by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A.
CC       DSIF also acts cooperatively with the negative elongation factor
CC       complex (NELF complex) to enhance transcriptional pausing at sites
CC       proximal to the promoter. Transcriptional pausing may facilitate the
CC       assembly of an elongation competent RNA polymerase II complex. DSIF and
CC       NELF promote pausing by inhibition of the transcription elongation
CC       factor TFIIS/S-II. TFIIS/S-II binds to RNA polymerase II at
CC       transcription pause sites and stimulates the weak intrinsic nuclease
CC       activity of the enzyme. Cleavage of blocked transcripts by RNA
CC       polymerase II promotes the resumption of transcription from the new 3'
CC       terminus and may allow repeated attempts at transcription through
CC       natural pause sites. DSIF can also positively regulate transcriptional
CC       elongation and is required for the efficient activation of
CC       transcriptional elongation by the HIV-1 nuclear transcriptional
CC       activator, Tat. DSIF acts to suppress transcriptional pausing in
CC       transcripts derived from the HIV-1 LTR and blocks premature release of
CC       HIV-1 transcripts at terminator sequences.
CC       {ECO:0000269|PubMed:10075709, ECO:0000269|PubMed:10199401,
CC       ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10912001,
CC       ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11553615,
CC       ECO:0000269|PubMed:12653964, ECO:0000269|PubMed:12718890,
CC       ECO:0000269|PubMed:15136722, ECO:0000269|PubMed:15380072,
CC       ECO:0000269|PubMed:16214896, ECO:0000269|PubMed:9450929,
CC       ECO:0000269|PubMed:9857195}.
CC   -!- SUBUNIT: Interacts with SUPT5H to form DSIF. DSIF interacts with the
CC       positive transcription elongation factor b complex (P-TEFb complex),
CC       which is composed of CDK9 and cyclin-T (CCNT1 or CCNT2). DSIF interacts
CC       with RNA polymerase II, and this interaction is reduced by
CC       phosphorylation of the C-terminal domain (CTD) of POLR2A by P-TEFb.
CC       DSIF also interacts with the NELF complex, which is composed of NELFA,
CC       NELFB, NELFD and NELFE, and this interaction occurs following prior
CC       binding of DSIF to RNA polymerase II. DSIF also interacts with
CC       PRMT1/HRMT1L2, HTATSF1/TATSF1, RNGTT/CAP1A, PRMT5/SKB1, SUPT6H, and can
CC       interact with PIN1. {ECO:0000269|PubMed:10075709,
CC       ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:12653964,
CC       ECO:0000269|PubMed:12718890, ECO:0000269|PubMed:15060154,
CC       ECO:0000269|PubMed:19860741, ECO:0000269|PubMed:9450929}.
CC   -!- INTERACTION:
CC       P63272; O00267: SUPT5H; NbExp=15; IntAct=EBI-727250, EBI-710464;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8649394}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8649394,
CC       ECO:0000269|PubMed:8786137}.
CC   -!- SIMILARITY: Belongs to the SPT4 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U38818; AAB18674.1; -; mRNA.
DR   EMBL; U38817; AAB18675.1; -; mRNA.
DR   EMBL; U43923; AAB07814.1; -; mRNA.
DR   EMBL; AK129758; BAC85230.1; -; mRNA.
DR   EMBL; AK311986; BAG34925.1; -; mRNA.
DR   EMBL; CR407663; CAG28591.1; -; mRNA.
DR   EMBL; CH471109; EAW94464.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94466.1; -; Genomic_DNA.
DR   EMBL; BC002802; AAH02802.1; -; mRNA.
DR   CCDS; CCDS11606.1; -.
DR   RefSeq; NP_003159.1; NM_003168.2.
DR   PDB; 3H7H; X-ray; 1.55 A; A=2-117.
DR   PDB; 5OIK; EM; 3.70 A; Y=1-117.
DR   PDB; 6GMH; EM; 3.10 A; Y=1-117.
DR   PDB; 6GML; EM; 3.20 A; Y=1-117.
DR   PDB; 6TED; EM; 3.10 A; Y=1-117.
DR   PDB; 7OKY; EM; 4.14 A; Y=1-117.
DR   PDB; 7UND; EM; 3.00 A; Y=1-117.
DR   PDBsum; 3H7H; -.
DR   PDBsum; 5OIK; -.
DR   PDBsum; 6GMH; -.
DR   PDBsum; 6GML; -.
DR   PDBsum; 6TED; -.
DR   PDBsum; 7OKY; -.
DR   PDBsum; 7UND; -.
DR   AlphaFoldDB; P63272; -.
DR   SMR; P63272; -.
DR   BioGRID; 112695; 54.
DR   ComplexPortal; CPX-891; DSIF transcription elongation factor complex.
DR   CORUM; P63272; -.
DR   DIP; DIP-40644N; -.
DR   IntAct; P63272; 17.
DR   MINT; P63272; -.
DR   STRING; 9606.ENSP00000225504; -.
DR   iPTMnet; P63272; -.
DR   PhosphoSitePlus; P63272; -.
DR   BioMuta; SUPT4H1; -.
DR   DMDM; 54039624; -.
DR   EPD; P63272; -.
DR   jPOST; P63272; -.
DR   MassIVE; P63272; -.
DR   MaxQB; P63272; -.
DR   PaxDb; P63272; -.
DR   PeptideAtlas; P63272; -.
DR   ProteomicsDB; 57516; -.
DR   Antibodypedia; 18387; 176 antibodies from 27 providers.
DR   DNASU; 6827; -.
DR   Ensembl; ENST00000225504.8; ENSP00000225504.3; ENSG00000213246.7.
DR   Ensembl; ENST00000580947.1; ENSP00000462670.1; ENSG00000213246.7.
DR   GeneID; 6827; -.
DR   KEGG; hsa:6827; -.
DR   MANE-Select; ENST00000225504.8; ENSP00000225504.3; NM_003168.3; NP_003159.1.
DR   UCSC; uc002iwe.3; human.
DR   AGR; HGNC:11467; -.
DR   CTD; 6827; -.
DR   DisGeNET; 6827; -.
DR   GeneCards; SUPT4H1; -.
DR   HGNC; HGNC:11467; SUPT4H1.
DR   HPA; ENSG00000213246; Low tissue specificity.
DR   MIM; 603555; gene.
DR   neXtProt; NX_P63272; -.
DR   OpenTargets; ENSG00000213246; -.
DR   PharmGKB; PA36253; -.
DR   VEuPathDB; HostDB:ENSG00000213246; -.
DR   eggNOG; KOG3490; Eukaryota.
DR   GeneTree; ENSGT00390000018559; -.
DR   HOGENOM; CLU_138052_3_0_1; -.
DR   InParanoid; P63272; -.
DR   OMA; FDGMIAV; -.
DR   OrthoDB; 130469at2759; -.
DR   PhylomeDB; P63272; -.
DR   TreeFam; TF300105; -.
DR   PathwayCommons; P63272; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SignaLink; P63272; -.
DR   BioGRID-ORCS; 6827; 442 hits in 1155 CRISPR screens.
DR   ChiTaRS; SUPT4H1; human.
DR   EvolutionaryTrace; P63272; -.
DR   GeneWiki; SUPT4H1; -.
DR   GenomeRNAi; 6827; -.
DR   Pharos; P63272; Tbio.
DR   PRO; PR:P63272; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P63272; protein.
DR   Bgee; ENSG00000213246; Expressed in monocyte and 104 other tissues.
DR   ExpressionAtlas; P63272; baseline and differential.
DR   Genevisible; P63272; HS.
DR   GO; GO:0032044; C:DSIF complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ComplexPortal.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0000993; F:RNA polymerase II complex binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0032785; P:negative regulation of DNA-templated transcription, elongation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0034244; P:negative regulation of transcription elongation by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:ProtInc.
DR   GO; GO:0034243; P:regulation of transcription elongation by RNA polymerase II; IDA:ComplexPortal.
DR   GO; GO:0006368; P:transcription elongation by RNA polymerase II promoter; IDA:UniProtKB.
DR   CDD; cd07973; Spt4; 1.
DR   Gene3D; 3.30.40.210; -; 1.
DR   InterPro; IPR029040; RPABC4/Spt4.
DR   InterPro; IPR009287; Spt4.
DR   InterPro; IPR022800; Spt4/RpoE2_Znf.
DR   InterPro; IPR038510; Spt4_sf.
DR   PANTHER; PTHR12882; SUPPRESSOR OF TY 4; 1.
DR   PANTHER; PTHR12882:SF1; TRANSCRIPTION ELONGATION FACTOR SPT4; 1.
DR   Pfam; PF06093; Spt4; 1.
DR   PIRSF; PIRSF025023; Spt4; 1.
DR   SMART; SM01389; Spt4; 1.
DR   SUPFAM; SSF63393; RNA polymerase subunits; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Metal-binding; Nucleus;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..117
FT                   /note="Transcription elongation factor SPT4"
FT                   /id="PRO_0000210325"
FT   ZN_FING         16..36
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   REGION          2..40
FT                   /note="Interaction with SUPT5H"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CONFLICT        95..117
FT                   /note="QGIVRELKSRGVAYKSRDTAIKT -> HAKDSRSNVNKYEPRESSEGHDTCL
FT                   ASLFHSLRHSNSLFAL (in Ref. 3; BAC85230)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..5
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          8..10
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          13..16
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   TURN            17..19
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          21..24
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           25..31
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   TURN            34..36
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           37..40
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           46..52
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          57..64
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           70..74
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   STRAND          82..89
FT                   /evidence="ECO:0007829|PDB:3H7H"
FT   HELIX           95..103
FT                   /evidence="ECO:0007829|PDB:3H7H"
SQ   SEQUENCE   117 AA;  13193 MW;  09EDF007501D0F03 CRC64;
     MALETVPKDL RHLRACLLCS LVKTIDQFEY DGCDNCDAYL QMKGNREMVY DCTSSSFDGI
     IAMMSPEDSW VSKWQRVSNF KPGVYAVSVT GRLPQGIVRE LKSRGVAYKS RDTAIKT
//
ID   RNF4_HUMAN              Reviewed;         190 AA.
AC   P78317; B2R6D6; D6RF58; Q49AR8;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-FEB-2023, entry version 194.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF4 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:35013556};
DE   AltName: Full=RING finger protein 4 {ECO:0000305};
DE   AltName: Full=Small nuclear ring finger protein {ECO:0000303|PubMed:15707587};
DE            Short=Protein SNURF {ECO:0000303|PubMed:15707587};
GN   Name=RNF4 {ECO:0000303|PubMed:15815621, ECO:0000312|HGNC:HGNC:10067};
GN   Synonyms=SNURF {ECO:0000303|PubMed:15707587}; ORFNames=RES4-26;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734812; DOI=10.1093/dnares/5.3.177;
RA   Hadano S., Ishida Y., Ikeda J.-E.;
RT   "The primary structure and genomic organization of five novel transcripts
RT   located close to the Huntington's disease gene on human chromosome
RT   4p16.3.";
RL   DNA Res. 5:177-186(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9479498; DOI=10.1006/geno.1997.5105;
RA   Chiariotti L., Benvenuto G., Fedele M., Santoro M., Simeone A., Fusco A.,
RA   Bruni C.B.;
RT   "Identification and characterization of a novel RING-finger gene (RNF4)
RT   mapping at 4p16.3.";
RL   Genomics 47:258-265(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hair follicle dermal papilla, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH PATZ1.
RX   PubMed=10713105; DOI=10.1074/jbc.275.11.7894;
RA   Fedele M., Benvenuto G., Pero R., Majello B., Battista S., Lembo F.,
RA   Vollono E., Day P.M., Santoro M., Lania L., Bruni C.B., Fusco A.,
RA   Chiatiotti L.;
RT   "A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING
RT   finger protein and acts as a transcriptional repressor.";
RL   J. Biol. Chem. 275:7894-7901(2000).
RN   [7]
RP   FUNCTION, INTERACTION WITH TRPS1, AND SUBCELLULAR LOCATION.
RX   PubMed=12885770; DOI=10.1074/jbc.m306259200;
RA   Kaiser F.J., Moeroey T., Chang G.T., Horsthemke B., Luedecke H.J.;
RT   "The RING finger protein RNF4, a co-regulator of transcription, interacts
RT   with the TRPS1 transcription factor.";
RL   J. Biol. Chem. 278:38780-38785(2003).
RN   [8]
RP   INTERACTION WITH PML, AND SUBCELLULAR LOCATION.
RX   PubMed=15707587; DOI=10.1016/j.yexcr.2004.10.029;
RA   Haekli M., Karvonen U., Jaenne O.A., Palvimo J.J.;
RT   "SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.";
RL   Exp. Cell Res. 304:224-233(2005).
RN   [9]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=18408734; DOI=10.1038/ncb1716;
RA   Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N.,
RA   Jaffray E.G., Palvimo J.J., Hay R.T.;
RT   "RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-
RT   induced PML degradation.";
RL   Nat. Cell Biol. 10:538-546(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94 AND SER-95, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION.
RX   PubMed=19779455; DOI=10.1038/emboj.2009.279;
RA   Martin N., Schwamborn K., Schreiber V., Werner A., Guillier C., Zhang X.D.,
RA   Bischof O., Seeler J.S., Dejean A.;
RT   "PARP-1 transcriptional activity is regulated by sumoylation upon heat
RT   shock.";
RL   EMBO J. 28:3534-3548(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=19307308; DOI=10.1128/mcb.01128-08;
RA   Guo B., Sharrocks A.D.;
RT   "Extracellular signal-regulated kinase mitogen-activated protein kinase
RT   signaling initiates a dynamic interplay between sumoylation and
RT   ubiquitination to regulate the activity of the transcriptional activator
RT   PEA3.";
RL   Mol. Cell. Biol. 29:3204-3218(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94 AND SER-95, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION.
RX   PubMed=20212317; DOI=10.1083/jcb.200909008;
RA   Mukhopadhyay D., Arnaoutov A., Dasso M.;
RT   "The SUMO protease SENP6 is essential for inner kinetochore assembly.";
RL   J. Cell Biol. 188:681-692(2010).
RN   [15]
RP   FUNCTION, INTERACTION WITH SUMOYLATED PML, AND SUBCELLULAR LOCATION.
RX   PubMed=20943951; DOI=10.1091/mbc.e10-05-0449;
RA   Geoffroy M.C., Jaffray E.G., Walker K.J., Hay R.T.;
RT   "Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear
RT   bodies.";
RL   Mol. Biol. Cell 21:4227-4239(2010).
RN   [16]
RP   FUNCTION.
RX   PubMed=20026589; DOI=10.1093/nar/gkp1157;
RA   van Hagen M., Overmeer R.M., Abolvardi S.S., Vertegaal A.C.;
RT   "RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated
RT   Hypoxia-Inducible Factor-2alpha.";
RL   Nucleic Acids Res. 38:1922-1931(2010).
RN   [17]
RP   INTERACTION WITH PML.
RX   PubMed=23028697; DOI=10.1371/journal.pone.0044949;
RA   Maroui M.A., Kheddache-Atmane S., El Asmi F., Dianoux L., Aubry M.,
RA   Chelbi-Alix M.K.;
RT   "Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-
RT   induced degradation of nuclear PML isoforms.";
RL   PLoS ONE 7:E44949-E44949(2012).
RN   [18]
RP   INTERACTION WITH PRDM1.
RX   PubMed=28842558; DOI=10.1038/s41467-017-00476-w;
RA   Wang W.F., Yan L., Liu Z., Liu L.X., Lin J., Liu Z.Y., Chen X.P., Zhang W.,
RA   Xu Z.Z., Shi T., Li J.M., Zhao Y.L., Meng G., Xia Y., Li J.Y., Zhu J.;
RT   "HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal
RT   misfolded Blimp-1s in lymphoma cells.";
RL   Nat. Commun. 8:363-363(2017).
RN   [19]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND MUTAGENESIS OF MET-136; HIS-156
RP   AND ARG-177.
RX   PubMed=35013556; DOI=10.1038/s41556-021-00807-6;
RA   Krastev D.B., Li S., Sun Y., Wicks A.J., Hoslett G., Weekes D.,
RA   Badder L.M., Knight E.G., Marlow R., Pardo M.C., Yu L., Talele T.T.,
RA   Bartek J., Choudhary J.S., Pommier Y., Pettitt S.J., Tutt A.N.J.,
RA   Ramadan K., Lord C.J.;
RT   "The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from
RT   chromatin.";
RL   Nat. Cell Biol. 24:62-73(2022).
RN   [20]
RP   STRUCTURE BY NMR OF 122-183.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RING domain of the human RING finger protein
RT   4.";
RL   Submitted (JUL-2007) to the PDB data bank.
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which binds polysumoylated chains
CC       covalently attached to proteins and mediates 'Lys-6'-, 'Lys-11'-, 'Lys-
CC       48'- and 'Lys-63'-linked polyubiquitination of those substrates and
CC       their subsequent targeting to the proteasome for degradation
CC       (PubMed:18408734, PubMed:19307308, PubMed:35013556). Regulates the
CC       degradation of several proteins including PML and the transcriptional
CC       activator PEA3 (PubMed:18408734, PubMed:19307308, PubMed:20943951).
CC       Involved in chromosome alignment and spindle assembly, it regulates the
CC       kinetochore CENPH-CENPI-CENPK complex by targeting polysumoylated CENPI
CC       to proteasomal degradation (PubMed:20212317). Regulates the cellular
CC       responses to hypoxia and heat shock through degradation of respectively
CC       EPAS1 and PARP1 (PubMed:19779455, PubMed:20026589). Alternatively, it
CC       may also bind DNA/nucleosomes and have a more direct role in the
CC       regulation of transcription for instance enhancing basal transcription
CC       and steroid receptor-mediated transcriptional activation
CC       (PubMed:12885770). Catalyzes ubiquitination of sumoylated PARP1 in
CC       response to PARP1 trapping to chromatin, leading to PARP1 removal from
CC       chromatin by VCP/p97 (PubMed:35013556). {ECO:0000269|PubMed:12885770,
CC       ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:19307308,
CC       ECO:0000269|PubMed:19779455, ECO:0000269|PubMed:20026589,
CC       ECO:0000269|PubMed:20212317, ECO:0000269|PubMed:20943951,
CC       ECO:0000269|PubMed:35013556}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:35013556};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:35013556}.
CC   -!- SUBUNIT: Homodimer (via RING-type zinc finger domain) (By similarity).
CC       Interacts with GSC2 (By similarity). Interacts with AR/the androgen
CC       receptor and TBP (By similarity). Interacts with TCF20 (By similarity).
CC       Interacts with PATZ1 (PubMed:10713105). Interacts with TRPS1;
CC       negatively regulates TRPS1 transcriptional repressor activity
CC       (PubMed:12885770). Interacts with PML (isoform PML-1, isoform PML-2,
CC       isoform PML-3, isoform PML-4, isoform PML-5 and isoform PML-6)
CC       (PubMed:15707587, PubMed:20943951, PubMed:23028697). Interacts with
CC       PRDM1/Blimp-1 (PubMed:28842558). {ECO:0000250|UniProtKB:O88846,
CC       ECO:0000250|UniProtKB:Q9QZS2, ECO:0000269|PubMed:10713105,
CC       ECO:0000269|PubMed:12885770, ECO:0000269|PubMed:15707587,
CC       ECO:0000269|PubMed:20943951, ECO:0000269|PubMed:23028697,
CC       ECO:0000269|PubMed:28842558}.
CC   -!- INTERACTION:
CC       P78317; P60709: ACTB; NbExp=3; IntAct=EBI-2340927, EBI-353944;
CC       P78317; Q02040: AKAP17A; NbExp=5; IntAct=EBI-2340927, EBI-1042725;
CC       P78317; A6NKF2: ARID3C; NbExp=3; IntAct=EBI-2340927, EBI-12805486;
CC       P78317; P15336: ATF2; NbExp=3; IntAct=EBI-2340927, EBI-1170906;
CC       P78317; Q07817: BCL2L1; NbExp=3; IntAct=EBI-2340927, EBI-78035;
CC       P78317; Q9H0C5: BTBD1; NbExp=3; IntAct=EBI-2340927, EBI-935503;
CC       P78317; Q9Y2F9: BTBD3; NbExp=3; IntAct=EBI-2340927, EBI-311155;
CC       P78317; Q9NWQ9: C14orf119; NbExp=3; IntAct=EBI-2340927, EBI-725606;
CC       P78317; Q96B23: C18orf25; NbExp=3; IntAct=EBI-2340927, EBI-742108;
CC       P78317; Q13554-3: CAMK2B; NbExp=3; IntAct=EBI-2340927, EBI-11523526;
CC       P78317; Q13557-8: CAMK2D; NbExp=3; IntAct=EBI-2340927, EBI-11534483;
CC       P78317; P13500: CCL2; NbExp=3; IntAct=EBI-2340927, EBI-1034732;
CC       P78317; Q9Y281: CFL2; NbExp=3; IntAct=EBI-2340927, EBI-351218;
CC       P78317; P16220: CREB1; NbExp=3; IntAct=EBI-2340927, EBI-711855;
CC       P78317; Q9UER7: DAXX; NbExp=3; IntAct=EBI-2340927, EBI-77321;
CC       P78317; O00148: DDX39A; NbExp=3; IntAct=EBI-2340927, EBI-348253;
CC       P78317; Q13838: DDX39B; NbExp=3; IntAct=EBI-2340927, EBI-348622;
CC       P78317; P17661: DES; NbExp=3; IntAct=EBI-2340927, EBI-1055572;
CC       P78317; Q6ICB0: DESI1; NbExp=3; IntAct=EBI-2340927, EBI-2806959;
CC       P78317; Q08426: EHHADH; NbExp=3; IntAct=EBI-2340927, EBI-2339219;
CC       P78317; P11474: ESRRA; NbExp=3; IntAct=EBI-2340927, EBI-372412;
CC       P78317; Q13158: FADD; NbExp=5; IntAct=EBI-2340927, EBI-494804;
CC       P78317; Q9NWS6: FAM118A; NbExp=3; IntAct=EBI-2340927, EBI-8638992;
CC       P78317; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-2340927, EBI-8468186;
CC       P78317; O75344: FKBP6; NbExp=3; IntAct=EBI-2340927, EBI-744771;
CC       P78317; Q96IK5: GMCL1; NbExp=5; IntAct=EBI-2340927, EBI-2548508;
CC       P78317; O14964: HGS; NbExp=3; IntAct=EBI-2340927, EBI-740220;
CC       P78317; P07910: HNRNPC; NbExp=3; IntAct=EBI-2340927, EBI-357966;
CC       P78317; O60812: HNRNPCL1; NbExp=3; IntAct=EBI-2340927, EBI-1046507;
CC       P78317; B2RXH8: HNRNPCL2; NbExp=3; IntAct=EBI-2340927, EBI-9512317;
CC       P78317; P31943: HNRNPH1; NbExp=3; IntAct=EBI-2340927, EBI-351590;
CC       P78317; P61978-2: HNRNPK; NbExp=3; IntAct=EBI-2340927, EBI-7060731;
CC       P78317; Q13422-7: IKZF1; NbExp=3; IntAct=EBI-2340927, EBI-11522367;
CC       P78317; P20839-3: IMPDH1; NbExp=3; IntAct=EBI-2340927, EBI-12188657;
CC       P78317; Q53G59: KLHL12; NbExp=3; IntAct=EBI-2340927, EBI-740929;
CC       P78317; Q5T7P3: LCE1B; NbExp=3; IntAct=EBI-2340927, EBI-10245913;
CC       P78317; Q5T752: LCE1D; NbExp=3; IntAct=EBI-2340927, EBI-11741311;
CC       P78317; Q5T753: LCE1E; NbExp=3; IntAct=EBI-2340927, EBI-11955335;
CC       P78317; Q5T754: LCE1F; NbExp=3; IntAct=EBI-2340927, EBI-11958008;
CC       P78317; O14633: LCE2B; NbExp=3; IntAct=EBI-2340927, EBI-11478468;
CC       P78317; Q5TA81: LCE2C; NbExp=5; IntAct=EBI-2340927, EBI-11973993;
CC       P78317; Q5TA82: LCE2D; NbExp=3; IntAct=EBI-2340927, EBI-10246750;
CC       P78317; Q5TA77: LCE3B; NbExp=3; IntAct=EBI-2340927, EBI-11974495;
CC       P78317; Q5TCM9: LCE5A; NbExp=3; IntAct=EBI-2340927, EBI-11955689;
CC       P78317; Q9BS40: LXN; NbExp=3; IntAct=EBI-2340927, EBI-1044504;
CC       P78317; Q99836: MYD88; NbExp=3; IntAct=EBI-2340927, EBI-447677;
CC       P78317; Q99801: NKX3-1; NbExp=3; IntAct=EBI-2340927, EBI-1385894;
CC       P78317; Q9HAN9: NMNAT1; NbExp=3; IntAct=EBI-2340927, EBI-3917542;
CC       P78317; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-2340927, EBI-741158;
CC       P78317; O15381-5: NVL; NbExp=3; IntAct=EBI-2340927, EBI-18577082;
CC       P78317; P22234: PAICS; NbExp=3; IntAct=EBI-2340927, EBI-712261;
CC       P78317; P57721-2: PCBP3; NbExp=3; IntAct=EBI-2340927, EBI-11983983;
CC       P78317; P78364: PHC1; NbExp=5; IntAct=EBI-2340927, EBI-725403;
CC       P78317; O75360: PROP1; NbExp=3; IntAct=EBI-2340927, EBI-9027467;
CC       P78317; P86480: PRR20D; NbExp=3; IntAct=EBI-2340927, EBI-12754095;
CC       P78317; Q9BQY4: RHOXF2; NbExp=3; IntAct=EBI-2340927, EBI-372094;
CC       P78317; P78317: RNF4; NbExp=2; IntAct=EBI-2340927, EBI-2340927;
CC       P78317; Q06455-2: RUNX1T1; NbExp=3; IntAct=EBI-2340927, EBI-11984663;
CC       P78317; Q9UQR0: SCML2; NbExp=3; IntAct=EBI-2340927, EBI-2513111;
CC       P78317; Q9UH03: SEPTIN3; NbExp=3; IntAct=EBI-2340927, EBI-727037;
CC       P78317; O75971-2: SNAPC5; NbExp=3; IntAct=EBI-2340927, EBI-12004298;
CC       P78317; P35711-4: SOX5; NbExp=3; IntAct=EBI-2340927, EBI-11954419;
CC       P78317; O43805: SSNA1; NbExp=3; IntAct=EBI-2340927, EBI-2515299;
CC       P78317; Q16623: STX1A; NbExp=3; IntAct=EBI-2340927, EBI-712466;
CC       P78317; P32856-2: STX2; NbExp=3; IntAct=EBI-2340927, EBI-11956649;
CC       P78317; Q12846: STX4; NbExp=3; IntAct=EBI-2340927, EBI-744942;
CC       P78317; P63165: SUMO1; NbExp=4; IntAct=EBI-2340927, EBI-80140;
CC       P78317; Q92734: TFG; NbExp=5; IntAct=EBI-2340927, EBI-357061;
CC       P78317; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-2340927, EBI-741515;
CC       P78317; Q12933: TRAF2; NbExp=3; IntAct=EBI-2340927, EBI-355744;
CC       P78317; Q13114: TRAF3; NbExp=3; IntAct=EBI-2340927, EBI-357631;
CC       P78317; Q9BUZ4: TRAF4; NbExp=5; IntAct=EBI-2340927, EBI-3650647;
CC       P78317; O00463: TRAF5; NbExp=5; IntAct=EBI-2340927, EBI-523498;
CC       P78317; O00635: TRIM38; NbExp=3; IntAct=EBI-2340927, EBI-2130415;
CC       P78317; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-2340927, EBI-2130429;
CC       P78317; Q15645: TRIP13; NbExp=3; IntAct=EBI-2340927, EBI-358993;
CC       P78317; Q9UHF7: TRPS1; NbExp=2; IntAct=EBI-2340927, EBI-2556151;
CC       P78317; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-2340927, EBI-10180829;
CC       P78317; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-2340927, EBI-741480;
CC       P78317; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-2340927, EBI-947187;
CC       P78317; Q8WUN7: UBTD2; NbExp=3; IntAct=EBI-2340927, EBI-12867288;
CC       P78317; O95231: VENTX; NbExp=3; IntAct=EBI-2340927, EBI-10191303;
CC       P78317; Q9HCK0: ZBTB26; NbExp=3; IntAct=EBI-2340927, EBI-3918996;
CC       P78317; Q8NCN2: ZBTB34; NbExp=3; IntAct=EBI-2340927, EBI-11317716;
CC       P78317; Q15916: ZBTB6; NbExp=3; IntAct=EBI-2340927, EBI-7227791;
CC       P78317; Q96K80: ZC3H10; NbExp=3; IntAct=EBI-2340927, EBI-742550;
CC       P78317; Q9NP64: ZCCHC17; NbExp=3; IntAct=EBI-2340927, EBI-746345;
CC       P78317; Q96MM3: ZFP42; NbExp=3; IntAct=EBI-2340927, EBI-12151755;
CC       P78317; Q9NSD4: ZNF275; NbExp=3; IntAct=EBI-2340927, EBI-17263125;
CC       P78317; Q9P2F9: ZNF319; NbExp=5; IntAct=EBI-2340927, EBI-11993110;
CC       P78317; Q9H7X3: ZNF696; NbExp=5; IntAct=EBI-2340927, EBI-11090299;
CC       P78317; Q3KQV3: ZNF792; NbExp=3; IntAct=EBI-2340927, EBI-10240849;
CC       P78317; O60232: ZNRD2; NbExp=3; IntAct=EBI-2340927, EBI-741415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12885770}. Nucleus
CC       {ECO:0000269|PubMed:12885770}. Nucleus, PML body
CC       {ECO:0000269|PubMed:15707587, ECO:0000269|PubMed:20943951}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78317-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78317-2; Sequence=VSP_045789, VSP_045790;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels in many tissues;
CC       highly expressed in testis. {ECO:0000269|PubMed:9479498}.
CC   -!- DOMAIN: The SUMO interaction motifs (SIMs) mediates the binding to
CC       polysumoylated substrate. {ECO:0000269|PubMed:18408734}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for the
CC       ubiquitination of polysumoylated substrates.
CC       {ECO:0000250|UniProtKB:O88846}.
CC   -!- PTM: Sumoylated; conjugated by one or two SUMO1 moieties.
CC       {ECO:0000250|UniProtKB:O88846}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000250|UniProtKB:O88846}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB000468; BAA19122.1; -; mRNA.
DR   EMBL; U95140; AAC52022.1; -; mRNA.
DR   EMBL; AK128038; BAG54620.1; -; mRNA.
DR   EMBL; AK309509; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK312534; BAG35433.1; -; mRNA.
DR   EMBL; AL110117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL645924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX322586; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR450722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR545473; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC031935; AAH31935.1; -; mRNA.
DR   CCDS; CCDS47001.1; -. [P78317-1]
DR   CCDS; CCDS54713.1; -. [P78317-2]
DR   RefSeq; NP_001171938.1; NM_001185009.2. [P78317-1]
DR   RefSeq; NP_001171939.1; NM_001185010.2. [P78317-2]
DR   RefSeq; NP_002929.1; NM_002938.4. [P78317-1]
DR   PDB; 2EA6; NMR; -; A=122-183.
DR   PDB; 2XEU; X-ray; 1.50 A; A=130-190.
DR   PDB; 4PPE; X-ray; 2.00 A; A/B=120-190.
DR   PDBsum; 2EA6; -.
DR   PDBsum; 2XEU; -.
DR   PDBsum; 4PPE; -.
DR   AlphaFoldDB; P78317; -.
DR   BMRB; P78317; -.
DR   SMR; P78317; -.
DR   BioGRID; 111974; 1414.
DR   IntAct; P78317; 116.
DR   MINT; P78317; -.
DR   STRING; 9606.ENSP00000426503; -.
DR   iPTMnet; P78317; -.
DR   PhosphoSitePlus; P78317; -.
DR   BioMuta; RNF4; -.
DR   DMDM; 18202358; -.
DR   EPD; P78317; -.
DR   jPOST; P78317; -.
DR   MassIVE; P78317; -.
DR   MaxQB; P78317; -.
DR   PaxDb; P78317; -.
DR   PeptideAtlas; P78317; -.
DR   ProteomicsDB; 57562; -. [P78317-1]
DR   Antibodypedia; 22369; 140 antibodies from 24 providers.
DR   DNASU; 6047; -.
DR   Ensembl; ENST00000314289.13; ENSP00000315212.8; ENSG00000063978.17. [P78317-1]
DR   Ensembl; ENST00000506706.5; ENSP00000424076.1; ENSG00000063978.17. [P78317-1]
DR   Ensembl; ENST00000511600.5; ENSP00000426503.1; ENSG00000063978.17. [P78317-1]
DR   Ensembl; ENST00000511859.5; ENSP00000426615.1; ENSG00000063978.17. [P78317-2]
DR   Ensembl; ENST00000541204.5; ENSP00000446369.2; ENSG00000063978.17. [P78317-2]
DR   GeneID; 6047; -.
DR   KEGG; hsa:6047; -.
DR   MANE-Select; ENST00000314289.13; ENSP00000315212.8; NM_002938.5; NP_002929.1.
DR   UCSC; uc003gfb.4; human. [P78317-1]
DR   AGR; HGNC:10067; -.
DR   CTD; 6047; -.
DR   DisGeNET; 6047; -.
DR   GeneCards; RNF4; -.
DR   HGNC; HGNC:10067; RNF4.
DR   HPA; ENSG00000063978; Low tissue specificity.
DR   MIM; 602850; gene.
DR   neXtProt; NX_P78317; -.
DR   OpenTargets; ENSG00000063978; -.
DR   PharmGKB; PA34439; -.
DR   VEuPathDB; HostDB:ENSG00000063978; -.
DR   eggNOG; KOG0320; Eukaryota.
DR   GeneTree; ENSGT00390000010318; -.
DR   HOGENOM; CLU_106856_0_0_1; -.
DR   InParanoid; P78317; -.
DR   OMA; LRNANSC; -.
DR   OrthoDB; 2919802at2759; -.
DR   PhylomeDB; P78317; -.
DR   TreeFam; TF328387; -.
DR   PathwayCommons; P78317; -.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P78317; -.
DR   SIGNOR; P78317; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 6047; 528 hits in 1204 CRISPR screens.
DR   ChiTaRS; RNF4; human.
DR   EvolutionaryTrace; P78317; -.
DR   GeneWiki; RNF4; -.
DR   GenomeRNAi; 6047; -.
DR   Pharos; P78317; Tbio.
DR   PRO; PR:P78317; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P78317; protein.
DR   Bgee; ENSG00000063978; Expressed in thymus and 202 other tissues.
DR   ExpressionAtlas; P78317; baseline and differential.
DR   Genevisible; P78317; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:1990752; C:microtubule end; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; TAS:UniProtKB.
DR   GO; GO:0031491; F:nucleosome binding; ISS:UniProtKB.
DR   GO; GO:0032184; F:SUMO polymer binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; ISS:UniProtKB.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0085020; P:protein K6-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0090234; P:regulation of kinetochore assembly; IMP:UniProtKB.
DR   GO; GO:0090169; P:regulation of spindle assembly; IMP:UniProtKB.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IDA:UniProtKB.
DR   CDD; cd16533; RING-HC_RNF4; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR043295; RING-HC_RNF4.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR23041:SF78; E3 UBIQUITIN-PROTEIN LIGASE RNF4; 1.
DR   PANTHER; PTHR23041; RING FINGER DOMAIN-CONTAINING; 1.
DR   Pfam; PF13923; zf-C3HC4_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Cytoplasm; DNA-binding;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..190
FT                   /note="E3 ubiquitin-protein ligase RNF4"
FT                   /id="PRO_0000056043"
FT   ZN_FING         132..177
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..16
FT                   /note="Required for ubiquitination activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZS2"
FT   REGION          4..61
FT                   /note="Mediates interaction with TRPS1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZS2"
FT   MOTIF           36..39
FT                   /note="SUMO interaction motif 1"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           46..49
FT                   /note="SUMO interaction motif 2"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           57..59
FT                   /note="SUMO interaction motif 3"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           67..70
FT                   /note="SUMO interaction motif 4"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   COMPBIAS        1..27
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         135
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         154
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         156
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         159
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         162
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         173
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   BINDING         176
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O88846"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   VAR_SEQ         72..113
FT                   /note="ERRRPRRNARRLPQDHADSCVVSSDDEELSRDRDVYVTTHTP -> GPQVLS
FT                   VVPSAWTDTQRSCRMDVSSFPQNAAMSSVASASVIP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045789"
FT   VAR_SEQ         114..190
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045790"
FT   MUTAGEN         136
FT                   /note="M->S: Dominant-negative E2-binding mutant, leads to
FT                   increased trapping of PARP1 to chromatin; when associated
FT                   with A-177."
FT                   /evidence="ECO:0000269|PubMed:35013556"
FT   MUTAGEN         156
FT                   /note="H->A: Abolished E3 ubiquitin-protein ligase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:35013556"
FT   MUTAGEN         177
FT                   /note="R->A: Dominant-negative E2-binding mutant, leads to
FT                   increased trapping of PARP1 to chromatin; when associated
FT                   with S-136."
FT                   /evidence="ECO:0000269|PubMed:35013556"
FT   TURN            133..135
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   HELIX           139..144
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   STRAND          149..152
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:2EA6"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   HELIX           160..169
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   TURN            174..176
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:2XEU"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:2XEU"
SQ   SEQUENCE   190 AA;  21319 MW;  E5E3AE4A9B28CF9D CRC64;
     MSTRKRRGGA INSRQAQKRT REATSTPEIS LEAEPIELVE TAGDEIVDLT CESLEPVVVD
     LTHNDSVVIV DERRRPRRNA RRLPQDHADS CVVSSDDEEL SRDRDVYVTT HTPRNARDEG
     ATGLRPSGTV SCPICMDGYS EIVQNGRLIV STECGHVFCS QCLRDSLKNA NTCPTCRKKI
     NHKRYHPIYI
//
ID   PRR3_HUMAN              Reviewed;         188 AA.
AC   P79522; A1A4H4; Q5RJB5; Q5STN6;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 2.
DT   22-FEB-2023, entry version 164.
DE   RecName: Full=Proline-rich protein 3;
DE   AltName: Full=MHC class I region proline-rich protein CAT56;
GN   Name=PRR3; Synonyms=CAT56;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wei H., Weissman S.M.;
RT   "Human proline rich sequence (CAT 56) from the MHC class I region.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-61.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       P79522; Q9NRW3: APOBEC3C; NbExp=3; IntAct=EBI-2803328, EBI-1044593;
CC       P79522; Q9Y294: ASF1A; NbExp=6; IntAct=EBI-2803328, EBI-749553;
CC       P79522; Q2TAC2: CCDC57; NbExp=3; IntAct=EBI-2803328, EBI-2808286;
CC       P79522; Q92989: CLP1; NbExp=3; IntAct=EBI-2803328, EBI-2559831;
CC       P79522; Q0VDC6: FKBP1A; NbExp=3; IntAct=EBI-2803328, EBI-10226858;
CC       P79522; P61978: HNRNPK; NbExp=7; IntAct=EBI-2803328, EBI-304185;
CC       P79522; P61978-2: HNRNPK; NbExp=5; IntAct=EBI-2803328, EBI-7060731;
CC       P79522; P54652: HSPA2; NbExp=3; IntAct=EBI-2803328, EBI-356991;
CC       P79522; Q5VWX1: KHDRBS2; NbExp=6; IntAct=EBI-2803328, EBI-742808;
CC       P79522; O75525: KHDRBS3; NbExp=3; IntAct=EBI-2803328, EBI-722504;
CC       P79522; Q13351: KLF1; NbExp=3; IntAct=EBI-2803328, EBI-8284732;
CC       P79522; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-2803328, EBI-11962084;
CC       P79522; Q86VE0: MYPOP; NbExp=3; IntAct=EBI-2803328, EBI-2858213;
CC       P79522; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-2803328, EBI-398874;
CC       P79522; P25788: PSMA3; NbExp=3; IntAct=EBI-2803328, EBI-348380;
CC       P79522; Q9BTL3: RAMAC; NbExp=3; IntAct=EBI-2803328, EBI-744023;
CC       P79522; P98179: RBM3; NbExp=3; IntAct=EBI-2803328, EBI-2949699;
CC       P79522; P38159: RBMX; NbExp=6; IntAct=EBI-2803328, EBI-743526;
CC       P79522; P0DJD3: RBMY1A1; NbExp=3; IntAct=EBI-2803328, EBI-8638511;
CC       P79522; P0DJD3-2: RBMY1A1; NbExp=3; IntAct=EBI-2803328, EBI-11994018;
CC       P79522; Q15415: RBMY1J; NbExp=7; IntAct=EBI-2803328, EBI-8642021;
CC       P79522; P49591: SARS1; NbExp=3; IntAct=EBI-2803328, EBI-1053431;
CC       P79522; Q08117: TLE5; NbExp=3; IntAct=EBI-2803328, EBI-717810;
CC       P79522; Q08117-2: TLE5; NbExp=3; IntAct=EBI-2803328, EBI-11741437;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P79522-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P79522-2; Sequence=VSP_012818;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB40147.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U63336; AAB40147.1; ALT_INIT; mRNA.
DR   EMBL; AL662825; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662800; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX000357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX248518; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR388372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR847863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126457; AAI26458.1; -; mRNA.
DR   CCDS; CCDS43440.1; -. [P79522-1]
DR   CCDS; CCDS43441.1; -. [P79522-2]
DR   RefSeq; NP_079539.2; NM_025263.3. [P79522-1]
DR   AlphaFoldDB; P79522; -.
DR   BioGRID; 123286; 262.
DR   IntAct; P79522; 40.
DR   STRING; 9606.ENSP00000365744; -.
DR   iPTMnet; P79522; -.
DR   MetOSite; P79522; -.
DR   PhosphoSitePlus; P79522; -.
DR   BioMuta; PRR3; -.
DR   DMDM; 59798092; -.
DR   EPD; P79522; -.
DR   jPOST; P79522; -.
DR   MassIVE; P79522; -.
DR   MaxQB; P79522; -.
DR   PaxDb; P79522; -.
DR   PeptideAtlas; P79522; -.
DR   ProteomicsDB; 57662; -. [P79522-1]
DR   ProteomicsDB; 57663; -. [P79522-2]
DR   Antibodypedia; 67374; 34 antibodies from 9 providers.
DR   DNASU; 80742; -.
DR   Ensembl; ENST00000376557.3; ENSP00000365740.3; ENSG00000204576.12. [P79522-2]
DR   Ensembl; ENST00000376560.8; ENSP00000365744.4; ENSG00000204576.12. [P79522-1]
DR   Ensembl; ENST00000383592.8; ENSP00000373086.4; ENSG00000206491.12. [P79522-1]
DR   Ensembl; ENST00000418065.2; ENSP00000404669.2; ENSG00000206491.12. [P79522-2]
DR   Ensembl; ENST00000422140.2; ENSP00000411802.2; ENSG00000228186.10. [P79522-2]
DR   Ensembl; ENST00000422639.2; ENSP00000401499.2; ENSG00000229202.10. [P79522-2]
DR   Ensembl; ENST00000427729.6; ENSP00000402596.2; ENSG00000223766.10. [P79522-1]
DR   Ensembl; ENST00000432371.6; ENSP00000396416.2; ENSG00000228186.10. [P79522-1]
DR   Ensembl; ENST00000436805.2; ENSP00000406321.2; ENSG00000233564.10. [P79522-2]
DR   Ensembl; ENST00000442290.2; ENSP00000401612.2; ENSG00000223887.10. [P79522-2]
DR   Ensembl; ENST00000444972.2; ENSP00000393410.2; ENSG00000223766.10. [P79522-2]
DR   Ensembl; ENST00000449754.6; ENSP00000398352.2; ENSG00000233564.10. [P79522-1]
DR   Ensembl; ENST00000453232.6; ENSP00000415432.2; ENSG00000229202.10. [P79522-1]
DR   Ensembl; ENST00000454399.6; ENSP00000392826.2; ENSG00000223887.10. [P79522-1]
DR   GeneID; 80742; -.
DR   KEGG; hsa:80742; -.
DR   MANE-Select; ENST00000376560.8; ENSP00000365744.4; NM_025263.4; NP_079539.2.
DR   UCSC; uc003nqj.3; human. [P79522-1]
DR   AGR; HGNC:21149; -.
DR   CTD; 80742; -.
DR   DisGeNET; 80742; -.
DR   GeneCards; PRR3; -.
DR   HGNC; HGNC:21149; PRR3.
DR   HPA; ENSG00000204576; Low tissue specificity.
DR   neXtProt; NX_P79522; -.
DR   OpenTargets; ENSG00000204576; -.
DR   PharmGKB; PA134950097; -.
DR   VEuPathDB; HostDB:ENSG00000204576; -.
DR   eggNOG; ENOG502TAPB; Eukaryota.
DR   GeneTree; ENSGT00940000161804; -.
DR   HOGENOM; CLU_112270_0_0_1; -.
DR   InParanoid; P79522; -.
DR   OMA; ESPIGPP; -.
DR   OrthoDB; 4740308at2759; -.
DR   PhylomeDB; P79522; -.
DR   TreeFam; TF337284; -.
DR   PathwayCommons; P79522; -.
DR   SignaLink; P79522; -.
DR   BioGRID-ORCS; 80742; 21 hits in 1160 CRISPR screens.
DR   ChiTaRS; PRR3; human.
DR   GenomeRNAi; 80742; -.
DR   Pharos; P79522; Tdark.
DR   PRO; PR:P79522; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P79522; protein.
DR   Bgee; ENSG00000204576; Expressed in cortical plate and 96 other tissues.
DR   ExpressionAtlas; P79522; baseline and differential.
DR   Genevisible; P79522; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   Gene3D; 4.10.1000.10; Zinc finger, CCCH-type; 1.
DR   InterPro; IPR042805; PRR3.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR47398; PROLINE-RICH PROTEIN 3; 1.
DR   PANTHER; PTHR47398:SF1; PROLINE-RICH PROTEIN 3-RELATED; 1.
DR   Pfam; PF00642; zf-CCCH; 1.
DR   SMART; SM00356; ZnF_C3H1; 1.
DR   SUPFAM; SSF90229; CCCH zinc finger; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Metal-binding; Reference proteome; Repeat; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..188
FT                   /note="Proline-rich protein 3"
FT                   /id="PRO_0000213889"
FT   ZN_FING         155..183
FT                   /note="C3H1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          1..157
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        65..85
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         36..56
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_012818"
FT   VARIANT         61
FT                   /note="G -> S (in dbSNP:rs3888778)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_052963"
SQ   SEQUENCE   188 AA;  20640 MW;  1EFDAFB4FFBBE153 CRC64;
     MPKRKKQNHH QPPTQQQPPL PEREETGDEE DGSPIGPPSL LGPPPMANGK PGDPKSALHR
     GPPGSRGPLI PPLLSLPPPP WGRGPIRRGL GPRSSPYGRG WWGVNAEPPF PGPGHGGPTR
     GSFHKEQRNP RRLKSWSLIK NTCPPKDDPQ VMEDKSDRPV CRHFAKKGHC RYEDLCAFYH
     PGVNGPPL
//
ID   ZNHI3_HUMAN             Reviewed;         155 AA.
AC   Q15649; A8K493; K7EQP1; Q8WVJ3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   22-FEB-2023, entry version 170.
DE   RecName: Full=Zinc finger HIT domain-containing protein 3;
DE   AltName: Full=HNF-4a coactivator;
DE   AltName: Full=Thyroid hormone receptor interactor 3;
DE   AltName: Full=Thyroid receptor-interacting protein 3;
DE            Short=TR-interacting protein 3;
DE            Short=TRIP-3;
GN   Name=ZNHIT3; Synonyms=TRIP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11916906; DOI=10.2337/diabetes.51.4.910;
RA   Iwahashi H., Yamagata K., Yoshiuchi I., Terasaki J., Yang Q., Fukui K.,
RA   Ihara A., Zhu Q., Asakura T., Cao Y., Imagawa A., Namba M., Hanafusa T.,
RA   Miyagawa J., Matsuzawa Y.;
RT   "Thyroid hormone receptor interacting protein 3 (trip3) is a novel
RT   coactivator of hepatocyte nuclear factor-4alpha.";
RL   Diabetes 51:910-914(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-155, AND INTERACTION WITH THYROID RECEPTOR.
RX   PubMed=7776974; DOI=10.1210/mend.9.2.7776974;
RA   Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D.;
RT   "Two classes of proteins dependent on either the presence or absence of
RT   thyroid hormone for interaction with the thyroid hormone receptor.";
RL   Mol. Endocrinol. 9:243-254(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   SUBCELLULAR LOCATION, INTERACTION WITH NUFIP1, INVOLVEMENT IN PEHO, VARIANT
RP   PEHO LEU-31, AND CHARACTERIZATION OF VARIANT PEHO LEU-31.
RX   PubMed=28335020; DOI=10.1093/brain/awx040;
RA   Anttonen A.K., Laari A., Kousi M., Yang Y.J., Jaeaeskelaeinen T., Somer M.,
RA   Siintola E., Jakkula E., Muona M., Tegelberg S., Loennqvist T., Pihko H.,
RA   Valanne L., Paetau A., Lun M.P., Haestbacka J., Kopra O., Joensuu T.,
RA   Katsanis N., Lehtinen M.K., Palvimo J.J., Lehesjoki A.E.;
RT   "ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with
RT   cerebellar granule neuron loss.";
RL   Brain 140:1267-1279(2017).
RN   [13]
RP   INTERACTION WITH RUVBL1/RUVBL2 COMPLEX.
RX   PubMed=28561026; DOI=10.1038/ncomms15615;
RA   Cloutier P., Poitras C., Durand M., Hekmat O., Fiola-Masson E.,
RA   Bouchard A., Faubert D., Chabot B., Coulombe B.;
RT   "R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2
RT   to regulate assembly of U5 small nuclear ribonucleoprotein.";
RL   Nat. Commun. 8:15615-15615(2017).
RN   [14]
RP   STRUCTURE BY NMR OF 1-46.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ZF-HIT domain in zinc finger HIT domain-
RT   containing protein 3 (TRIP-3).";
RL   Submitted (OCT-2007) to the PDB data bank.
CC   -!- SUBUNIT: Thyroid receptor interacting proteins (TRIPs) specifically
CC       interact with the ligand binding domain of the thyroid receptor (TR)
CC       (PubMed:7776974). Requires the presence of thyroid hormone for its
CC       interaction (PubMed:7776974). Interacts with NUFIP1 (PubMed:28335020).
CC       Interacts (via HIT-type zinc finger) with the RUVBL1/RUVBL2 complex in
CC       the presence of ADP (PubMed:28561026). {ECO:0000269|PubMed:28335020,
CC       ECO:0000269|PubMed:28561026}.
CC   -!- INTERACTION:
CC       Q15649; Q9UHK0: NUFIP1; NbExp=7; IntAct=EBI-2563564, EBI-2563549;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28335020}. Nucleus
CC       {ECO:0000269|PubMed:28335020}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15649-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15649-2; Sequence=VSP_055155;
CC   -!- DISEASE: PEHO syndrome (PEHO) [MIM:260565]: An autosomal recessive
CC       syndrome characterized by progressive encephalopathy, lack of
CC       psychomotor development, severe intellectual disability, early onset
CC       epileptic seizures, optic nerve/cerebellar atrophy, pedal edema, and
CC       early death. {ECO:0000269|PubMed:28335020}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF400652; AAM82423.1; -; mRNA.
DR   EMBL; AK290858; BAF83547.1; -; mRNA.
DR   EMBL; AC126327; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471199; EAW57552.1; -; Genomic_DNA.
DR   EMBL; BC017931; AAH17931.1; -; mRNA.
DR   EMBL; L40410; AAC41737.1; -; mRNA.
DR   CCDS; CCDS11312.1; -. [Q15649-1]
DR   CCDS; CCDS62156.1; -. [Q15649-2]
DR   RefSeq; NP_001268361.1; NM_001281432.1. [Q15649-2]
DR   RefSeq; NP_001268362.1; NM_001281433.1.
DR   RefSeq; NP_001268363.1; NM_001281434.1.
DR   RefSeq; NP_004764.1; NM_004773.3. [Q15649-1]
DR   PDB; 2YQQ; NMR; -; A=4-46.
DR   PDB; 5L85; NMR; -; A=85-155.
DR   PDBsum; 2YQQ; -.
DR   PDBsum; 5L85; -.
DR   AlphaFoldDB; Q15649; -.
DR   SMR; Q15649; -.
DR   BioGRID; 114736; 54.
DR   IntAct; Q15649; 21.
DR   STRING; 9606.ENSP00000484687; -.
DR   iPTMnet; Q15649; -.
DR   PhosphoSitePlus; Q15649; -.
DR   BioMuta; ZNHIT3; -.
DR   DMDM; 46397898; -.
DR   EPD; Q15649; -.
DR   jPOST; Q15649; -.
DR   MassIVE; Q15649; -.
DR   MaxQB; Q15649; -.
DR   PaxDb; Q15649; -.
DR   PeptideAtlas; Q15649; -.
DR   ProteomicsDB; 60687; -. [Q15649-1]
DR   Antibodypedia; 74086; 57 antibodies from 20 providers.
DR   DNASU; 9326; -.
DR   Ensembl; ENST00000617429.5; ENSP00000484687.1; ENSG00000273611.5. [Q15649-1]
DR   Ensembl; ENST00000619649.4; ENSP00000478183.1; ENSG00000278574.4. [Q15649-2]
DR   Ensembl; ENST00000620324.4; ENSP00000479727.1; ENSG00000273611.5. [Q15649-2]
DR   Ensembl; ENST00000620508.4; ENSP00000481504.1; ENSG00000278574.4. [Q15649-1]
DR   GeneID; 9326; -.
DR   KEGG; hsa:9326; -.
DR   MANE-Select; ENST00000617429.5; ENSP00000484687.1; NM_004773.4; NP_004764.1.
DR   UCSC; uc002hms.3; human. [Q15649-1]
DR   AGR; HGNC:12309; -.
DR   CTD; 9326; -.
DR   DisGeNET; 9326; -.
DR   GeneCards; ZNHIT3; -.
DR   HGNC; HGNC:12309; ZNHIT3.
DR   HPA; ENSG00000273611; Low tissue specificity.
DR   MalaCards; ZNHIT3; -.
DR   MIM; 260565; phenotype.
DR   MIM; 604500; gene.
DR   neXtProt; NX_Q15649; -.
DR   OpenTargets; ENSG00000273611; -.
DR   Orphanet; 2836; PEHO syndrome.
DR   PharmGKB; PA36987; -.
DR   VEuPathDB; HostDB:ENSG00000273611; -.
DR   eggNOG; KOG2857; Eukaryota.
DR   GeneTree; ENSGT00390000010822; -.
DR   HOGENOM; CLU_117355_1_0_1; -.
DR   InParanoid; Q15649; -.
DR   OMA; EAQSKYK; -.
DR   OrthoDB; 5487128at2759; -.
DR   PhylomeDB; Q15649; -.
DR   TreeFam; TF324673; -.
DR   PathwayCommons; Q15649; -.
DR   SignaLink; Q15649; -.
DR   BioGRID-ORCS; 9326; 453 hits in 1154 CRISPR screens.
DR   ChiTaRS; ZNHIT3; human.
DR   EvolutionaryTrace; Q15649; -.
DR   GenomeRNAi; 9326; -.
DR   Pharos; Q15649; Tbio.
DR   PRO; PR:Q15649; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q15649; protein.
DR   Bgee; ENSG00000273611; Expressed in cortical plate and 101 other tissues.
DR   ExpressionAtlas; Q15649; baseline and differential.
DR   Genevisible; Q15649; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070761; C:pre-snoRNP complex; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046966; F:nuclear thyroid hormone receptor binding; TAS:UniProtKB.
DR   GO; GO:0000492; P:box C/D snoRNP assembly; IBA:GO_Central.
DR   GO; GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:UniProtKB.
DR   GO; GO:0048254; P:snoRNA localization; IBA:GO_Central.
DR   Gene3D; 3.30.60.190; -; 1.
DR   InterPro; IPR007529; Znf_HIT.
DR   PANTHER; PTHR13483; UNCHARACTERIZED; 1.
DR   PANTHER; PTHR13483:SF11; ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3; 1.
DR   Pfam; PF04438; zf-HIT; 1.
DR   SUPFAM; SSF144232; HIT/MYND zinc finger-like; 1.
DR   PROSITE; PS51083; ZF_HIT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Disease variant; Epilepsy;
KW   Intellectual disability; Metal-binding; Neurodegeneration; Nucleus;
KW   Phosphoprotein; Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..155
FT                   /note="Zinc finger HIT domain-containing protein 3"
FT                   /id="PRO_0000173550"
FT   ZN_FING         11..42
FT                   /note="HIT-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         11
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         14
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         22
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         25
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         30
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         34
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         38
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   BINDING         42
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00453"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         96..155
FT                   /note="GESATLRSLLLNPHLRQLMVNLDQGEDKAKLMRAYMQEPLFVEFADCCLGIV
FT                   EPSQNEES -> DGLSSCHPGWSAAAQSRLTATSPSQIQAILMPQPPEQLGLQAPATTP
FT                   NQFLYF (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055155"
FT   VARIANT         31
FT                   /note="S -> L (in PEHO; increased protein degradation;
FT                   decreased protein abundance; does not affect localization
FT                   to cytoplasm and nucleus; dbSNP:rs148890852)"
FT                   /evidence="ECO:0000269|PubMed:28335020"
FT                   /id="VAR_079193"
FT   TURN            12..14
FT                   /evidence="ECO:0007829|PDB:2YQQ"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2YQQ"
FT   TURN            23..25
FT                   /evidence="ECO:0007829|PDB:2YQQ"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:2YQQ"
FT   HELIX           32..41
FT                   /evidence="ECO:0007829|PDB:2YQQ"
FT   HELIX           89..97
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   HELIX           99..102
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   TURN            103..106
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   HELIX           108..119
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:5L85"
FT   HELIX           134..147
FT                   /evidence="ECO:0007829|PDB:5L85"
SQ   SEQUENCE   155 AA;  17607 MW;  A115FD0AA9321AB0 CRC64;
     MASLKCSTVV CVICLEKPKY RCPACRVPYC SVVCFRKHKE QCNPETRPVE KKIRSALPTK
     TVKPVENKDD DDSIADFLNS DEEEDRVSLQ NLKNLGESAT LRSLLLNPHL RQLMVNLDQG
     EDKAKLMRAY MQEPLFVEFA DCCLGIVEPS QNEES
//
ID   ZSWM7_HUMAN             Reviewed;         140 AA.
AC   Q19AV6;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 1.
DT   22-FEB-2023, entry version 112.
DE   RecName: Full=Zinc finger SWIM domain-containing protein 7;
DE   AltName: Full=SWIM domain-containing and Srs2-interacting protein 1 homolog;
DE   AltName: Full=SWIM-type zinc finger domain-containing protein 7;
GN   Name=ZSWIM7; Synonyms=SWS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH RAD51D.
RX   PubMed=16710300; DOI=10.1038/sj.emboj.7601141;
RA   Martin V., Chahwan C., Gao H., Blais V., Wohlschlegel J., Yates J.R. III,
RA   McGowan C.H., Russell P.;
RT   "Sws1 is a conserved regulator of homologous recombination in eukaryotic
RT   cells.";
RL   EMBO J. 25:2564-2574(2006).
RN   [2]
RP   FUNCTION IN HOMOLOGOUS RECOMBINATION REPAIR, AND INTERACTION WITH RAD51D;
RP   SWSAP1 AND XRCC3.
RX   PubMed=21965664; DOI=10.1074/jbc.m111.271080;
RA   Liu T., Wan L., Wu Y., Chen J., Huang J.;
RT   "hSWS1.SWSAP1 is an evolutionarily conserved complex required for efficient
RT   homologous recombination repair.";
RL   J. Biol. Chem. 286:41758-41766(2011).
RN   [3]
RP   INVOLVEMENT IN SPGF71, AND FUNCTION.
RX   PubMed=32719396; DOI=10.1038/s41436-020-0916-0;
RA   Alhathal N., Maddirevula S., Coskun S., Alali H., Assoum M., Morris T.,
RA   Deek H.A., Hamed S.A., Alsuhaibani S., Mirdawi A., Ewida N., Al-Qahtani M.,
RA   Ibrahim N., Abdulwahab F., Altaweel W., Dasouki M.J., Assiri A., Qabbaj W.,
RA   Alkuraya F.S.;
RT   "A genomics approach to male infertility.";
RL   Genet. Med. 22:1967-1975(2020).
RN   [4]
RP   INVOLVEMENT IN SPGF71, AND FUNCTION.
RX   PubMed=33713115; DOI=10.1093/humrep/deab046;
RA   Li Y., Wu Y., Zhou J., Zhang H., Zhang Y., Ma H., Jiang X., Shi Q.;
RT   "A recurrent ZSWIM7 mutation causes male infertility resulting from
RT   decreased meiotic recombination.";
RL   Hum. Reprod. 36:1436-1445(2021).
RN   [5]
RP   INVOLVEMENT IN ODG10, VARIANT ODG10 58-SER--ALA-140 DEL, FUNCTION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=34402903; DOI=10.1210/clinem/dgab597;
RA   McGlacken-Byrne S.M., Le Quesne Stabej P., Del Valle I., Ocaka L.,
RA   Gagunashvili A., Crespo B., Moreno N., James C., Bacchelli C.,
RA   Dattani M.T., Williams H.J., Kelberman D., Achermann J.C., Conway G.S.;
RT   "ZSWIM7 is associated with human female meiosis and familial primary
RT   ovarian insufficiency.";
RL   J. Clin. Endocrinol. Metab. 107:e254-e263(2022).
CC   -!- FUNCTION: Involved in early stages of the homologous recombination
CC       repair (HRR) pathway of double-stranded DNA breaks arising during DNA
CC       replication or induced by DNA-damaging agents. Required for meiotic
CC       progression, hence for fertility (PubMed:32719396, PubMed:33713115,
CC       PubMed:34402903). {ECO:0000269|PubMed:16710300,
CC       ECO:0000269|PubMed:21965664, ECO:0000269|PubMed:32719396,
CC       ECO:0000269|PubMed:33713115, ECO:0000269|PubMed:34402903}.
CC   -!- SUBUNIT: Interacts with RAD51D and XRCC3; involved in homologous
CC       recombination repair. Interacts with SWSAP1; they form a functional
CC       complex involved in homologous recombination repair and stabilize each
CC       other. {ECO:0000269|PubMed:16710300, ECO:0000269|PubMed:21965664}.
CC   -!- INTERACTION:
CC       Q19AV6; Q6NVH7: SWSAP1; NbExp=11; IntAct=EBI-5281647, EBI-5281637;
CC       Q19AV6; P14927: UQCRB; NbExp=3; IntAct=EBI-5281647, EBI-743128;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in ovary and testis.
CC       {ECO:0000269|PubMed:34402903}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal testis and ovary. In the
CC       developing ovary, detected at least from Carnegie stages (CS) 22/23.
CC       Expression seems to peak at 15/16 weeks post conception (wpc)
CC       (PubMed:34402903). In the developing testis, expressed at CS22/23 and
CC       until at least 19/20 wpc (PubMed:34402903).
CC       {ECO:0000269|PubMed:34402903}.
CC   -!- DISEASE: Ovarian dysgenesis 10 (ODG10) [MIM:619834]: An autosomal
CC       recessive form of ovarian dysgenesis, a disorder characterized by lack
CC       of spontaneous pubertal development, primary amenorrhea, uterine
CC       hypoplasia, and hypergonadotropic hypogonadism as a result of streak
CC       gonads. {ECO:0000269|PubMed:34402903}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- DISEASE: Spermatogenic failure 71 (SPGF71) [MIM:619831]: An autosomal
CC       recessive male infertility disorder characterized by non-obstructive
CC       azoospermia. {ECO:0000269|PubMed:32719396,
CC       ECO:0000269|PubMed:33713115}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SWS1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ530600; ABF72190.1; -; mRNA.
DR   CCDS; CCDS42266.1; -.
DR   RefSeq; NP_001036162.1; NM_001042697.1.
DR   RefSeq; NP_001036163.1; NM_001042698.1.
DR   AlphaFoldDB; Q19AV6; -.
DR   BioGRID; 125919; 16.
DR   IntAct; Q19AV6; 5.
DR   STRING; 9606.ENSP00000382218; -.
DR   iPTMnet; Q19AV6; -.
DR   PhosphoSitePlus; Q19AV6; -.
DR   BioMuta; ZSWIM7; -.
DR   DMDM; 121940600; -.
DR   EPD; Q19AV6; -.
DR   MassIVE; Q19AV6; -.
DR   MaxQB; Q19AV6; -.
DR   PaxDb; Q19AV6; -.
DR   PeptideAtlas; Q19AV6; -.
DR   ProteomicsDB; 61179; -.
DR   Antibodypedia; 58364; 17 antibodies from 8 providers.
DR   DNASU; 125150; -.
DR   Ensembl; ENST00000399277.6; ENSP00000382218.1; ENSG00000214941.8.
DR   Ensembl; ENST00000472495.5; ENSP00000419138.1; ENSG00000214941.8.
DR   GeneID; 125150; -.
DR   KEGG; hsa:125150; -.
DR   MANE-Select; ENST00000399277.6; ENSP00000382218.1; NM_001042697.2; NP_001036162.1.
DR   UCSC; uc002gpe.4; human.
DR   AGR; HGNC:26993; -.
DR   CTD; 125150; -.
DR   DisGeNET; 125150; -.
DR   GeneCards; ZSWIM7; -.
DR   HGNC; HGNC:26993; ZSWIM7.
DR   HPA; ENSG00000214941; Low tissue specificity.
DR   MalaCards; ZSWIM7; -.
DR   MIM; 614535; gene.
DR   MIM; 619831; phenotype.
DR   MIM; 619834; phenotype.
DR   neXtProt; NX_Q19AV6; -.
DR   OpenTargets; ENSG00000214941; -.
DR   Orphanet; 243; 46,XX gonadal dysgenesis.
DR   PharmGKB; PA162411055; -.
DR   VEuPathDB; HostDB:ENSG00000214941; -.
DR   eggNOG; ENOG502RZB5; Eukaryota.
DR   GeneTree; ENSGT00390000017523; -.
DR   HOGENOM; CLU_132858_0_1_1; -.
DR   InParanoid; Q19AV6; -.
DR   OMA; YTCFVSC; -.
DR   OrthoDB; 5151at2759; -.
DR   PhylomeDB; Q19AV6; -.
DR   TreeFam; TF339438; -.
DR   PathwayCommons; Q19AV6; -.
DR   SignaLink; Q19AV6; -.
DR   BioGRID-ORCS; 125150; 47 hits in 1151 CRISPR screens.
DR   ChiTaRS; ZSWIM7; human.
DR   GenomeRNAi; 125150; -.
DR   Pharos; Q19AV6; Tbio.
DR   PRO; PR:Q19AV6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q19AV6; protein.
DR   Bgee; ENSG00000214941; Expressed in tendon of biceps brachii and 180 other tissues.
DR   ExpressionAtlas; Q19AV6; baseline and differential.
DR   Genevisible; Q19AV6; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0097196; C:Shu complex; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   InterPro; IPR007527; Znf_SWIM.
DR   PANTHER; PTHR28498; ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; 1.
DR   PANTHER; PTHR28498:SF1; ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; 1.
DR   Pfam; PF04434; SWIM; 1.
DR   PROSITE; PS50966; ZF_SWIM; 1.
PE   1: Evidence at protein level;
KW   Disease variant; DNA damage; DNA recombination; DNA repair; Metal-binding;
KW   Nucleus; Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..140
FT                   /note="Zinc finger SWIM domain-containing protein 7"
FT                   /id="PRO_0000307403"
FT   ZN_FING         66..114
FT                   /note="SWIM-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00325"
FT   VARIANT         58..140
FT                   /note="Missing (in ODG10)"
FT                   /evidence="ECO:0000269|PubMed:34402903"
FT                   /id="VAR_087123"
SQ   SEQUENCE   140 AA;  15386 MW;  4DECCC679C537F18 CRC64;
     MAVVLPAVVE ELLSEMAAAV QESARIPDEY LLSLKFLFGS SATQALDLVD RQSITLISSP
     SGRRVYQVLG SSSKTYTCLA SCHYCSCPAF AFSVLRKSDS ILCKHLLAVY LSQVMRTCQQ
     LSVSDKQLTD ILLMEKKQEA
//
ID   FAP20_HUMAN             Reviewed;         180 AA.
AC   Q6NZ36; A6PW39; A6PW40; A6PW41; A8MQT6; F2Z2L4; Q6ZT64; Q71M24; Q96ND7;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   22-FEB-2023, entry version 137.
DE   RecName: Full=Fanconi anemia core complex-associated protein 20 {ECO:0000312|HGNC:HGNC:26428};
DE   AltName: Full=FANCA-associated protein of 20 kDa {ECO:0000303|PubMed:22343915};
DE   AltName: Full=Fanconi anemia-associated protein of 20 kDa {ECO:0000303|PubMed:22343915};
GN   Name=FAAP20 {ECO:0000303|PubMed:22343915,
GN   ECO:0000312|HGNC:HGNC:26428}; Synonyms=C1orf86; ORFNames=FP7162;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Amygdala, and Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 152-180 (ISOFORM 5).
RC   TISSUE=Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN THE FA COMPLEX, SUBCELLULAR LOCATION, DOMAIN,
RP   INTERACTION WITH FANCA, AND MUTAGENESIS OF CYS-170.
RX   PubMed=22343915; DOI=10.1182/blood-2011-10-385963;
RA   Ali A.M., Pradhan A., Singh T.R., Du C., Li J., Wahengbam K., Grassman E.,
RA   Auerbach A.D., Pang Q., Meetei A.R.;
RT   "FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required
RT   for functional integrity of the FA-BRCA DNA repair pathway.";
RL   Blood 119:3285-3294(2012).
RN   [7]
RP   FUNCTION, IDENTIFICATION IN THE FA COMPLEX, SUBCELLULAR LOCATION, DOMAIN,
RP   INTERACTION WITH FANCA, AND MUTAGENESIS OF CYS-147 AND ASP-164.
RX   PubMed=22705371; DOI=10.1016/j.molcel.2012.05.026;
RA   Yan Z., Guo R., Paramasivam M., Shen W., Ling C., Fox D. III, Wang Y.,
RA   Oostra A.B., Kuehl J., Lee D.Y., Takata M., Hoatlin M.E., Schindler D.,
RA   Joenje H., de Winter J.P., Li L., Seidman M.M., Wang W.;
RT   "A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to
RT   the Fanconi anemia DNA repair network.";
RL   Mol. Cell 47:61-75(2012).
RN   [8]
RP   FUNCTION, IDENTIFICATION IN THE FA COMPLEX, DOMAIN, INTERACTION WITH REV1,
RP   AND MUTAGENESIS OF CYS-147 AND CYS-150.
RX   PubMed=22266823; DOI=10.1038/nsmb.2222;
RA   Kim H., Yang K., Dejsuphong D., D'Andrea A.D.;
RT   "Regulation of Rev1 by the Fanconi anemia core complex.";
RL   Nat. Struct. Mol. Biol. 19:164-170(2012).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN THE FA COMPLEX, DOMAIN, INTERACTION WITH FANCA,
RP   AND MUTAGENESIS OF CYS-147 AND CYS-150.
RX   PubMed=22396592; DOI=10.1073/pnas.1118720109;
RA   Leung J.W., Wang Y., Fong K.W., Huen M.S., Li L., Chen J.;
RT   "Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation
RT   group A (FANCA) and participates in interstrand cross-link repair.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:4491-4496(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113 AND SER-137, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Component of the Fanconi anemia (FA) complex required to
CC       recruit the FA complex to DNA interstrand cross-links (ICLs) and
CC       promote ICLs repair. Following DNA damage recognizes and binds 'Lys-
CC       63'-linked ubiquitin generated by RNF8 at ICLs and recruits other
CC       components of the FA complex. Promotes translesion synthesis via
CC       interaction with REV1. {ECO:0000269|PubMed:22266823,
CC       ECO:0000269|PubMed:22343915, ECO:0000269|PubMed:22396592,
CC       ECO:0000269|PubMed:22705371}.
CC   -!- SUBUNIT: Component of the Fanconi anemia (FA) complex. Interacts with
CC       FANCA; interaction is direct. Interacts with REV1. Reported to bind
CC       monoubiquitinated REV1; however it binds better to non-ubiquitinated
CC       REV1 (PubMed:22266823). {ECO:0000269|PubMed:22266823,
CC       ECO:0000269|PubMed:22343915, ECO:0000269|PubMed:22396592,
CC       ECO:0000269|PubMed:22705371}.
CC   -!- INTERACTION:
CC       Q6NZ36; Q9UBZ9: REV1; NbExp=2; IntAct=EBI-2817693, EBI-7353917;
CC       Q6NZ36-1; O15360: FANCA; NbExp=5; IntAct=EBI-15965017, EBI-81570;
CC       Q6NZ36-1; Q920Q2: Rev1; Xeno; NbExp=7; IntAct=EBI-15965017, EBI-2114764;
CC       Q6NZ36-4; Q9HBZ2: ARNT2; NbExp=3; IntAct=EBI-12013806, EBI-765971;
CC       Q6NZ36-4; Q86V38: ATN1; NbExp=3; IntAct=EBI-12013806, EBI-11954292;
CC       Q6NZ36-4; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-12013806, EBI-953896;
CC       Q6NZ36-4; O43186: CRX; NbExp=3; IntAct=EBI-12013806, EBI-748171;
CC       Q6NZ36-4; P02489: CRYAA; NbExp=3; IntAct=EBI-12013806, EBI-6875961;
CC       Q6NZ36-4; Q8WUE5: CT55; NbExp=3; IntAct=EBI-12013806, EBI-6873363;
CC       Q6NZ36-4; Q9GZU7: CTDSP1; NbExp=3; IntAct=EBI-12013806, EBI-751587;
CC       Q6NZ36-4; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-12013806, EBI-742054;
CC       Q6NZ36-4; Q9H596: DUSP21; NbExp=3; IntAct=EBI-12013806, EBI-7357329;
CC       Q6NZ36-4; O14908-2: GIPC1; NbExp=3; IntAct=EBI-12013806, EBI-25913156;
CC       Q6NZ36-4; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-12013806, EBI-5916454;
CC       Q6NZ36-4; Q0VD86: INCA1; NbExp=3; IntAct=EBI-12013806, EBI-6509505;
CC       Q6NZ36-4; Q92876: KLK6; NbExp=3; IntAct=EBI-12013806, EBI-2432309;
CC       Q6NZ36-4; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-12013806, EBI-11962084;
CC       Q6NZ36-4; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-12013806, EBI-10261141;
CC       Q6NZ36-4; P80188: LCN2; NbExp=3; IntAct=EBI-12013806, EBI-11911016;
CC       Q6NZ36-4; P25791-3: LMO2; NbExp=3; IntAct=EBI-12013806, EBI-11959475;
CC       Q6NZ36-4; Q9P2M1: LRP2BP; NbExp=3; IntAct=EBI-12013806, EBI-18273118;
CC       Q6NZ36-4; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12013806, EBI-16439278;
CC       Q6NZ36-4; Q70IA6: MOB2; NbExp=3; IntAct=EBI-12013806, EBI-2558739;
CC       Q6NZ36-4; Q8NI38: NFKBID; NbExp=6; IntAct=EBI-12013806, EBI-10271199;
CC       Q6NZ36-4; Q13153: PAK1; NbExp=3; IntAct=EBI-12013806, EBI-1307;
CC       Q6NZ36-4; Q99471: PFDN5; NbExp=3; IntAct=EBI-12013806, EBI-357275;
CC       Q6NZ36-4; Q9NQX1-2: PRDM5; NbExp=3; IntAct=EBI-12013806, EBI-12859340;
CC       Q6NZ36-4; Q04864-2: REL; NbExp=3; IntAct=EBI-12013806, EBI-10829018;
CC       Q6NZ36-4; Q9UHV2: SERTAD1; NbExp=3; IntAct=EBI-12013806, EBI-748601;
CC       Q6NZ36-4; Q9UJW9: SERTAD3; NbExp=3; IntAct=EBI-12013806, EBI-748621;
CC       Q6NZ36-4; Q8IYF3-3: TEX11; NbExp=3; IntAct=EBI-12013806, EBI-11523345;
CC       Q6NZ36-4; Q96RU7: TRIB3; NbExp=3; IntAct=EBI-12013806, EBI-492476;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22343915,
CC       ECO:0000269|PubMed:22705371}. Chromosome {ECO:0000305|PubMed:22343915,
CC       ECO:0000305|PubMed:22705371}. Note=Following DNA damage, recruited to
CC       DNA interstrand cross-links (ICLs) sites by binding to ubiquitin
CC       generated by RNF8. {ECO:0000269|PubMed:22705371}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q6NZ36-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NZ36-2; Sequence=VSP_030812;
CC       Name=3;
CC         IsoId=Q6NZ36-3; Sequence=VSP_030813;
CC       Name=4;
CC         IsoId=Q6NZ36-4; Sequence=VSP_030816;
CC       Name=5;
CC         IsoId=Q6NZ36-5; Sequence=VSP_030814, VSP_030815;
CC       Name=6;
CC         IsoId=Q6NZ36-6; Sequence=VSP_047264;
CC   -!- DOMAIN: The UBZ2-type zinc finger binds both 'Lys-48'- and 'Lys-63'-
CC       linked polyubiquitin with preference for 'Lys-63'-linked polyubiquitin.
CC       {ECO:0000255|PROSITE-ProRule:PRU01254, ECO:0000269|PubMed:22266823,
CC       ECO:0000269|PubMed:22343915, ECO:0000269|PubMed:22396592,
CC       ECO:0000269|PubMed:22705371}.
CC   -!- MISCELLANEOUS: [Isoform 4]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- CAUTION: According to a report, ubiquitin-binding is dispensable for
CC       function (PubMed:22396592). However, such data are not confirmed by
CC       PubMed:22705371. {ECO:0000305|PubMed:22396592}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH66360.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK055593; BAB70965.1; -; mRNA.
DR   EMBL; AK126870; BAC86730.1; -; mRNA.
DR   EMBL; AF461903; AAQ04817.1; -; mRNA.
DR   EMBL; AL590822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471183; EAW56125.1; -; Genomic_DNA.
DR   EMBL; BC066360; AAH66360.1; ALT_INIT; mRNA.
DR   EMBL; BC078145; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC103992; AAI03993.1; -; mRNA.
DR   CCDS; CCDS38.2; -. [Q6NZ36-1]
DR   CCDS; CCDS57965.1; -. [Q6NZ36-6]
DR   CCDS; CCDS72687.1; -. [Q6NZ36-5]
DR   RefSeq; NP_001243874.1; NM_001256945.1.
DR   RefSeq; NP_001243875.1; NM_001256946.1.
DR   RefSeq; NP_001243876.1; NM_001256947.1. [Q6NZ36-6]
DR   RefSeq; NP_001269599.1; NM_001282670.1. [Q6NZ36-2]
DR   RefSeq; NP_001269600.1; NM_001282671.1.
DR   RefSeq; NP_001269601.1; NM_001282672.1.
DR   RefSeq; NP_001269602.1; NM_001282673.1. [Q6NZ36-5]
DR   RefSeq; NP_872339.2; NM_182533.2. [Q6NZ36-1]
DR   PDB; 2MUQ; NMR; -; A=140-180.
DR   PDB; 2MUR; NMR; -; A=140-180.
DR   PDB; 3WWQ; X-ray; 1.90 A; C/F/I/L=142-180.
DR   PDBsum; 2MUQ; -.
DR   PDBsum; 2MUR; -.
DR   PDBsum; 3WWQ; -.
DR   AlphaFoldDB; Q6NZ36; -.
DR   SMR; Q6NZ36; -.
DR   BioGRID; 128288; 72.
DR   ComplexPortal; CPX-6263; Fanconi anemia ubiquitin ligase complex.
DR   DIP; DIP-59917N; -.
DR   IntAct; Q6NZ36; 42.
DR   MINT; Q6NZ36; -.
DR   iPTMnet; Q6NZ36; -.
DR   BioMuta; FAAP20; -.
DR   DMDM; 166991449; -.
DR   EPD; Q6NZ36; -.
DR   jPOST; Q6NZ36; -.
DR   MassIVE; Q6NZ36; -.
DR   MaxQB; Q6NZ36; -.
DR   PaxDb; Q6NZ36; -.
DR   PeptideAtlas; Q6NZ36; -.
DR   ProteomicsDB; 23749; -.
DR   ProteomicsDB; 66786; -. [Q6NZ36-1]
DR   ProteomicsDB; 66787; -. [Q6NZ36-2]
DR   ProteomicsDB; 66788; -. [Q6NZ36-3]
DR   ProteomicsDB; 66789; -. [Q6NZ36-4]
DR   ProteomicsDB; 66790; -. [Q6NZ36-5]
DR   Antibodypedia; 52488; 60 antibodies from 14 providers.
DR   DNASU; 199990; -.
DR   Ensembl; ENST00000378543.2; ENSP00000367804.2; ENSG00000162585.17. [Q6NZ36-6]
DR   Ensembl; ENST00000378546.9; ENSP00000367808.4; ENSG00000162585.17. [Q6NZ36-1]
DR   Ensembl; ENST00000400918.7; ENSP00000383709.3; ENSG00000162585.17. [Q6NZ36-5]
DR   Ensembl; ENST00000414253.5; ENSP00000410450.1; ENSG00000162585.17. [Q6NZ36-4]
DR   GeneID; 199990; -.
DR   KEGG; hsa:199990; -.
DR   MANE-Select; ENST00000378546.9; ENSP00000367808.4; NM_182533.4; NP_872339.3.
DR   UCSC; uc001aiy.4; human. [Q6NZ36-1]
DR   AGR; HGNC:26428; -.
DR   CTD; 199990; -.
DR   DisGeNET; 199990; -.
DR   GeneCards; FAAP20; -.
DR   HGNC; HGNC:26428; FAAP20.
DR   HPA; ENSG00000162585; Low tissue specificity.
DR   MIM; 615183; gene.
DR   neXtProt; NX_Q6NZ36; -.
DR   OpenTargets; ENSG00000162585; -.
DR   PharmGKB; PA142672470; -.
DR   VEuPathDB; HostDB:ENSG00000162585; -.
DR   GeneTree; ENSGT00390000010531; -.
DR   HOGENOM; CLU_2145000_0_0_1; -.
DR   InParanoid; Q6NZ36; -.
DR   OMA; CARPWAE; -.
DR   OrthoDB; 2972135at2759; -.
DR   PhylomeDB; Q6NZ36; -.
DR   TreeFam; TF336358; -.
DR   PathwayCommons; Q6NZ36; -.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   SignaLink; Q6NZ36; -.
DR   BioGRID-ORCS; 199990; 118 hits in 1130 CRISPR screens.
DR   ChiTaRS; FAAP20; human.
DR   GenomeRNAi; 199990; -.
DR   Pharos; Q6NZ36; Tbio.
DR   PRO; PR:Q6NZ36; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q6NZ36; protein.
DR   Bgee; ENSG00000162585; Expressed in adenohypophysis and 169 other tissues.
DR   ExpressionAtlas; Q6NZ36; baseline and differential.
DR   Genevisible; Q6NZ36; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0000785; C:chromatin; IDA:ComplexPortal.
DR   GO; GO:0005694; C:chromosome; IDA:UniProtKB.
DR   GO; GO:0043240; C:Fanconi anaemia nuclear complex; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0070530; F:K63-linked polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IEA:InterPro.
DR   GO; GO:0140036; F:ubiquitin-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0036297; P:interstrand cross-link repair; IMP:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:ComplexPortal.
DR   GO; GO:0019985; P:translesion synthesis; IMP:UniProtKB.
DR   InterPro; IPR031491; FANCA_interact.
DR   InterPro; IPR031490; UBZ2_FAAP20.
DR   PANTHER; PTHR37862; FANCONI ANEMIA CORE COMPLEX-ASSOCIATED PROTEIN 20; 1.
DR   PANTHER; PTHR37862:SF1; FANCONI ANEMIA CORE COMPLEX-ASSOCIATED PROTEIN 20; 1.
DR   Pfam; PF15751; FANCA_interact; 1.
DR   Pfam; PF15750; UBZ_FAAP20; 1.
DR   PROSITE; PS51906; ZF_UBZ2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosome; DNA damage; DNA repair;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..180
FT                   /note="Fanconi anemia core complex-associated protein 20"
FT                   /id="PRO_0000316882"
FT   ZN_FING         144..180
FT                   /note="UBZ2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01254"
FT   REGION          1..28
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          106..135
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         147
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01254"
FT   BINDING         150
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01254"
FT   BINDING         166
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01254"
FT   BINDING         170
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01254"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..21
FT                   /note="MEAARRPRLGLSRRRPRPAGG -> MCGPEHLLCCPKDLAMFPRQLSLTACL
FT                   PGTPVSHKCHHIWLWVGVPAWHPRASRCGGAQPSSWLRQKAARAFWLSLPAAKLRHHSS
FT                   RWLRRSGAFSSGSTLKPPPSPSPAPLCHADNLRTGRTR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_030812"
FT   VAR_SEQ         1..21
FT                   /note="MEAARRPRLGLSRRRPRPAGG -> MNFGLEKTHFHCARVSPNQKLFSNKAK
FT                   LRHHSSRWLRRSGAFSSGSTLKPPPSPSPAPLCHADNLRTGRTR (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:15498874"
FT                   /id="VSP_030813"
FT   VAR_SEQ         22..180
FT                   /note="PSGGRPWFLLGGDERERLWAELLRTVSPELILDHEVPSLPAFPGQEPRCGPE
FT                   PTEVFTVGPKTFSWTPFPPDLWGPGRSYRLLHGAGGHLESPARSLPQRPAPDPCRAPRV
FT                   EQQPSVEGAAALRSCPMCQKEFAPRLTQLDVDSHLAQCLAESTEDVTW -> SPGAARS
FT                   PLKSSLSDPRPFPGHPFRRTCGARAVPTGCFTGQEGTWNPPPGPCPSARHLIPAGPPGW
FT                   SSSRLWRVPRPCAAAPCARRSSPPG (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047264"
FT   VAR_SEQ         158
FT                   /note="L -> YFNSRPHLCPAGS (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030814"
FT   VAR_SEQ         159..180
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030815"
FT   VAR_SEQ         180
FT                   /note="W -> CLSWMCKTLNDPGSQG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030816"
FT   VARIANT         126
FT                   /note="P -> S (in dbSNP:rs1058411)"
FT                   /id="VAR_038434"
FT   MUTAGEN         147
FT                   /note="C->A: Abolishes binding to ubiquitin. Abolishes
FT                   binding to ubiquitin; when associated with A-150."
FT                   /evidence="ECO:0000269|PubMed:22266823,
FT                   ECO:0000269|PubMed:22396592, ECO:0000269|PubMed:22705371"
FT   MUTAGEN         150
FT                   /note="C->A: Abolishes binding to ubiquitin; when
FT                   associated with A-147."
FT                   /evidence="ECO:0000269|PubMed:22266823,
FT                   ECO:0000269|PubMed:22396592"
FT   MUTAGEN         164
FT                   /note="D->A: Abolishes binding to ubiquitin."
FT                   /evidence="ECO:0000269|PubMed:22705371"
FT   MUTAGEN         170
FT                   /note="C->A: Abolishes binding to ubiquitin."
FT                   /evidence="ECO:0000269|PubMed:22343915"
FT   CONFLICT        1
FT                   /note="M -> V (in Ref. 5; AAH66360)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        17
FT                   /note="R -> P (in Ref. 1; BAB70965, 4; EAW56125 and 5;
FT                   AAH66360/AAI03993)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="S -> N (in Ref. 2; AAQ04817)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176..177
FT                   /note="ED -> KN (in Ref. 2; AAQ04817)"
FT                   /evidence="ECO:0000305"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:2MUQ"
FT   TURN            148..150
FT                   /evidence="ECO:0007829|PDB:3WWQ"
FT   HELIX           160..173
FT                   /evidence="ECO:0007829|PDB:3WWQ"
FT   STRAND          174..176
FT                   /evidence="ECO:0007829|PDB:3WWQ"
FT   CONFLICT        Q6NZ36-2:65
FT                   /note="R -> H (in Ref. 1; BAC86730)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   180 AA;  19869 MW;  D8FC889A20AF732F CRC64;
     MEAARRPRLG LSRRRPRPAG GPSGGRPWFL LGGDERERLW AELLRTVSPE LILDHEVPSL
     PAFPGQEPRC GPEPTEVFTV GPKTFSWTPF PPDLWGPGRS YRLLHGAGGH LESPARSLPQ
     RPAPDPCRAP RVEQQPSVEG AAALRSCPMC QKEFAPRLTQ LDVDSHLAQC LAESTEDVTW
//
ID   RS27L_HUMAN             Reviewed;          84 AA.
AC   Q71UM5; Q9BTJ1;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-FEB-2023, entry version 162.
DE   RecName: Full=40S ribosomal protein S27-like;
DE   AltName: Full=Small ribosomal subunit protein eS27-like;
GN   Name=RPS27L {ECO:0000312|HGNC:HGNC:18476};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000312|EMBL:AAD20974.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood {ECO:0000269|PubMed:11042152};
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [2] {ECO:0000312|EMBL:AAH03667.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAH03667.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000305};
CC   -!- INTERACTION:
CC       Q71UM5; Q00987: MDM2; NbExp=6; IntAct=EBI-355126, EBI-389668;
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eS27 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF070668; AAD20974.1; -; mRNA.
DR   EMBL; BC003667; AAH03667.1; -; mRNA.
DR   CCDS; CCDS42048.1; -.
DR   RefSeq; NP_057004.1; NM_015920.3.
DR   AlphaFoldDB; Q71UM5; -.
DR   SMR; Q71UM5; -.
DR   BioGRID; 119256; 187.
DR   IntAct; Q71UM5; 56.
DR   MINT; Q71UM5; -.
DR   STRING; 9606.ENSP00000331019; -.
DR   iPTMnet; Q71UM5; -.
DR   PhosphoSitePlus; Q71UM5; -.
DR   SwissPalm; Q71UM5; -.
DR   BioMuta; RPS27L; -.
DR   DMDM; 51316258; -.
DR   EPD; Q71UM5; -.
DR   jPOST; Q71UM5; -.
DR   MassIVE; Q71UM5; -.
DR   MaxQB; Q71UM5; -.
DR   PaxDb; Q71UM5; -.
DR   PeptideAtlas; Q71UM5; -.
DR   ProteomicsDB; 68634; -.
DR   TopDownProteomics; Q71UM5; -.
DR   Antibodypedia; 42798; 89 antibodies from 25 providers.
DR   DNASU; 51065; -.
DR   Ensembl; ENST00000330964.10; ENSP00000331019.5; ENSG00000185088.14.
DR   GeneID; 51065; -.
DR   KEGG; hsa:51065; -.
DR   MANE-Select; ENST00000330964.10; ENSP00000331019.5; NM_015920.4; NP_057004.1.
DR   UCSC; uc002aly.4; human.
DR   AGR; HGNC:18476; -.
DR   CTD; 51065; -.
DR   DisGeNET; 51065; -.
DR   GeneCards; RPS27L; -.
DR   HGNC; HGNC:18476; RPS27L.
DR   HPA; ENSG00000185088; Low tissue specificity.
DR   MIM; 612055; gene.
DR   neXtProt; NX_Q71UM5; -.
DR   OpenTargets; ENSG00000185088; -.
DR   PharmGKB; PA38546; -.
DR   VEuPathDB; HostDB:ENSG00000185088; -.
DR   eggNOG; KOG1779; Eukaryota.
DR   GeneTree; ENSGT00950000182891; -.
DR   HOGENOM; CLU_130128_3_0_1; -.
DR   InParanoid; Q71UM5; -.
DR   OMA; LHPAIDF; -.
DR   OrthoDB; 5470875at2759; -.
DR   PhylomeDB; Q71UM5; -.
DR   TreeFam; TF300265; -.
DR   PathwayCommons; Q71UM5; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9735869; SARS-CoV-1 modulates host translation machinery.
DR   Reactome; R-HSA-9754678; SARS-CoV-2 modulates host translation machinery.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; Q71UM5; -.
DR   SIGNOR; Q71UM5; -.
DR   BioGRID-ORCS; 51065; 24 hits in 1126 CRISPR screens.
DR   ChiTaRS; RPS27L; human.
DR   GenomeRNAi; 51065; -.
DR   Pharos; Q71UM5; Tbio.
DR   PRO; PR:Q71UM5; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q71UM5; protein.
DR   Bgee; ENSG00000185088; Expressed in seminal vesicle and 200 other tissues.
DR   ExpressionAtlas; Q71UM5; baseline and differential.
DR   Genevisible; Q71UM5; HS.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IBA:GO_Central.
DR   GO; GO:0008494; F:translation activator activity; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB.
DR   GO; GO:0031571; P:mitotic G1 DNA damage checkpoint signaling; IMP:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IDA:UniProtKB.
DR   GO; GO:0000028; P:ribosomal small subunit assembly; IBA:GO_Central.
DR   GO; GO:0006412; P:translation; IEA:InterPro.
DR   Gene3D; 2.20.25.100; Zn-binding ribosomal proteins; 1.
DR   HAMAP; MF_00371; Ribosomal_S27e; 1.
DR   InterPro; IPR000592; Ribosomal_S27.
DR   InterPro; IPR023407; Ribosomal_S27_Zn-bd_dom_sf.
DR   InterPro; IPR011332; Ribosomal_zn-bd.
DR   PANTHER; PTHR11594; 40S RIBOSOMAL PROTEIN S27; 1.
DR   PANTHER; PTHR11594:SF2; 40S RIBOSOMAL PROTEIN S27-LIKE; 1.
DR   Pfam; PF01667; Ribosomal_S27e; 1.
DR   SUPFAM; SSF57829; Zn-binding ribosomal proteins; 1.
DR   PROSITE; PS01168; RIBOSOMAL_S27E; 1.
PE   1: Evidence at protein level;
KW   Metal-binding; Reference proteome; Ribonucleoprotein; Ribosomal protein;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..84
FT                   /note="40S ribosomal protein S27-like"
FT                   /id="PRO_0000149054"
FT   ZN_FING         38..60
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CONFLICT        22
FT                   /note="K -> E (in Ref. 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   84 AA;  9477 MW;  271CCACFBB269E38 CRC64;
     MPLARDLLHP SLEEEKKKHK KKRLVQSPNS YFMDVKCPGC YKITTVFSHA QTVVLCVGCS
     TVLCQPTGGK ARLTEGCSFR RKQH
//
ID   YAF2_HUMAN              Reviewed;         180 AA.
AC   Q8IY57; A8K5P0; B4DFU3; G3V465; Q99710;
DT   31-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   22-FEB-2023, entry version 180.
DE   RecName: Full=YY1-associated factor 2;
GN   Name=YAF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH YY1.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9016636; DOI=10.1093/nar/25.4.843;
RA   Kalenik J.L., Chen D., Bradley M.E., Chen S.-J., Lee T.-C.;
RT   "Yeast two-hybrid cloning of a novel zinc finger protein that interacts
RT   with the multifunctional transcription factor YY1.";
RL   Nucleic Acids Res. 25:843-849(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Amygdala, Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MYCN.
RX   PubMed=11593398; DOI=10.1038/sj.onc.1204747;
RA   Bannasch D., Maedge B., Schwab M.;
RT   "Functional interaction of Yaf2 with the central region of MycN.";
RL   Oncogene 20:5913-5919(2001).
RN   [7]
RP   IDENTIFICATION IN COMPLEX WITH E2F6; TFDP1; MAX; MGA; EUHMTASE1; CBX3;
RP   RING1; RNF2; MBLR; L3MBTL2 AND BAT8.
RX   PubMed=12004135; DOI=10.1126/science.1069861;
RA   Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., Nakatani Y.;
RT   "A complex with chromatin modifiers that occupies E2F- and Myc-responsive
RT   genes in G0 cells.";
RL   Science 296:1132-1136(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MYC.
RX   PubMed=12706874; DOI=10.1016/s0304-3835(02)00696-1;
RA   Maedge B., Geisen C., Moeroey T., Schwab M.;
RT   "Yaf2 inhibits Myc biological function.";
RL   Cancer Lett. 193:171-176(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   STRUCTURE BY NMR OF 17-58.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ZF-RANBP domain of YY1-associated factor 2.";
RL   Submitted (JUN-2006) to the PDB data bank.
CC   -!- FUNCTION: Binds to MYC and inhibits MYC-mediated transactivation. Also
CC       binds to MYCN and enhances MYCN-dependent transcriptional activation.
CC       Increases calpain 2-mediated proteolysis of YY1 in vitro. Component of
CC       the E2F6.com-1 complex, a repressive complex that methylates 'Lys-9' of
CC       histone H3, suggesting that it is involved in chromatin-remodeling.
CC       {ECO:0000269|PubMed:11593398, ECO:0000269|PubMed:12706874,
CC       ECO:0000269|PubMed:9016636}.
CC   -!- SUBUNIT: Interacts with MYC, MYCN, RNF2/RING1B and YY1. Part of the
CC       E2F6.com-1 complex in G0 phase composed of E2F6, MGA, MAX, TFDP1, CBX3,
CC       BAT8, EUHMTASE1, RING1, RNF2, MBLR, L3MBTL2 and YAF2.
CC       {ECO:0000269|PubMed:11593398, ECO:0000269|PubMed:12004135,
CC       ECO:0000269|PubMed:12706874, ECO:0000269|PubMed:9016636}.
CC   -!- INTERACTION:
CC       Q8IY57; Q06587: RING1; NbExp=7; IntAct=EBI-2842031, EBI-752313;
CC       Q8IY57; Q9Y6X0: SETBP1; NbExp=3; IntAct=EBI-2842031, EBI-2548259;
CC       Q8IY57; Q9HD64: XAGE1B; NbExp=3; IntAct=EBI-2842031, EBI-2340004;
CC       Q8IY57-5; Q92688: ANP32B; NbExp=3; IntAct=EBI-12111538, EBI-762428;
CC       Q8IY57-5; Q6NZI2: CAVIN1; NbExp=3; IntAct=EBI-12111538, EBI-2559016;
CC       Q8IY57-5; Q8TDQ1-4: CD300LF; NbExp=3; IntAct=EBI-12111538, EBI-17784261;
CC       Q8IY57-5; G5E9A7: DMWD; NbExp=3; IntAct=EBI-12111538, EBI-10976677;
CC       Q8IY57-5; Q9NQM4: DNAAF6; NbExp=3; IntAct=EBI-12111538, EBI-10239299;
CC       Q8IY57-5; Q96JC9: EAF1; NbExp=5; IntAct=EBI-12111538, EBI-769261;
CC       Q8IY57-5; P28799: GRN; NbExp=3; IntAct=EBI-12111538, EBI-747754;
CC       Q8IY57-5; Q9NWB7: IFT57; NbExp=3; IntAct=EBI-12111538, EBI-725672;
CC       Q8IY57-5; Q9C086: INO80B; NbExp=3; IntAct=EBI-12111538, EBI-715611;
CC       Q8IY57-5; P47929: LGALS7B; NbExp=3; IntAct=EBI-12111538, EBI-357504;
CC       Q8IY57-5; Q9UPY8: MAPRE3; NbExp=3; IntAct=EBI-12111538, EBI-726739;
CC       Q8IY57-5; Q9P0L2: MARK1; NbExp=3; IntAct=EBI-12111538, EBI-968587;
CC       Q8IY57-5; P61970: NUTF2; NbExp=3; IntAct=EBI-12111538, EBI-591778;
CC       Q8IY57-5; O14917: PCDH17; NbExp=3; IntAct=EBI-12111538, EBI-947061;
CC       Q8IY57-5; Q9BT43: POLR3GL; NbExp=3; IntAct=EBI-12111538, EBI-2855862;
CC       Q8IY57-5; O60927: PPP1R11; NbExp=3; IntAct=EBI-12111538, EBI-1048104;
CC       Q8IY57-5; Q06587: RING1; NbExp=8; IntAct=EBI-12111538, EBI-752313;
CC       Q8IY57-5; Q99496: RNF2; NbExp=5; IntAct=EBI-12111538, EBI-722416;
CC       Q8IY57-5; Q5MJ10: SPANXN2; NbExp=3; IntAct=EBI-12111538, EBI-12023934;
CC       Q8IY57-5; Q5MJ09: SPANXN3; NbExp=3; IntAct=EBI-12111538, EBI-12037215;
CC       Q8IY57-5; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-12111538, EBI-5235340;
CC       Q8IY57-5; Q9UKI8: TLK1; NbExp=3; IntAct=EBI-12111538, EBI-740492;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11593398}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IY57-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IY57-5; Sequence=VSP_055659;
CC       Name=3;
CC         IsoId=Q8IY57-3; Sequence=VSP_043415;
CC       Name=4;
CC         IsoId=Q8IY57-4; Sequence=VSP_044598, VSP_044599;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U72209; AAC51116.1; -; mRNA.
DR   EMBL; AK127531; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK291355; BAF84044.1; -; mRNA.
DR   EMBL; AK294260; BAG57554.1; -; mRNA.
DR   EMBL; AC020629; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW57839.1; -; Genomic_DNA.
DR   EMBL; BC037777; AAH37777.1; -; mRNA.
DR   CCDS; CCDS31775.1; -. [Q8IY57-1]
DR   CCDS; CCDS53778.1; -. [Q8IY57-3]
DR   CCDS; CCDS53779.1; -. [Q8IY57-5]
DR   CCDS; CCDS53780.1; -. [Q8IY57-4]
DR   RefSeq; NP_001177906.1; NM_001190977.2. [Q8IY57-3]
DR   RefSeq; NP_001177908.1; NM_001190979.2. [Q8IY57-5]
DR   RefSeq; NP_001177909.1; NM_001190980.2. [Q8IY57-4]
DR   RefSeq; NP_005739.2; NM_005748.5. [Q8IY57-1]
DR   PDB; 2D9G; NMR; -; A=19-58.
DR   PDBsum; 2D9G; -.
DR   AlphaFoldDB; Q8IY57; -.
DR   SMR; Q8IY57; -.
DR   BioGRID; 115441; 194.
DR   CORUM; Q8IY57; -.
DR   DIP; DIP-44919N; -.
DR   IntAct; Q8IY57; 95.
DR   MINT; Q8IY57; -.
DR   GlyCosmos; Q8IY57; 2 sites, 1 glycan.
DR   GlyGen; Q8IY57; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q8IY57; -.
DR   PhosphoSitePlus; Q8IY57; -.
DR   BioMuta; YAF2; -.
DR   DMDM; 215274199; -.
DR   EPD; Q8IY57; -.
DR   jPOST; Q8IY57; -.
DR   MassIVE; Q8IY57; -.
DR   MaxQB; Q8IY57; -.
DR   PeptideAtlas; Q8IY57; -.
DR   ProteomicsDB; 71112; -. [Q8IY57-1]
DR   ProteomicsDB; 71114; -. [Q8IY57-3]
DR   Antibodypedia; 13166; 159 antibodies from 27 providers.
DR   DNASU; 10138; -.
DR   Ensembl; ENST00000327791.8; ENSP00000328004.5; ENSG00000015153.15. [Q8IY57-5]
DR   Ensembl; ENST00000380790.4; ENSP00000370167.4; ENSG00000015153.15. [Q8IY57-3]
DR   Ensembl; ENST00000534854.7; ENSP00000439256.2; ENSG00000015153.15. [Q8IY57-1]
DR   Ensembl; ENST00000555248.2; ENSP00000451626.2; ENSG00000015153.15. [Q8IY57-4]
DR   GeneID; 10138; -.
DR   KEGG; hsa:10138; -.
DR   MANE-Select; ENST00000534854.7; ENSP00000439256.2; NM_005748.6; NP_005739.2.
DR   UCSC; uc001rmv.4; human. [Q8IY57-1]
DR   AGR; HGNC:17363; -.
DR   CTD; 10138; -.
DR   DisGeNET; 10138; -.
DR   GeneCards; YAF2; -.
DR   HGNC; HGNC:17363; YAF2.
DR   HPA; ENSG00000015153; Low tissue specificity.
DR   MIM; 607534; gene.
DR   neXtProt; NX_Q8IY57; -.
DR   OpenTargets; ENSG00000015153; -.
DR   PharmGKB; PA38236; -.
DR   VEuPathDB; HostDB:ENSG00000015153; -.
DR   GeneTree; ENSGT00390000013995; -.
DR   HOGENOM; CLU_095374_0_0_1; -.
DR   InParanoid; Q8IY57; -.
DR   OMA; VCTFRNG; -.
DR   OrthoDB; 2968533at2759; -.
DR   PhylomeDB; Q8IY57; -.
DR   TreeFam; TF350501; -.
DR   PathwayCommons; Q8IY57; -.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.
DR   SignaLink; Q8IY57; -.
DR   BioGRID-ORCS; 10138; 16 hits in 1162 CRISPR screens.
DR   ChiTaRS; YAF2; human.
DR   EvolutionaryTrace; Q8IY57; -.
DR   GeneWiki; YAF2; -.
DR   GenomeRNAi; 10138; -.
DR   Pharos; Q8IY57; Tbio.
DR   PRO; PR:Q8IY57; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8IY57; protein.
DR   Bgee; ENSG00000015153; Expressed in right atrium auricular region and 126 other tissues.
DR   ExpressionAtlas; Q8IY57; baseline and differential.
DR   Genevisible; Q8IY57; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   Gene3D; 4.10.1060.10; Zinc finger, RanBP2-type; 1.
DR   InterPro; IPR039958; RYBP/YAF2.
DR   InterPro; IPR033774; YAF2_RYBP.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR12920; RYBP AND YAF2-RELATED; 1.
DR   PANTHER; PTHR12920:SF2; YY1-ASSOCIATED FACTOR 2; 1.
DR   Pfam; PF17219; YAF2_RYBP; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF90209; Ran binding protein zinc finger-like; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..180
FT                   /note="YY1-associated factor 2"
FT                   /id="PRO_0000066113"
FT   ZN_FING         19..48
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          47..120
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          132..180
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..18
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..72
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        73..95
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        134..180
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   VAR_SEQ         8..49
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043415"
FT   VAR_SEQ         50
FT                   /note="T -> TRSTLFEVIVSASRTKEPLKFPISG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055659"
FT   VAR_SEQ         52..117
FT                   /note="KPRPVSQLVAQQVTQQFVPPTQSKKEKKDKVEKEKSEKETTSKKNSHKKTRP
FT                   RLKNVDRSSAQHLE -> DSKEGGKLVSYSTASLGVRGTLRNRVGGGSSEEKKQAEYLA
FT                   PGRRRNIVHRGVGPGQRSGPSLKEA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044598"
FT   VAR_SEQ         118..180
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044599"
FT   CONFLICT        13..14
FT                   /note="QP -> HA (in Ref. 1; AAC51116)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..28
FT                   /evidence="ECO:0007829|PDB:2D9G"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:2D9G"
SQ   SEQUENCE   180 AA;  19901 MW;  199A56EE06BB4FBE CRC64;
     MGDKKSPTRP KRQPKPSSDE GYWDCSVCTF RNSAEAFKCM MCDVRKGTST RKPRPVSQLV
     AQQVTQQFVP PTQSKKEKKD KVEKEKSEKE TTSKKNSHKK TRPRLKNVDR SSAQHLEVTV
     GDLTVIITDF KEKTKSPPAS SAASADQHSQ SGSSSDNTER GMSRSSSPRG EASSLNGESH
//
ID   SR1IP_HUMAN             Reviewed;         155 AA.
AC   Q8N9Q2; Q32NC8;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   22-FEB-2023, entry version 144.
DE   RecName: Full=Protein SREK1IP1;
DE   AltName: Full=SFRS12-interacting protein 1;
DE   AltName: Full=SREK1-interacting protein 1;
DE   AltName: Full=Splicing regulatory protein of 18 kDa;
DE            Short=p18SRP;
GN   Name=SREK1IP1; Synonyms=P18SRP, SFRS12IP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   POSSIBLE FUNCTION, INDUCTION, AND INTERACTION WITH SFRS12.
RX   PubMed=15456940; DOI=10.1385/jmn:24:2:269;
RA   Heese K., Fujita M., Akatsu H., Yamamoto T., Kosaka K., Nagai Y.,
RA   Sawada T.;
RT   "The splicing regulatory protein p18SRP is down-regulated in Alzheimer's
RT   disease brain.";
RL   J. Mol. Neurosci. 24:269-276(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Possible splicing regulator involved in the control of
CC       cellular survival.
CC   -!- SUBUNIT: Interacts with SREK1/SFRS12. {ECO:0000269|PubMed:15456940}.
CC   -!- INTERACTION:
CC       Q8N9Q2; Q9NRZ7: AGPAT3; NbExp=3; IntAct=EBI-10268630, EBI-2803601;
CC       Q8N9Q2; Q96LM5: C4orf45; NbExp=3; IntAct=EBI-10268630, EBI-12020542;
CC       Q8N9Q2; Q9UK58: CCNL1; NbExp=3; IntAct=EBI-10268630, EBI-2836773;
CC       Q8N9Q2; Q5HYN5: CT45A1; NbExp=3; IntAct=EBI-10268630, EBI-12051833;
CC       Q8N9Q2; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-10268630, EBI-742054;
CC       Q8N9Q2; Q8IYF1: ELOA2; NbExp=3; IntAct=EBI-10268630, EBI-741705;
CC       Q8N9Q2; O15520: FGF10; NbExp=3; IntAct=EBI-10268630, EBI-1035684;
CC       Q8N9Q2; Q92759: GTF2H4; NbExp=3; IntAct=EBI-10268630, EBI-6380495;
CC       Q8N9Q2; U3KQK0: H2BC15; NbExp=3; IntAct=EBI-10268630, EBI-12142839;
CC       Q8N9Q2; A0A024RA76: hCG_1744368; NbExp=3; IntAct=EBI-10268630, EBI-10180729;
CC       Q8N9Q2; P00492: HPRT1; NbExp=3; IntAct=EBI-10268630, EBI-748210;
CC       Q8N9Q2; Q9BPX1: HSD17B14; NbExp=5; IntAct=EBI-10268630, EBI-742664;
CC       Q8N9Q2; Q9NX58: LYAR; NbExp=3; IntAct=EBI-10268630, EBI-713507;
CC       Q8N9Q2; O75367: MACROH2A1; NbExp=3; IntAct=EBI-10268630, EBI-2868511;
CC       Q8N9Q2; Q6ZUT1: NKAPD1; NbExp=6; IntAct=EBI-10268630, EBI-3920396;
CC       Q8N9Q2; Q5M9Q1: NKAPL; NbExp=3; IntAct=EBI-10268630, EBI-11423380;
CC       Q8N9Q2; P15531: NME1; NbExp=3; IntAct=EBI-10268630, EBI-741141;
CC       Q8N9Q2; Q96CD2: PPCDC; NbExp=3; IntAct=EBI-10268630, EBI-724333;
CC       Q8N9Q2; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-10268630, EBI-5280197;
CC       Q8N9Q2; Q9NZ81: PRR13; NbExp=3; IntAct=EBI-10268630, EBI-740924;
CC       Q8N9Q2; Q14498: RBM39; NbExp=3; IntAct=EBI-10268630, EBI-395290;
CC       Q8N9Q2; Q2KHN1: RNF151; NbExp=3; IntAct=EBI-10268630, EBI-12002474;
CC       Q8N9Q2; Q8TA86: RP9; NbExp=3; IntAct=EBI-10268630, EBI-630339;
CC       Q8N9Q2; P32969: RPL9P9; NbExp=3; IntAct=EBI-10268630, EBI-358122;
CC       Q8N9Q2; O00560: SDCBP; NbExp=6; IntAct=EBI-10268630, EBI-727004;
CC       Q8N9Q2; Q9H190: SDCBP2; NbExp=6; IntAct=EBI-10268630, EBI-742426;
CC       Q8N9Q2; Q96MF2: STAC3; NbExp=6; IntAct=EBI-10268630, EBI-745680;
CC       Q8N9Q2; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-10268630, EBI-741515;
CC   -!- INDUCTION: Down-regulated in the brains of Alzheimer disease patients.
CC       {ECO:0000269|PubMed:15456940}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI08717.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK094073; BAC04279.1; -; mRNA.
DR   EMBL; CH471137; EAW51368.1; -; Genomic_DNA.
DR   EMBL; BC108716; AAI08717.1; ALT_FRAME; mRNA.
DR   EMBL; BC127085; AAI27086.1; -; mRNA.
DR   EMBL; BC127086; AAI27087.1; -; mRNA.
DR   CCDS; CCDS34171.1; -.
DR   RefSeq; NP_776190.1; NM_173829.3.
DR   AlphaFoldDB; Q8N9Q2; -.
DR   BioGRID; 130175; 60.
DR   IntAct; Q8N9Q2; 50.
DR   STRING; 9606.ENSP00000427401; -.
DR   iPTMnet; Q8N9Q2; -.
DR   PhosphoSitePlus; Q8N9Q2; -.
DR   BioMuta; SREK1IP1; -.
DR   DMDM; 74729743; -.
DR   EPD; Q8N9Q2; -.
DR   jPOST; Q8N9Q2; -.
DR   MassIVE; Q8N9Q2; -.
DR   MaxQB; Q8N9Q2; -.
DR   PaxDb; Q8N9Q2; -.
DR   PeptideAtlas; Q8N9Q2; -.
DR   ProteomicsDB; 72573; -.
DR   Antibodypedia; 23725; 54 antibodies from 16 providers.
DR   DNASU; 285672; -.
DR   Ensembl; ENST00000513458.9; ENSP00000427401.3; ENSG00000153006.16.
DR   GeneID; 285672; -.
DR   KEGG; hsa:285672; -.
DR   MANE-Select; ENST00000513458.9; ENSP00000427401.3; NM_173829.4; NP_776190.1.
DR   UCSC; uc003jtk.4; human.
DR   AGR; HGNC:26716; -.
DR   CTD; 285672; -.
DR   DisGeNET; 285672; -.
DR   GeneCards; SREK1IP1; -.
DR   HGNC; HGNC:26716; SREK1IP1.
DR   HPA; ENSG00000153006; Low tissue specificity.
DR   neXtProt; NX_Q8N9Q2; -.
DR   OpenTargets; ENSG00000153006; -.
DR   PharmGKB; PA162402954; -.
DR   VEuPathDB; HostDB:ENSG00000153006; -.
DR   eggNOG; KOG2985; Eukaryota.
DR   GeneTree; ENSGT00510000047710; -.
DR   HOGENOM; CLU_122662_0_0_1; -.
DR   InParanoid; Q8N9Q2; -.
DR   OMA; KHHKKRQ; -.
DR   OrthoDB; 1388040at2759; -.
DR   PhylomeDB; Q8N9Q2; -.
DR   TreeFam; TF318225; -.
DR   PathwayCommons; Q8N9Q2; -.
DR   SignaLink; Q8N9Q2; -.
DR   BioGRID-ORCS; 285672; 40 hits in 1081 CRISPR screens.
DR   ChiTaRS; SREK1IP1; human.
DR   GenomeRNAi; 285672; -.
DR   Pharos; Q8N9Q2; Tdark.
DR   PRO; PR:Q8N9Q2; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8N9Q2; protein.
DR   Bgee; ENSG00000153006; Expressed in buccal mucosa cell and 208 other tissues.
DR   Genevisible; Q8N9Q2; HS.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   InterPro; IPR001878; Znf_CCHC.
DR   PANTHER; PTHR31437:SF1; PROTEIN SREK1IP1; 1.
DR   PANTHER; PTHR31437; SREK1IP1 FAMILY MEMBER; 1.
DR   Pfam; PF13917; zf-CCHC_3; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
PE   1: Evidence at protein level;
KW   Metal-binding; mRNA processing; mRNA splicing; Phosphoprotein;
KW   Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..155
FT                   /note="Protein SREK1IP1"
FT                   /id="PRO_0000311922"
FT   ZN_FING         13..30
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   REGION          44..155
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        58..81
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        94..110
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        111..143
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4V9W2"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4V9W2"
FT   MOD_RES         146
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
SQ   SEQUENCE   155 AA;  18177 MW;  9BABECE4783AFF27 CRC64;
     MAVPGCNKDS VRAGCKKCGY PGHLTFECRN FLRVDPKRDI VLDVSSTSSE DSDEENEELN
     KLQALQEKRI NEEEEKKKEK SKEKIKLKKK RKRSYSSSST EEDTSKQKKQ KYQKKEKKKE
     KKSKSKKGKH HKKEKKKRKK EKHSSTPNSS EFSRK
//
ID   ZCH10_HUMAN             Reviewed;         192 AA.
AC   Q8TBK6; Q9NXR4;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   22-FEB-2023, entry version 143.
DE   RecName: Full=Zinc finger CCHC domain-containing protein 10;
GN   Name=ZCCHC10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q8TBK6; Q8N2N9-4: ANKRD36B; NbExp=3; IntAct=EBI-597063, EBI-12170453;
CC       Q8TBK6; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-597063, EBI-10181188;
CC       Q8TBK6; Q6NZI2: CAVIN1; NbExp=3; IntAct=EBI-597063, EBI-2559016;
CC       Q8TBK6; Q96MT8: CEP63; NbExp=3; IntAct=EBI-597063, EBI-741977;
CC       Q8TBK6; Q8NHQ1: CEP70; NbExp=4; IntAct=EBI-597063, EBI-739624;
CC       Q8TBK6; P38432: COIL; NbExp=3; IntAct=EBI-597063, EBI-945751;
CC       Q8TBK6; O75553: DAB1; NbExp=3; IntAct=EBI-597063, EBI-7875264;
CC       Q8TBK6; Q9UI36-2: DACH1; NbExp=3; IntAct=EBI-597063, EBI-10186082;
CC       Q8TBK6; Q86Y13: DZIP3; NbExp=6; IntAct=EBI-597063, EBI-948630;
CC       Q8TBK6; Q8IYF1: ELOA2; NbExp=3; IntAct=EBI-597063, EBI-741705;
CC       Q8TBK6; P11171-2: EPB41; NbExp=3; IntAct=EBI-597063, EBI-10197451;
CC       Q8TBK6; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-597063, EBI-10175124;
CC       Q8TBK6; Q5VSY0: GKAP1; NbExp=3; IntAct=EBI-597063, EBI-743722;
CC       Q8TBK6; Q9UGU5: HMGXB4; NbExp=5; IntAct=EBI-597063, EBI-7261162;
CC       Q8TBK6; Q8NC69: KCTD6; NbExp=3; IntAct=EBI-597063, EBI-2511344;
CC       Q8TBK6; O00505: KPNA3; NbExp=3; IntAct=EBI-597063, EBI-358297;
CC       Q8TBK6; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-597063, EBI-739832;
CC       Q8TBK6; Q8N8X9: MAB21L3; NbExp=3; IntAct=EBI-597063, EBI-10268010;
CC       Q8TBK6; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-597063, EBI-348259;
CC       Q8TBK6; P50221: MEOX1; NbExp=3; IntAct=EBI-597063, EBI-2864512;
CC       Q8TBK6; O95848: NUDT14; NbExp=3; IntAct=EBI-597063, EBI-536866;
CC       Q8TBK6; Q9NZ81: PRR13; NbExp=4; IntAct=EBI-597063, EBI-740924;
CC       Q8TBK6; P61289: PSME3; NbExp=7; IntAct=EBI-597063, EBI-355546;
CC       Q8TBK6; P26045: PTPN3; NbExp=3; IntAct=EBI-597063, EBI-1047946;
CC       Q8TBK6; Q14498: RBM39; NbExp=4; IntAct=EBI-597063, EBI-395290;
CC       Q8TBK6; Q14498-3: RBM39; NbExp=3; IntAct=EBI-597063, EBI-6654703;
CC       Q8TBK6; P35268: RPL22; NbExp=3; IntAct=EBI-597063, EBI-354533;
CC       Q8TBK6; O00560: SDCBP; NbExp=3; IntAct=EBI-597063, EBI-727004;
CC       Q8TBK6; Q9H190: SDCBP2; NbExp=4; IntAct=EBI-597063, EBI-742426;
CC       Q8TBK6; Q15427: SF3B4; NbExp=3; IntAct=EBI-597063, EBI-348469;
CC       Q8TBK6; Q9UHJ3: SFMBT1; NbExp=6; IntAct=EBI-597063, EBI-747398;
CC       Q8TBK6; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-597063, EBI-747107;
CC       Q8TBK6; Q96MF2: STAC3; NbExp=7; IntAct=EBI-597063, EBI-745680;
CC       Q8TBK6; O75558: STX11; NbExp=4; IntAct=EBI-597063, EBI-714135;
CC       Q8TBK6; Q12800: TFCP2; NbExp=4; IntAct=EBI-597063, EBI-717422;
CC       Q8TBK6; Q9NVV9: THAP1; NbExp=10; IntAct=EBI-597063, EBI-741515;
CC       Q8TBK6; O43829: ZBTB14; NbExp=3; IntAct=EBI-597063, EBI-10176632;
CC       Q8TBK6; Q96BR9: ZBTB8A; NbExp=3; IntAct=EBI-597063, EBI-742740;
CC       Q8TBK6; Q5ZXN6: ankX; Xeno; NbExp=2; IntAct=EBI-597063, EBI-26359852;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TBK6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TBK6-2; Sequence=VSP_013718;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK000101; BAA90946.1; -; mRNA.
DR   EMBL; BC005211; AAH05211.1; -; mRNA.
DR   EMBL; BC022443; AAH22443.1; -; mRNA.
DR   CCDS; CCDS4165.1; -. [Q8TBK6-2]
DR   CCDS; CCDS75301.1; -. [Q8TBK6-1]
DR   RefSeq; NP_001287745.1; NM_001300816.2. [Q8TBK6-1]
DR   RefSeq; NP_001287746.1; NM_001300817.2.
DR   RefSeq; NP_001287747.1; NM_001300818.2.
DR   RefSeq; NP_001287748.1; NM_001300819.2.
DR   RefSeq; NP_001287751.1; NM_001300822.2.
DR   RefSeq; NP_001295056.1; NM_001308127.1.
DR   RefSeq; NP_001295057.1; NM_001308128.1.
DR   RefSeq; NP_001295058.1; NM_001308129.1.
DR   RefSeq; NP_001295059.1; NM_001308130.1.
DR   RefSeq; NP_060135.1; NM_017665.3. [Q8TBK6-2]
DR   AlphaFoldDB; Q8TBK6; -.
DR   BioGRID; 120174; 235.
DR   IntAct; Q8TBK6; 66.
DR   MINT; Q8TBK6; -.
DR   STRING; 9606.ENSP00000423276; -.
DR   iPTMnet; Q8TBK6; -.
DR   PhosphoSitePlus; Q8TBK6; -.
DR   BioMuta; ZCCHC10; -.
DR   DMDM; 84028163; -.
DR   EPD; Q8TBK6; -.
DR   jPOST; Q8TBK6; -.
DR   MassIVE; Q8TBK6; -.
DR   MaxQB; Q8TBK6; -.
DR   PeptideAtlas; Q8TBK6; -.
DR   ProteomicsDB; 74024; -. [Q8TBK6-1]
DR   ProteomicsDB; 74025; -. [Q8TBK6-2]
DR   Antibodypedia; 26217; 32 antibodies from 12 providers.
DR   DNASU; 54819; -.
DR   Ensembl; ENST00000324170.7; ENSP00000324274.3; ENSG00000155329.12. [Q8TBK6-2]
DR   Ensembl; ENST00000509437.6; ENSP00000423276.1; ENSG00000155329.12. [Q8TBK6-1]
DR   GeneID; 54819; -.
DR   KEGG; hsa:54819; -.
DR   MANE-Select; ENST00000509437.6; ENSP00000423276.1; NM_001300816.3; NP_001287745.1.
DR   UCSC; uc003kyg.4; human. [Q8TBK6-1]
DR   AGR; HGNC:25954; -.
DR   CTD; 54819; -.
DR   DisGeNET; 54819; -.
DR   GeneCards; ZCCHC10; -.
DR   HGNC; HGNC:25954; ZCCHC10.
DR   HPA; ENSG00000155329; Low tissue specificity.
DR   neXtProt; NX_Q8TBK6; -.
DR   OpenTargets; ENSG00000155329; -.
DR   PharmGKB; PA134876515; -.
DR   VEuPathDB; HostDB:ENSG00000155329; -.
DR   eggNOG; KOG3116; Eukaryota.
DR   GeneTree; ENSGT00730000111200; -.
DR   HOGENOM; CLU_111178_0_0_1; -.
DR   InParanoid; Q8TBK6; -.
DR   OMA; RKYVQRT; -.
DR   OrthoDB; 77859at2759; -.
DR   PhylomeDB; Q8TBK6; -.
DR   PathwayCommons; Q8TBK6; -.
DR   SignaLink; Q8TBK6; -.
DR   BioGRID-ORCS; 54819; 17 hits in 1155 CRISPR screens.
DR   ChiTaRS; ZCCHC10; human.
DR   GenomeRNAi; 54819; -.
DR   Pharos; Q8TBK6; Tdark.
DR   PRO; PR:Q8TBK6; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8TBK6; protein.
DR   Bgee; ENSG00000155329; Expressed in endothelial cell and 207 other tissues.
DR   ExpressionAtlas; Q8TBK6; baseline and differential.
DR   Genevisible; Q8TBK6; HS.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR039715; ZCCHC10.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   PANTHER; PTHR13491; ZCCHC10 PROTEIN; 1.
DR   PANTHER; PTHR13491:SF0; ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 10; 1.
DR   Pfam; PF13917; zf-CCHC_3; 1.
DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Metal-binding; Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..192
FT                   /note="Zinc finger CCHC domain-containing protein 10"
FT                   /id="PRO_0000150967"
FT   ZN_FING         43..60
FT                   /note="CCHC-type"
FT   REGION          89..192
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        107..180
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         15..36
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013718"
SQ   SEQUENCE   192 AA;  20967 MW;  E600FD109936B53E CRC64;
     MATPMHRLIA RRQAFDTELQ PVKTFWILIQ PSIVISEANK QHVRCQKCLE FGHWTYECTG
     KRKYLHRPSR TAELKKALKE KENRLLLQQS IGETNVERKA KKKRSKSVTS SSSSSSDSSA
     SDSSSESEET STSSSSEDSD TDESSSSSSS SASSTTSSSS SDSDSDSSSS SSSSTSTDSS
     SDDEPPKKKK KK
//
ID   RN183_HUMAN             Reviewed;         192 AA.
AC   Q96D59;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 2.
DT   22-FEB-2023, entry version 148.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF183;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:29507230};
GN   Name=RNF183;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-82 AND ARG-114.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, INTERACTION WITH FATE1, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   CYS-13 AND CYS-59, AND UBIQUITINATION.
RX   PubMed=26567849; DOI=10.1038/ncomms9840;
RA   Maxfield K.E., Taus P.J., Corcoran K., Wooten J., Macion J., Zhou Y.,
RA   Borromeo M., Kollipara R.K., Yan J., Xie Y., Xie X.J., Whitehurst A.W.;
RT   "Comprehensive functional characterization of cancer-testis antigens
RT   defines obligate participation in multiple hallmarks of cancer.";
RL   Nat. Commun. 6:8840-8840(2015).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=29300766; DOI=10.1371/journal.pone.0190407;
RA   Wu Y., Guo X.P., Kanemoto S., Maeoka Y., Saito A., Asada R., Matsuhisa K.,
RA   Ohtake Y., Imaizumi K., Kaneko M.;
RT   "Sec16A, a key protein in COPII vesicle formation, regulates the stability
RT   and localization of the novel ubiquitin ligase RNF183.";
RL   PLoS ONE 13:E0190407-E0190407(2018).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TOPOLOGY, INDUCTION,
RP   INTERACTION WITH BCL2L1, AND MUTAGENESIS OF CYS-13; CYS-16; LYS-28; LYS-101
RP   AND LYS-105.
RX   PubMed=29507230; DOI=10.1073/pnas.1716439115;
RA   Wu Y., Li X., Jia J., Zhang Y., Li J., Zhu Z., Wang H., Tang J., Hu J.;
RT   "Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by
RT   degrading Bcl-xL.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:E2762-E2771(2018).
CC   -!- FUNCTION: Acts as a E3 ubiquitin ligase catalyzing the covalent
CC       attachment of ubiquitin moieties onto substrate proteins
CC       (PubMed:29507230). Triggers apoptosis in response to prolonged ER
CC       stress by mediating the polyubiquitination and subsequent proteasomal
CC       degradation of BCL2L1 (PubMed:29507230). May collaborate with FATE1 to
CC       restrain BIK protein levels thus regulating apoptotic signaling
CC       (PubMed:26567849). {ECO:0000269|PubMed:29507230,
CC       ECO:0000305|PubMed:26567849}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:29507230};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:29507230}.
CC   -!- SUBUNIT: Interacts with FATE1 (PubMed:26567849). Interacts with SEC16A
CC       (By similarity). Interacts with BCL2L1 (PubMed:29507230).
CC       {ECO:0000250|UniProtKB:Q8QZS5, ECO:0000269|PubMed:26567849,
CC       ECO:0000269|PubMed:29507230}.
CC   -!- INTERACTION:
CC       Q96D59; P01023: A2M; NbExp=3; IntAct=EBI-743938, EBI-640741;
CC       Q96D59; Q92870-2: APBB2; NbExp=3; IntAct=EBI-743938, EBI-21535880;
CC       Q96D59; P54253: ATXN1; NbExp=6; IntAct=EBI-743938, EBI-930964;
CC       Q96D59; P09172: DBH; NbExp=3; IntAct=EBI-743938, EBI-8589586;
CC       Q96D59; Q14203-5: DCTN1; NbExp=3; IntAct=EBI-743938, EBI-25840379;
CC       Q96D59; P50570-2: DNM2; NbExp=3; IntAct=EBI-743938, EBI-10968534;
CC       Q96D59; Q01658: DR1; NbExp=3; IntAct=EBI-743938, EBI-750300;
CC       Q96D59; Q13216-2: ERCC8; NbExp=3; IntAct=EBI-743938, EBI-16466949;
CC       Q96D59; Q969F0: FATE1; NbExp=4; IntAct=EBI-743938, EBI-743099;
CC       Q96D59; Q16595: FXN; NbExp=3; IntAct=EBI-743938, EBI-949340;
CC       Q96D59; Q53GS7: GLE1; NbExp=3; IntAct=EBI-743938, EBI-1955541;
CC       Q96D59; Q9HD26: GOPC; NbExp=3; IntAct=EBI-743938, EBI-349832;
CC       Q96D59; Q9HD26-2: GOPC; NbExp=3; IntAct=EBI-743938, EBI-11102276;
CC       Q96D59; Q00403: GTF2B; NbExp=3; IntAct=EBI-743938, EBI-389564;
CC       Q96D59; Q9Y5Q9: GTF3C3; NbExp=3; IntAct=EBI-743938, EBI-1054873;
CC       Q96D59; P07686: HEXB; NbExp=3; IntAct=EBI-743938, EBI-7133736;
CC       Q96D59; P28358: HOXD10; NbExp=3; IntAct=EBI-743938, EBI-12690664;
CC       Q96D59; P04792: HSPB1; NbExp=3; IntAct=EBI-743938, EBI-352682;
CC       Q96D59; O43464: HTRA2; NbExp=3; IntAct=EBI-743938, EBI-517086;
CC       Q96D59; P42858: HTT; NbExp=3; IntAct=EBI-743938, EBI-466029;
CC       Q96D59; O60333-2: KIF1B; NbExp=3; IntAct=EBI-743938, EBI-10975473;
CC       Q96D59; Q99732: LITAF; NbExp=3; IntAct=EBI-743938, EBI-725647;
CC       Q96D59; P51608: MECP2; NbExp=3; IntAct=EBI-743938, EBI-1189067;
CC       Q96D59; P19404: NDUFV2; NbExp=3; IntAct=EBI-743938, EBI-713665;
CC       Q96D59; P35240-4: NF2; NbExp=3; IntAct=EBI-743938, EBI-1014514;
CC       Q96D59; P29474: NOS3; NbExp=3; IntAct=EBI-743938, EBI-1391623;
CC       Q96D59; D3DTS7: PMP22; NbExp=3; IntAct=EBI-743938, EBI-25882629;
CC       Q96D59; O60260-5: PRKN; NbExp=3; IntAct=EBI-743938, EBI-21251460;
CC       Q96D59; P41219: PRPH; NbExp=3; IntAct=EBI-743938, EBI-752074;
CC       Q96D59; P60891: PRPS1; NbExp=3; IntAct=EBI-743938, EBI-749195;
CC       Q96D59; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-743938, EBI-396669;
CC       Q96D59; P37840: SNCA; NbExp=3; IntAct=EBI-743938, EBI-985879;
CC       Q96D59; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-743938, EBI-5235340;
CC       Q96D59; Q13148: TARDBP; NbExp=3; IntAct=EBI-743938, EBI-372899;
CC       Q96D59; O14907: TAX1BP3; NbExp=3; IntAct=EBI-743938, EBI-723259;
CC       Q96D59; O14773: TPP1; NbExp=3; IntAct=EBI-743938, EBI-2800203;
CC       Q96D59; Q86WV8: TSC1; NbExp=3; IntAct=EBI-743938, EBI-12806590;
CC       Q96D59; P02766: TTR; NbExp=3; IntAct=EBI-743938, EBI-711909;
CC       Q96D59; P61086: UBE2K; NbExp=3; IntAct=EBI-743938, EBI-473850;
CC       Q96D59; Q96FI0: UBE2W; NbExp=3; IntAct=EBI-743938, EBI-10285774;
CC       Q96D59; O76024: WFS1; NbExp=3; IntAct=EBI-743938, EBI-720609;
CC       Q96D59; Q9P1N4; NbExp=3; IntAct=EBI-743938, EBI-25878161;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:29507230}; Single-pass type IV membrane protein
CC       {ECO:0000305|PubMed:29507230}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:26567849}. Golgi apparatus, cis-Golgi network
CC       membrane {ECO:0000250|UniProtKB:Q8QZS5}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:Q8QZS5}.
CC   -!- TISSUE SPECIFICITY: Kidney and testis. {ECO:0000269|PubMed:29300766}.
CC   -!- INDUCTION: Up-regulated by ER stress in an ERN1-dependent manner.
CC       {ECO:0000269|PubMed:29507230}.
CC   -!- PTM: Autoubiquitinated (in vitro). {ECO:0000269|PubMed:26567849,
CC       ECO:0000269|PubMed:29507230}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL449305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013036; AAH13036.1; -; mRNA.
DR   CCDS; CCDS43866.1; -.
DR   RefSeq; NP_659488.2; NM_145051.3.
DR   RefSeq; XP_006717015.1; XM_006716952.2.
DR   RefSeq; XP_011516520.1; XM_011518218.1.
DR   RefSeq; XP_011516521.1; XM_011518219.1.
DR   RefSeq; XP_011516522.1; XM_011518220.1.
DR   RefSeq; XP_016869757.1; XM_017014268.1.
DR   AlphaFoldDB; Q96D59; -.
DR   SMR; Q96D59; -.
DR   BioGRID; 126500; 22.
DR   IntAct; Q96D59; 45.
DR   STRING; 9606.ENSP00000419454; -.
DR   BioMuta; RNF183; -.
DR   DMDM; 74760778; -.
DR   PaxDb; Q96D59; -.
DR   PeptideAtlas; Q96D59; -.
DR   Antibodypedia; 54188; 105 antibodies from 20 providers.
DR   DNASU; 138065; -.
DR   Ensembl; ENST00000297894.5; ENSP00000417943.1; ENSG00000165188.14.
DR   Ensembl; ENST00000416588.2; ENSP00000420740.1; ENSG00000165188.14.
DR   Ensembl; ENST00000441031.3; ENSP00000417176.1; ENSG00000165188.14.
DR   Ensembl; ENST00000478815.1; ENSP00000419454.1; ENSG00000165188.14.
DR   Ensembl; ENST00000489339.2; ENSP00000508293.1; ENSG00000165188.14.
DR   GeneID; 138065; -.
DR   KEGG; hsa:138065; -.
DR   MANE-Select; ENST00000489339.2; ENSP00000508293.1; NM_001371237.1; NP_001358166.1.
DR   UCSC; uc004bgz.4; human.
DR   AGR; HGNC:28721; -.
DR   CTD; 138065; -.
DR   DisGeNET; 138065; -.
DR   GeneCards; RNF183; -.
DR   HGNC; HGNC:28721; RNF183.
DR   HPA; ENSG00000165188; Tissue enhanced (epididymis, kidney).
DR   neXtProt; NX_Q96D59; -.
DR   OpenTargets; ENSG00000165188; -.
DR   PharmGKB; PA142671055; -.
DR   VEuPathDB; HostDB:ENSG00000165188; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT00940000162965; -.
DR   HOGENOM; CLU_122905_0_0_1; -.
DR   InParanoid; Q96D59; -.
DR   OMA; QTGPPQD; -.
DR   OrthoDB; 52495at2759; -.
DR   PhylomeDB; Q96D59; -.
DR   TreeFam; TF337102; -.
DR   PathwayCommons; Q96D59; -.
DR   SignaLink; Q96D59; -.
DR   SIGNOR; Q96D59; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 138065; 11 hits in 1184 CRISPR screens.
DR   ChiTaRS; RNF183; human.
DR   GenomeRNAi; 138065; -.
DR   Pharos; Q96D59; Tbio.
DR   PRO; PR:Q96D59; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q96D59; protein.
DR   Bgee; ENSG00000165188; Expressed in pancreatic ductal cell and 108 other tissues.
DR   ExpressionAtlas; Q96D59; baseline and differential.
DR   Genevisible; Q96D59; HS.
DR   GO; GO:0033106; C:cis-Golgi network membrane; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1902237; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   CDD; cd16556; RING-HC_RNF183_like; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR22791:SF7; E3 UBIQUITIN-PROTEIN LIGASE RNF183; 1.
DR   PANTHER; PTHR22791; UNCHARACTERIZED; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Endoplasmic reticulum; Golgi apparatus; Lysosome; Membrane;
KW   Metal-binding; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..192
FT                   /note="E3 ubiquitin-protein ligase RNF183"
FT                   /id="PRO_0000247358"
FT   TOPO_DOM        1..161
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:29507230"
FT   TRANSMEM        162..182
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        183..192
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:29507230"
FT   ZN_FING         13..60
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   VARIANT         82
FT                   /note="A -> T (in dbSNP:rs3750533)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027095"
FT   VARIANT         114
FT                   /note="Q -> R (in dbSNP:rs3750534)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027096"
FT   MUTAGEN         13
FT                   /note="C->A: Abolishes autoubiquitination; when associated
FT                   with A-59."
FT                   /evidence="ECO:0000269|PubMed:26567849"
FT   MUTAGEN         13
FT                   /note="C->S: Loss of autoubiquitination and reduced
FT                   ubiquitination of BCL2L1; when associated with S-16."
FT                   /evidence="ECO:0000269|PubMed:29507230"
FT   MUTAGEN         16
FT                   /note="C->S: Loss of autoubiquitination and reduced
FT                   ubiquitination of BCL2L1; when associated with S-13."
FT                   /evidence="ECO:0000269|PubMed:29507230"
FT   MUTAGEN         28
FT                   /note="K->R: Loss of autoubiquitination but no effect on
FT                   ubiquitination of BCL2L1; when associated with R-101 and
FT                   R-105."
FT                   /evidence="ECO:0000269|PubMed:29507230"
FT   MUTAGEN         59
FT                   /note="C->A: Abolishes autoubiquitination; when associated
FT                   with A-13."
FT                   /evidence="ECO:0000269|PubMed:26567849"
FT   MUTAGEN         101
FT                   /note="K->R: Loss of autoubiquitination but no effect on
FT                   ubiquitination of BCL2L1; when associated with R-28 and
FT                   R-105."
FT                   /evidence="ECO:0000269|PubMed:29507230"
FT   MUTAGEN         105
FT                   /note="K->R: Loss of autoubiquitination but no effect on
FT                   ubiquitination of BCL2L1; when associated with R-28 and
FT                   R-101."
FT                   /evidence="ECO:0000269|PubMed:29507230"
SQ   SEQUENCE   192 AA;  21617 MW;  51D5B5272DFC9540 CRC64;
     MAEQQGRELE AECPVCWNPF NNTFHTPKML DCCHSFCVEC LAHLSLVTPA RRRLLCPLCR
     QPTVLASGQP VTDLPTDTAM LALLRLEPHH VILEGHQLCL KDQPKSRYFL RQPQVYTLDL
     GPQPGGQTGP PPDTASATVS TPILIPSHHS LRECFRNPQF RIFAYLMAVI LSVTLLLIFS
     IFWTKQFLWG VG
//
ID   RN185_HUMAN             Reviewed;         192 AA.
AC   Q96GF1; A8K5C1; A9X3T8; Q8N900;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-FEB-2023, entry version 162.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF185 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:21931693, ECO:0000269|PubMed:27485036, ECO:0000269|PubMed:28273161};
DE   AltName: Full=RING finger protein 185;
GN   Name=RNF185 {ECO:0000303|Ref.1, ECO:0000312|HGNC:HGNC:26783};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pancreas, and Testis;
RA   Martinez Gamboa L., Stuhlmueller B., Burmester G.R.;
RT   "Multiple splice variants of the gene coding for ring finger protein
RT   RNF185.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Lung, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   INTERACTION WITH ATG5 AND BNIP1.
RX   PubMed=21931693; DOI=10.1371/journal.pone.0024367;
RA   Tang F., Wang B., Li N., Wu Y., Jia J., Suo T., Chen Q., Liu Y.J., Tang J.;
RT   "RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates autophagy
RT   through interaction with BNIP1.";
RL   PLoS ONE 6:E24367-E24367(2011).
RN   [8]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24019521; DOI=10.1074/jbc.m113.470500;
RA   El Khouri E., Le Pavec G., Toledano M.B., Delaunay-Moisan A.;
RT   "RNF185 is a novel E3 ligase of endoplasmic reticulum-associated
RT   degradation (ERAD) that targets cystic fibrosis transmembrane conductance
RT   regulator (CFTR).";
RL   J. Biol. Chem. 288:31177-31191(2013).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INDUCTION, DOMAIN, AND MUTAGENESIS OF CYS-39.
RX   PubMed=27485036; DOI=10.1038/srep30955;
RA   Kaneko M., Iwase I., Yamasaki Y., Takai T., Wu Y., Kanemoto S.,
RA   Matsuhisa K., Asada R., Okuma Y., Watanabe T., Imaizumi K., Nomura Y.;
RT   "Genome-wide identification and gene expression profiling of ubiquitin
RT   ligases for endoplasmic reticulum protein degradation.";
RL   Sci. Rep. 6:30955-30955(2016).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND MUTAGENESIS OF CYS-39 AND
RP   CYS-79.
RX   PubMed=28273161; DOI=10.1371/journal.ppat.1006264;
RA   Wang Q., Huang L., Hong Z., Lv Z., Mao Z., Tang Y., Kong X., Li S., Cui Y.,
RA   Liu H., Zhang L., Zhang X., Jiang L., Wang C., Zhou Q.;
RT   "The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune
RT   response.";
RL   PLoS Pathog. 13:e1006264-e1006264(2017).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that regulates selective
CC       mitochondrial autophagy by mediating 'Lys-63'-linked polyubiquitination
CC       of BNIP1 (PubMed:21931693). Acts in the endoplasmic reticulum (ER)-
CC       associated degradation (ERAD) pathway, which targets misfolded proteins
CC       that accumulate in the endoplasmic reticulum (ER) for ubiquitination
CC       and subsequent proteasome-mediated degradation (PubMed:27485036).
CC       Protects cells from ER stress-induced apoptosis (PubMed:27485036).
CC       Responsible for the cotranslational ubiquitination and degradation of
CC       CFTR in the ERAD pathway (PubMed:24019521). Also acts as a regulator of
CC       the innate antiviral response by catalyzing 'Lys-27'-linked
CC       polyubiquitination of CGAS at 'Lys-173' and 'Lys-384', thereby
CC       promoting CGAS cyclic GMP-AMP synthase activity (PubMed:28273161).
CC       Preferentially associates with the E2 enzymes UBE2J1 and UBE2J2
CC       (PubMed:24019521). {ECO:0000269|PubMed:21931693,
CC       ECO:0000269|PubMed:24019521, ECO:0000269|PubMed:27485036,
CC       ECO:0000269|PubMed:28273161}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:21931693,
CC         ECO:0000269|PubMed:27485036, ECO:0000269|PubMed:28273161};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:21931693, ECO:0000269|PubMed:27485036,
CC       ECO:0000269|PubMed:28273161}.
CC   -!- SUBUNIT: Interacts with ATG5 and BNIP1. {ECO:0000269|PubMed:21931693}.
CC   -!- INTERACTION:
CC       Q96GF1; O75915: ARL6IP5; NbExp=3; IntAct=EBI-2340249, EBI-2860752;
CC       Q96GF1; Q96DZ9: CMTM5; NbExp=3; IntAct=EBI-2340249, EBI-2548702;
CC       Q96GF1; Q8NBI2: CYB561A3; NbExp=3; IntAct=EBI-2340249, EBI-10269179;
CC       Q96GF1; Q96D05-2: FAM241B; NbExp=3; IntAct=EBI-2340249, EBI-12118888;
CC       Q96GF1; Q13021: MALL; NbExp=3; IntAct=EBI-2340249, EBI-750078;
CC       Q96GF1; Q5J8X5: MS4A13; NbExp=3; IntAct=EBI-2340249, EBI-12070086;
CC       Q96GF1; A6NDP7: MYADML2; NbExp=3; IntAct=EBI-2340249, EBI-17641390;
CC       Q96GF1; Q0D2K0: NIPAL4; NbExp=3; IntAct=EBI-2340249, EBI-9550165;
CC       Q96GF1; Q99942: RNF5; NbExp=3; IntAct=EBI-2340249, EBI-348482;
CC       Q96GF1; P55061: TMBIM6; NbExp=4; IntAct=EBI-2340249, EBI-1045825;
CC       Q96GF1; Q9BVK8: TMEM147; NbExp=3; IntAct=EBI-2340249, EBI-348587;
CC       Q96GF1; Q96HH6: TMEM19; NbExp=3; IntAct=EBI-2340249, EBI-741829;
CC       Q96GF1; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-2340249, EBI-12015604;
CC       Q96GF1; P51668: UBE2D1; NbExp=4; IntAct=EBI-2340249, EBI-743540;
CC       Q96GF1; P62837: UBE2D2; NbExp=4; IntAct=EBI-2340249, EBI-347677;
CC       Q96GF1; Q9Y2X8: UBE2D4; NbExp=4; IntAct=EBI-2340249, EBI-745527;
CC       Q96GF1; Q96LR5: UBE2E2; NbExp=4; IntAct=EBI-2340249, EBI-2129763;
CC       Q96GF1; Q969T4: UBE2E3; NbExp=8; IntAct=EBI-2340249, EBI-348496;
CC       Q96GF1; P61086: UBE2K; NbExp=3; IntAct=EBI-2340249, EBI-473850;
CC       Q96GF1; Q9BWQ6: YIPF2; NbExp=6; IntAct=EBI-2340249, EBI-751204;
CC       Q96GF1; Q9BSR8: YIPF4; NbExp=3; IntAct=EBI-2340249, EBI-751253;
CC       Q96GF1; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-2340249, EBI-751210;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:21931693}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24019521, ECO:0000269|PubMed:27485036}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96GF1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96GF1-2; Sequence=VSP_020004;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:27485036}.
CC   -!- INDUCTION: Up-regulated by unfolded protein response (UPR) and
CC       endoplasmic reticulum (ER) stress triggered by thapsigargin or
CC       tunicamycin. {ECO:0000269|PubMed:24019521,
CC       ECO:0000269|PubMed:27485036}.
CC   -!- DOMAIN: The RING-type zinc finger domain is responsible for E3
CC       ubiquitin ligase activity. {ECO:0000269|PubMed:27485036}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ296559; ABB97506.1; -; mRNA.
DR   EMBL; DQ296561; ABB97508.1; -; mRNA.
DR   EMBL; DQ296562; ABB97509.1; -; mRNA.
DR   EMBL; DQ296565; ABB97512.1; -; mRNA.
DR   EMBL; CR456349; CAG30235.1; -; mRNA.
DR   EMBL; AK095947; BAC04659.1; -; mRNA.
DR   EMBL; AK291236; BAF83925.1; -; mRNA.
DR   EMBL; AC002073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005005; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW59947.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59949.1; -; Genomic_DNA.
DR   EMBL; BC009504; AAH09504.1; -; mRNA.
DR   EMBL; BC026040; AAH26040.1; -; mRNA.
DR   EMBL; BC033166; AAH33166.1; -; mRNA.
DR   EMBL; BC012817; AAH12817.1; -; mRNA.
DR   EMBL; BC035684; AAH35684.1; -; mRNA.
DR   CCDS; CCDS13890.1; -. [Q96GF1-1]
DR   CCDS; CCDS46689.1; -. [Q96GF1-2]
DR   RefSeq; NP_001129297.1; NM_001135825.1. [Q96GF1-2]
DR   RefSeq; NP_689480.2; NM_152267.3. [Q96GF1-1]
DR   AlphaFoldDB; Q96GF1; -.
DR   SMR; Q96GF1; -.
DR   BioGRID; 124834; 185.
DR   IntAct; Q96GF1; 43.
DR   MINT; Q96GF1; -.
DR   STRING; 9606.ENSP00000320508; -.
DR   iPTMnet; Q96GF1; -.
DR   PhosphoSitePlus; Q96GF1; -.
DR   BioMuta; RNF185; -.
DR   DMDM; 74751883; -.
DR   EPD; Q96GF1; -.
DR   jPOST; Q96GF1; -.
DR   MassIVE; Q96GF1; -.
DR   MaxQB; Q96GF1; -.
DR   PaxDb; Q96GF1; -.
DR   PeptideAtlas; Q96GF1; -.
DR   ProteomicsDB; 76632; -. [Q96GF1-1]
DR   ProteomicsDB; 76633; -. [Q96GF1-2]
DR   TopDownProteomics; Q96GF1-1; -. [Q96GF1-1]
DR   TopDownProteomics; Q96GF1-2; -. [Q96GF1-2]
DR   Antibodypedia; 24963; 154 antibodies from 23 providers.
DR   DNASU; 91445; -.
DR   Ensembl; ENST00000266252.8; ENSP00000266252.7; ENSG00000138942.17. [Q96GF1-2]
DR   Ensembl; ENST00000326132.11; ENSP00000320508.5; ENSG00000138942.17. [Q96GF1-1]
DR   Ensembl; ENST00000518626.5; ENSP00000427755.1; ENSG00000138942.17. [Q96GF1-1]
DR   GeneID; 91445; -.
DR   KEGG; hsa:91445; -.
DR   MANE-Select; ENST00000326132.11; ENSP00000320508.5; NM_152267.4; NP_689480.2.
DR   UCSC; uc003akb.4; human. [Q96GF1-1]
DR   AGR; HGNC:26783; -.
DR   CTD; 91445; -.
DR   DisGeNET; 91445; -.
DR   GeneCards; RNF185; -.
DR   HGNC; HGNC:26783; RNF185.
DR   HPA; ENSG00000138942; Low tissue specificity.
DR   MIM; 620096; gene.
DR   neXtProt; NX_Q96GF1; -.
DR   OpenTargets; ENSG00000138942; -.
DR   PharmGKB; PA142671056; -.
DR   VEuPathDB; HostDB:ENSG00000138942; -.
DR   eggNOG; KOG0823; Eukaryota.
DR   GeneTree; ENSGT00390000014107; -.
DR   HOGENOM; CLU_055198_2_2_1; -.
DR   InParanoid; Q96GF1; -.
DR   OMA; RTFECNI; -.
DR   OrthoDB; 276791at2759; -.
DR   PhylomeDB; Q96GF1; -.
DR   TreeFam; TF317334; -.
DR   PathwayCommons; Q96GF1; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; Q96GF1; -.
DR   SIGNOR; Q96GF1; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 91445; 15 hits in 1194 CRISPR screens.
DR   ChiTaRS; RNF185; human.
DR   GenomeRNAi; 91445; -.
DR   Pharos; Q96GF1; Tbio.
DR   PRO; PR:Q96GF1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q96GF1; protein.
DR   Bgee; ENSG00000138942; Expressed in kidney epithelium and 179 other tissues.
DR   ExpressionAtlas; Q96GF1; baseline and differential.
DR   Genevisible; Q96GF1; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0044390; F:ubiquitin-like protein conjugating enzyme binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; IDA:UniProtKB.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:0036503; P:ERAD pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:1904294; P:positive regulation of ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0044314; P:protein K27-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16744; RING-HC_RNF185; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR045103; RNF5/RNF185-like.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR12313:SF13; E3 UBIQUITIN-PROTEIN LIGASE RNF185; 1.
DR   PANTHER; PTHR12313; E3 UBIQUITIN-PROTEIN LIGASE RNF5-RELATED; 1.
DR   Pfam; PF13920; zf-C3HC4_3; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autophagy; Endoplasmic reticulum; Immunity;
KW   Innate immunity; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion outer membrane; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..192
FT                   /note="E3 ubiquitin-protein ligase RNF185"
FT                   /id="PRO_0000247520"
FT   TOPO_DOM        1..130
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:21931693"
FT   TRANSMEM        131..151
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        152..171
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000269|PubMed:21931693"
FT   TRANSMEM        172..192
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         39..80
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          29..80
FT                   /note="Required for ubiquitin ligase activity and
FT                   protection against ER stress-induced cell death"
FT                   /evidence="ECO:0000269|PubMed:27485036"
FT   REGION          90..123
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         66..121
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.1"
FT                   /id="VSP_020004"
FT   MUTAGEN         39
FT                   /note="C->A: Abolished E3 ubiquitin-protein ligase activity
FT                   and ability to regulate the cGAS-STING pathway; when
FT                   associated with A-79."
FT                   /evidence="ECO:0000269|PubMed:28273161"
FT   MUTAGEN         39
FT                   /note="C->S: Decreased ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:27485036"
FT   MUTAGEN         79
FT                   /note="C->A: Abolished E3 ubiquitin-protein ligase activity
FT                   and ability to regulate the cGAS-STING pathway; when
FT                   associated with A-39."
FT                   /evidence="ECO:0000269|PubMed:28273161"
SQ   SEQUENCE   192 AA;  20459 MW;  F24B49EA566740B3 CRC64;
     MASKGPSASA SPENSSAGGP SGSSNGAGES GGQDSTFECN ICLDTAKDAV ISLCGHLFCW
     PCLHQWLETR PNRQVCPVCK AGISRDKVIP LYGRGSTGQQ DPREKTPPRP QGQRPEPENR
     GGFQGFGFGD GGFQMSFGIG AFPFGIFATA FNINDGRPPP AVPGTPQYVD EQFLSRLFLF
     VALVIMFWLL IA
//
ID   ZMAT2_HUMAN             Reviewed;         199 AA.
AC   Q96NC0;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-FEB-2023, entry version 158.
DE   RecName: Full=Zinc finger matrin-type protein 2;
GN   Name=ZMAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-45 AND LYS-64, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-36; LYS-39; LYS-45;
RP   LYS-55; LYS-61; LYS-64; LYS-70; LYS-102 AND LYS-123, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [8] {ECO:0007744|PDB:5O9Z}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.50 ANGSTROMS), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=28781166; DOI=10.1016/j.cell.2017.07.011;
RA   Bertram K., Agafonov D.E., Dybkov O., Haselbach D., Leelaram M.N.,
RA   Will C.L., Urlaub H., Kastner B., Luhrmann R., Stark H.;
RT   "Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for
RT   Activation.";
RL   Cell 170:701-713(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing as a component of the
CC       spliceosome. {ECO:0000269|PubMed:28781166}.
CC   -!- SUBUNIT: Component of the spliceosome B complex.
CC       {ECO:0000269|PubMed:28781166}.
CC   -!- INTERACTION:
CC       Q96NC0; Q96MA6: AK8; NbExp=3; IntAct=EBI-2682299, EBI-8466265;
CC       Q96NC0; Q92870-2: APBB2; NbExp=3; IntAct=EBI-2682299, EBI-21535880;
CC       Q96NC0; P54253: ATXN1; NbExp=6; IntAct=EBI-2682299, EBI-930964;
CC       Q96NC0; P54252: ATXN3; NbExp=3; IntAct=EBI-2682299, EBI-946046;
CC       Q96NC0; Q8TD16-2: BICD2; NbExp=3; IntAct=EBI-2682299, EBI-11975051;
CC       Q96NC0; Q9P1Z2: CALCOCO1; NbExp=3; IntAct=EBI-2682299, EBI-749920;
CC       Q96NC0; Q8NA61: CBY2; NbExp=3; IntAct=EBI-2682299, EBI-741724;
CC       Q96NC0; Q2TAC2: CCDC57; NbExp=3; IntAct=EBI-2682299, EBI-2808286;
CC       Q96NC0; Q01850: CDR2; NbExp=3; IntAct=EBI-2682299, EBI-1181367;
CC       Q96NC0; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-2682299, EBI-742887;
CC       Q96NC0; A1L4K1: FSD2; NbExp=3; IntAct=EBI-2682299, EBI-5661036;
CC       Q96NC0; P51114-2: FXR1; NbExp=3; IntAct=EBI-2682299, EBI-11022345;
CC       Q96NC0; P51116: FXR2; NbExp=6; IntAct=EBI-2682299, EBI-740459;
CC       Q96NC0; Q08379: GOLGA2; NbExp=6; IntAct=EBI-2682299, EBI-618309;
CC       Q96NC0; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-2682299, EBI-5916454;
CC       Q96NC0; Q4V328: GRIPAP1; NbExp=3; IntAct=EBI-2682299, EBI-717919;
CC       Q96NC0; P54257: HAP1; NbExp=3; IntAct=EBI-2682299, EBI-712814;
CC       Q96NC0; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-2682299, EBI-2549423;
CC       Q96NC0; P42858: HTT; NbExp=20; IntAct=EBI-2682299, EBI-466029;
CC       Q96NC0; Q13422: IKZF1; NbExp=3; IntAct=EBI-2682299, EBI-745305;
CC       Q96NC0; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-2682299, EBI-2556193;
CC       Q96NC0; Q6A162: KRT40; NbExp=3; IntAct=EBI-2682299, EBI-10171697;
CC       Q96NC0; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-2682299, EBI-741037;
CC       Q96NC0; P50222: MEOX2; NbExp=3; IntAct=EBI-2682299, EBI-748397;
CC       Q96NC0; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-2682299, EBI-742948;
CC       Q96NC0; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-2682299, EBI-11522433;
CC       Q96NC0; Q15742: NAB2; NbExp=3; IntAct=EBI-2682299, EBI-8641936;
CC       Q96NC0; Q92597: NDRG1; NbExp=3; IntAct=EBI-2682299, EBI-716486;
CC       Q96NC0; P61970: NUTF2; NbExp=3; IntAct=EBI-2682299, EBI-591778;
CC       Q96NC0; Q96CV9: OPTN; NbExp=4; IntAct=EBI-2682299, EBI-748974;
CC       Q96NC0; Q7Z412: PEX26; NbExp=3; IntAct=EBI-2682299, EBI-752057;
CC       Q96NC0; Q8IXK0: PHC2; NbExp=3; IntAct=EBI-2682299, EBI-713786;
CC       Q96NC0; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-2682299, EBI-79165;
CC       Q96NC0; D3DTS7: PMP22; NbExp=3; IntAct=EBI-2682299, EBI-25882629;
CC       Q96NC0; P41219: PRPH; NbExp=3; IntAct=EBI-2682299, EBI-752074;
CC       Q96NC0; P49768-2: PSEN1; NbExp=6; IntAct=EBI-2682299, EBI-11047108;
CC       Q96NC0; P49810: PSEN2; NbExp=3; IntAct=EBI-2682299, EBI-2010251;
CC       Q96NC0; P37840: SNCA; NbExp=3; IntAct=EBI-2682299, EBI-985879;
CC       Q96NC0; P00441: SOD1; NbExp=3; IntAct=EBI-2682299, EBI-990792;
CC       Q96NC0; Q96R06: SPAG5; NbExp=3; IntAct=EBI-2682299, EBI-413317;
CC       Q96NC0; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-2682299, EBI-2212028;
CC       Q96NC0; Q9UBB9: TFIP11; NbExp=4; IntAct=EBI-2682299, EBI-1105213;
CC       Q96NC0; Q15025: TNIP1; NbExp=3; IntAct=EBI-2682299, EBI-357849;
CC       Q96NC0; Q12933: TRAF2; NbExp=6; IntAct=EBI-2682299, EBI-355744;
CC       Q96NC0; Q9NQ86: TRIM36; NbExp=3; IntAct=EBI-2682299, EBI-2341518;
CC       Q96NC0; O94972: TRIM37; NbExp=3; IntAct=EBI-2682299, EBI-741602;
CC       Q96NC0; Q8WW01: TSEN15; NbExp=5; IntAct=EBI-2682299, EBI-372432;
CC       Q96NC0; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-2682299, EBI-2799833;
CC       Q96NC0; O43829: ZBTB14; NbExp=3; IntAct=EBI-2682299, EBI-10176632;
CC       Q96NC0; Q96BR9: ZBTB8A; NbExp=3; IntAct=EBI-2682299, EBI-742740;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28781166}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK055683; BAB70983.1; -; mRNA.
DR   EMBL; BC056668; AAH56668.1; -; mRNA.
DR   CCDS; CCDS4239.1; -.
DR   RefSeq; NP_653324.1; NM_144723.2.
DR   PDB; 5O9Z; EM; 4.50 A; N=1-199.
DR   PDB; 6AHD; EM; 3.80 A; 8=1-199.
DR   PDB; 7AAV; EM; 4.20 A; N=1-199.
DR   PDB; 7ABF; EM; 3.90 A; N=1-199.
DR   PDB; 7ABG; EM; 7.80 A; N=1-199.
DR   PDB; 7ABI; EM; 8.00 A; N=1-199.
DR   PDBsum; 5O9Z; -.
DR   PDBsum; 6AHD; -.
DR   PDBsum; 7AAV; -.
DR   PDBsum; 7ABF; -.
DR   PDBsum; 7ABG; -.
DR   PDBsum; 7ABI; -.
DR   AlphaFoldDB; Q96NC0; -.
DR   SMR; Q96NC0; -.
DR   BioGRID; 127499; 124.
DR   IntAct; Q96NC0; 63.
DR   MINT; Q96NC0; -.
DR   STRING; 9606.ENSP00000274712; -.
DR   iPTMnet; Q96NC0; -.
DR   PhosphoSitePlus; Q96NC0; -.
DR   BioMuta; ZMAT2; -.
DR   DMDM; 52783532; -.
DR   EPD; Q96NC0; -.
DR   jPOST; Q96NC0; -.
DR   MassIVE; Q96NC0; -.
DR   MaxQB; Q96NC0; -.
DR   PaxDb; Q96NC0; -.
DR   PeptideAtlas; Q96NC0; -.
DR   ProteomicsDB; 77501; -.
DR   TopDownProteomics; Q96NC0; -.
DR   Antibodypedia; 27104; 172 antibodies from 24 providers.
DR   DNASU; 153527; -.
DR   Ensembl; ENST00000274712.8; ENSP00000274712.2; ENSG00000146007.11.
DR   GeneID; 153527; -.
DR   KEGG; hsa:153527; -.
DR   MANE-Select; ENST00000274712.8; ENSP00000274712.2; NM_144723.3; NP_653324.1.
DR   UCSC; uc003lgy.2; human.
DR   AGR; HGNC:26433; -.
DR   CTD; 153527; -.
DR   DisGeNET; 153527; -.
DR   GeneCards; ZMAT2; -.
DR   HGNC; HGNC:26433; ZMAT2.
DR   HPA; ENSG00000146007; Low tissue specificity.
DR   MIM; 619930; gene.
DR   neXtProt; NX_Q96NC0; -.
DR   OpenTargets; ENSG00000146007; -.
DR   PharmGKB; PA134931664; -.
DR   VEuPathDB; HostDB:ENSG00000146007; -.
DR   eggNOG; KOG4727; Eukaryota.
DR   GeneTree; ENSGT00390000010712; -.
DR   HOGENOM; CLU_067237_1_1_1; -.
DR   InParanoid; Q96NC0; -.
DR   OMA; FKDNLQW; -.
DR   OrthoDB; 276684at2759; -.
DR   PhylomeDB; Q96NC0; -.
DR   TreeFam; TF314475; -.
DR   PathwayCommons; Q96NC0; -.
DR   SignaLink; Q96NC0; -.
DR   BioGRID-ORCS; 153527; 576 hits in 1165 CRISPR screens.
DR   ChiTaRS; ZMAT2; human.
DR   GenomeRNAi; 153527; -.
DR   Pharos; Q96NC0; Tbio.
DR   PRO; PR:Q96NC0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q96NC0; protein.
DR   Bgee; ENSG00000146007; Expressed in cortical plate and 181 other tissues.
DR   ExpressionAtlas; Q96NC0; baseline and differential.
DR   Genevisible; Q96NC0; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0071005; C:U2-type precatalytic spliceosome; IDA:UniProtKB.
DR   GO; GO:0046540; C:U4/U6 x U5 tri-snRNP complex; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR040107; Snu23.
DR   InterPro; IPR022755; Znf_C2H2_jaz.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   PANTHER; PTHR45986; ZINC FINGER MATRIN-TYPE PROTEIN 2; 1.
DR   PANTHER; PTHR45986:SF1; ZINC FINGER MATRIN-TYPE PROTEIN 2; 1.
DR   Pfam; PF12171; zf-C2H2_jaz; 1.
DR   SMART; SM00451; ZnF_U1; 1.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; DNA-binding; Isopeptide bond; Metal-binding;
KW   mRNA processing; mRNA splicing; Nucleus; Reference proteome; Spliceosome;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..199
FT                   /note="Zinc finger matrin-type protein 2"
FT                   /id="PRO_0000047327"
FT   ZN_FING         80..104
FT                   /note="Matrin-type"
FT   REGION          27..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          150..175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CROSSLNK        8
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        36
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        39
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        45
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        55
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        61
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        64
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        70
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        102
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        123
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
SQ   SEQUENCE   199 AA;  23612 MW;  EF419358B7977E36 CRC64;
     MASGSGTKNL DFRRKWDKDE YEKLAEKRLT EEREKKDGKP VQPVKRELLR HRDYKVDLES
     KLGKTIVITK TTPQSEMGGY YCNVCDCVVK DSINFLDHIN GKKHQRNLGM SMRVERSTLD
     QVKKRFEVNK KKMEEKQKDY DFEERMKELR EEEEKAKAYK KEKQKEKKRR AEEDLTFEED
     DEMAAVMGFS GFGSTKKSY
//
ID   RNF5_HUMAN              Reviewed;         180 AA.
AC   Q99942; A2BFI6; B2R4K3; Q0VDB7; Q9UMQ2;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-FEB-2023, entry version 198.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF5 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:19269966, ECO:0000269|PubMed:19285439, ECO:0000269|PubMed:23093945};
DE   AltName: Full=RING finger protein 5 {ECO:0000303|PubMed:9533025};
DE   AltName: Full=Ram1 homolog {ECO:0000303|PubMed:16176924};
DE            Short=HsRma1 {ECO:0000303|PubMed:16176924};
GN   Name=RNF5 {ECO:0000303|PubMed:9533025, ECO:0000312|HGNC:HGNC:10068};
GN   Synonyms=G16 {ECO:0000303|Ref.3}, NG2, RMA1
GN   {ECO:0000303|PubMed:11329381};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9533025; DOI=10.1159/000134695;
RA   Kyushiki H., Kuga Y., Suzuki M., Takahashi E., Horie M.;
RT   "Cloning, expression and mapping of a novel RING-finger gene (RNF5), a
RT   human homologue of a putative zinc-finger gene from Caenorhabditis
RT   elegans.";
RL   Cytogenet. Cell Genet. 79:114-117(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND MUTAGENESIS OF CYS-42.
RX   PubMed=11329381; DOI=10.1242/jcs.114.10.1949;
RA   Matsuda N., Suzuki T., Tanaka K., Nakano A.;
RT   "Rma1, a novel type of RING finger protein conserved from Arabidopsis to
RT   human, is a membrane-bound ubiquitin ligase.";
RL   J. Cell Sci. 114:1949-1957(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Khanna A., Campbell R.D.;
RT   "Characterisation of a novel gene, G16, in the class III region of the
RT   human major histocompatibility complex.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D.,
RA   Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PXN.
RX   PubMed=12861019; DOI=10.1128/mcb.23.15.5331-5345.2003;
RA   Didier C., Broday L., Bhoumik A., Israeli S., Takahashi S., Nakayama K.,
RA   Thomas S.M., Turner C.E., Henderson S., Sabe H., Ronai Z.;
RT   "RNF5, a RING finger protein that regulates cell motility by targeting
RT   paxillin ubiquitination and altered localization.";
RL   Mol. Cell. Biol. 23:5331-5345(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=16176924; DOI=10.1074/jbc.m506309200;
RA   Zhang Y., Higashide W., Dai S., Sherman D.M., Zhou D.;
RT   "Recognition and ubiquitination of Salmonella type III effector SopA by a
RT   ubiquitin E3 ligase, HsRMA1.";
RL   J. Biol. Chem. 280:38682-38688(2005).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   FUNCTION IN UBIQUITINATION OF STING1, INTERACTION WITH STING1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19285439; DOI=10.1016/j.immuni.2009.01.008;
RA   Zhong B., Zhang L., Lei C., Li Y., Mao A.P., Yang Y., Wang Y.Y.,
RA   Zhang X.L., Shu H.B.;
RT   "The ubiquitin ligase RNF5 regulates antiviral responses by mediating
RT   degradation of the adaptor protein MITA.";
RL   Immunity 30:397-407(2009).
RN   [13]
RP   FUNCTION IN UBIQUITINATION OF JKAMP, AND INTERACTION WITH JKAMP.
RX   PubMed=19269966; DOI=10.1074/jbc.m808222200;
RA   Tcherpakov M., Delaunay A., Toth J., Kadoya T., Petroski M.D., Ronai Z.A.;
RT   "Regulation of endoplasmic reticulum-associated degradation by RNF5-
RT   dependent ubiquitination of JNK-associated membrane protein (JAMP).";
RL   J. Biol. Chem. 284:12099-12109(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=23093945; DOI=10.1371/journal.pgen.1003007;
RA   Kuang E., Okumura C.Y., Sheffy-Levin S., Varsano T., Shu V.C., Qi J.,
RA   Niesman I.R., Yang H.J., Lopez-Otin C., Yang W.Y., Reed J.C., Broday L.,
RA   Nizet V., Ronai Z.A.;
RT   "Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and
RT   influences susceptibility to bacterial infection.";
RL   PLoS Genet. 8:e1003007-e1003007(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; THR-94 AND SER-107, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   ACETYLATION AT ALA-2, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=25489052; DOI=10.1093/hmg/ddu611;
RA   Myklebust L.M., Van Damme P., Stoeve S.I., Doerfel M.J., Abboud A.,
RA   Kalvik T.V., Grauffel C., Jonckheere V., Wu Y., Swensen J., Kaasa H.,
RA   Liszczak G., Marmorstein R., Reuter N., Lyon G.J., Gevaert K., Arnesen T.;
RT   "Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-
RT   acetylation defects.";
RL   Hum. Mol. Genet. 24:1956-1976(2015).
CC   -!- FUNCTION: Membrane-bound E3 ubiquitin-protein ligase that mediates
CC       ubiquitination of target proteins (PubMed:11329381, PubMed:12861019,
CC       PubMed:16176924, PubMed:19285439, PubMed:19269966). May function
CC       together with E2 ubiquitin-conjugating enzymes UBE2D1/UBCH5A and
CC       UBE2D2/UBC4 (PubMed:11329381). Mediates ubiquitination of
CC       PXN/paxillin,thereby regulating cell motility and localization of
CC       PXN/paxillin (PubMed:12861019). Catalyzes ubiquitination of Salmonella
CC       type III secreted protein sopA (PubMed:16176924). Mediates the 'Lys-
CC       63'-linked polyubiquitination of JKAMP thereby regulating JKAMP
CC       function by decreasing its association with components of the
CC       proteasome and ERAD; the ubiquitination appears to involve E2
CC       ubiquitin-conjugating enzyme UBE2N (PubMed:19269966). Mediates the
CC       'Lys-48'-linked polyubiquitination of STING1 at 'Lys-150' leading to
CC       its proteasomal degradation; the ubiquitination occurs in mitochondria
CC       after viral transfection and regulates antiviral responses
CC       (PubMed:19285439). Catalyzes ubiquitination and subsequent degradation
CC       of ATG4B, thereby inhibiting autophagy (PubMed:23093945).
CC       {ECO:0000269|PubMed:11329381, ECO:0000269|PubMed:12861019,
CC       ECO:0000269|PubMed:16176924, ECO:0000269|PubMed:19269966,
CC       ECO:0000269|PubMed:19285439, ECO:0000269|PubMed:23093945}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:19269966,
CC         ECO:0000269|PubMed:19285439, ECO:0000269|PubMed:23093945};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:19269966, ECO:0000269|PubMed:19285439,
CC       ECO:0000269|PubMed:23093945}.
CC   -!- SUBUNIT: Interacts with PXN (PubMed:12861019). Interacts with
CC       Salmonella typhimurium sopA (PubMed:12861019). Interacts with JKAMP
CC       (PubMed:19269966). Interacts with STING1; the interaction of endogenous
CC       proteins is dependent on viral infection (PubMed:19285439).
CC       {ECO:0000269|PubMed:12861019, ECO:0000269|PubMed:19269966,
CC       ECO:0000269|PubMed:19285439}.
CC   -!- INTERACTION:
CC       Q99942; O95870: ABHD16A; NbExp=9; IntAct=EBI-348482, EBI-348517;
CC       Q99942; Q15041: ARL6IP1; NbExp=3; IntAct=EBI-348482, EBI-714543;
CC       Q99942; P13569: CFTR; NbExp=3; IntAct=EBI-348482, EBI-349854;
CC       Q99942; P49447: CYB561; NbExp=3; IntAct=EBI-348482, EBI-8646596;
CC       Q99942; Q8NBI2: CYB561A3; NbExp=6; IntAct=EBI-348482, EBI-10269179;
CC       Q99942; Q6ZPD8: DGAT2L6; NbExp=3; IntAct=EBI-348482, EBI-12831978;
CC       Q99942; Q96D05-2: FAM241B; NbExp=3; IntAct=EBI-348482, EBI-12118888;
CC       Q99942; Q9Y5U4: INSIG2; NbExp=6; IntAct=EBI-348482, EBI-8503746;
CC       Q99942; O95214: LEPROTL1; NbExp=3; IntAct=EBI-348482, EBI-750776;
CC       Q99942; P11836: MS4A1; NbExp=3; IntAct=EBI-348482, EBI-2808234;
CC       Q99942; Q96CV9: OPTN; NbExp=3; IntAct=EBI-348482, EBI-748974;
CC       Q99942; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-348482, EBI-1054848;
CC       Q99942; Q8N138: ORMDL3; NbExp=3; IntAct=EBI-348482, EBI-721750;
CC       Q99942; Q04941: PLP2; NbExp=3; IntAct=EBI-348482, EBI-608347;
CC       Q99942; Q8IY26: PLPP6; NbExp=3; IntAct=EBI-348482, EBI-11721828;
CC       Q99942; O60831: PRAF2; NbExp=3; IntAct=EBI-348482, EBI-2506064;
CC       Q99942; P49023: PXN; NbExp=6; IntAct=EBI-348482, EBI-702209;
CC       Q99942; Q9UI14: RABAC1; NbExp=3; IntAct=EBI-348482, EBI-712367;
CC       Q99942; Q8TEB9: RHBDD1; NbExp=3; IntAct=EBI-348482, EBI-9916444;
CC       Q99942; Q96GF1: RNF185; NbExp=3; IntAct=EBI-348482, EBI-2340249;
CC       Q99942; Q99942: RNF5; NbExp=4; IntAct=EBI-348482, EBI-348482;
CC       Q99942; Q96GQ5: RUSF1; NbExp=3; IntAct=EBI-348482, EBI-8636004;
CC       Q99942; O00767: SCD; NbExp=3; IntAct=EBI-348482, EBI-2684237;
CC       Q99942; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-348482, EBI-8652744;
CC       Q99942; P43005: SLC1A1; NbExp=6; IntAct=EBI-348482, EBI-745376;
CC       Q99942; Q15758: SLC1A5; NbExp=4; IntAct=EBI-348482, EBI-356576;
CC       Q99942; Q7Z769: SLC35E3; NbExp=3; IntAct=EBI-348482, EBI-13389236;
CC       Q99942; Q96QD8: SLC38A2; NbExp=3; IntAct=EBI-348482, EBI-723083;
CC       Q99942; Q9NVC3: SLC38A7; NbExp=8; IntAct=EBI-348482, EBI-10314552;
CC       Q99942; A0PK00: TMEM120B; NbExp=3; IntAct=EBI-348482, EBI-10171534;
CC       Q99942; Q9NWH2: TMEM242; NbExp=3; IntAct=EBI-348482, EBI-10315004;
CC       Q99942; P51668: UBE2D1; NbExp=10; IntAct=EBI-348482, EBI-743540;
CC       Q99942; P62837: UBE2D2; NbExp=9; IntAct=EBI-348482, EBI-347677;
CC       Q99942; P61077: UBE2D3; NbExp=11; IntAct=EBI-348482, EBI-348268;
CC       Q99942; Q9Y2X8: UBE2D4; NbExp=7; IntAct=EBI-348482, EBI-745527;
CC       Q99942; Q96LR5: UBE2E2; NbExp=10; IntAct=EBI-348482, EBI-2129763;
CC       Q99942; Q969T4: UBE2E3; NbExp=11; IntAct=EBI-348482, EBI-348496;
CC       Q99942; P61086: UBE2K; NbExp=11; IntAct=EBI-348482, EBI-473850;
CC       Q99942; Q96B02: UBE2W; NbExp=4; IntAct=EBI-348482, EBI-716589;
CC       Q99942; Q96FI0: UBE2W; NbExp=3; IntAct=EBI-348482, EBI-10285774;
CC       Q99942; Q9HAC8: UBTD1; NbExp=5; IntAct=EBI-348482, EBI-745871;
CC       Q99942; Q9Y548: YIPF1; NbExp=3; IntAct=EBI-348482, EBI-7850136;
CC       Q99942; Q9BWQ6: YIPF2; NbExp=6; IntAct=EBI-348482, EBI-751204;
CC       Q99942; Q9BSR8: YIPF4; NbExp=3; IntAct=EBI-348482, EBI-751253;
CC       Q99942; Q5VVQ6: YOD1; NbExp=3; IntAct=EBI-348482, EBI-2510804;
CC       Q99942; Q6UX98: ZDHHC24; NbExp=3; IntAct=EBI-348482, EBI-10254561;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9533025};
CC       Multi-pass membrane protein {ECO:0000255}. Mitochondrion membrane
CC       {ECO:0000269|PubMed:19285439}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19285439}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Predominantly located in the plasma membrane, with
CC       some localization occurring within cytoplasmic organelles.
CC       {ECO:0000269|PubMed:9533025}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9533025}.
CC   -!- SIMILARITY: Belongs to the RNF5 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB056869; BAB39359.1; -; mRNA.
DR   EMBL; AJ243936; CAB51286.1; -; mRNA.
DR   EMBL; AK311859; BAG34800.1; -; mRNA.
DR   EMBL; BT007105; AAP35769.1; -; mRNA.
DR   EMBL; U89336; AAB47492.1; -; Genomic_DNA.
DR   EMBL; AL845464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662830; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX284686; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR812478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR933878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004155; AAH04155.1; -; mRNA.
DR   EMBL; BC111392; AAI11393.1; -; mRNA.
DR   EMBL; BC119741; AAI19742.1; -; mRNA.
DR   EMBL; BC119742; AAI19743.1; -; mRNA.
DR   EMBL; BC127651; AAI27652.1; -; mRNA.
DR   EMBL; BC127652; AAI27653.1; -; mRNA.
DR   EMBL; BC148255; AAI48256.1; -; mRNA.
DR   CCDS; CCDS4745.1; -.
DR   RefSeq; NP_008844.1; NM_006913.3.
DR   AlphaFoldDB; Q99942; -.
DR   SMR; Q99942; -.
DR   BioGRID; 111975; 154.
DR   DIP; DIP-29268N; -.
DR   IntAct; Q99942; 76.
DR   MINT; Q99942; -.
DR   STRING; 9606.ENSP00000364235; -.
DR   iPTMnet; Q99942; -.
DR   PhosphoSitePlus; Q99942; -.
DR   BioMuta; RNF5; -.
DR   DMDM; 74762702; -.
DR   EPD; Q99942; -.
DR   jPOST; Q99942; -.
DR   MassIVE; Q99942; -.
DR   MaxQB; Q99942; -.
DR   PaxDb; Q99942; -.
DR   PeptideAtlas; Q99942; -.
DR   ProteomicsDB; 78533; -.
DR   TopDownProteomics; Q99942; -.
DR   Antibodypedia; 28471; 239 antibodies from 29 providers.
DR   DNASU; 6048; -.
DR   Ensembl; ENST00000375094.4; ENSP00000364235.3; ENSG00000204308.8.
DR   Ensembl; ENST00000413786.2; ENSP00000387879.2; ENSG00000225452.5.
DR   Ensembl; ENST00000432616.2; ENSP00000413131.2; ENSG00000183574.12.
DR   Ensembl; ENST00000445885.6; ENSP00000401172.2; ENSG00000227277.9.
DR   Ensembl; ENST00000449794.2; ENSP00000415784.2; ENSG00000223767.5.
DR   Ensembl; ENST00000453473.2; ENSP00000415127.2; ENSG00000228907.5.
DR   Ensembl; ENST00000456167.2; ENSP00000388795.2; ENSG00000228405.5.
DR   GeneID; 6048; -.
DR   KEGG; hsa:6048; -.
DR   MANE-Select; ENST00000375094.4; ENSP00000364235.3; NM_006913.4; NP_008844.1.
DR   UCSC; uc003oaj.5; human.
DR   AGR; HGNC:10068; -.
DR   CTD; 6048; -.
DR   DisGeNET; 6048; -.
DR   GeneCards; RNF5; -.
DR   HGNC; HGNC:10068; RNF5.
DR   HPA; ENSG00000204308; Low tissue specificity.
DR   MIM; 602677; gene.
DR   neXtProt; NX_Q99942; -.
DR   OpenTargets; ENSG00000204308; -.
DR   PharmGKB; PA34442; -.
DR   VEuPathDB; HostDB:ENSG00000204308; -.
DR   eggNOG; KOG0823; Eukaryota.
DR   GeneTree; ENSGT00390000014107; -.
DR   HOGENOM; CLU_055198_2_1_1; -.
DR   InParanoid; Q99942; -.
DR   OMA; PFGYITT; -.
DR   OrthoDB; 276791at2759; -.
DR   PhylomeDB; Q99942; -.
DR   TreeFam; TF317334; -.
DR   PathwayCommons; Q99942; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; Q99942; -.
DR   SIGNOR; Q99942; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 6048; 104 hits in 1191 CRISPR screens.
DR   GeneWiki; RNF5; -.
DR   GenomeRNAi; 6048; -.
DR   Pharos; Q99942; Tbio.
DR   PRO; PR:Q99942; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99942; protein.
DR   Bgee; ENSG00000204308; Expressed in ganglionic eminence and 101 other tissues.
DR   ExpressionAtlas; Q99942; baseline and differential.
DR   Genevisible; Q99942; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0044390; F:ubiquitin-like protein conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010507; P:negative regulation of autophagy; IEA:Ensembl.
DR   GO; GO:0030163; P:protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000785; P:regulation of autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16743; RING-HC_RNF5; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR045103; RNF5/RNF185-like.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR12313:SF4; E3 UBIQUITIN-PROTEIN LIGASE RNF5; 1.
DR   PANTHER; PTHR12313; E3 UBIQUITIN-PROTEIN LIGASE RNF5-RELATED; 1.
DR   Pfam; PF13920; zf-C3HC4_3; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Endoplasmic reticulum; Membrane; Metal-binding;
KW   Mitochondrion; Phosphoprotein; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25489052,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..180
FT                   /note="E3 ubiquitin-protein ligase RNF5"
FT                   /id="PRO_0000240393"
FT   TRANSMEM        118..138
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        160..180
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         27..68
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          79..110
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:25489052,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         94
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MUTAGEN         42
FT                   /note="C->S: Loss of E3 ubiquitin-protein ligase activity."
FT                   /evidence="ECO:0000269|PubMed:11329381"
FT   CONFLICT        22
FT                   /note="G -> S (in Ref. 3; CAB51286)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        60
FT                   /note="E -> D (in Ref. 3; CAB51286)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        117
FT                   /note="T -> A (in Ref. 3; CAB51286)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="T -> A (in Ref. 3; CAB51286)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   180 AA;  19881 MW;  E5AFA4DE6DE85942 CRC64;
     MAAAEEEDGG PEGPNRERGG AGATFECNIC LETAREAVVS VCGHLYCWPC LHQWLETRPE
     RQECPVCKAG ISREKVVPLY GRGSQKPQDP RLKTPPRPQG QRPAPESRGG FQPFGDTGGF
     HFSFGVGAFP FGFFTTVFNA HEPFRRGTGV DLGQGHPASS WQDSLFLFLA IFFFFWLLSI
//
ID   CXXC4_HUMAN             Reviewed;         198 AA.
AC   Q9H2H0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-FEB-2023, entry version 131.
DE   RecName: Full=CXXC-type zinc finger protein 4;
DE   AltName: Full=Inhibition of the Dvl and axin complex protein;
GN   Name=CXXC4; Synonyms=IDAX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11113207; DOI=10.1128/mcb.21.1.330-342.2001;
RA   Hino S., Kishida S., Michiue T., Fukui A., Sakamoto I., Takada S.,
RA   Asashima M., Kikuchi A.;
RT   "Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding
RT   protein.";
RL   Mol. Cell. Biol. 21:330-342(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0007744|PDB:5VC9}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 133-180 IN COMPLEX WITH CPG DNA,
RP   FUNCTION, DOMAIN CXXC-TYPE ZINC-FINGER, AND ZINC-BINDING.
RX   PubMed=29276034; DOI=10.1016/j.str.2017.11.022;
RA   Xu C., Liu K., Lei M., Yang A., Li Y., Hughes T.R., Min J.;
RT   "DNA Sequence Recognition of Human CXXC Domains and Their Structural
RT   Determinants.";
RL   Structure 26:85-95.e3(2018).
CC   -!- FUNCTION: Acts as a negative regulator of the Wnt signaling pathway via
CC       its interaction with DVL1 (By similarity). Binds preferentially to DNA
CC       containing cytidine-phosphate-guanosine (CpG) dinucleotides over CpH
CC       (H=A, T, and C), hemimethylated-CpG and hemimethylated-hydroxymethyl-
CC       CpG (PubMed:29276034). {ECO:0000250|UniProtKB:Q6NXI8,
CC       ECO:0000269|PubMed:29276034}.
CC   -!- SUBUNIT: Interacts with the PDZ domain of DVL1.
CC       {ECO:0000250|UniProtKB:Q9EQC9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9EQC9}.
CC   -!- DOMAIN: The CXXC zinc finger mediates binding to CpG-DNA.
CC       {ECO:0000269|PubMed:29276034}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF272159; AAG42072.1; -; mRNA.
DR   EMBL; AC093628; AAY40933.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06175.1; -; Genomic_DNA.
DR   EMBL; BC119751; AAI19752.1; -; mRNA.
DR   EMBL; BC119752; AAI19753.1; -; mRNA.
DR   PDB; 5VC9; X-ray; 2.10 A; C/F=133-180.
DR   PDBsum; 5VC9; -.
DR   AlphaFoldDB; Q9H2H0; -.
DR   SMR; Q9H2H0; -.
DR   IntAct; Q9H2H0; 7.
DR   STRING; 9606.ENSP00000378248; -.
DR   iPTMnet; Q9H2H0; -.
DR   PhosphoSitePlus; Q9H2H0; -.
DR   BioMuta; CXXC4; -.
DR   DMDM; 74752605; -.
DR   MassIVE; Q9H2H0; -.
DR   PaxDb; Q9H2H0; -.
DR   PeptideAtlas; Q9H2H0; -.
DR   ProteomicsDB; 80549; -.
DR   AGR; HGNC:24593; -.
DR   GeneCards; CXXC4; -.
DR   HGNC; HGNC:24593; CXXC4.
DR   MIM; 611645; gene.
DR   neXtProt; NX_Q9H2H0; -.
DR   PharmGKB; PA134992016; -.
DR   eggNOG; ENOG502QQVJ; Eukaryota.
DR   InParanoid; Q9H2H0; -.
DR   PhylomeDB; Q9H2H0; -.
DR   TreeFam; TF326617; -.
DR   PathwayCommons; Q9H2H0; -.
DR   Reactome; R-HSA-5368598; Negative regulation of TCF-dependent signaling by DVL-interacting proteins.
DR   SignaLink; Q9H2H0; -.
DR   ChiTaRS; CXXC4; human.
DR   Pharos; Q9H2H0; Tbio.
DR   PRO; PR:Q9H2H0; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; Q9H2H0; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0008327; F:methyl-CpG binding; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007352; P:zygotic specification of dorsal/ventral axis; ISS:BHF-UCL.
DR   InterPro; IPR040388; CXXC4/CXXC5.
DR   InterPro; IPR002857; Znf_CXXC.
DR   PANTHER; PTHR13419:SF1; CXXC FINGER PROTEIN 4; 1.
DR   PANTHER; PTHR13419; ZINC FINGER-CONTAINING; 1.
DR   Pfam; PF02008; zf-CXXC; 1.
DR   PROSITE; PS51058; ZF_CXXC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; DNA-binding; Metal-binding; Reference proteome;
KW   Wnt signaling pathway; Zinc; Zinc-finger.
FT   CHAIN           1..198
FT                   /note="CXXC-type zinc finger protein 4"
FT                   /id="PRO_0000317542"
FT   ZN_FING         132..173
FT                   /note="CXXC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034"
FT   REGION          114..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          161..166
FT                   /note="Interaction with DVL1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EQC9"
FT   BINDING         139
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         142
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         145
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         151
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         154
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         157
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         167
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   BINDING         172
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509,
FT                   ECO:0000269|PubMed:29276034, ECO:0007744|PDB:5VC9"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:5VC9"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:5VC9"
FT   HELIX           160..163
FT                   /evidence="ECO:0007829|PDB:5VC9"
FT   TURN            168..170
FT                   /evidence="ECO:0007829|PDB:5VC9"
FT   HELIX           173..175
FT                   /evidence="ECO:0007829|PDB:5VC9"
SQ   SEQUENCE   198 AA;  20978 MW;  9D9F7FAD11A9B759 CRC64;
     MHHRNDSQRL GKAGCPPEPS LQMANTNFLS TLSPEHCRPL AGECMNKLKC GAAEAEIMNL
     PERVGTFSAI PALGGISLPP GVIVMTALHS PAAASAAVTD SAFQIANLAD CPQNHSSSSS
     SSSGGAGGAN PAKKKRKRCG VCVPCKRLIN CGVCSSCRNR KTGHQICKFR KCEELKKKPG
     TSLERTPVPS AEAFRWFF
//
ID   RN122_HUMAN             Reviewed;         155 AA.
AC   Q9H9V4; Q52LK3;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   22-FEB-2023, entry version 142.
DE   RecName: Full=RING finger protein 122;
GN   Name=RNF122;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16778963;
RA   Wang L., Shi T.P., Wang L., Yu C.F., Zeng L.E., Wang J., Wang L.;
RT   "Cloning, expression and subcellular localization of a novel human gene
RT   -- RNF122.";
RL   Beijing Da Xue Xue Bao 38:239-243(2006).
RN   [4]
RP   FUNCTION.
RX   PubMed=16751333; DOI=10.1177/1087057106286654;
RA   Wang L., Gao X., Gao P., Deng W., Yu P., Ma J., Guo J., Wang X., Cheng H.,
RA   Zhang C., Yu C., Ma X., Lv B., Lu Y., Shi T., Ma D.;
RT   "Cell-based screening and validation of human novel genes associated with
RT   cell viability.";
RL   J. Biomol. Screen. 11:369-376(2006).
CC   -!- FUNCTION: May induce necrosis and apoptosis. May play a role in cell
CC       viability. {ECO:0000269|PubMed:16751333}.
CC   -!- INTERACTION:
CC       Q9H9V4; P29972: AQP1; NbExp=3; IntAct=EBI-2129998, EBI-745213;
CC       Q9H9V4; O95674: CDS2; NbExp=3; IntAct=EBI-2129998, EBI-3913685;
CC       Q9H9V4; O60883: GPR37L1; NbExp=3; IntAct=EBI-2129998, EBI-2927498;
CC       Q9H9V4; Q9Y342: PLLP; NbExp=3; IntAct=EBI-2129998, EBI-3919291;
CC       Q9H9V4; Q59EV6: PPGB; NbExp=3; IntAct=EBI-2129998, EBI-14210385;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:16778963}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:16778963}. Membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed in several tissues and cell lines.
CC       {ECO:0000269|PubMed:16778963}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK022588; BAB14115.1; -; mRNA.
DR   EMBL; BC093884; AAH93884.1; -; mRNA.
DR   EMBL; BC101573; AAI01574.1; -; mRNA.
DR   CCDS; CCDS6091.1; -.
DR   RefSeq; NP_079063.2; NM_024787.3.
DR   AlphaFoldDB; Q9H9V4; -.
DR   SMR; Q9H9V4; -.
DR   BioGRID; 122936; 16.
DR   IntAct; Q9H9V4; 10.
DR   STRING; 9606.ENSP00000256257; -.
DR   iPTMnet; Q9H9V4; -.
DR   PhosphoSitePlus; Q9H9V4; -.
DR   BioMuta; RNF122; -.
DR   DMDM; 110816410; -.
DR   jPOST; Q9H9V4; -.
DR   MassIVE; Q9H9V4; -.
DR   MaxQB; Q9H9V4; -.
DR   PaxDb; Q9H9V4; -.
DR   PeptideAtlas; Q9H9V4; -.
DR   ProteomicsDB; 81364; -.
DR   Antibodypedia; 1235; 177 antibodies from 24 providers.
DR   DNASU; 79845; -.
DR   Ensembl; ENST00000256257.2; ENSP00000256257.1; ENSG00000133874.2.
DR   GeneID; 79845; -.
DR   KEGG; hsa:79845; -.
DR   MANE-Select; ENST00000256257.2; ENSP00000256257.1; NM_024787.3; NP_079063.2.
DR   UCSC; uc003xjo.3; human.
DR   AGR; HGNC:21147; -.
DR   CTD; 79845; -.
DR   DisGeNET; 79845; -.
DR   GeneCards; RNF122; -.
DR   HGNC; HGNC:21147; RNF122.
DR   HPA; ENSG00000133874; Low tissue specificity.
DR   neXtProt; NX_Q9H9V4; -.
DR   OpenTargets; ENSG00000133874; -.
DR   PharmGKB; PA134892945; -.
DR   VEuPathDB; HostDB:ENSG00000133874; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   GeneTree; ENSGT00940000159152; -.
DR   HOGENOM; CLU_142341_0_0_1; -.
DR   InParanoid; Q9H9V4; -.
DR   OMA; ANKSCTM; -.
DR   OrthoDB; 5474929at2759; -.
DR   PhylomeDB; Q9H9V4; -.
DR   PathwayCommons; Q9H9V4; -.
DR   SignaLink; Q9H9V4; -.
DR   SIGNOR; Q9H9V4; -.
DR   BioGRID-ORCS; 79845; 13 hits in 1196 CRISPR screens.
DR   ChiTaRS; RNF122; human.
DR   GeneWiki; RNF122; -.
DR   GenomeRNAi; 79845; -.
DR   Pharos; Q9H9V4; Tdark.
DR   PRO; PR:Q9H9V4; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q9H9V4; protein.
DR   Bgee; ENSG00000133874; Expressed in left uterine tube and 116 other tissues.
DR   Genevisible; Q9H9V4; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0010917; P:negative regulation of mitochondrial membrane potential; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IMP:UniProtKB.
DR   CDD; cd16469; RING-H2_RNF24_like; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR45931:SF3; RING-TYPE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR45931; SI:CH211-59O9.10; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Golgi apparatus; Membrane; Metal-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Zinc; Zinc-finger.
FT   CHAIN           1..155
FT                   /note="RING finger protein 122"
FT                   /id="PRO_0000247852"
FT   TRANSMEM        40..60
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         93..134
FT                   /note="RING-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   CONFLICT        70
FT                   /note="E -> D (in Ref. 1; BAB14115)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   155 AA;  17475 MW;  E86B8E6F4954457B CRC64;
     MHPFQWCNGC FCGLGLVSTN KSCSMPPISF QDLPLNIYMV IFGTGIFVFM LSLIFCCYFI
     SKLRNQAQSE RYGYKEVVLK GDAKKLQLYG QTCAVCLEDF KGKDELGVLP CQHAFHRKCL
     VKWLEVRCVC PMCNKPIASP SEATQNIGIL LDELV
//
ID   SP30L_HUMAN             Reviewed;         183 AA.
AC   Q9HAJ7; E9PAU7; E9PAY2;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-FEB-2023, entry version 162.
DE   RecName: Full=Histone deacetylase complex subunit SAP30L;
DE   AltName: Full=HCV non-structural protein 4A-transactivated protein 2;
DE   AltName: Full=Sin3 corepressor complex subunit SAP30L;
DE   AltName: Full=Sin3-associated protein p30-like;
GN   Name=SAP30L; Synonyms=NS4ATP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, MUTAGENESIS
RP   OF 88-ARG-LYS-89, INDUCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=14680513; DOI=10.1186/1471-2164-4-53;
RA   Lindfors K., Viiri K.M., Niittynen M., Heinonen T.Y., Maki M.,
RA   Kainulainen H.;
RT   "TGF-beta induces the expression of SAP30L, a novel nuclear protein.";
RL   BMC Genomics 4:53-53(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Liu Y., Yang Y., Cheng J., Ji D., Li L., Zhang L., Chen J.;
RT   "Homo sapiens gene 2 transactivated by nonstructural protein 4A of
RT   hepatitis C virus (NS4ATP2) mRNA.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-135 (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-137 (ISOFORM 3).
RC   TISSUE=Chronic myeloid leukemia cell, and Oligodendroglioma;
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   INTERACTION WITH FEZ1.
RX   PubMed=16484223; DOI=10.1074/jbc.m513280200;
RA   Assmann E.M., Alborghetti M.R., Camargo M.E.R., Kobarg J.;
RT   "FEZ1 dimerization and interaction with transcription regulatory proteins
RT   involves its coiled-coil region.";
RL   J. Biol. Chem. 281:9869-9881(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SIN3A; HDAC1 AND HDAC2,
RP   AND MUTAGENESIS OF 120-ARG--LYS-127.
RX   PubMed=16820529; DOI=10.1093/nar/gkl401;
RA   Viiri K.M., Korkeamaeki H., Kukkonen M.K., Nieminen L.K., Lindfors K.,
RA   Peterson P., Maeki M., Kainulainen H., Lohi O.;
RT   "SAP30L interacts with members of the Sin3A corepressor complex and targets
RT   Sin3A to the nucleolus.";
RL   Nucleic Acids Res. 34:3288-3298(2006).
RN   [10]
RP   ALTERNATIVE SPLICING, IDENTIFICATION OF ISOFORMS 1; 2 AND 3, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   109-VAL--GLN-113.
RX   PubMed=18070604; DOI=10.1016/j.febslet.2007.11.084;
RA   Korkeamaeki H., Viiri K., Kukkonen M.K., Maeki M., Lohi O.;
RT   "Alternative mRNA splicing of SAP30L regulates its transcriptional
RT   repression activity.";
RL   FEBS Lett. 582:379-384(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-92 AND SER-99, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, LIPID-BINDING, DNA-BINDING, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF 88-ARG--ARG-90.
RX   PubMed=19015240; DOI=10.1128/mcb.01213-08;
RA   Viiri K.M., Jaenis J., Siggers T., Heinonen T.Y., Valjakka J., Bulyk M.L.,
RA   Maeki M., Lohi O.;
RT   "DNA-binding and -bending activities of SAP30L and SAP30 are mediated by a
RT   zinc-dependent module and monophosphoinositides.";
RL   Mol. Cell. Biol. 29:342-356(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 25-92 IN COMPLEX WITH ZINC IONS, FUNCTION, ZINC-FINGER
RP   DOMAIN, LIPID-BINDING, DNA-BINDING, AND DISULFIDE BONDS.
RX   PubMed=26609676; DOI=10.1002/pro.2849;
RA   Laitaoja M., Tossavainen H., Pihlajamaa T., Valjakka J., Viiri K., Lohi O.,
RA   Permi P., Janis J.;
RT   "Redox-dependent disulfide bond formation in SAP30L corepressor protein:
RT   Implications for structure and function.";
RL   Protein Sci. 25:572-586(2016).
CC   -!- FUNCTION: [Isoform 1]: Functions as transcription repressor, probably
CC       via its interaction with histone deacetylase complexes
CC       (PubMed:16820529, PubMed:18070604). Involved in the functional
CC       recruitment of the class 1 Sin3-histone deacetylase complex (HDAC) to
CC       the nucleolus (PubMed:16820529). Binds DNA, apparently without
CC       sequence-specificity, and bends bound double-stranded DNA
CC       (PubMed:19015240). Binds phosphoinositol phosphates (phosphoinositol 3-
CC       phosphate, phosphoinositol 4-phosphate and phosphoinositol 5-phosphate)
CC       via the same basic sequence motif that mediates DNA binding and nuclear
CC       import (PubMed:19015240, PubMed:26609676).
CC       {ECO:0000269|PubMed:16820529, ECO:0000269|PubMed:18070604,
CC       ECO:0000269|PubMed:19015240, ECO:0000269|PubMed:26609676}.
CC   -!- FUNCTION: [Isoform 2]: Functions as transcription repressor; isoform 2
CC       has lower transcription repressor activity than isoform 1 and isoform
CC       3. {ECO:0000269|PubMed:18070604}.
CC   -!- FUNCTION: [Isoform 3]: Functions as transcription repressor; its
CC       activity is marginally lower than that of isoform 1.
CC       {ECO:0000269|PubMed:18070604}.
CC   -!- SUBUNIT: Interacts with components of the histone deacetylase complex
CC       SIN3A, HDAC1 and HDAC2 (PubMed:16820529). Binds histones and
CC       nucleosomes (PubMed:19015240). Interacts with FEZ1 (PubMed:16484223).
CC       {ECO:0000269|PubMed:16484223, ECO:0000269|PubMed:16820529,
CC       ECO:0000269|PubMed:19015240}.
CC   -!- INTERACTION:
CC       Q9HAJ7; Q92997: DVL3; NbExp=3; IntAct=EBI-2340040, EBI-739789;
CC       Q9HAJ7; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-2340040, EBI-2549423;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:14680513, ECO:0000269|PubMed:16820529,
CC       ECO:0000269|PubMed:18070604, ECO:0000269|PubMed:19015240}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:18070604}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:18070604}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HAJ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HAJ7-2; Sequence=VSP_046221;
CC       Name=3;
CC         IsoId=Q9HAJ7-3; Sequence=VSP_046860;
CC   -!- TISSUE SPECIFICITY: Detected in brain and ovary, and at lower levels in
CC       heart, small intestine, lung, kidney, skeletal muscle, stomach and
CC       spleen (at protein level) (PubMed:18070604). Ubiquitous; expressed in
CC       all tissues tested with highest levels in testis (PubMed:14680513).
CC       {ECO:0000269|PubMed:14680513, ECO:0000269|PubMed:18070604}.
CC   -!- INDUCTION: Up-regulated by TGFB1. {ECO:0000269|PubMed:14680513}.
CC   -!- DOMAIN: The zinc-finger domain mediates direct interaction with DNA and
CC       phosphoinositol phosphates (phosphoinositol 3-phosphate,
CC       phosphoinositol 4-phosphate and phosphoinositol 5-phosphate)
CC       (PubMed:26609676). In vitro oxydation causes reversible disulfide bond
CC       formation between Cys residues in the zinc-finger domain and reversible
CC       loss of zinc ion binding (PubMed:26609676).
CC       {ECO:0000269|PubMed:26609676}.
CC   -!- SIMILARITY: Belongs to the SAP30 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY341060; AAQ16562.1; -; mRNA.
DR   EMBL; AY846876; AAX54477.1; -; mRNA.
DR   EMBL; AK021588; BAB13848.1; -; mRNA.
DR   EMBL; AC008625; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61637.1; -; Genomic_DNA.
DR   EMBL; BC009829; AAH09829.1; -; mRNA.
DR   EMBL; AI199517; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AI436556; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS4326.1; -. [Q9HAJ7-1]
DR   CCDS; CCDS47321.1; -. [Q9HAJ7-3]
DR   CCDS; CCDS47322.1; -. [Q9HAJ7-2]
DR   RefSeq; NP_001124534.1; NM_001131062.1. [Q9HAJ7-3]
DR   RefSeq; NP_001124535.1; NM_001131063.1. [Q9HAJ7-2]
DR   RefSeq; NP_078908.1; NM_024632.5. [Q9HAJ7-1]
DR   PDB; 2N1U; NMR; -; A=25-92.
DR   PDBsum; 2N1U; -.
DR   AlphaFoldDB; Q9HAJ7; -.
DR   SMR; Q9HAJ7; -.
DR   BioGRID; 122808; 34.
DR   ComplexPortal; CPX-3321; SIN3A histone deacetylase complex.
DR   ComplexPortal; CPX-3322; SIN3B histone deacetylase complex.
DR   ComplexPortal; CPX-3323; SIN3A histone deacetylase complex, ES cell-specific variant.
DR   IntAct; Q9HAJ7; 14.
DR   MINT; Q9HAJ7; -.
DR   STRING; 9606.ENSP00000297109; -.
DR   iPTMnet; Q9HAJ7; -.
DR   PhosphoSitePlus; Q9HAJ7; -.
DR   BioMuta; SAP30L; -.
DR   DMDM; 74734226; -.
DR   EPD; Q9HAJ7; -.
DR   jPOST; Q9HAJ7; -.
DR   MassIVE; Q9HAJ7; -.
DR   MaxQB; Q9HAJ7; -.
DR   PaxDb; Q9HAJ7; -.
DR   PeptideAtlas; Q9HAJ7; -.
DR   ProteomicsDB; 19082; -.
DR   ProteomicsDB; 19103; -.
DR   ProteomicsDB; 81408; -. [Q9HAJ7-1]
DR   Antibodypedia; 16444; 112 antibodies from 25 providers.
DR   DNASU; 79685; -.
DR   Ensembl; ENST00000297109.11; ENSP00000297109.5; ENSG00000164576.12. [Q9HAJ7-1]
DR   Ensembl; ENST00000426761.2; ENSP00000416393.2; ENSG00000164576.12. [Q9HAJ7-2]
DR   Ensembl; ENST00000440364.6; ENSP00000390927.2; ENSG00000164576.12. [Q9HAJ7-3]
DR   GeneID; 79685; -.
DR   KEGG; hsa:79685; -.
DR   MANE-Select; ENST00000297109.11; ENSP00000297109.5; NM_024632.6; NP_078908.1.
DR   UCSC; uc003lvk.4; human. [Q9HAJ7-1]
DR   AGR; HGNC:25663; -.
DR   CTD; 79685; -.
DR   DisGeNET; 79685; -.
DR   GeneCards; SAP30L; -.
DR   HGNC; HGNC:25663; SAP30L.
DR   HPA; ENSG00000164576; Low tissue specificity.
DR   MIM; 610398; gene.
DR   neXtProt; NX_Q9HAJ7; -.
DR   OpenTargets; ENSG00000164576; -.
DR   PharmGKB; PA144596386; -.
DR   VEuPathDB; HostDB:ENSG00000164576; -.
DR   eggNOG; ENOG502QWFH; Eukaryota.
DR   GeneTree; ENSGT00390000006633; -.
DR   HOGENOM; CLU_097961_1_0_1; -.
DR   InParanoid; Q9HAJ7; -.
DR   OMA; QCARTKR; -.
DR   OrthoDB; 2944795at2759; -.
DR   PhylomeDB; Q9HAJ7; -.
DR   TreeFam; TF324135; -.
DR   PathwayCommons; Q9HAJ7; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   SignaLink; Q9HAJ7; -.
DR   BioGRID-ORCS; 79685; 11 hits in 1161 CRISPR screens.
DR   ChiTaRS; SAP30L; human.
DR   GenomeRNAi; 79685; -.
DR   Pharos; Q9HAJ7; Tbio.
DR   PRO; PR:Q9HAJ7; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9HAJ7; protein.
DR   Bgee; ENSG00000164576; Expressed in right testis and 181 other tissues.
DR   Genevisible; Q9HAJ7; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0000118; C:histone deacetylase complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:ComplexPortal.
DR   GO; GO:0016580; C:Sin3 complex; NAS:ComplexPortal.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0044378; F:non-sequence-specific DNA binding, bending; IDA:UniProtKB.
DR   GO; GO:0031491; F:nucleosome binding; IDA:UniProtKB.
DR   GO; GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB.
DR   GO; GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB.
DR   GO; GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; NAS:ComplexPortal.
DR   GO; GO:1902455; P:negative regulation of stem cell population maintenance; NAS:ComplexPortal.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; NAS:ComplexPortal.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; NAS:ComplexPortal.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   Gene3D; 3.40.1800.30; -; 1.
DR   Gene3D; 6.10.160.20; -; 1.
DR   InterPro; IPR024145; His_deAcase_SAP30/SAP30L.
DR   InterPro; IPR038291; SAP30_C_sf.
DR   InterPro; IPR025718; SAP30_Sin3-bd.
DR   InterPro; IPR025717; SAP30_zn-finger.
DR   PANTHER; PTHR13286:SF5; HISTONE DEACETYLASE COMPLEX SUBUNIT SAP30L; 1.
DR   PANTHER; PTHR13286; SAP30; 1.
DR   Pfam; PF13867; SAP30_Sin3_bdg; 1.
DR   Pfam; PF13866; zf-SAP30; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disulfide bond;
KW   DNA-binding; Isopeptide bond; Lipid-binding; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..183
FT                   /note="Histone deacetylase complex subunit SAP30L"
FT                   /id="PRO_0000309500"
FT   ZN_FING         29..77
FT                   /note="Atypical"
FT                   /evidence="ECO:0000305|PubMed:26609676"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          85..105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          88..90
FT                   /note="Important for DNA and phosphoinositide binding"
FT                   /evidence="ECO:0000269|PubMed:19015240"
FT   MOTIF           86..91
FT                   /note="Nuclear localization signal (NLS)"
FT                   /evidence="ECO:0000305|PubMed:14680513"
FT   COMPBIAS        87..105
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         92
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         93
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SQF8"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   DISULFID        29..30
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:26609676"
FT   DISULFID        38..74
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:26609676"
FT   CROSSLNK        49
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75446"
FT   CROSSLNK        155
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75446"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75446"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75446"
FT   VAR_SEQ         68..113
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.7, ECO:0000305|PubMed:18070604"
FT                   /id="VSP_046221"
FT   VAR_SEQ         68..108
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.7, ECO:0000305|PubMed:18070604"
FT                   /id="VSP_046860"
FT   MUTAGEN         88..90
FT                   /note="RKR->AAA: Strongly reduces affinity for DNA and for
FT                   phosphoinositides."
FT                   /evidence="ECO:0000269|PubMed:19015240"
FT   MUTAGEN         88..89
FT                   /note="RK->KS: Impairs nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:14680513"
FT   MUTAGEN         109..113
FT                   /note="Missing: Reduces transcriptional repressor activity,
FT                   reduces localization in nucleoli, but has no effect on
FT                   association with histone deacylase complexes."
FT                   /evidence="ECO:0000269|PubMed:18070604"
FT   MUTAGEN         120..127
FT                   /note="RRYKRHYK->AAAAAAAA: Abolishes nucleolar
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:16820529"
FT   CONFLICT        31
FT                   /note="L -> R (in Ref. 7; AI199517)"
FT                   /evidence="ECO:0000305"
FT   STRAND          31..33
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   STRAND          41..46
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   HELIX           51..56
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   STRAND          61..64
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   TURN            66..69
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:2N1U"
FT   HELIX           75..83
FT                   /evidence="ECO:0007829|PDB:2N1U"
SQ   SEQUENCE   183 AA;  20877 MW;  EB19E448C6A1FA45 CRC64;
     MNGFSTEEDS REGPPAAPAA AAPGYGQSCC LIEDGERCVR PAGNASFSKR VQKSISQKKL
     KLDIDKSVRH LYICDFHKNF IQSVRNKRKR KTSDDGGDSP EHDTDIPEVD LFQLQVNTLR
     RYKRHYKLQT RPGFNKAQLA ETVSRHFRNI PVNEKETLAY FIYMVKSNKS RLDQKSEGGK
     QLE
//
ID   APC11_HUMAN             Reviewed;          84 AA.
AC   Q9NYG5; A8MTT2; B7ZW64; Q502X9; Q9BW64; Q9P0R2;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-FEB-2023, entry version 197.
DE   RecName: Full=Anaphase-promoting complex subunit 11;
DE            Short=APC11;
DE   AltName: Full=Cyclosome subunit 11;
DE   AltName: Full=Hepatocellular carcinoma-associated RING finger protein;
GN   Name=ANAPC11; ORFNames=HSPC214;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11573242; DOI=10.1002/jcb.1217;
RA   Chan A.H., Lee S.M.Y., Chim S.S., Kok L.D., Waye M.M.Y., Lee C.Y.,
RA   Fung K.P., Tsui S.K.W.;
RT   "Molecular cloning and characterization of a RING-H2 finger protein,
RT   ANAPC11, the human homolog of yeast Apc11p.";
RL   J. Cell. Biochem. 83:249-258(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li N., Wan T., Zhang W., Cao X.;
RT   "Novel human APC11 anaphase-promoting complex subunit.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION IN APC/C COMPLEX.
RX   PubMed=10922056; DOI=10.1073/pnas.97.16.8973;
RA   Gmachl M., Gieffers C., Podtelejnikov A.V., Mann M., Peters J.-M.;
RT   "The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to
RT   ubiquitinate substrates of the anaphase-promoting complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8973-8978(2000).
RN   [7]
RP   FUNCTION, MUTAGENESIS, AND INTERACTION WITH ANAPC2 AND UBE2D2.
RX   PubMed=11739784; DOI=10.1091/mbc.12.12.3839;
RA   Tang Z., Li B., Bharadwaj R., Zhu H., Oezkan E., Hakala K., Deisenhofer J.,
RA   Yu H.;
RT   "APC2 cullin protein and APC11 RING protein comprise the minimal ubiquitin
RT   ligase module of the anaphase-promoting complex.";
RL   Mol. Biol. Cell 12:3839-3851(2001).
RN   [8]
RP   FUNCTION OF THE APC/C.
RX   PubMed=18485873; DOI=10.1016/j.cell.2008.04.012;
RA   Jin L., Williamson A., Banerjee S., Philipp I., Rape M.;
RT   "Mechanism of ubiquitin-chain formation by the human anaphase-promoting
RT   complex.";
RL   Cell 133:653-665(2008).
RN   [9]
RP   ELECTRON MICROSCOPY OF THE APC/C.
RX   PubMed=16364912; DOI=10.1016/j.molcel.2005.11.008;
RA   Dube P., Herzog F., Gieffers C., Sander B., Riedel D., Mueller S.A.,
RA   Engel A., Peters J.-M., Stark H.;
RT   "Localization of the coactivator Cdh1 and the cullin subunit Apc2 in a
RT   cryo-electron microscopy model of vertebrate APC/C.";
RL   Mol. Cell 20:867-879(2005).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (7.4 ANGSTROMS) OF THE APC/C, AND SUBUNIT.
RX   PubMed=25043029; DOI=10.1038/nature13543;
RA   Chang L., Zhang Z., Yang J., McLaughlin S.H., Barford D.;
RT   "Molecular architecture and mechanism of the anaphase-promoting complex.";
RL   Nature 513:388-393(2014).
RN   [11] {ECO:0007744|PDB:4UI9, ECO:0007744|PDB:5A31}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF APC/C, AND SUBUNIT.
RX   PubMed=26083744; DOI=10.1038/nature14471;
RA   Chang L., Zhang Z., Yang J., McLaughlin S.H., Barford D.;
RT   "Atomic structure of the APC/C and its mechanism of protein
RT   ubiquitination.";
RL   Nature 522:450-454(2015).
CC   -!- FUNCTION: Together with the cullin protein ANAPC2, constitutes the
CC       catalytic component of the anaphase promoting complex/cyclosome
CC       (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls
CC       progression through mitosis and the G1 phase of the cell cycle. The
CC       APC/C complex acts by mediating ubiquitination and subsequent
CC       degradation of target proteins: it mainly mediates the formation of
CC       'Lys-11'-linked polyubiquitin chains and, to a lower extent, the
CC       formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. May
CC       recruit the E2 ubiquitin-conjugating enzymes to the complex.
CC       {ECO:0000269|PubMed:11739784, ECO:0000269|PubMed:18485873}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: The mammalian APC/C is composed at least of 14 distinct
CC       subunits ANAPC1, ANAPC2, CDC27/APC3, ANAPC4, ANAPC5, CDC16/APC6,
CC       ANAPC7, CDC23/APC8, ANAPC10, ANAPC11, CDC26/APC12, ANAPC13, ANAPC15 and
CC       ANAPC16 that assemble into a complex of at least 19 chains with a
CC       combined molecular mass of around 1.2 MDa; APC/C interacts with FZR1
CC       and FBXO5 (PubMed:26083744, PubMed:10922056, PubMed:25043029).
CC       Interacts with the cullin domain of ANAPC2 (PubMed:11739784). Interacts
CC       with UBE2D2 (PubMed:11739784). {ECO:0000269|PubMed:10922056,
CC       ECO:0000269|PubMed:11739784, ECO:0000269|PubMed:25043029,
CC       ECO:0000269|PubMed:26083744}.
CC   -!- INTERACTION:
CC       Q9NYG5; P28799: GRN; NbExp=3; IntAct=EBI-2130187, EBI-747754;
CC       Q9NYG5; O43933: PEX1; NbExp=3; IntAct=EBI-2130187, EBI-988601;
CC       Q9NYG5-2; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-12224467, EBI-11524452;
CC       Q9NYG5-2; Q8NDZ0: BEND2; NbExp=3; IntAct=EBI-12224467, EBI-954079;
CC       Q9NYG5-2; Q02930-3: CREB5; NbExp=3; IntAct=EBI-12224467, EBI-10192698;
CC       Q9NYG5-2; P53672: CRYBA2; NbExp=3; IntAct=EBI-12224467, EBI-750444;
CC       Q9NYG5-2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-12224467, EBI-3867333;
CC       Q9NYG5-2; Q86UW9: DTX2; NbExp=3; IntAct=EBI-12224467, EBI-740376;
CC       Q9NYG5-2; Q12805: EFEMP1; NbExp=3; IntAct=EBI-12224467, EBI-536772;
CC       Q9NYG5-2; O95967: EFEMP2; NbExp=3; IntAct=EBI-12224467, EBI-743414;
CC       Q9NYG5-2; O43559: FRS3; NbExp=3; IntAct=EBI-12224467, EBI-725515;
CC       Q9NYG5-2; O95872: GPANK1; NbExp=3; IntAct=EBI-12224467, EBI-751540;
CC       Q9NYG5-2; Q9H2F3: HSD3B7; NbExp=3; IntAct=EBI-12224467, EBI-3918847;
CC       Q9NYG5-2; Q8NA54: IQUB; NbExp=3; IntAct=EBI-12224467, EBI-10220600;
CC       Q9NYG5-2; Q8IUC1: KRTAP11-1; NbExp=3; IntAct=EBI-12224467, EBI-1052037;
CC       Q9NYG5-2; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-12224467, EBI-11953846;
CC       Q9NYG5-2; Q3LHN2: KRTAP19-2; NbExp=3; IntAct=EBI-12224467, EBI-12196745;
CC       Q9NYG5-2; Q9BYR8: KRTAP3-1; NbExp=3; IntAct=EBI-12224467, EBI-9996449;
CC       Q9NYG5-2; Q9BYR6: KRTAP3-3; NbExp=3; IntAct=EBI-12224467, EBI-3957694;
CC       Q9NYG5-2; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-12224467, EBI-12111050;
CC       Q9NYG5-2; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-12224467, EBI-11962084;
CC       Q9NYG5-2; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-12224467, EBI-12813389;
CC       Q9NYG5-2; Q7Z4N8: P4HA3; NbExp=3; IntAct=EBI-12224467, EBI-10181968;
CC       Q9NYG5-2; P54646: PRKAA2; NbExp=3; IntAct=EBI-12224467, EBI-1383852;
CC       Q9NYG5-2; O43741: PRKAB2; NbExp=3; IntAct=EBI-12224467, EBI-1053424;
CC       Q9NYG5-2; Q93062-3: RBPMS; NbExp=3; IntAct=EBI-12224467, EBI-740343;
CC       Q9NYG5-2; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-12224467, EBI-11955057;
CC       Q9NYG5-2; Q96LM6: TEX37; NbExp=3; IntAct=EBI-12224467, EBI-743976;
CC       Q9NYG5-2; Q08117-2: TLE5; NbExp=3; IntAct=EBI-12224467, EBI-11741437;
CC       Q9NYG5-2; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-12224467, EBI-12040603;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11573242}. Nucleus
CC       {ECO:0000269|PubMed:11573242}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NYG5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYG5-2; Sequence=VSP_012347;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in skeletal muscle and
CC       heart; in moderate levels in brain, kidney, and liver; and at low
CC       levels in colon, thymus, spleen, small intestine, placenta, lung and
CC       peripheral blood leukocyte. {ECO:0000269|PubMed:11573242}.
CC   -!- DOMAIN: The RING-type zinc finger domain coordinates an additional
CC       third zinc ion.
CC   -!- PTM: Auto-ubiquitinated.
CC   -!- SIMILARITY: Belongs to the RING-box family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF36134.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF247565; AAF65816.1; -; mRNA.
DR   EMBL; AF247789; AAL95694.1; -; mRNA.
DR   EMBL; AF151048; AAF36134.1; ALT_FRAME; mRNA.
DR   EMBL; AC145207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000607; AAH00607.2; -; mRNA.
DR   EMBL; BC066308; AAH66308.1; -; mRNA.
DR   EMBL; BC095454; AAH95454.1; -; mRNA.
DR   EMBL; BC104641; AAI04642.1; -; mRNA.
DR   EMBL; BC171892; AAI71892.1; -; mRNA.
DR   EMBL; BC171898; AAI71898.1; -; mRNA.
DR   EMBL; BC171899; AAI71899.1; -; mRNA.
DR   EMBL; BC171900; AAI71900.1; -; mRNA.
DR   CCDS; CCDS11789.1; -. [Q9NYG5-1]
DR   CCDS; CCDS32769.1; -. [Q9NYG5-2]
DR   RefSeq; NP_001002244.1; NM_001002244.2. [Q9NYG5-2]
DR   RefSeq; NP_001002245.1; NM_001002245.2. [Q9NYG5-1]
DR   RefSeq; NP_001002246.1; NM_001002246.2. [Q9NYG5-1]
DR   RefSeq; NP_001002247.1; NM_001002247.2. [Q9NYG5-1]
DR   RefSeq; NP_001002248.1; NM_001002248.2. [Q9NYG5-1]
DR   RefSeq; NP_001002249.1; NM_001002249.2. [Q9NYG5-1]
DR   RefSeq; NP_001276343.1; NM_001289414.1. [Q9NYG5-1]
DR   RefSeq; NP_001276344.1; NM_001289415.1. [Q9NYG5-1]
DR   RefSeq; NP_001276345.1; NM_001289416.1. [Q9NYG5-1]
DR   RefSeq; NP_001276346.1; NM_001289417.1. [Q9NYG5-1]
DR   RefSeq; NP_001276349.1; NM_001289420.1.
DR   RefSeq; NP_057560.8; NM_016476.11. [Q9NYG5-1]
DR   PDB; 2MT5; NMR; -; A=17-84.
DR   PDB; 4R2Y; X-ray; 1.76 A; A/B/C/D=17-84.
DR   PDB; 4UI9; EM; 3.60 A; B=1-84.
DR   PDB; 5A31; EM; 4.30 A; B=1-84.
DR   PDB; 5G04; EM; 4.00 A; B=1-84.
DR   PDB; 5G05; EM; 3.40 A; B=1-84.
DR   PDB; 5JG6; X-ray; 2.00 A; A/D=17-84.
DR   PDB; 5KHR; EM; 6.10 A; B=1-84.
DR   PDB; 5KHU; EM; 4.80 A; B=1-84.
DR   PDB; 5L9T; EM; 6.40 A; B=1-84.
DR   PDB; 5L9U; EM; 6.40 A; B=1-84.
DR   PDB; 5LCW; EM; 4.00 A; B=1-84.
DR   PDB; 6Q6G; EM; 3.20 A; C=1-84.
DR   PDB; 6Q6H; EM; 3.20 A; C=1-84.
DR   PDB; 6TLJ; EM; 3.80 A; B=1-84.
DR   PDB; 6TM5; EM; 3.90 A; B=1-84.
DR   PDB; 6TNT; EM; 3.78 A; B=1-84.
DR   PDB; 7QE7; EM; 2.90 A; C=1-84.
DR   PDBsum; 2MT5; -.
DR   PDBsum; 4R2Y; -.
DR   PDBsum; 4UI9; -.
DR   PDBsum; 5A31; -.
DR   PDBsum; 5G04; -.
DR   PDBsum; 5G05; -.
DR   PDBsum; 5JG6; -.
DR   PDBsum; 5KHR; -.
DR   PDBsum; 5KHU; -.
DR   PDBsum; 5L9T; -.
DR   PDBsum; 5L9U; -.
DR   PDBsum; 5LCW; -.
DR   PDBsum; 6Q6G; -.
DR   PDBsum; 6Q6H; -.
DR   PDBsum; 6TLJ; -.
DR   PDBsum; 6TM5; -.
DR   PDBsum; 6TNT; -.
DR   PDBsum; 7QE7; -.
DR   AlphaFoldDB; Q9NYG5; -.
DR   BMRB; Q9NYG5; -.
DR   SMR; Q9NYG5; -.
DR   BioGRID; 119591; 81.
DR   ComplexPortal; CPX-1860; Anaphase-promoting core complex.
DR   DIP; DIP-52741N; -.
DR   IntAct; Q9NYG5; 45.
DR   iPTMnet; Q9NYG5; -.
DR   PhosphoSitePlus; Q9NYG5; -.
DR   BioMuta; ANAPC11; -.
DR   DMDM; 19924286; -.
DR   EPD; Q9NYG5; -.
DR   jPOST; Q9NYG5; -.
DR   MassIVE; Q9NYG5; -.
DR   MaxQB; Q9NYG5; -.
DR   PeptideAtlas; Q9NYG5; -.
DR   ProteomicsDB; 83227; -. [Q9NYG5-1]
DR   ProteomicsDB; 83228; -. [Q9NYG5-2]
DR   Antibodypedia; 19841; 387 antibodies from 37 providers.
DR   DNASU; 51529; -.
DR   Ensembl; ENST00000344877.10; ENSP00000339695.5; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000357385.7; ENSP00000349957.3; ENSG00000141552.18. [Q9NYG5-2]
DR   Ensembl; ENST00000392376.7; ENSP00000376181.3; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000571024.6; ENSP00000461648.2; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000571570.5; ENSP00000458143.1; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000571874.6; ENSP00000459200.2; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000572639.5; ENSP00000460678.1; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000572851.6; ENSP00000458265.2; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000574924.6; ENSP00000460064.2; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000575195.2; ENSP00000458515.2; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000577747.5; ENSP00000463567.1; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000578550.5; ENSP00000464615.1; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000579978.5; ENSP00000463640.1; ENSG00000141552.18. [Q9NYG5-1]
DR   Ensembl; ENST00000583839.1; ENSP00000463598.1; ENSG00000141552.18. [Q9NYG5-1]
DR   GeneID; 51529; -.
DR   KEGG; hsa:51529; -.
DR   MANE-Select; ENST00000344877.10; ENSP00000339695.5; NM_001002248.3; NP_001002248.1.
DR   UCSC; uc002kbv.3; human. [Q9NYG5-1]
DR   AGR; HGNC:14452; -.
DR   CTD; 51529; -.
DR   DisGeNET; 51529; -.
DR   GeneCards; ANAPC11; -.
DR   HGNC; HGNC:14452; ANAPC11.
DR   HPA; ENSG00000141552; Low tissue specificity.
DR   MIM; 614534; gene.
DR   neXtProt; NX_Q9NYG5; -.
DR   OpenTargets; ENSG00000141552; -.
DR   PharmGKB; PA24787; -.
DR   VEuPathDB; HostDB:ENSG00000141552; -.
DR   GeneTree; ENSGT00550000075186; -.
DR   HOGENOM; CLU_115512_0_2_1; -.
DR   InParanoid; Q9NYG5; -.
DR   OMA; QWRWDTG; -.
DR   OrthoDB; 4663070at2759; -.
DR   PhylomeDB; Q9NYG5; -.
DR   TreeFam; TF354219; -.
DR   PathwayCommons; Q9NYG5; -.
DR   Reactome; R-HSA-141430; Inactivation of APC/C via direct inhibition of the APC/C complex.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-176407; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase.
DR   Reactome; R-HSA-176408; Regulation of APC/C activators between G1/S and early anaphase.
DR   Reactome; R-HSA-176409; APC/C:Cdc20 mediated degradation of mitotic proteins.
DR   Reactome; R-HSA-176412; Phosphorylation of the APC/C.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-68867; Assembly of the pre-replicative complex.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-8853884; Transcriptional Regulation by VENTX.
DR   Reactome; R-HSA-9687136; Aberrant regulation of mitotic exit in cancer due to RB1 defects.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9NYG5; -.
DR   SIGNOR; Q9NYG5; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 51529; 746 hits in 1212 CRISPR screens.
DR   ChiTaRS; ANAPC11; human.
DR   GeneWiki; ANAPC11; -.
DR   GenomeRNAi; 51529; -.
DR   Pharos; Q9NYG5; Tbio.
DR   PRO; PR:Q9NYG5; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9NYG5; protein.
DR   Bgee; ENSG00000141552; Expressed in right testis and 99 other tissues.
DR   ExpressionAtlas; Q9NYG5; baseline and differential.
DR   Genevisible; Q9NYG5; HS.
DR   GO; GO:0005680; C:anaphase-promoting complex; IDA:UniProtKB.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0097602; F:cullin family protein binding; IDA:MGI.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; NAS:ComplexPortal.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IBA:GO_Central.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0051445; P:regulation of meiotic cell cycle; NAS:ComplexPortal.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; NAS:ComplexPortal.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16456; RING-H2_APC11; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR024991; RING-H2_APC11.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR11210:SF1; ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; 1.
DR   PANTHER; PTHR11210; RING BOX; 1.
DR   Pfam; PF12861; zf-ANAPC11; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division; Cytoplasm;
KW   Metal-binding; Mitosis; Nucleus; Reference proteome; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..84
FT                   /note="Anaphase-promoting complex subunit 11"
FT                   /id="PRO_0000055747"
FT   ZN_FING         34..77
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   BINDING         23
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         26
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         34
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         37
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         44
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         51
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         53
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         56
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         58
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         59
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         73
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         76
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         38..84
FT                   /note="KVPGDDCPLVWGQCSHCFHMHCILKWLHAQQVQQHCPMCRQEWKFKE -> P
FT                   LHGESISRCLGWCPQPVPVLGGRAHPQVPINTASPTPGQHTGSLMSREESSRSPDPTPP
FT                   ALDQETSSLLRCTSPWCLDHSCDLFGITDQVSADGPRACRQGARRRLPAGVGPVLPLLP
FT                   HALHPQVAARTAGAAALPHVPPGMEVQGVRPDLALAGGAS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012347"
FT   MUTAGEN         23
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         26
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         34
FT                   /note="C->S: Slightly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         37
FT                   /note="C->S: Slightly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         44
FT                   /note="C->S: Slightly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         51
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         53
FT                   /note="H->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         56
FT                   /note="H->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         58
FT                   /note="H->S: Slightly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         59
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         73
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   MUTAGEN         76
FT                   /note="C->S: Greatly reduces autoubiquitination activity;
FT                   in isoform 1."
FT                   /evidence="ECO:0000269|PubMed:11739784"
FT   STRAND          2..16
FT                   /evidence="ECO:0007829|PDB:7QE7"
FT   STRAND          19..22
FT                   /evidence="ECO:0007829|PDB:6Q6G"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:6Q6G"
FT   HELIX           35..37
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   TURN            38..41
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:2MT5"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   HELIX           57..67
FT                   /evidence="ECO:0007829|PDB:4R2Y"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:5JG6"
FT   STRAND          76..79
FT                   /evidence="ECO:0007829|PDB:4R2Y"
SQ   SEQUENCE   84 AA;  9841 MW;  EACBD5A54FDC11AE CRC64;
     MKVKIKCWNG VATWLWVAND ENCGICRMAF NGCCPDCKVP GDDCPLVWGQ CSHCFHMHCI
     LKWLHAQQVQ QHCPMCRQEW KFKE
//
ID   RN181_HUMAN             Reviewed;         153 AA.
AC   Q9P0P0; Q53H81;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-FEB-2023, entry version 166.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF181 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:18331836, ECO:0000269|PubMed:24811749};
DE   AltName: Full=RING finger protein 181 {ECO:0000303|PubMed:18331836};
GN   Name=RNF181 {ECO:0000303|PubMed:24811749,
GN   ECO:0000312|HGNC:HGNC:28037};
GN   ORFNames=HSPC238 {ECO:0000303|PubMed:11042152};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-118.
RC   TISSUE=Brain;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH ITGA2B, TISSUE SPECIFICITY, AND
RP   AUTOUBIQUITINATION.
RX   PubMed=18331836; DOI=10.1016/j.bbrc.2008.02.142;
RA   Brophy T.M., Raab M., Daxecker H., Culligan K.G., Lehmann I., Chubb A.J.,
RA   Treumann A., Moran N.;
RT   "RN181, a novel ubiquitin E3 ligase that interacts with the KVGFFKR motif
RT   of platelet integrin alpha(IIb)beta3.";
RL   Biochem. Biophys. Res. Commun. 369:1088-1093(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=24811749; DOI=10.1002/embj.201386906;
RA   Besche H.C., Sha Z., Kukushkin N.V., Peth A., Hock E.M., Kim W., Gygi S.,
RA   Gutierrez J.A., Liao H., Dick L., Goldberg A.L.;
RT   "Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of
RT   ubiquitin conjugates.";
RL   EMBO J. 33:1159-1176(2014).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an
CC       E2 ubiquitin-conjugating enzyme in the form of a thioester and then
CC       directly transfers the ubiquitin to targeted substrates
CC       (PubMed:18331836). Catalyzes monoubiquitination of 26S proteasome
CC       subunit PSMC2/RPT1 (PubMed:24811749). {ECO:0000269|PubMed:18331836,
CC       ECO:0000269|PubMed:24811749}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:18331836,
CC         ECO:0000269|PubMed:24811749};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:18331836, ECO:0000269|PubMed:24811749}.
CC   -!- SUBUNIT: Directly interacts with ITGA2B and, as a result, with integrin
CC       ITGA2B/ITGB3 (PubMed:18331836). There is no evidence that integrin
CC       ITGA2B/ITGB3 is an endogenous substrate for RNF181-directed
CC       ubiquitination (PubMed:18331836). {ECO:0000269|PubMed:18331836}.
CC   -!- INTERACTION:
CC       Q9P0P0; P51668: UBE2D1; NbExp=4; IntAct=EBI-2129136, EBI-743540;
CC       Q9P0P0; Q9Y2X8: UBE2D4; NbExp=4; IntAct=EBI-2129136, EBI-745527;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in liver and
CC       heart and lowest levels in brain and skeletal muscle. Expressed in
CC       platelets (at protein level). {ECO:0000269|PubMed:18331836}.
CC   -!- PTM: Autoubiquitinated as part of the enzymatic reaction.
CC       {ECO:0000269|PubMed:18331836}.
CC   -!- SIMILARITY: Belongs to the RNF181 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF151072; AAF36158.1; -; mRNA.
DR   EMBL; CR457165; CAG33446.1; -; mRNA.
DR   EMBL; AK222700; BAD96420.1; -; mRNA.
DR   EMBL; AC016753; AAY24343.1; -; Genomic_DNA.
DR   EMBL; BC002803; AAH02803.1; -; mRNA.
DR   CCDS; CCDS1981.1; -.
DR   RefSeq; NP_057578.1; NM_016494.3.
DR   AlphaFoldDB; Q9P0P0; -.
DR   SMR; Q9P0P0; -.
DR   BioGRID; 119411; 150.
DR   IntAct; Q9P0P0; 29.
DR   MINT; Q9P0P0; -.
DR   STRING; 9606.ENSP00000306906; -.
DR   iPTMnet; Q9P0P0; -.
DR   MetOSite; Q9P0P0; -.
DR   PhosphoSitePlus; Q9P0P0; -.
DR   BioMuta; RNF181; -.
DR   DMDM; 74761852; -.
DR   EPD; Q9P0P0; -.
DR   jPOST; Q9P0P0; -.
DR   MassIVE; Q9P0P0; -.
DR   MaxQB; Q9P0P0; -.
DR   PaxDb; Q9P0P0; -.
DR   PeptideAtlas; Q9P0P0; -.
DR   ProteomicsDB; 83589; -.
DR   Antibodypedia; 31897; 103 antibodies from 23 providers.
DR   DNASU; 51255; -.
DR   Ensembl; ENST00000306368.9; ENSP00000306906.4; ENSG00000168894.10.
DR   GeneID; 51255; -.
DR   KEGG; hsa:51255; -.
DR   MANE-Select; ENST00000306368.9; ENSP00000306906.4; NM_016494.4; NP_057578.1.
DR   UCSC; uc002spv.2; human.
DR   AGR; HGNC:28037; -.
DR   CTD; 51255; -.
DR   DisGeNET; 51255; -.
DR   GeneCards; RNF181; -.
DR   HGNC; HGNC:28037; RNF181.
DR   HPA; ENSG00000168894; Low tissue specificity.
DR   MIM; 612490; gene.
DR   neXtProt; NX_Q9P0P0; -.
DR   OpenTargets; ENSG00000168894; -.
DR   PharmGKB; PA162401586; -.
DR   VEuPathDB; HostDB:ENSG00000168894; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   GeneTree; ENSGT00940000160552; -.
DR   HOGENOM; CLU_144247_0_0_1; -.
DR   InParanoid; Q9P0P0; -.
DR   OMA; EHLHGAM; -.
DR   OrthoDB; 5474929at2759; -.
DR   PhylomeDB; Q9P0P0; -.
DR   TreeFam; TF332127; -.
DR   BRENDA; 2.3.2.27; 2681.
DR   PathwayCommons; Q9P0P0; -.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; Q9P0P0; -.
DR   SIGNOR; Q9P0P0; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 51255; 28 hits in 1186 CRISPR screens.
DR   ChiTaRS; RNF181; human.
DR   GenomeRNAi; 51255; -.
DR   Pharos; Q9P0P0; Tbio.
DR   PRO; PR:Q9P0P0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9P0P0; protein.
DR   Bgee; ENSG00000168894; Expressed in kidney epithelium and 183 other tissues.
DR   ExpressionAtlas; Q9P0P0; baseline and differential.
DR   Genevisible; Q9P0P0; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:FlyBase.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:FlyBase.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   CDD; cd16669; RING-H2_RNF181; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR15710; E3 UBIQUITIN-PROTEIN LIGASE PRAJA; 1.
DR   PANTHER; PTHR15710:SF160; E3 UBIQUITIN-PROTEIN LIGASE RNF181; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Metal-binding; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..153
FT                   /note="E3 ubiquitin-protein ligase RNF181"
FT                   /id="PRO_0000295174"
FT   ZN_FING         76..117
FT                   /note="RING-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          127..153
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        127..143
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         153
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   VARIANT         118
FT                   /note="Y -> H (in dbSNP:rs6643)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_033323"
SQ   SEQUENCE   153 AA;  17909 MW;  AF0CEC8D438FF0AB CRC64;
     MASYFDEHDC EPSDPEQETR TNMLLELARS LFNRMDFEDL GLVVDWDHHL PPPAAKTVVE
     NLPRTVIRGS QAELKCPVCL LEFEEEETAI EMPCHHLFHS SCILPWLSKT NSCPLCRYEL
     PTDDDTYEEH RRDKARKQQQ QHRLENLHGA MYT
//
ID   ZN581_HUMAN             Reviewed;         197 AA.
AC   Q9P0T4; B2RDM6;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-FEB-2023, entry version 169.
DE   RecName: Full=Zinc finger protein 581;
GN   Name=ZNF581; ORFNames=HSPC189;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell, Kidney, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q9P0T4; Q96CW1: AP2M1; NbExp=3; IntAct=EBI-745520, EBI-297683;
CC       Q9P0T4; Q9NRW3: APOBEC3C; NbExp=3; IntAct=EBI-745520, EBI-1044593;
CC       Q9P0T4; Q8WXK3-2: ASB13; NbExp=3; IntAct=EBI-745520, EBI-12015080;
CC       Q9P0T4; Q7Z3C6-3: ATG9A; NbExp=3; IntAct=EBI-745520, EBI-12006308;
CC       Q9P0T4; Q8N9N5: BANP; NbExp=3; IntAct=EBI-745520, EBI-744695;
CC       Q9P0T4; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-745520, EBI-11524452;
CC       Q9P0T4; A0A087WZT3: BOLA2-SMG1P6; NbExp=3; IntAct=EBI-745520, EBI-12006120;
CC       Q9P0T4; Q13895: BYSL; NbExp=3; IntAct=EBI-745520, EBI-358049;
CC       Q9P0T4; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-745520, EBI-739580;
CC       Q9P0T4; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-745520, EBI-3866279;
CC       Q9P0T4; Q8NA61: CBY2; NbExp=3; IntAct=EBI-745520, EBI-741724;
CC       Q9P0T4; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-745520, EBI-11524851;
CC       Q9P0T4; Q96JN2-2: CCDC136; NbExp=3; IntAct=EBI-745520, EBI-10171416;
CC       Q9P0T4; O95273: CCNDBP1; NbExp=3; IntAct=EBI-745520, EBI-748961;
CC       Q9P0T4; Q8WUH1: CHURC1; NbExp=3; IntAct=EBI-745520, EBI-11156883;
CC       Q9P0T4; Q9BYD5: CNFN; NbExp=3; IntAct=EBI-745520, EBI-12819063;
CC       Q9P0T4; A8MQ03: CYSRT1; NbExp=6; IntAct=EBI-745520, EBI-3867333;
CC       Q9P0T4; G5E9A7: DMWD; NbExp=3; IntAct=EBI-745520, EBI-10976677;
CC       Q9P0T4; Q8NF50-2: DOCK8; NbExp=3; IntAct=EBI-745520, EBI-10174653;
CC       Q9P0T4; Q01658: DR1; NbExp=3; IntAct=EBI-745520, EBI-750300;
CC       Q9P0T4; Q92997: DVL3; NbExp=3; IntAct=EBI-745520, EBI-739789;
CC       Q9P0T4; O95967: EFEMP2; NbExp=3; IntAct=EBI-745520, EBI-743414;
CC       Q9P0T4; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-745520, EBI-744099;
CC       Q9P0T4; Q16134: ETFDH; NbExp=3; IntAct=EBI-745520, EBI-2870454;
CC       Q9P0T4; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-745520, EBI-6658203;
CC       Q9P0T4; Q9NW38: FANCL; NbExp=3; IntAct=EBI-745520, EBI-2339898;
CC       Q9P0T4; P22607: FGFR3; NbExp=3; IntAct=EBI-745520, EBI-348399;
CC       Q9P0T4; Q5TD97: FHL5; NbExp=3; IntAct=EBI-745520, EBI-750641;
CC       Q9P0T4; A1L4K1: FSD2; NbExp=6; IntAct=EBI-745520, EBI-5661036;
CC       Q9P0T4; P14136: GFAP; NbExp=3; IntAct=EBI-745520, EBI-744302;
CC       Q9P0T4; Q08379: GOLGA2; NbExp=3; IntAct=EBI-745520, EBI-618309;
CC       Q9P0T4; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-745520, EBI-5916454;
CC       Q9P0T4; Q9HD26: GOPC; NbExp=3; IntAct=EBI-745520, EBI-349832;
CC       Q9P0T4; Q9Y4H4: GPSM3; NbExp=3; IntAct=EBI-745520, EBI-347538;
CC       Q9P0T4; P06396: GSN; NbExp=3; IntAct=EBI-745520, EBI-351506;
CC       Q9P0T4; Q9Y5Q9: GTF3C3; NbExp=3; IntAct=EBI-745520, EBI-1054873;
CC       Q9P0T4; Q6NT76: HMBOX1; NbExp=6; IntAct=EBI-745520, EBI-2549423;
CC       Q9P0T4; P52597: HNRNPF; NbExp=3; IntAct=EBI-745520, EBI-352986;
CC       Q9P0T4; O75031: HSF2BP; NbExp=6; IntAct=EBI-745520, EBI-7116203;
CC       Q9P0T4; Q13422: IKZF1; NbExp=3; IntAct=EBI-745520, EBI-745305;
CC       Q9P0T4; Q14005-2: IL16; NbExp=3; IntAct=EBI-745520, EBI-17178971;
CC       Q9P0T4; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-745520, EBI-1055254;
CC       Q9P0T4; Q5VWX1: KHDRBS2; NbExp=3; IntAct=EBI-745520, EBI-742808;
CC       Q9P0T4; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-745520, EBI-3044087;
CC       Q9P0T4; O76011: KRT34; NbExp=3; IntAct=EBI-745520, EBI-1047093;
CC       Q9P0T4; Q6A162: KRT40; NbExp=6; IntAct=EBI-745520, EBI-10171697;
CC       Q9P0T4; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-745520, EBI-11959885;
CC       Q9P0T4; P60409: KRTAP10-7; NbExp=6; IntAct=EBI-745520, EBI-10172290;
CC       Q9P0T4; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-745520, EBI-10171774;
CC       Q9P0T4; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-745520, EBI-10172052;
CC       Q9P0T4; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-745520, EBI-10176379;
CC       Q9P0T4; Q9BYR9: KRTAP2-4; NbExp=3; IntAct=EBI-745520, EBI-14065470;
CC       Q9P0T4; Q9BQ66: KRTAP4-12; NbExp=4; IntAct=EBI-745520, EBI-739863;
CC       Q9P0T4; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-745520, EBI-10172511;
CC       Q9P0T4; P26371: KRTAP5-9; NbExp=3; IntAct=EBI-745520, EBI-3958099;
CC       Q9P0T4; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-745520, EBI-11962084;
CC       Q9P0T4; Q8TBB1: LNX1; NbExp=6; IntAct=EBI-745520, EBI-739832;
CC       Q9P0T4; Q9BRK4: LZTS2; NbExp=4; IntAct=EBI-745520, EBI-741037;
CC       Q9P0T4; Q99750: MDFI; NbExp=8; IntAct=EBI-745520, EBI-724076;
CC       Q9P0T4; Q5JR59: MTUS2; NbExp=4; IntAct=EBI-745520, EBI-742948;
CC       Q9P0T4; Q8IV28: NID2; NbExp=3; IntAct=EBI-745520, EBI-10261509;
CC       Q9P0T4; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-745520, EBI-945833;
CC       Q9P0T4; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-745520, EBI-22310682;
CC       Q9P0T4; Q9BRQ3: NUDT22; NbExp=3; IntAct=EBI-745520, EBI-10297093;
CC       Q9P0T4; Q5VU43: PDE4DIP; NbExp=3; IntAct=EBI-745520, EBI-1105124;
CC       Q9P0T4; Q5VU43-2: PDE4DIP; NbExp=3; IntAct=EBI-745520, EBI-9640281;
CC       Q9P0T4; Q16512: PKN1; NbExp=3; IntAct=EBI-745520, EBI-602382;
CC       Q9P0T4; Q9UPG8: PLAGL2; NbExp=3; IntAct=EBI-745520, EBI-2876622;
CC       Q9P0T4; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-745520, EBI-742388;
CC       Q9P0T4; Q8ND90: PNMA1; NbExp=8; IntAct=EBI-745520, EBI-302345;
CC       Q9P0T4; Q16633: POU2AF1; NbExp=3; IntAct=EBI-745520, EBI-943588;
CC       Q9P0T4; O43741: PRKAB2; NbExp=3; IntAct=EBI-745520, EBI-1053424;
CC       Q9P0T4; Q93062: RBPMS; NbExp=4; IntAct=EBI-745520, EBI-740322;
CC       Q9P0T4; Q93062-3: RBPMS; NbExp=8; IntAct=EBI-745520, EBI-740343;
CC       Q9P0T4; Q9UFD9: RIMBP3; NbExp=3; IntAct=EBI-745520, EBI-10182375;
CC       Q9P0T4; Q96LW2: RSKR; NbExp=3; IntAct=EBI-745520, EBI-1054572;
CC       Q9P0T4; Q9H190: SDCBP2; NbExp=3; IntAct=EBI-745520, EBI-742426;
CC       Q9P0T4; Q14140: SERTAD2; NbExp=3; IntAct=EBI-745520, EBI-2822051;
CC       Q9P0T4; Q92922: SMARCC1; NbExp=3; IntAct=EBI-745520, EBI-355653;
CC       Q9P0T4; P35711: SOX5; NbExp=3; IntAct=EBI-745520, EBI-3505701;
CC       Q9P0T4; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-745520, EBI-11959123;
CC       Q9P0T4; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-745520, EBI-742688;
CC       Q9P0T4; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-745520, EBI-5235340;
CC       Q9P0T4; Q13148: TARDBP; NbExp=6; IntAct=EBI-745520, EBI-372899;
CC       Q9P0T4; Q8WW24: TEKT4; NbExp=3; IntAct=EBI-745520, EBI-750487;
CC       Q9P0T4; Q13077: TRAF1; NbExp=3; IntAct=EBI-745520, EBI-359224;
CC       Q9P0T4; Q9BUZ4: TRAF4; NbExp=6; IntAct=EBI-745520, EBI-3650647;
CC       Q9P0T4; P36406: TRIM23; NbExp=8; IntAct=EBI-745520, EBI-740098;
CC       Q9P0T4; P14373: TRIM27; NbExp=6; IntAct=EBI-745520, EBI-719493;
CC       Q9P0T4; Q15654: TRIP6; NbExp=3; IntAct=EBI-745520, EBI-742327;
CC       Q9P0T4; P31930: UQCRC1; NbExp=3; IntAct=EBI-745520, EBI-1052596;
CC       Q9P0T4; P61758: VBP1; NbExp=3; IntAct=EBI-745520, EBI-357430;
CC       Q9P0T4; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-745520, EBI-12040603;
CC       Q9P0T4; Q7L2R6-2: ZNF765; NbExp=3; IntAct=EBI-745520, EBI-12834294;
CC       Q9P0T4; Q3KQV3: ZNF792; NbExp=3; IntAct=EBI-745520, EBI-10240849;
CC       Q9P0T4; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-745520, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF151023; AAF36109.2; -; mRNA.
DR   EMBL; AK315603; BAG37973.1; -; mRNA.
DR   EMBL; CH471135; EAW72400.1; -; Genomic_DNA.
DR   EMBL; BC010097; AAH10097.1; -; mRNA.
DR   EMBL; BC001219; AAH01219.1; -; mRNA.
DR   EMBL; BC071620; AAH71620.1; -; mRNA.
DR   EMBL; BC071845; AAH71845.1; -; mRNA.
DR   CCDS; CCDS12932.1; -.
DR   RefSeq; NP_057619.1; NM_016535.3.
DR   RefSeq; XP_006723303.1; XM_006723240.3.
DR   RefSeq; XP_016882356.1; XM_017026867.1.
DR   AlphaFoldDB; Q9P0T4; -.
DR   SMR; Q9P0T4; -.
DR   BioGRID; 119601; 113.
DR   IntAct; Q9P0T4; 115.
DR   MINT; Q9P0T4; -.
DR   STRING; 9606.ENSP00000466047; -.
DR   iPTMnet; Q9P0T4; -.
DR   MetOSite; Q9P0T4; -.
DR   PhosphoSitePlus; Q9P0T4; -.
DR   BioMuta; ZNF581; -.
DR   DMDM; 55976774; -.
DR   EPD; Q9P0T4; -.
DR   jPOST; Q9P0T4; -.
DR   MassIVE; Q9P0T4; -.
DR   MaxQB; Q9P0T4; -.
DR   PaxDb; Q9P0T4; -.
DR   PeptideAtlas; Q9P0T4; -.
DR   ProteomicsDB; 83595; -.
DR   Antibodypedia; 33134; 63 antibodies from 19 providers.
DR   DNASU; 51545; -.
DR   Ensembl; ENST00000270451.6; ENSP00000270451.4; ENSG00000171425.10.
DR   Ensembl; ENST00000587252.5; ENSP00000466047.1; ENSG00000171425.10.
DR   Ensembl; ENST00000588537.1; ENSP00000466564.1; ENSG00000171425.10.
DR   GeneID; 51545; -.
DR   KEGG; hsa:51545; -.
DR   MANE-Select; ENST00000270451.6; ENSP00000270451.4; NM_016535.4; NP_057619.1.
DR   UCSC; uc002qln.4; human.
DR   AGR; HGNC:25017; -.
DR   CTD; 51545; -.
DR   GeneCards; ZNF581; -.
DR   HGNC; HGNC:25017; ZNF581.
DR   HPA; ENSG00000171425; Low tissue specificity.
DR   neXtProt; NX_Q9P0T4; -.
DR   OpenTargets; ENSG00000171425; -.
DR   PharmGKB; PA134899657; -.
DR   VEuPathDB; HostDB:ENSG00000171425; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000163608; -.
DR   HOGENOM; CLU_002678_42_5_1; -.
DR   InParanoid; Q9P0T4; -.
DR   OMA; KHARWKH; -.
DR   OrthoDB; 3378355at2759; -.
DR   PhylomeDB; Q9P0T4; -.
DR   PathwayCommons; Q9P0T4; -.
DR   SignaLink; Q9P0T4; -.
DR   BioGRID-ORCS; 51545; 18 hits in 1174 CRISPR screens.
DR   ChiTaRS; ZNF581; human.
DR   GenomeRNAi; 51545; -.
DR   Pharos; Q9P0T4; Tdark.
DR   PRO; PR:Q9P0T4; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9P0T4; protein.
DR   Bgee; ENSG00000171425; Expressed in upper arm skin and 154 other tissues.
DR   ExpressionAtlas; Q9P0T4; baseline and differential.
DR   Genevisible; Q9P0T4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 4.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24390; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24390:SF76; ZINC FINGER PROTEIN 581; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   Pfam; PF13894; zf-C2H2_4; 1.
DR   SMART; SM00355; ZnF_C2H2; 4.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   DNA-binding; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..197
FT                   /note="Zinc finger protein 581"
FT                   /id="PRO_0000047673"
FT   ZN_FING         87..109
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         115..137
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         145..167
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         173..196
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..52
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..48
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   197 AA;  22010 MW;  B62F1FAFD4829EE5 CRC64;
     MLVLPSPCPQ PLAFSSVETM EGPPRRTCRS PEPGPSSSIG SPQASSPPRP NHYLLIDTQG
     VPYTVLVDEE SQREPGASGA PGQKKCYSCP VCSRVFEYMS YLQRHSITHS EVKPFECDIC
     GKAFKRASHL ARHHSIHLAG GGRPHGCPLC PRRFRDAGEL AQHSRVHSGE RPFQCPHCPR
     RFMEQNTLQK HTRWKHP
//
ID   RPA12_HUMAN             Reviewed;         126 AA.
AC   Q9P1U0;
DT   02-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-FEB-2023, entry version 172.
DE   RecName: Full=DNA-directed RNA polymerase I subunit RPA12 {ECO:0000305|Ref.2};
DE   AltName: Full=DNA-directed RNA polymerase I subunit H {ECO:0000312|HGNC:HGNC:13182};
DE   AltName: Full=Zinc ribbon domain-containing protein 1 {ECO:0000303|PubMed:10662553};
GN   Name=POLR1H {ECO:0000312|HGNC:HGNC:13182};
GN   Synonyms=RPA12 {ECO:0000303|Ref.2}, ZNRD1
GN   {ECO:0000303|PubMed:10662553};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10662553; DOI=10.1006/geno.1999.6040;
RA   Fan W., Wang Z., Kyzysztof F., Prange C., Lennon G.;
RT   "A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I
RT   region.";
RL   Genomics 63:139-141(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Shematorova E.K., Lebedenko E.N., Shpakovski G.V.;
RT   "Complementation studies of Rpa12, small specific subunit of nuclear RNA
RT   polymerase I.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of
CC       DNA into RNA using the four ribonucleoside triphosphates as substrates.
CC       Component of RNA polymerase I which synthesizes ribosomal RNA
CC       precursors.
CC   -!- SUBUNIT: Component of the RNA polymerase I (Pol I) complex consisting
CC       of at least 13 subunits. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9P1U0; P54253: ATXN1; NbExp=3; IntAct=EBI-355434, EBI-930964;
CC       Q9P1U0; P06396: GSN; NbExp=3; IntAct=EBI-355434, EBI-351506;
CC       Q9P1U0; Q8N7C3: TRIML2; NbExp=3; IntAct=EBI-355434, EBI-11059915;
CC       Q9P1U0; Q9Y649; NbExp=3; IntAct=EBI-355434, EBI-25900580;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P32529}.
CC   -!- SIMILARITY: Belongs to the archaeal RpoM/eukaryotic RPA12/RPB9/RPC11
CC       RNA polymerase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF024617; AAF40469.1; -; mRNA.
DR   EMBL; AF230337; AAG50159.1; -; mRNA.
DR   EMBL; AF230338; AAG50160.1; -; Genomic_DNA.
DR   EMBL; CR457109; CAG33390.1; -; mRNA.
DR   EMBL; AL669914; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671859; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX088647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010898; AAH10898.1; -; mRNA.
DR   EMBL; BC050608; AAH50608.1; -; mRNA.
DR   CCDS; CCDS4670.1; -.
DR   RefSeq; NP_001265714.1; NM_001278785.1.
DR   RefSeq; NP_001265715.1; NM_001278786.1.
DR   RefSeq; NP_055411.1; NM_014596.5.
DR   RefSeq; NP_740753.1; NM_170783.3.
DR   PDB; 7OB9; EM; 2.70 A; I=1-126.
DR   PDB; 7OBA; EM; 3.10 A; I=1-126.
DR   PDB; 7OBB; EM; 3.30 A; I=1-126.
DR   PDB; 7VBA; EM; 2.89 A; I=1-126.
DR   PDB; 7VBB; EM; 2.81 A; I=1-126.
DR   PDB; 7VBC; EM; 3.01 A; I=1-126.
DR   PDB; 8A43; EM; 4.09 A; I=1-126.
DR   PDBsum; 7OB9; -.
DR   PDBsum; 7OBA; -.
DR   PDBsum; 7OBB; -.
DR   PDBsum; 7VBA; -.
DR   PDBsum; 7VBB; -.
DR   PDBsum; 7VBC; -.
DR   PDBsum; 8A43; -.
DR   AlphaFoldDB; Q9P1U0; -.
DR   SMR; Q9P1U0; -.
DR   BioGRID; 119050; 72.
DR   IntAct; Q9P1U0; 24.
DR   MINT; Q9P1U0; -.
DR   STRING; 9606.ENSP00000331111; -.
DR   GlyGen; Q9P1U0; 1 site, 1 O-linked glycan (1 site).
DR   BioMuta; ZNRD1; -.
DR   DMDM; 71649339; -.
DR   EPD; Q9P1U0; -.
DR   jPOST; Q9P1U0; -.
DR   MassIVE; Q9P1U0; -.
DR   MaxQB; Q9P1U0; -.
DR   PaxDb; Q9P1U0; -.
DR   PeptideAtlas; Q9P1U0; -.
DR   ProteomicsDB; 83665; -.
DR   Antibodypedia; 26188; 157 antibodies from 21 providers.
DR   DNASU; 30834; -.
DR   Ensembl; ENST00000332435.10; ENSP00000331111.5; ENSG00000066379.15.
DR   Ensembl; ENST00000359374.8; ENSP00000352333.4; ENSG00000066379.15.
DR   Ensembl; ENST00000376782.6; ENSP00000365978.2; ENSG00000066379.15.
DR   Ensembl; ENST00000376785.2; ENSP00000365981.2; ENSG00000066379.15.
DR   Ensembl; ENST00000383613.6; ENSP00000373108.2; ENSG00000206502.8.
DR   Ensembl; ENST00000400659.1; ENSP00000383500.1; ENSG00000206502.8.
DR   Ensembl; ENST00000400660.7; ENSP00000383501.3; ENSG00000206502.8.
DR   Ensembl; ENST00000400662.7; ENSP00000383503.3; ENSG00000206502.8.
DR   Ensembl; ENST00000412396.1; ENSP00000396922.1; ENSG00000233795.6.
DR   Ensembl; ENST00000417275.6; ENSP00000397636.2; ENSG00000233795.6.
DR   Ensembl; ENST00000417738.6; ENSP00000407715.2; ENSG00000235176.6.
DR   Ensembl; ENST00000420100.5; ENSP00000410530.1; ENSG00000236808.6.
DR   Ensembl; ENST00000428913.5; ENSP00000414110.1; ENSG00000224859.6.
DR   Ensembl; ENST00000429558.5; ENSP00000410954.1; ENSG00000235176.6.
DR   Ensembl; ENST00000431032.5; ENSP00000416599.1; ENSG00000236949.6.
DR   Ensembl; ENST00000431416.1; ENSP00000395065.1; ENSG00000235176.6.
DR   Ensembl; ENST00000432227.6; ENSP00000399302.2; ENSG00000236808.6.
DR   Ensembl; ENST00000432545.1; ENSP00000405264.1; ENSG00000236949.6.
DR   Ensembl; ENST00000432904.6; ENSP00000414720.2; ENSG00000236808.6.
DR   Ensembl; ENST00000433264.6; ENSP00000393236.2; ENSG00000236949.6.
DR   Ensembl; ENST00000437373.6; ENSP00000410127.2; ENSG00000236949.6.
DR   Ensembl; ENST00000437507.5; ENSP00000412369.1; ENSG00000235443.6.
DR   Ensembl; ENST00000441251.6; ENSP00000413265.2; ENSG00000235176.6.
DR   Ensembl; ENST00000442585.6; ENSP00000394779.2; ENSG00000233795.6.
DR   Ensembl; ENST00000443142.6; ENSP00000391809.2; ENSG00000235443.6.
DR   Ensembl; ENST00000443494.6; ENSP00000395397.2; ENSG00000235443.6.
DR   Ensembl; ENST00000444027.1; ENSP00000396661.1; ENSG00000236808.6.
DR   Ensembl; ENST00000444794.5; ENSP00000407364.1; ENSG00000233795.6.
DR   Ensembl; ENST00000446493.6; ENSP00000399966.2; ENSG00000224859.6.
DR   Ensembl; ENST00000451875.1; ENSP00000387914.1; ENSG00000224859.6.
DR   Ensembl; ENST00000453694.1; ENSP00000405636.1; ENSG00000235443.6.
DR   Ensembl; ENST00000455948.6; ENSP00000402198.2; ENSG00000224859.6.
DR   GeneID; 30834; -.
DR   KEGG; hsa:30834; -.
DR   MANE-Select; ENST00000332435.10; ENSP00000331111.5; NM_170783.4; NP_740753.1.
DR   UCSC; uc003noz.5; human.
DR   AGR; HGNC:13182; -.
DR   CTD; 30834; -.
DR   DisGeNET; 30834; -.
DR   GeneCards; POLR1H; -.
DR   HGNC; HGNC:13182; POLR1H.
DR   HPA; ENSG00000066379; Low tissue specificity.
DR   MIM; 607525; gene.
DR   neXtProt; NX_Q9P1U0; -.
DR   OpenTargets; ENSG00000066379; -.
DR   PharmGKB; PA37754; -.
DR   VEuPathDB; HostDB:ENSG00000066379; -.
DR   eggNOG; KOG2907; Eukaryota.
DR   GeneTree; ENSGT00390000008126; -.
DR   HOGENOM; CLU_093932_1_2_1; -.
DR   InParanoid; Q9P1U0; -.
DR   OMA; EMQYHTL; -.
DR   OrthoDB; 170134at2759; -.
DR   PhylomeDB; Q9P1U0; -.
DR   TreeFam; TF313881; -.
DR   PathwayCommons; Q9P1U0; -.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   SignaLink; Q9P1U0; -.
DR   SIGNOR; Q9P1U0; -.
DR   BioGRID-ORCS; 30834; 672 hits in 1165 CRISPR screens.
DR   ChiTaRS; ZNRD1; human.
DR   GeneWiki; ZNRD1; -.
DR   GenomeRNAi; 30834; -.
DR   Pharos; Q9P1U0; Tbio.
DR   PRO; PR:Q9P1U0; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9P1U0; protein.
DR   Bgee; ENSG00000066379; Expressed in granulocyte and 97 other tissues.
DR   ExpressionAtlas; Q9P1U0; baseline and differential.
DR   Genevisible; Q9P1U0; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005736; C:RNA polymerase I complex; IBA:GO_Central.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:InterPro.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006379; P:mRNA cleavage; IEA:InterPro.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; IBA:GO_Central.
DR   CDD; cd10507; Zn-ribbon_RPA12; 1.
DR   Gene3D; 2.20.25.10; -; 1.
DR   InterPro; IPR019761; DNA-dir_RNA_pol-M_15_CS.
DR   InterPro; IPR012164; Rpa12/Rpb9/Rpc10/TFS.
DR   InterPro; IPR034004; Zn_ribbon_RPA12_C.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   PANTHER; PTHR11239; DNA-DIRECTED RNA POLYMERASE; 1.
DR   PANTHER; PTHR11239:SF14; DNA-DIRECTED RNA POLYMERASE I SUBUNIT RPA12; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   PIRSF; PIRSF005586; RNApol_RpoM; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF57783; Zinc beta-ribbon; 1.
DR   PROSITE; PS01030; RNA_POL_M_15KD; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-directed RNA polymerase; Metal-binding; Nucleus;
KW   Reference proteome; Transcription; Zinc; Zinc-finger.
FT   CHAIN           1..126
FT                   /note="DNA-directed RNA polymerase I subunit RPA12"
FT                   /id="PRO_0000121460"
FT   ZN_FING         20..41
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         83..123
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         87
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         90
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         115
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         118
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   VARIANT         14
FT                   /note="Q -> H (in dbSNP:rs17187658)"
FT                   /id="VAR_052287"
FT   STRAND          12..14
FT                   /evidence="ECO:0007829|PDB:7OBB"
FT   TURN            21..23
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   TURN            39..41
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   HELIX           47..52
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          57..62
FT                   /evidence="ECO:0007829|PDB:7OB9"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:7OBA"
FT   STRAND          95..99
FT                   /evidence="ECO:0007829|PDB:7OBA"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:7OBB"
FT   STRAND          111..118
FT                   /evidence="ECO:0007829|PDB:7OBA"
FT   STRAND          121..124
FT                   /evidence="ECO:0007829|PDB:7OBA"
SQ   SEQUENCE   126 AA;  13904 MW;  C678AC7132A91432 CRC64;
     MSVMDLANTC SSFQSDLDFC SDCGSVLPLP GAQDTVTCIR CGFNINVRDF EGKVVKTSVV
     FHQLGTAMPM SVEEGPECQG PVVDRRCPRC GHEGMAYHTR QMRSADEGQT VFYTCTNCKF
     QEKEDS
//
ID   RBX2_HUMAN              Reviewed;         113 AA.
AC   Q9UBF6; A8K1H9; A8MTB5; C9JYL3; D3DNF7; D3DNF8; Q9BXN8; Q9Y5M7;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-FEB-2023, entry version 183.
DE   RecName: Full=RING-box protein 2;
DE            Short=Rbx2;
DE   AltName: Full=CKII beta-binding protein 1;
DE            Short=CKBBP1;
DE   AltName: Full=RING finger protein 7;
DE   AltName: Full=Regulator of cullins 2;
DE   AltName: Full=Sensitive to apoptosis gene protein;
GN   Name=RNF7; Synonyms=RBX2, ROC2, SAG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10512750; DOI=10.1006/bbrc.1999.1460;
RA   Son M.-Y., Park J.-W., Kim Y.-S., Kang S.-W., Marshak D.R., Park W.,
RA   Bae Y.-S.;
RT   "Protein kinase CKII interacts with and phosphorylates the SAG protein
RT   containing ring-H2 finger motif.";
RL   Biochem. Biophys. Res. Commun. 263:743-748(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH CULLINS.
RX   PubMed=10230407; DOI=10.1016/s1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with an
RT   associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10082581; DOI=10.1128/mcb.19.4.3145;
RA   Duan H., Wang Y., Aviram M., Swaroop M., Loo J.A., Bian J., Tian Y.,
RA   Mueller T., Bisgaier C.L., Sun Y.;
RT   "SAG, a novel zinc RING finger protein that protects cells from apoptosis
RT   induced by redox agents.";
RL   Mol. Cell. Biol. 19:3145-3155(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11506706; DOI=10.1089/104454901750361488;
RA   Swaroop M., Gosink M., Sun Y.;
RT   "SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: genomic
RT   structure, a splicing variant, and two family pseudogenes.";
RL   DNA Cell Biol. 20:425-434(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Corpus callosum, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH CUL1, AND FUNCTION.
RX   PubMed=10851089; DOI=10.1038/sj.onc.1203635;
RA   Swaroop M., Wang Y., Miller P., Duan H., Jatkoe T., Madore S.J., Sun Y.;
RT   "Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth,
RT   but not for germination: chip profiling implicates its role in cell cycle
RT   regulation.";
RL   Oncogene 19:2855-2866(2000).
RN   [11]
RP   PHOSPHORYLATION AT THR-10 BY CK2.
RX   PubMed=12748192; DOI=10.1074/jbc.m302584200;
RA   Kim Y.-S., Lee J.-Y., Son M.-Y., Park W., Bae Y.-S.;
RT   "Phosphorylation of threonine 10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase
RT   CKII promotes the degradation of IkappaBalpha and p27Kip1.";
RL   J. Biol. Chem. 278:28462-28469(2003).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   INTERACTION WITH UBE2F.
RX   PubMed=19250909; DOI=10.1016/j.molcel.2009.01.011;
RA   Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M., Scott D.C.,
RA   Borg L.A., Neale G., Murray P.J., Roussel M.F., Schulman B.A.;
RT   "E2-RING expansion of the NEDD8 cascade confers specificity to cullin
RT   modification.";
RL   Mol. Cell 33:483-495(2009).
RN   [14]
RP   INTERACTION WITH DCUN1D1; DCUN1D2; DCUN1D3; DCUN1D4 AND DCUN1D5.
RX   PubMed=26906416; DOI=10.1242/jcs.181784;
RA   Keuss M.J., Thomas Y., Mcarthur R., Wood N.T., Knebel A., Kurz T.;
RT   "Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.";
RL   J. Cell Sci. 129:1441-1454(2016).
RN   [15]
RP   STRUCTURE BY NMR OF 40-113.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RING domain of the human RING-box protein 2.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Probable component of the SCF (SKP1-CUL1-F-box protein) E3
CC       ubiquitin ligase complex which mediates the ubiquitination and
CC       subsequent proteasomal degradation of target proteins involved in cell
CC       cycle progression, signal transduction and transcription
CC       (PubMed:10851089). CRLs complexes and ARIH1 collaborate in tandem to
CC       mediate ubiquitination of target proteins, ARIH1 mediating addition of
CC       the first ubiquitin on CRLs targets (By similarity). Through the RING-
CC       type zinc finger, seems to recruit the E2 ubiquitination enzyme to the
CC       complex and brings it into close proximity to the substrate. Promotes
CC       the neddylation of CUL5 via its interaction with UBE2F. May play a role
CC       in protecting cells from apoptosis induced by redox agents.
CC       {ECO:0000250|UniProtKB:P62877, ECO:0000269|PubMed:10851089}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Probable part of SCF complexes, which consist of SKP1, CUL1,
CC       RNF7/RBX2 and a F-box protein. Interacts (preferentially) with CUL5.
CC       Also interacts (with lower preference) with CUL1, CUL2, CUL3, CUL4A and
CC       CUL4B. Interacts with UBE2F. Interacts with CSNK2B, the interaction is
CC       not affected by phosphorylation by CK2. May also interact with DCUN1D1,
CC       DCUN1D2, DCUN1D3, DCUN1D4 and DCUN1D5 (PubMed:26906416).
CC       {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10851089,
CC       ECO:0000269|PubMed:19250909, ECO:0000269|PubMed:26906416}.
CC   -!- INTERACTION:
CC       Q9UBF6; Q93034: CUL5; NbExp=8; IntAct=EBI-398632, EBI-1057139;
CC       Q9UBF6; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-398632, EBI-81279;
CC       Q9UBF6; P12004: PCNA; NbExp=3; IntAct=EBI-398632, EBI-358311;
CC       Q9UBF6; P12504: vif; Xeno; NbExp=4; IntAct=EBI-398632, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10082581}. Nucleus
CC       {ECO:0000269|PubMed:10082581}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UBF6-1; Sequence=Displayed;
CC       Name=2; Synonyms=SAG-v;
CC         IsoId=Q9UBF6-2; Sequence=VSP_008449;
CC       Name=3;
CC         IsoId=Q9UBF6-3; Sequence=VSP_041444;
CC       Name=4;
CC         IsoId=Q9UBF6-4; Sequence=VSP_044525;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, liver, skeletal muscle and
CC       pancreas. At very low levels expressed in brain, placenta and lung.
CC       {ECO:0000269|PubMed:10512750}.
CC   -!- INDUCTION: By 1,10-phenanthroline. {ECO:0000269|PubMed:10082581}.
CC   -!- DOMAIN: The RING-type zinc finger domain is essential for ubiquitin
CC       ligase activity. It coordinates an additional third zinc ion.
CC   -!- PTM: Phosphorylation by CK2 is required for efficient degradation of
CC       NFKBIA and CDKN1B. {ECO:0000269|PubMed:12748192}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Inactive. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the RING-box family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/44108/RNF7";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF164679; AAD55984.1; -; mRNA.
DR   EMBL; AF142060; AAD30147.1; -; mRNA.
DR   EMBL; AF092878; AAD25962.1; -; mRNA.
DR   EMBL; AF312226; AAK37450.1; -; mRNA.
DR   EMBL; BT007348; AAP36012.1; -; mRNA.
DR   EMBL; AK289894; BAF82583.1; -; mRNA.
DR   EMBL; DB272382; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC112771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78991.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78992.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78994.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78995.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78996.1; -; Genomic_DNA.
DR   EMBL; BC005966; AAH05966.1; -; mRNA.
DR   EMBL; BC008627; AAH08627.1; -; mRNA.
DR   CCDS; CCDS3118.1; -. [Q9UBF6-1]
DR   CCDS; CCDS43158.1; -. [Q9UBF6-3]
DR   CCDS; CCDS56283.1; -. [Q9UBF6-4]
DR   RefSeq; NP_001188299.1; NM_001201370.1. [Q9UBF6-4]
DR   RefSeq; NP_055060.1; NM_014245.4. [Q9UBF6-1]
DR   RefSeq; NP_899060.1; NM_183237.2. [Q9UBF6-3]
DR   PDB; 2ECL; NMR; -; A=40-113.
DR   PDB; 7ONI; EM; 3.40 A; R=5-113.
DR   PDBsum; 2ECL; -.
DR   PDBsum; 7ONI; -.
DR   AlphaFoldDB; Q9UBF6; -.
DR   BMRB; Q9UBF6; -.
DR   SMR; Q9UBF6; -.
DR   BioGRID; 114977; 150.
DR   CORUM; Q9UBF6; -.
DR   IntAct; Q9UBF6; 30.
DR   MINT; Q9UBF6; -.
DR   STRING; 9606.ENSP00000273480; -.
DR   GlyGen; Q9UBF6; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UBF6; -.
DR   MetOSite; Q9UBF6; -.
DR   PhosphoSitePlus; Q9UBF6; -.
DR   BioMuta; RNF7; -.
DR   DMDM; 37538003; -.
DR   EPD; Q9UBF6; -.
DR   jPOST; Q9UBF6; -.
DR   MassIVE; Q9UBF6; -.
DR   MaxQB; Q9UBF6; -.
DR   PaxDb; Q9UBF6; -.
DR   PeptideAtlas; Q9UBF6; -.
DR   ProteomicsDB; 12270; -.
DR   ProteomicsDB; 83956; -. [Q9UBF6-1]
DR   ProteomicsDB; 83957; -. [Q9UBF6-2]
DR   ProteomicsDB; 83958; -. [Q9UBF6-3]
DR   Antibodypedia; 18025; 194 antibodies from 33 providers.
DR   DNASU; 9616; -.
DR   Ensembl; ENST00000273480.4; ENSP00000273480.3; ENSG00000114125.14. [Q9UBF6-1]
DR   Ensembl; ENST00000393000.3; ENSP00000376725.3; ENSG00000114125.14. [Q9UBF6-3]
DR   Ensembl; ENST00000477012.5; ENSP00000419339.1; ENSG00000114125.14. [Q9UBF6-2]
DR   Ensembl; ENST00000480908.1; ENSP00000419084.1; ENSG00000114125.14. [Q9UBF6-4]
DR   GeneID; 9616; -.
DR   KEGG; hsa:9616; -.
DR   MANE-Select; ENST00000273480.4; ENSP00000273480.3; NM_014245.5; NP_055060.1.
DR   UCSC; uc003euc.4; human. [Q9UBF6-1]
DR   AGR; HGNC:10070; -.
DR   CTD; 9616; -.
DR   DisGeNET; 9616; -.
DR   GeneCards; RNF7; -.
DR   HGNC; HGNC:10070; RNF7.
DR   HPA; ENSG00000114125; Low tissue specificity.
DR   MIM; 603863; gene.
DR   neXtProt; NX_Q9UBF6; -.
DR   OpenTargets; ENSG00000114125; -.
DR   PharmGKB; PA34444; -.
DR   VEuPathDB; HostDB:ENSG00000114125; -.
DR   eggNOG; KOG2930; Eukaryota.
DR   GeneTree; ENSGT00940000155481; -.
DR   HOGENOM; CLU_115512_2_2_1; -.
DR   InParanoid; Q9UBF6; -.
DR   OMA; RQNNRCP; -.
DR   OrthoDB; 3546417at2759; -.
DR   PhylomeDB; Q9UBF6; -.
DR   TreeFam; TF351049; -.
DR   PathwayCommons; Q9UBF6; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9705462; Inactivation of CSF3 (G-CSF) signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9UBF6; -.
DR   SIGNOR; Q9UBF6; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 9616; 60 hits in 1211 CRISPR screens.
DR   ChiTaRS; RNF7; human.
DR   EvolutionaryTrace; Q9UBF6; -.
DR   GeneWiki; RNF7; -.
DR   GenomeRNAi; 9616; -.
DR   Pharos; Q9UBF6; Tbio.
DR   PRO; PR:Q9UBF6; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UBF6; protein.
DR   Bgee; ENSG00000114125; Expressed in left adrenal gland and 195 other tissues.
DR   ExpressionAtlas; Q9UBF6; baseline and differential.
DR   Genevisible; Q9UBF6; HS.
DR   GO; GO:0031466; C:Cul5-RING ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005507; F:copper ion binding; TAS:ProtInc.
DR   GO; GO:0097602; F:cullin family protein binding; IDA:MGI.
DR   GO; GO:0061663; F:NEDD8 ligase activity; IDA:UniProtKB.
DR   GO; GO:0019788; F:NEDD8 transferase activity; TAS:Reactome.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0045116; P:protein neddylation; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0051775; P:response to redox state; TAS:ProtInc.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd16466; RING-H2_RBX2; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR024766; Znf_RING_H2.
DR   PANTHER; PTHR11210:SF2; E3 UBIQUITIN-PROTEIN LIGASE RBX1-RELATED; 1.
DR   PANTHER; PTHR11210; RING BOX; 1.
DR   Pfam; PF12678; zf-rbx1; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..113
FT                   /note="RING-box protein 2"
FT                   /id="PRO_0000056023"
FT   ZN_FING         61..103
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         50
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         53
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         61
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         64
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         73
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         80
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         82
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         85
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         87
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         88
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         99
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         102
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         10
FT                   /note="Phosphothreonine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:12748192"
FT   VAR_SEQ         57..113
FT                   /note="VMDACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQNNRCPLCQQDWVV
FT                   QRIGK -> MPVLDVKLKTNKRTVLWSGENVIIPSTTAACPCG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041444"
FT   VAR_SEQ         59..74
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_044525"
FT   VAR_SEQ         60..113
FT                   /note="ACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQNNRCPLCQQDWVVQRI
FT                   GK -> EGIGVRNWSEALNLINASEMGFDCRSGSTALAVPSVSLASHQPCLDDHR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11506706,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_008449"
FT   CONFLICT        23
FT                   /note="K -> T (in Ref. 2; AAD30147)"
FT                   /evidence="ECO:0000305"
FT   STRAND          30..36
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   HELIX           62..67
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   TURN            70..72
FT                   /evidence="ECO:0007829|PDB:2ECL"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:2ECL"
FT   HELIX           86..95
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:7ONI"
SQ   SEQUENCE   113 AA;  12683 MW;  CE1E6CAC940C8257 CRC64;
     MADVEDGEET CALASHSGSS GSKSGGDKMF SLKKWNAVAM WSWDVECDTC AICRVQVMDA
     CLRCQAENKQ EDCVVVWGEC NHSFHNCCMS LWVKQNNRCP LCQQDWVVQR IGK
//
ID   ZMAT5_HUMAN             Reviewed;         170 AA.
AC   Q9UDW3; A8K9F6;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-FEB-2023, entry version 160.
DE   RecName: Full=Zinc finger matrin-type protein 5;
DE   AltName: Full=U11/U12 small nuclear ribonucleoprotein 20 kDa protein;
DE            Short=U11/U12 snRNP 20 kDa protein;
DE            Short=U11/U12-20K;
GN   Name=ZMAT5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH THE U11/U12 SPLICEOSOME, SUBCELLULAR
RP   LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15146077; DOI=10.1261/rna.7320604;
RA   Will C.L., Schneider C., Hossbach M., Urlaub H., Rauhut R., Elbashir S.,
RA   Tuschl T., Luehrmann R.;
RT   "The human 18S U11/U12 snRNP contains a set of novel proteins not found in
RT   the U2-dependent spliceosome.";
RL   RNA 10:929-941(2004).
CC   -!- SUBUNIT: Component of the U11/U12 snRNPs that are part of the U12-type
CC       spliceosome. Not found in the major spliceosome.
CC       {ECO:0000269|PubMed:15146077}.
CC   -!- INTERACTION:
CC       Q9UDW3; Q9H6L4: ARMC7; NbExp=3; IntAct=EBI-7850213, EBI-742909;
CC       Q9UDW3; Q13895: BYSL; NbExp=3; IntAct=EBI-7850213, EBI-358049;
CC       Q9UDW3; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-7850213, EBI-8643161;
CC       Q9UDW3; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-7850213, EBI-744556;
CC       Q9UDW3; Q02930-3: CREB5; NbExp=3; IntAct=EBI-7850213, EBI-10192698;
CC       Q9UDW3; Q9NW38: FANCL; NbExp=3; IntAct=EBI-7850213, EBI-2339898;
CC       Q9UDW3; P55040: GEM; NbExp=3; IntAct=EBI-7850213, EBI-744104;
CC       Q9UDW3; O95872: GPANK1; NbExp=3; IntAct=EBI-7850213, EBI-751540;
CC       Q9UDW3; P31273: HOXC8; NbExp=3; IntAct=EBI-7850213, EBI-1752118;
CC       Q9UDW3; P40692: MLH1; NbExp=3; IntAct=EBI-7850213, EBI-744248;
CC       Q9UDW3; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-7850213, EBI-10232538;
CC       Q9UDW3; Q6IQ23-2: PLEKHA7; NbExp=3; IntAct=EBI-7850213, EBI-12069346;
CC       Q9UDW3; Q6ZRY4: RBPMS2; NbExp=3; IntAct=EBI-7850213, EBI-11987469;
CC       Q9UDW3; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-7850213, EBI-358489;
CC       Q9UDW3; Q9BT92: TCHP; NbExp=3; IntAct=EBI-7850213, EBI-740781;
CC       Q9UDW3; Q8WV44: TRIM41; NbExp=3; IntAct=EBI-7850213, EBI-725997;
CC       Q9UDW3; A5D8V6: VPS37C; NbExp=3; IntAct=EBI-7850213, EBI-2559305;
CC       Q9UDW3; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-7850213, EBI-740727;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15146077}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL160311; CAB77284.1; -; mRNA.
DR   EMBL; CR456353; CAG30239.1; -; mRNA.
DR   EMBL; CR457393; CAG33674.1; -; mRNA.
DR   EMBL; AK292671; BAF85360.1; -; mRNA.
DR   EMBL; CH471095; EAW59837.1; -; Genomic_DNA.
DR   EMBL; BC009717; AAH09717.1; -; mRNA.
DR   EMBL; BK005198; DAA05496.1; -; mRNA.
DR   CCDS; CCDS13868.1; -.
DR   RefSeq; NP_001003692.1; NM_001003692.1.
DR   RefSeq; NP_001305058.1; NM_001318129.1.
DR   RefSeq; NP_061976.1; NM_019103.2.
DR   AlphaFoldDB; Q9UDW3; -.
DR   SMR; Q9UDW3; -.
DR   BioGRID; 121007; 61.
DR   CORUM; Q9UDW3; -.
DR   IntAct; Q9UDW3; 37.
DR   MINT; Q9UDW3; -.
DR   STRING; 9606.ENSP00000344241; -.
DR   iPTMnet; Q9UDW3; -.
DR   PhosphoSitePlus; Q9UDW3; -.
DR   BioMuta; ZMAT5; -.
DR   DMDM; 74753269; -.
DR   EPD; Q9UDW3; -.
DR   MassIVE; Q9UDW3; -.
DR   MaxQB; Q9UDW3; -.
DR   PaxDb; Q9UDW3; -.
DR   PeptideAtlas; Q9UDW3; -.
DR   ProteomicsDB; 84122; -.
DR   Antibodypedia; 330; 60 antibodies from 13 providers.
DR   DNASU; 55954; -.
DR   Ensembl; ENST00000344318.4; ENSP00000344241.3; ENSG00000100319.13.
DR   GeneID; 55954; -.
DR   KEGG; hsa:55954; -.
DR   MANE-Select; ENST00000344318.4; ENSP00000344241.3; NM_001003692.2; NP_001003692.1.
DR   UCSC; uc003agn.4; human.
DR   AGR; HGNC:28046; -.
DR   CTD; 55954; -.
DR   DisGeNET; 55954; -.
DR   GeneCards; ZMAT5; -.
DR   HGNC; HGNC:28046; ZMAT5.
DR   HPA; ENSG00000100319; Low tissue specificity.
DR   MIM; 619741; gene.
DR   neXtProt; NX_Q9UDW3; -.
DR   PharmGKB; PA142670524; -.
DR   VEuPathDB; HostDB:ENSG00000100319; -.
DR   eggNOG; KOG3454; Eukaryota.
DR   GeneTree; ENSGT00390000009869; -.
DR   HOGENOM; CLU_100385_1_0_1; -.
DR   InParanoid; Q9UDW3; -.
DR   OMA; WPPIQEL; -.
DR   OrthoDB; 5471112at2759; -.
DR   PhylomeDB; Q9UDW3; -.
DR   TreeFam; TF332784; -.
DR   PathwayCommons; Q9UDW3; -.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   SignaLink; Q9UDW3; -.
DR   BioGRID-ORCS; 55954; 611 hits in 1156 CRISPR screens.
DR   ChiTaRS; ZMAT5; human.
DR   GenomeRNAi; 55954; -.
DR   Pharos; Q9UDW3; Tdark.
DR   PRO; PR:Q9UDW3; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9UDW3; protein.
DR   Bgee; ENSG00000100319; Expressed in hindlimb stylopod muscle and 120 other tissues.
DR   ExpressionAtlas; Q9UDW3; baseline and differential.
DR   Genevisible; Q9UDW3; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005689; C:U12-type spliceosomal complex; IDA:HGNC-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; IC:HGNC-UCL.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 4.10.1000.10; Zinc finger, CCCH-type; 1.
DR   InterPro; IPR013085; U1-CZ_Znf_C2H2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR16465; NUCLEASE-RELATED; 1.
DR   PANTHER; PTHR16465:SF0; ZINC FINGER MATRIN-TYPE PROTEIN 5; 1.
DR   Pfam; PF00642; zf-CCCH; 1.
DR   Pfam; PF06220; zf-U1; 1.
DR   SMART; SM00356; ZnF_C3H1; 1.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
DR   SUPFAM; SSF90229; CCCH zinc finger; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
PE   1: Evidence at protein level;
KW   Metal-binding; mRNA processing; mRNA splicing; Nucleus; Reference proteome;
KW   Spliceosome; Zinc; Zinc-finger.
FT   CHAIN           1..170
FT                   /note="Zinc finger matrin-type protein 5"
FT                   /id="PRO_0000254114"
FT   ZN_FING         51..79
FT                   /note="C3H1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          150..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   170 AA;  19971 MW;  FEBF7BD946EFA5FA CRC64;
     MGKRYFCDYC DRSFQDNLHN RKKHLNGLQH LKAKKVWYDM FRDAAAILLD EQNKRPCRKF
     LLTGQCDFGS NCRFSHMSER DLQELSIQVE EERRAREWLL DAPELPEGHL EDWLEKRAKR
     LSSAPSSRAE PIRTTVFQYP VGWPPVQELP PSLRAPPPGG WPLQPRVQWG
//
ID   ZN580_HUMAN             Reviewed;         172 AA.
AC   Q9UK33; B2RC05; Q9NPP7;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-FEB-2023, entry version 171.
DE   RecName: Full=Zinc finger protein 580;
DE   AltName: Full=LDL-induced EC protein;
GN   Name=ZNF580;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Vascular endothelial cell;
RA   Zhang W.C., Zhang K.M., Chen B.S.;
RT   "A novel gene associated with LDL stimulation in vascular endothelial
RT   cells.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION BY SPHINGOSINE-1-PHOSPHATE.
RX   PubMed=20382120; DOI=10.1016/j.bbrc.2010.04.019;
RA   Sun H.Y., Wei S.P., Xu R.C., Xu P.X., Zhang W.C.;
RT   "Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2
RT   production via transcription factor ZNF580: novel insights into
RT   angiogenesis.";
RL   Biochem. Biophys. Res. Commun. 395:361-366(2010).
RN   [7]
RP   INTERACTION WITH SMAD2, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21599657; DOI=10.1042/cbi20110050;
RA   Luo Y., Hu W., Xu R., Hou B., Zhang L., Zhang W.;
RT   "ZNF580, a novel C2H2 zinc-finger transcription factor, interacts with the
RT   TGF-beta signal molecule Smad2.";
RL   Cell Biol. Int. 35:1153-1157(2011).
RN   [8]
RP   FUNCTION, AND INDUCTION BY REACTIVE OXYGEN SPECIES.
RX   PubMed=21830064; DOI=10.1007/s11010-011-1013-0;
RA   DangLi R., HeKong W., JiQin L., MingHua Z., WenCheng Z.;
RT   "ROS-induced ZNF580 expression: a key role for H2O2/NF-kappaB signaling
RT   pathway in vascular endothelial inflammation.";
RL   Mol. Cell. Biochem. 359:183-191(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-31 AND LYS-118, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in the regulation of endothelial cell proliferation
CC       and migration. Mediates H(2)O(2)-induced leukocyte chemotaxis by
CC       elevating interleukin-8 production and may play a role in inflammation.
CC       May be involved in transcriptional regulation.
CC       {ECO:0000269|PubMed:20382120, ECO:0000269|PubMed:21830064}.
CC   -!- SUBUNIT: Interacts with SMAD2. {ECO:0000269|PubMed:21599657}.
CC   -!- INTERACTION:
CC       Q9UK33; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-746277, EBI-11524452;
CC       Q9UK33; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-746277, EBI-3867333;
CC       Q9UK33; A1L4K1: FSD2; NbExp=3; IntAct=EBI-746277, EBI-5661036;
CC       Q9UK33; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-746277, EBI-5916454;
CC       Q9UK33; Q13422-7: IKZF1; NbExp=3; IntAct=EBI-746277, EBI-11522367;
CC       Q9UK33; O75525: KHDRBS3; NbExp=3; IntAct=EBI-746277, EBI-722504;
CC       Q9UK33; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-746277, EBI-3044087;
CC       Q9UK33; O76011: KRT34; NbExp=3; IntAct=EBI-746277, EBI-1047093;
CC       Q9UK33; Q6A162: KRT40; NbExp=3; IntAct=EBI-746277, EBI-10171697;
CC       Q9UK33; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-746277, EBI-10172290;
CC       Q9UK33; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-746277, EBI-10171774;
CC       Q9UK33; Q99750: MDFI; NbExp=3; IntAct=EBI-746277, EBI-724076;
CC       Q9UK33; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-746277, EBI-11522433;
CC       Q9UK33; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-746277, EBI-22310682;
CC       Q9UK33; O43586: PSTPIP1; NbExp=3; IntAct=EBI-746277, EBI-1050964;
CC       Q9UK33; P14373: TRIM27; NbExp=3; IntAct=EBI-746277, EBI-719493;
CC       Q9UK33; Q15654: TRIP6; NbExp=3; IntAct=EBI-746277, EBI-742327;
CC       Q9UK33; Q9C0F3: ZNF436; NbExp=3; IntAct=EBI-746277, EBI-8489702;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20382120,
CC       ECO:0000269|PubMed:21599657}. Note=Colocalized with SMAD2 in the
CC       nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in endothelial cells.
CC       {ECO:0000269|PubMed:21599657}.
CC   -!- INDUCTION: Up-regulated in presence of reactive oxygen species (ROS),
CC       like H(2)O(2), through the NF-kappaB signaling pathway. Up-regulated by
CC       sphingosine-1-phosphate (SP1) through the p38 MAPK signaling pathway
CC       (at protein level). {ECO:0000269|PubMed:20382120,
CC       ECO:0000269|PubMed:21830064}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94389.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF184939; AAD56549.1; -; mRNA.
DR   EMBL; AL359054; CAB94389.1; ALT_INIT; mRNA.
DR   EMBL; AK314888; BAG37402.1; -; mRNA.
DR   EMBL; BC017698; AAH17698.1; -; mRNA.
DR   CCDS; CCDS12931.1; -.
DR   RefSeq; NP_001156895.1; NM_001163423.1.
DR   RefSeq; NP_057286.1; NM_016202.2.
DR   RefSeq; NP_996998.1; NM_207115.1.
DR   AlphaFoldDB; Q9UK33; -.
DR   SMR; Q9UK33; -.
DR   BioGRID; 119340; 29.
DR   IntAct; Q9UK33; 25.
DR   MINT; Q9UK33; -.
DR   STRING; 9606.ENSP00000443957; -.
DR   iPTMnet; Q9UK33; -.
DR   PhosphoSitePlus; Q9UK33; -.
DR   BioMuta; ZNF580; -.
DR   DMDM; 55976777; -.
DR   EPD; Q9UK33; -.
DR   jPOST; Q9UK33; -.
DR   MassIVE; Q9UK33; -.
DR   MaxQB; Q9UK33; -.
DR   PaxDb; Q9UK33; -.
DR   PeptideAtlas; Q9UK33; -.
DR   ProteomicsDB; 84713; -.
DR   Antibodypedia; 19580; 87 antibodies from 15 providers.
DR   DNASU; 51157; -.
DR   Ensembl; ENST00000325333.10; ENSP00000320050.4; ENSG00000213015.9.
DR   Ensembl; ENST00000543039.2; ENSP00000443957.1; ENSG00000213015.9.
DR   Ensembl; ENST00000545125.1; ENSP00000446126.1; ENSG00000213015.9.
DR   GeneID; 51157; -.
DR   KEGG; hsa:51157; -.
DR   MANE-Select; ENST00000325333.10; ENSP00000320050.4; NM_207115.2; NP_996998.1.
DR   UCSC; uc002qlo.4; human.
DR   AGR; HGNC:29473; -.
DR   CTD; 51157; -.
DR   DisGeNET; 51157; -.
DR   GeneCards; ZNF580; -.
DR   HGNC; HGNC:29473; ZNF580.
DR   HPA; ENSG00000213015; Low tissue specificity.
DR   MIM; 617888; gene.
DR   neXtProt; NX_Q9UK33; -.
DR   OpenTargets; ENSG00000213015; -.
DR   PharmGKB; PA134867016; -.
DR   VEuPathDB; HostDB:ENSG00000213015; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000163086; -.
DR   HOGENOM; CLU_002678_42_5_1; -.
DR   InParanoid; Q9UK33; -.
DR   OMA; VWPRVGF; -.
DR   OrthoDB; 3378355at2759; -.
DR   PhylomeDB; Q9UK33; -.
DR   TreeFam; TF338348; -.
DR   PathwayCommons; Q9UK33; -.
DR   SignaLink; Q9UK33; -.
DR   BioGRID-ORCS; 51157; 35 hits in 1178 CRISPR screens.
DR   ChiTaRS; ZNF580; human.
DR   GenomeRNAi; 51157; -.
DR   Pharos; Q9UK33; Tbio.
DR   PRO; PR:Q9UK33; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9UK33; protein.
DR   Bgee; ENSG00000213015; Expressed in adenohypophysis and 177 other tissues.
DR   ExpressionAtlas; Q9UK33; baseline and differential.
DR   Genevisible; Q9UK33; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; IEA:UniProtKB-KW.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24393; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24393:SF54; ZINC FINGER PROTEIN 580; 1.
DR   Pfam; PF00096; zf-C2H2; 2.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 3.
PE   1: Evidence at protein level;
KW   Chemotaxis; DNA-binding; Inflammatory response; Isopeptide bond;
KW   Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..172
FT                   /note="Zinc finger protein 580"
FT                   /id="PRO_0000047671"
FT   ZN_FING         92..114
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         120..142
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         150..172
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..93
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..34
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        31
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        118
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
SQ   SEQUENCE   172 AA;  18756 MW;  55A89DD94E0440A8 CRC64;
     MLLLPPRPPH PRSSSPEAMD PPPPKAPPFP KAEGPSSTPS SAAGPRPPRL GRHLLIDANG
     VPYTYTVQLE EEPRGPPQRE APPGEPGPRK GYSCPECARV FASPLRLQSH RVSHSDLKPF
     TCGACGKAFK RSSHLSRHRA THRARAGPPH TCPLCPRRFQ DAAELAQHVR LH
//
ID   RNF24_HUMAN             Reviewed;         148 AA.
AC   Q9Y225; D3DVZ2; D3DVZ3; Q9UMH1;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-FEB-2023, entry version 162.
DE   RecName: Full=RING finger protein 24;
GN   Name=RNF24;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Stavrides G.S., Huckle E.J., Deloukas P.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Blood, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 45-148.
RG   The European IMAGE consortium;
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION, INTERACTION WITH TRPC1; TRPC3; TRPC4; TRPC5; TRPC6 AND TRPC7, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009;
RA   Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.;
RT   "RNF24, a new TRPC interacting protein, causes the intracellular retention
RT   of TRPC.";
RL   Cell Calcium 43:432-443(2008).
RN   [8]
RP   STRUCTURE BY NMR OF 68-128 IN COMPLEX WITH ZINC.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RING finger from human RING finger protein 24.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: May play a role in TRPCs intracellular trafficking.
CC       {ECO:0000269|PubMed:17850865}.
CC   -!- SUBUNIT: Interacts with TRPC1, TRPC3, TRPC4, TRPC5, TRPC6 and TRPC7.
CC       {ECO:0000269|PubMed:17850865, ECO:0000269|Ref.8}.
CC   -!- INTERACTION:
CC       Q9Y225; P07919: UQCRH; NbExp=3; IntAct=EBI-10195462, EBI-1224427;
CC       Q9Y225-2; Q8WTS1: ABHD5; NbExp=3; IntAct=EBI-13044680, EBI-2813554;
CC       Q9Y225-2; Q9NVT9: ARMC1; NbExp=3; IntAct=EBI-13044680, EBI-3506974;
CC       Q9Y225-2; Q12983: BNIP3; NbExp=3; IntAct=EBI-13044680, EBI-749464;
CC       Q9Y225-2; O95406: CNIH1; NbExp=3; IntAct=EBI-13044680, EBI-12172273;
CC       Q9Y225-2; Q6ZVE7: GOLT1A; NbExp=3; IntAct=EBI-13044680, EBI-17231387;
CC       Q9Y225-2; Q86UP9: LHFPL3; NbExp=3; IntAct=EBI-13044680, EBI-12925734;
CC       Q9Y225-2; Q5SR56: MFSD14B; NbExp=3; IntAct=EBI-13044680, EBI-373355;
CC       Q9Y225-2; Q16617: NKG7; NbExp=3; IntAct=EBI-13044680, EBI-3919611;
CC       Q9Y225-2; Q8IZ57: NRSN1; NbExp=3; IntAct=EBI-13044680, EBI-10264528;
CC       Q9Y225-2; P21589: NT5E; NbExp=3; IntAct=EBI-13044680, EBI-6393623;
CC       Q9Y225-2; P60201-2: PLP1; NbExp=3; IntAct=EBI-13044680, EBI-12188331;
CC       Q9Y225-2; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-13044680, EBI-18159983;
CC       Q9Y225-2; Q9NPL8: TIMMDC1; NbExp=3; IntAct=EBI-13044680, EBI-6268651;
CC       Q9Y225-2; Q9Y320: TMX2; NbExp=3; IntAct=EBI-13044680, EBI-6447886;
CC       Q9Y225-2; P23763-3: VAMP1; NbExp=3; IntAct=EBI-13044680, EBI-12097582;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:17850865}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:17850865}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y225-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y225-2; Sequence=VSP_041026;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL096778; CAB46627.1; -; mRNA.
DR   EMBL; BT007406; AAP36074.1; -; mRNA.
DR   EMBL; AL031670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10467.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10468.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10469.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10471.1; -; Genomic_DNA.
DR   EMBL; BC000213; AAH00213.1; -; mRNA.
DR   EMBL; BC039584; AAH39584.1; -; mRNA.
DR   EMBL; AL079313; CAB45279.1; -; mRNA.
DR   CCDS; CCDS13074.1; -. [Q9Y225-1]
DR   CCDS; CCDS46577.1; -. [Q9Y225-2]
DR   RefSeq; NP_001127809.1; NM_001134337.2. [Q9Y225-1]
DR   RefSeq; NP_001127810.1; NM_001134338.2. [Q9Y225-2]
DR   RefSeq; NP_001308678.1; NM_001321749.1. [Q9Y225-1]
DR   RefSeq; NP_009150.1; NM_007219.4. [Q9Y225-1]
DR   RefSeq; XP_011527447.1; XM_011529145.2. [Q9Y225-2]
DR   RefSeq; XP_016883109.1; XM_017027620.1. [Q9Y225-2]
DR   RefSeq; XP_016883110.1; XM_017027621.1. [Q9Y225-2]
DR   PDB; 2EP4; NMR; -; A=68-128.
DR   PDBsum; 2EP4; -.
DR   AlphaFoldDB; Q9Y225; -.
DR   SMR; Q9Y225; -.
DR   BioGRID; 116402; 18.
DR   IntAct; Q9Y225; 16.
DR   STRING; 9606.ENSP00000388550; -.
DR   iPTMnet; Q9Y225; -.
DR   PhosphoSitePlus; Q9Y225; -.
DR   BioMuta; RNF24; -.
DR   DMDM; 20139860; -.
DR   jPOST; Q9Y225; -.
DR   MassIVE; Q9Y225; -.
DR   MaxQB; Q9Y225; -.
DR   PaxDb; Q9Y225; -.
DR   PeptideAtlas; Q9Y225; -.
DR   ProteomicsDB; 85610; -. [Q9Y225-1]
DR   ProteomicsDB; 85611; -. [Q9Y225-2]
DR   Antibodypedia; 23773; 117 antibodies from 19 providers.
DR   DNASU; 11237; -.
DR   Ensembl; ENST00000336095.10; ENSP00000336753.5; ENSG00000101236.17. [Q9Y225-1]
DR   Ensembl; ENST00000358395.11; ENSP00000351166.6; ENSG00000101236.17. [Q9Y225-1]
DR   Ensembl; ENST00000432261.6; ENSP00000388550.2; ENSG00000101236.17. [Q9Y225-2]
DR   Ensembl; ENST00000545616.2; ENSP00000444711.1; ENSG00000101236.17. [Q9Y225-2]
DR   GeneID; 11237; -.
DR   KEGG; hsa:11237; -.
DR   MANE-Select; ENST00000358395.11; ENSP00000351166.6; NM_001134337.3; NP_001127809.1.
DR   UCSC; uc002wkh.4; human. [Q9Y225-1]
DR   AGR; HGNC:13779; -.
DR   CTD; 11237; -.
DR   DisGeNET; 11237; -.
DR   GeneCards; RNF24; -.
DR   HGNC; HGNC:13779; RNF24.
DR   HPA; ENSG00000101236; Tissue enhanced (bone).
DR   MIM; 612489; gene.
DR   neXtProt; NX_Q9Y225; -.
DR   OpenTargets; ENSG00000101236; -.
DR   PharmGKB; PA34428; -.
DR   VEuPathDB; HostDB:ENSG00000101236; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   GeneTree; ENSGT00940000159443; -.
DR   HOGENOM; CLU_142341_0_0_1; -.
DR   InParanoid; Q9Y225; -.
DR   OMA; HSKQDPG; -.
DR   OrthoDB; 5474929at2759; -.
DR   PhylomeDB; Q9Y225; -.
DR   PathwayCommons; Q9Y225; -.
DR   SignaLink; Q9Y225; -.
DR   SIGNOR; Q9Y225; -.
DR   BioGRID-ORCS; 11237; 31 hits in 1195 CRISPR screens.
DR   ChiTaRS; RNF24; human.
DR   EvolutionaryTrace; Q9Y225; -.
DR   GeneWiki; RNF24; -.
DR   GenomeRNAi; 11237; -.
DR   Pharos; Q9Y225; Tbio.
DR   PRO; PR:Q9Y225; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9Y225; protein.
DR   Bgee; ENSG00000101236; Expressed in secondary oocyte and 180 other tissues.
DR   Genevisible; Q9Y225; HS.
DR   GO; GO:0012505; C:endomembrane system; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   CDD; cd16469; RING-H2_RNF24_like; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22763; RING ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR22763:SF162; RING-TYPE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00744; RINGv; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Golgi apparatus; Membrane;
KW   Metal-binding; Reference proteome; Transmembrane; Transmembrane helix;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..148
FT                   /note="RING finger protein 24"
FT                   /id="PRO_0000056063"
FT   TRANSMEM        24..44
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         78..119
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   VAR_SEQ         1
FT                   /note="M -> MLNKSGESRYPALFPVLGGSSM (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_041026"
FT   CONFLICT        45
FT                   /note="Y -> S (in Ref. 6; CAB45279)"
FT                   /evidence="ECO:0000305"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   STRAND          91..94
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   HELIX           102..111
FT                   /evidence="ECO:0007829|PDB:2EP4"
FT   TURN            116..118
FT                   /evidence="ECO:0007829|PDB:2EP4"
SQ   SEQUENCE   148 AA;  17210 MW;  66C240C3A5991EA5 CRC64;
     MSSDFPHYNF RMPNIGFQNL PLNIYIVVFG TAIFVFILSL LFCCYLIRLR HQAHKEFYAY
     KQVILKEKVK ELNLHELCAV CLEDFKPRDE LGICPCKHAF HRKCLIKWLE VRKVCPLCNM
     PVLQLAQLHS KQDRGPPQGP LPGAENIV
//
ID   RPC10_HUMAN             Reviewed;         108 AA.
AC   Q9Y2Y1; Q1W6H4; Q96S35;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-FEB-2022, sequence version 3.
DT   22-FEB-2023, entry version 194.
DE   RecName: Full=DNA-directed RNA polymerase III subunit RPC10;
DE            Short=RNA polymerase III subunit C10;
DE   AltName: Full=DNA-directed RNA polymerase III subunit K;
DE   AltName: Full=RNA polymerase III 12.5 kDa subunit;
DE            Short=RPC12.5;
DE   AltName: Full=RNA polymerase III subunit C11;
DE            Short=HsC11p;
DE            Short=RPC11;
DE            Short=hRPC11;
GN   Name=POLR3K; Synonyms=RPC11; ORFNames=My010;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9869639; DOI=10.1101/gad.12.24.3857;
RA   Chedin S., Riva M., Schultz P., Sentenac A., Carles C.;
RT   "The RNA cleavage activity of RNA polymerase III is mediated by an
RT   essential TFIIS-like subunit and is important for transcription
RT   termination.";
RL   Genes Dev. 12:3857-3871(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10079944;
RA   Spakovskii G.V., Lebedenko E.N.;
RT   "Molecular identification and characteristics of hRPC11, the smallest
RT   specific subunit of human RNA polymerase III.";
RL   Bioorg. Khim. 24:877-880(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain;
RA   Mao Y.M., Xie Y., Zheng Z.H., Gu S.H., Ying K., Lin Q., Dai J.L., Tang R.,
RA   Dong H., Wu X.Z.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=16728641; DOI=10.1126/science.1126431;
RA   De Gobbi M., Viprakasit V., Hughes J.R., Fisher C., Buckle V.J., Ayyub H.,
RA   Gibbons R.J., Vernimmen D., Yoshinaga Y., de Jong P., Cheng J.-F.,
RA   Rubin E.M., Wood W.G., Bowden D., Higgs D.R.;
RT   "A regulatory SNP causes a human genetic disease by creating a new
RT   transcriptional promoter.";
RL   Science 312:1215-1217(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., Tufarelli C.,
RA   Kearney L., Buckle V.J., Doggett N.A., Flint J., Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2 Mb of
RT   the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION IN THE RNA POL III COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, AND SUBUNIT.
RX   PubMed=12391170; DOI=10.1128/mcb.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P., Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues for
RT   Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=19631370; DOI=10.1016/j.cell.2009.06.015;
RA   Chiu Y.-H., Macmillan J.B., Chen Z.J.;
RT   "RNA polymerase III detects cytosolic DNA and induces type I interferons
RT   through the RIG-I pathway.";
RL   Cell 138:576-591(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=19609254; DOI=10.1038/ni.1779;
RA   Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A.,
RA   Hornung V.;
RT   "RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA
RT   polymerase III-transcribed RNA intermediate.";
RL   Nat. Immunol. 10:1065-1072(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INVOLVEMENT IN HLD21, VARIANT HLD21 TRP-41, CHARACTERIZATION OF VARIANT
RP   HLD21 TRP-41, AND FUNCTION.
RX   PubMed=30584594; DOI=10.1212/nxg.0000000000000289;
RA   Dorboz I., Dumay-Odelot H., Boussaid K., Bouyacoub Y., Barreau P.,
RA   Samaan S., Jmel H., Eymard-Pierre E., Cances C., Bar C., Poulat A.L.,
RA   Rousselle C., Renaldo F., Elmaleh-Berges M., Teichmann M.,
RA   Boespflug-Tanguy O.;
RT   "Mutation in POLR3K causes hypomyelinating leukodystrophy and abnormal
RT   ribosomal RNA regulation.";
RL   Neurol. Genet. 4:e289-e289(2018).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of
CC       DNA into RNA using the four ribonucleoside triphosphates as substrates
CC       (PubMed:12391170). Component of RNA polymerase III which synthesizes
CC       small RNAs, such as 5S rRNA and tRNAs (PubMed:12391170,
CC       PubMed:30584594). Plays a key role in sensing and limiting infection by
CC       intracellular bacteria and DNA viruses (PubMed:19631370,
CC       PubMed:19609254). Acts as nuclear and cytosolic DNA sensor involved in
CC       innate immune response (PubMed:19631370, PubMed:19609254). Can sense
CC       non-self dsDNA that serves as template for transcription into dsRNA
CC       (PubMed:19631370, PubMed:19609254). The non-self RNA polymerase III
CC       transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce
CC       type I interferon and NF-kappa-B through the RIG-I pathway
CC       (PubMed:19631370, PubMed:19609254). {ECO:0000269|PubMed:12391170,
CC       ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370,
CC       ECO:0000269|PubMed:30584594}.
CC   -!- SUBUNIT: Component of the RNA polymerase III (Pol III) complex
CC       consisting of 17 subunits. {ECO:0000269|PubMed:19609254}.
CC   -!- INTERACTION:
CC       Q9Y2Y1; Q6IPU0: CENPP; NbExp=3; IntAct=EBI-11023785, EBI-10250303;
CC       Q9Y2Y1; O00560: SDCBP; NbExp=3; IntAct=EBI-11023785, EBI-727004;
CC       Q9Y2Y1; Q86WT6-2: TRIM69; NbExp=3; IntAct=EBI-11023785, EBI-11525489;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P32529}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 21 (HLD21) [MIM:619310]: An
CC       autosomal recessive neurodegenerative disorder characterized by global
CC       developmental delay, loss of motor, speech and cognitive milestones in
CC       the first decades of life, and diffuse hypomyelination of the white
CC       matter and atrophy of the cerebellum and corpus callosum observed on
CC       brain imaging. Clinical features include nystagmus, ataxia, dystonia,
CC       and spasticity. Other more variable features are feeding difficulties,
CC       poor overall growth with microcephaly, optic atrophy, and seizures.The
CC       disorder is progressive and may lead to premature death.
CC       {ECO:0000269|PubMed:30584594}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the archaeal RpoM/eukaryotic RPA12/RPB9/RPC11
CC       RNA polymerase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK61210.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI95605.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF126531; AAD31424.1; -; Genomic_DNA.
DR   EMBL; AF051316; AAF18268.1; -; mRNA.
DR   EMBL; AF060223; AAG43123.1; -; mRNA.
DR   EMBL; DQ431198; ABD95903.1; -; Genomic_DNA.
DR   EMBL; AE006462; AAK61210.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; Z69719; CAI95605.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC011932; AAH11932.1; -; mRNA.
DR   CCDS; CCDS10395.1; -.
DR   RefSeq; NP_057394.3; NM_016310.4.
DR   PDB; 7A6H; EM; 3.30 A; I=1-108.
DR   PDB; 7AE1; EM; 2.80 A; I=1-108.
DR   PDB; 7AE3; EM; 3.10 A; I=1-108.
DR   PDB; 7AEA; EM; 3.40 A; I=1-108.
DR   PDB; 7AST; EM; 4.00 A; A=1-108.
DR   PDB; 7D58; EM; 2.90 A; I=1-108.
DR   PDB; 7D59; EM; 3.10 A; I=1-108.
DR   PDB; 7DN3; EM; 3.50 A; I=1-108.
DR   PDB; 7DU2; EM; 3.35 A; I=1-108.
DR   PDB; 7FJI; EM; 3.60 A; I=1-108.
DR   PDB; 7FJJ; EM; 3.60 A; I=1-108.
DR   PDBsum; 7A6H; -.
DR   PDBsum; 7AE1; -.
DR   PDBsum; 7AE3; -.
DR   PDBsum; 7AEA; -.
DR   PDBsum; 7AST; -.
DR   PDBsum; 7D58; -.
DR   PDBsum; 7D59; -.
DR   PDBsum; 7DN3; -.
DR   PDBsum; 7DU2; -.
DR   PDBsum; 7FJI; -.
DR   PDBsum; 7FJJ; -.
DR   AlphaFoldDB; Q9Y2Y1; -.
DR   SMR; Q9Y2Y1; -.
DR   BioGRID; 119701; 89.
DR   IntAct; Q9Y2Y1; 15.
DR   MINT; Q9Y2Y1; -.
DR   STRING; 9606.ENSP00000293860; -.
DR   GlyGen; Q9Y2Y1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y2Y1; -.
DR   PhosphoSitePlus; Q9Y2Y1; -.
DR   SwissPalm; Q9Y2Y1; -.
DR   BioMuta; POLR3K; -.
DR   DMDM; 116242768; -.
DR   EPD; Q9Y2Y1; -.
DR   jPOST; Q9Y2Y1; -.
DR   MassIVE; Q9Y2Y1; -.
DR   MaxQB; Q9Y2Y1; -.
DR   PaxDb; Q9Y2Y1; -.
DR   PeptideAtlas; Q9Y2Y1; -.
DR   ProteomicsDB; 85935; -.
DR   Antibodypedia; 1811; 155 antibodies from 24 providers.
DR   DNASU; 51728; -.
DR   Ensembl; ENST00000293860.6; ENSP00000293860.5; ENSG00000161980.6.
DR   GeneID; 51728; -.
DR   KEGG; hsa:51728; -.
DR   MANE-Select; ENST00000293860.6; ENSP00000293860.5; NM_016310.5; NP_057394.3.
DR   UCSC; uc002cfi.3; human.
DR   AGR; HGNC:14121; -.
DR   CTD; 51728; -.
DR   DisGeNET; 51728; -.
DR   GeneCards; POLR3K; -.
DR   HGNC; HGNC:14121; POLR3K.
DR   HPA; ENSG00000161980; Low tissue specificity.
DR   MalaCards; POLR3K; -.
DR   MIM; 606007; gene.
DR   MIM; 619310; phenotype.
DR   neXtProt; NX_Q9Y2Y1; -.
DR   OpenTargets; ENSG00000161980; -.
DR   PharmGKB; PA33521; -.
DR   VEuPathDB; HostDB:ENSG00000161980; -.
DR   eggNOG; KOG2906; Eukaryota.
DR   GeneTree; ENSGT00550000075071; -.
DR   HOGENOM; CLU_093932_3_0_1; -.
DR   InParanoid; Q9Y2Y1; -.
DR   OrthoDB; 19847at2759; -.
DR   PhylomeDB; Q9Y2Y1; -.
DR   TreeFam; TF103031; -.
DR   PathwayCommons; Q9Y2Y1; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   SignaLink; Q9Y2Y1; -.
DR   SIGNOR; Q9Y2Y1; -.
DR   BioGRID-ORCS; 51728; 796 hits in 1163 CRISPR screens.
DR   ChiTaRS; POLR3K; human.
DR   GeneWiki; POLR3K; -.
DR   GenomeRNAi; 51728; -.
DR   Pharos; Q9Y2Y1; Tbio.
DR   PRO; PR:Q9Y2Y1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9Y2Y1; protein.
DR   Bgee; ENSG00000161980; Expressed in mucosa of transverse colon and 194 other tissues.
DR   Genevisible; Q9Y2Y1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005666; C:RNA polymerase III complex; IBA:GO_Central.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006386; P:termination of RNA polymerase III transcription; IBA:GO_Central.
DR   GO; GO:0006383; P:transcription by RNA polymerase III; TAS:ProtInc.
DR   GO; GO:0042779; P:tRNA 3'-trailer cleavage; IEA:InterPro.
DR   CDD; cd10509; Zn-ribbon_RPC11; 1.
DR   Gene3D; 2.20.25.10; -; 1.
DR   InterPro; IPR019761; DNA-dir_RNA_pol-M_15_CS.
DR   InterPro; IPR001529; DNA-dir_RNA_pol_M/15kDasu.
DR   InterPro; IPR012164; Rpa12/Rpb9/Rpc10/TFS.
DR   InterPro; IPR034014; Zn_ribbon_RPC11_C.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   PANTHER; PTHR11239; DNA-DIRECTED RNA POLYMERASE; 1.
DR   PANTHER; PTHR11239:SF12; DNA-DIRECTED RNA POLYMERASE III SUBUNIT RPC10; 1.
DR   Pfam; PF02150; RNA_POL_M_15KD; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   PIRSF; PIRSF005586; RNApol_RpoM; 1.
DR   SMART; SM00661; RPOL9; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF57783; Zinc beta-ribbon; 1.
DR   PROSITE; PS01030; RNA_POL_M_15KD; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense; Disease variant;
KW   DNA-directed RNA polymerase; Immunity; Innate immunity; Leukodystrophy;
KW   Metal-binding; Neurodegeneration; Nucleus; Reference proteome;
KW   Transcription; Zinc; Zinc-finger.
FT   CHAIN           1..108
FT                   /note="DNA-directed RNA polymerase III subunit RPC10"
FT                   /id="PRO_0000121475"
FT   ZN_FING         5..28
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         65..107
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         69
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         72
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         97
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   BINDING         102
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   VARIANT         24
FT                   /note="A -> S (in dbSNP:rs183360)"
FT                   /id="VAR_027918"
FT   VARIANT         41
FT                   /note="R -> W (in HLD21; decrease in expression levels of
FT                   RNA polymerase III-transcribed genes such as 5S and 7S
FT                   ribosomal RNAs; dbSNP:rs1432006875)"
FT                   /evidence="ECO:0000269|PubMed:30584594"
FT                   /id="VAR_085543"
FT   TURN            6..8
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          13..16
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          18..24
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          26..33
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          38..41
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   HELIX           50..53
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   TURN            54..56
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:7D58"
FT   TURN            70..72
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          77..82
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:7D58"
FT   STRAND          92..99
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:7AE1"
SQ   SEQUENCE   108 AA;  12320 MW;  3E96C0F2B48F9D1B CRC64;
     MLLFCPGCGN GLIVEEGQRC HRFACNTCPY VHNITRKVTN RKYPKLKEVD DVLGGAAAWE
     NVDSTAESCP KCEHPRAYFM QLQTRSADEP MTTFYKCCNA QCGHRWRD
//
ID   RNF11_HUMAN             Reviewed;         154 AA.
AC   Q9Y3C5; A8KAI2; Q5T7R8;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-FEB-2023, entry version 174.
DE   RecName: Full=RING finger protein 11;
GN   Name=RNF11; ORFNames=CGI-123;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10673045; DOI=10.1016/s0167-4781(99)00190-6;
RA   Seki N., Hattori A., Hayashi A., Kozuma S., Sasaki M., Suzuki Y.,
RA   Sugano S., Muramatsu M., Saito T.;
RT   "Cloning and expression profile of mouse and human genes, Rnf11/RNF11,
RT   encoding a novel RING-H2 finger protein.";
RL   Biochim. Biophys. Acta 1489:421-427(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 70-113 AND 132-154, PHOSPHORYLATION AT THR-135,
RP   SUBCELLULAR LOCATION, INTERACTION WITH 14-3-3, AND MUTAGENESIS OF THR-135.
RX   PubMed=16123141; DOI=10.1158/1541-7786.mcr-04-0166;
RA   Connor M.K., Azmi P.B., Subramaniam V., Li H., Seth A.K.;
RT   "Molecular characterization of ring finger protein 11.";
RL   Mol. Cancer Res. 3:453-461(2005).
RN   [8]
RP   INTERACTION WITH ITCH, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF TYR-40.
RX   PubMed=14559117; DOI=10.1016/j.bbadis.2003.07.001;
RA   Kitching R., Wong M.J., Koehler D., Burger A.M., Landberg G., Gish G.,
RA   Seth A.K.;
RT   "The RING-H2 protein RNF11 is differentially expressed in breast tumours
RT   and interacts with HECT-type E3 ligases.";
RL   Biochim. Biophys. Acta 1639:104-112(2003).
RN   [9]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH SMURF2 AND
RP   UBE2D1, UBIQUITINATION, AND MUTAGENESIS OF TYR-40; CYS-99 AND CYS-102.
RX   PubMed=14562029; DOI=10.1038/sj.bjc.6601301;
RA   Subramaniam V., Li H., Wong M.J., Kitching R., Attisano L., Wrana J.,
RA   Zubovits J., Burger A.M., Seth A.K.;
RT   "The RING-H2 protein RNF11 is overexpressed in breast cancer and is a
RT   target of Smurf2 E3 ligase.";
RL   Br. J. Cancer 89:1538-1544(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH ZNF350; EPS15 AND STAMBP, AND MUTAGENESIS OF
RP   TYR-40; CYS-99 AND CYS-102.
RX   PubMed=14755250; DOI=10.1038/sj.onc.1207319;
RA   Li H., Seth A.K.;
RT   "An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein.";
RL   Oncogene 23:1801-1808(2004).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=17917589; DOI=10.1097/nen.0b013e3181567f17;
RA   Anderson L.R., Betarbet R., Gearing M., Gulcher J., Hicks A.A.,
RA   Stefansson K., Lah J.J., Levey A.I.;
RT   "PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to
RT   Lewy bodies in Parkinson disease brain.";
RL   J. Neuropathol. Exp. Neurol. 66:955-964(2007).
RN   [12]
RP   INTERACTION WITH WWP1, AND MUTAGENESIS OF TYR-40.
RX   PubMed=18724389; DOI=10.1038/onc.2008.288;
RA   Chen C., Zhou Z., Liu R., Li Y., Azmi P.B., Seth A.K.;
RT   "The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2
RT   and EGFR through RING finger protein 11.";
RL   Oncogene 27:6845-6855(2008).
RN   [13]
RP   INTERACTION WITH TAX1BP1; TNFAIP3 AND RIPK1, AND MUTAGENESIS OF TYR-40 AND
RP   CYS-99.
RX   PubMed=19131965; DOI=10.1038/emboj.2008.285;
RA   Shembade N., Parvatiyar K., Harhaj N.S., Harhaj E.W.;
RT   "The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB
RT   signalling.";
RL   EMBO J. 28:513-522(2009).
RN   [14]
RP   INTERACTION WITH UBE2N, AND MUTAGENESIS OF MET-103; ASP-127 AND ASP-128.
RX   PubMed=18615712; DOI=10.1002/prot.22120;
RA   Scheper J., Oliva B., Villa-Freixa J., Thomson T.M.;
RT   "Analysis of electrostatic contributions to the selectivity of interactions
RT   between RING-finger domains and ubiquitin-conjugating enzymes.";
RL   Proteins 74:92-103(2009).
RN   [15]
RP   INTERACTION WITH GGA1, MYRISTOYLATION AT GLY-2, PALMITOYLATION AT CYS-4,
RP   UBIQUITINATION BY ITCH, AND MUTAGENESIS OF GLY-2; CYS-4; ASP-12; LEU-15;
RP   LEU-16; CYS-99 AND CYS-102.
RX   PubMed=20676133; DOI=10.1038/onc.2010.294;
RA   Santonico E., Belleudi F., Panni S., Torrisi M.R., Cesareni G.,
RA   Castagnoli L.;
RT   "Multiple modification and protein interaction signals drive the Ring
RT   finger protein 11 (RNF11) E3 ligase to the endosomal compartment.";
RL   Oncogene 29:5604-5618(2010).
RN   [16]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Essential component of a ubiquitin-editing protein complex,
CC       comprising also TNFAIP3, ITCH and TAX1BP1, that ensures the transient
CC       nature of inflammatory signaling pathways. Promotes the association of
CC       TNFAIP3 to RIPK1 after TNF stimulation. TNFAIP3 deubiquitinates 'Lys-
CC       63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-
CC       48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation
CC       and consequently termination of the TNF- or LPS-mediated activation of
CC       NF-kappa-B. Recruits STAMBP to the E3 ubiquitin-ligase SMURF2 for
CC       ubiquitination, leading to its degradation by the 26S proteasome.
CC       {ECO:0000269|PubMed:14755250}.
CC   -!- SUBUNIT: Interacts (when phosphorylated) with 14-3-3. Interacts with
CC       the E3 ubiquitin-ligases NEDD4, ITCH, SMURF2 and WWP1 (By similarity).
CC       Also interacts with the E2 ubiquitin-conjugating enzymes UBE2D1 and
CC       UBE2N, but neither with CDC34, nor with UBE2L3. Interacts with ZNF350,
CC       EPS15 and STAMBP. After TNF stimulation, interacts with TAX1BP1,
CC       TNFAIP3 and RIPK1; these interactions are transient and they are lost
CC       after 1 hour of stimulation with TNF (By similarity). Interacts with
CC       GGA1. {ECO:0000250, ECO:0000269|PubMed:14559117,
CC       ECO:0000269|PubMed:14562029, ECO:0000269|PubMed:14755250,
CC       ECO:0000269|PubMed:16123141, ECO:0000269|PubMed:18615712,
CC       ECO:0000269|PubMed:18724389, ECO:0000269|PubMed:19131965,
CC       ECO:0000269|PubMed:20676133}.
CC   -!- INTERACTION:
CC       Q9Y3C5; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-396669, EBI-10173507;
CC       Q9Y3C5; Q6ZTN6-2: ANKRD13D; NbExp=3; IntAct=EBI-396669, EBI-25840993;
CC       Q9Y3C5; Q8N8A2-2: ANKRD44; NbExp=3; IntAct=EBI-396669, EBI-21636328;
CC       Q9Y3C5; Q86WR3: ANUBL1; NbExp=3; IntAct=EBI-396669, EBI-25880850;
CC       Q9Y3C5; P13928: ANXA8; NbExp=3; IntAct=EBI-396669, EBI-2556915;
CC       Q9Y3C5; D3DTF8: APLN; NbExp=3; IntAct=EBI-396669, EBI-22002556;
CC       Q9Y3C5; P05067: APP; NbExp=3; IntAct=EBI-396669, EBI-77613;
CC       Q9Y3C5; O94778: AQP8; NbExp=3; IntAct=EBI-396669, EBI-19124986;
CC       Q9Y3C5; Q9NP61: ARFGAP3; NbExp=3; IntAct=EBI-396669, EBI-2875816;
CC       Q9Y3C5; Q86TN1: ARNT2; NbExp=3; IntAct=EBI-396669, EBI-25844820;
CC       Q9Y3C5; Q8WXK3: ASB13; NbExp=3; IntAct=EBI-396669, EBI-707573;
CC       Q9Y3C5; Q9Y575-3: ASB3; NbExp=3; IntAct=EBI-396669, EBI-14199987;
CC       Q9Y3C5; Q6XD76: ASCL4; NbExp=3; IntAct=EBI-396669, EBI-10254793;
CC       Q9Y3C5; Q96FT7-4: ASIC4; NbExp=3; IntAct=EBI-396669, EBI-9089489;
CC       Q9Y3C5; Q9H0Y0: ATG10; NbExp=3; IntAct=EBI-396669, EBI-1048913;
CC       Q9Y3C5; P15313: ATP6V1B1; NbExp=3; IntAct=EBI-396669, EBI-2891281;
CC       Q9Y3C5; P21281: ATP6V1B2; NbExp=3; IntAct=EBI-396669, EBI-4290814;
CC       Q9Y3C5; P46379-2: BAG6; NbExp=3; IntAct=EBI-396669, EBI-10988864;
CC       Q9Y3C5; Q16611: BAK1; NbExp=3; IntAct=EBI-396669, EBI-519866;
CC       Q9Y3C5; Q8IXM2: BAP18; NbExp=3; IntAct=EBI-396669, EBI-4280811;
CC       Q9Y3C5; Q14457: BECN1; NbExp=3; IntAct=EBI-396669, EBI-949378;
CC       Q9Y3C5; Q8WUW1: BRK1; NbExp=3; IntAct=EBI-396669, EBI-2837444;
CC       Q9Y3C5; Q9NSI6-4: BRWD1; NbExp=3; IntAct=EBI-396669, EBI-10693038;
CC       Q9Y3C5; Q8WZ55: BSND; NbExp=3; IntAct=EBI-396669, EBI-7996695;
CC       Q9Y3C5; Q8N865: C7orf31; NbExp=3; IntAct=EBI-396669, EBI-10174456;
CC       Q9Y3C5; Q96LL4: C8orf48; NbExp=3; IntAct=EBI-396669, EBI-751596;
CC       Q9Y3C5; Q8N5S9-2: CAMKK1; NbExp=3; IntAct=EBI-396669, EBI-25850646;
CC       Q9Y3C5; Q96DZ5: CLIP3; NbExp=3; IntAct=EBI-396669, EBI-12823145;
CC       Q9Y3C5; Q9BT09: CNPY3; NbExp=3; IntAct=EBI-396669, EBI-2835965;
CC       Q9Y3C5; Q6PJW8-3: CNST; NbExp=3; IntAct=EBI-396669, EBI-25836090;
CC       Q9Y3C5; Q9UNS2: COPS3; NbExp=3; IntAct=EBI-396669, EBI-350590;
CC       Q9Y3C5; P01040: CSTA; NbExp=3; IntAct=EBI-396669, EBI-724303;
CC       Q9Y3C5; Q8TB03: CXorf38; NbExp=3; IntAct=EBI-396669, EBI-12024320;
CC       Q9Y3C5; P00167: CYB5A; NbExp=3; IntAct=EBI-396669, EBI-1047284;
CC       Q9Y3C5; Q5TAQ9-2: DCAF8; NbExp=3; IntAct=EBI-396669, EBI-25842815;
CC       Q9Y3C5; Q8NDP9: DKFZp547K2416; NbExp=3; IntAct=EBI-396669, EBI-25842538;
CC       Q9Y3C5; Q5VZB9: DMRTA1; NbExp=3; IntAct=EBI-396669, EBI-3939812;
CC       Q9Y3C5; Q7L591-3: DOK3; NbExp=3; IntAct=EBI-396669, EBI-10694655;
CC       Q9Y3C5; A0A024RCP2: DOM3Z; NbExp=3; IntAct=EBI-396669, EBI-25847826;
CC       Q9Y3C5; Q9BPU6: DPYSL5; NbExp=3; IntAct=EBI-396669, EBI-724653;
CC       Q9Y3C5; O75530-2: EED; NbExp=3; IntAct=EBI-396669, EBI-11132357;
CC       Q9Y3C5; I6L9I8: EPN3; NbExp=3; IntAct=EBI-396669, EBI-12866582;
CC       Q9Y3C5; Q9NQ30: ESM1; NbExp=3; IntAct=EBI-396669, EBI-12260294;
CC       Q9Y3C5; Q6NXG1: ESRP1; NbExp=3; IntAct=EBI-396669, EBI-10213520;
CC       Q9Y3C5; Q99504: EYA3; NbExp=3; IntAct=EBI-396669, EBI-9089567;
CC       Q9Y3C5; O15540: FABP7; NbExp=3; IntAct=EBI-396669, EBI-10697159;
CC       Q9Y3C5; Q6P587-2: FAHD1; NbExp=3; IntAct=EBI-396669, EBI-12902289;
CC       Q9Y3C5; Q6P1L5: FAM117B; NbExp=3; IntAct=EBI-396669, EBI-3893327;
CC       Q9Y3C5; Q96GL9: FAM163A; NbExp=3; IntAct=EBI-396669, EBI-11793142;
CC       Q9Y3C5; Q17RN3: FAM98C; NbExp=3; IntAct=EBI-396669, EBI-5461838;
CC       Q9Y3C5; Q9NW38: FANCL; NbExp=3; IntAct=EBI-396669, EBI-2339898;
CC       Q9Y3C5; P15407: FOSL1; NbExp=3; IntAct=EBI-396669, EBI-744510;
CC       Q9Y3C5; P35575: G6PC1; NbExp=3; IntAct=EBI-396669, EBI-3906612;
CC       Q9Y3C5; P15976-2: GATA1; NbExp=3; IntAct=EBI-396669, EBI-9090198;
CC       Q9Y3C5; P23769-2: GATA2; NbExp=3; IntAct=EBI-396669, EBI-21856389;
CC       Q9Y3C5; Q9NXC2: GFOD1; NbExp=3; IntAct=EBI-396669, EBI-8799578;
CC       Q9Y3C5; Q9UJY5: GGA1; NbExp=3; IntAct=EBI-396669, EBI-447141;
CC       Q9Y3C5; P62879: GNB2; NbExp=3; IntAct=EBI-396669, EBI-356942;
CC       Q9Y3C5; Q9HBQ8: GOLGA2P5; NbExp=3; IntAct=EBI-396669, EBI-22000587;
CC       Q9Y3C5; O95872: GPANK1; NbExp=3; IntAct=EBI-396669, EBI-751540;
CC       Q9Y3C5; Q7Z602: GPR141; NbExp=3; IntAct=EBI-396669, EBI-21649723;
CC       Q9Y3C5; Q9Y4H4: GPSM3; NbExp=3; IntAct=EBI-396669, EBI-347538;
CC       Q9Y3C5; Q6NXT2: H3-5; NbExp=3; IntAct=EBI-396669, EBI-2868501;
CC       Q9Y3C5; P68431: H3C12; NbExp=3; IntAct=EBI-396669, EBI-79722;
CC       Q9Y3C5; A0A024R1L7: hCG_41307; NbExp=3; IntAct=EBI-396669, EBI-25849938;
CC       Q9Y3C5; P52790: HK3; NbExp=3; IntAct=EBI-396669, EBI-2965780;
CC       Q9Y3C5; P09017: HOXC4; NbExp=3; IntAct=EBI-396669, EBI-3923226;
CC       Q9Y3C5; Q14005-2: IL16; NbExp=3; IntAct=EBI-396669, EBI-17178971;
CC       Q9Y3C5; Q9NXX0: ILF3; NbExp=3; IntAct=EBI-396669, EBI-743980;
CC       Q9Y3C5; Q9UNL4: ING4; NbExp=3; IntAct=EBI-396669, EBI-2866661;
CC       Q9Y3C5; Q8IXL9: IQCF2; NbExp=3; IntAct=EBI-396669, EBI-10238842;
CC       Q9Y3C5; Q8NA54: IQUB; NbExp=3; IntAct=EBI-396669, EBI-10220600;
CC       Q9Y3C5; Q96J02: ITCH; NbExp=2; IntAct=EBI-396669, EBI-1564678;
CC       Q9Y3C5; Q9NVX7-2: KBTBD4; NbExp=3; IntAct=EBI-396669, EBI-25871195;
CC       Q9Y3C5; Q8WZ19: KCTD13; NbExp=3; IntAct=EBI-396669, EBI-742916;
CC       Q9Y3C5; Q9UIH9: KLF15; NbExp=3; IntAct=EBI-396669, EBI-2796400;
CC       Q9Y3C5; Q9Y2M5: KLHL20; NbExp=3; IntAct=EBI-396669, EBI-714379;
CC       Q9Y3C5; Q14525: KRT33B; NbExp=3; IntAct=EBI-396669, EBI-1049638;
CC       Q9Y3C5; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-396669, EBI-10241353;
CC       Q9Y3C5; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-396669, EBI-10261141;
CC       Q9Y3C5; Q14847-2: LASP1; NbExp=3; IntAct=EBI-396669, EBI-9088686;
CC       Q9Y3C5; Q5T7P3: LCE1B; NbExp=3; IntAct=EBI-396669, EBI-10245913;
CC       Q9Y3C5; Q9UPM6: LHX6; NbExp=3; IntAct=EBI-396669, EBI-10258746;
CC       Q9Y3C5; Q68G74: LHX8; NbExp=3; IntAct=EBI-396669, EBI-8474075;
CC       Q9Y3C5; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-396669, EBI-739832;
CC       Q9Y3C5; A2RU56: LOC401296; NbExp=3; IntAct=EBI-396669, EBI-9088215;
CC       Q9Y3C5; Q96JB6: LOXL4; NbExp=3; IntAct=EBI-396669, EBI-749562;
CC       Q9Y3C5; Q14693: LPIN1; NbExp=3; IntAct=EBI-396669, EBI-5278370;
CC       Q9Y3C5; P61244-4: MAX; NbExp=3; IntAct=EBI-396669, EBI-25848049;
CC       Q9Y3C5; Q03112-9: MECOM; NbExp=3; IntAct=EBI-396669, EBI-23820194;
CC       Q9Y3C5; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-396669, EBI-8487781;
CC       Q9Y3C5; Q15049: MLC1; NbExp=3; IntAct=EBI-396669, EBI-8475277;
CC       Q9Y3C5; P51948: MNAT1; NbExp=3; IntAct=EBI-396669, EBI-716139;
CC       Q9Y3C5; Q8N594: MPND; NbExp=3; IntAct=EBI-396669, EBI-2512452;
CC       Q9Y3C5; Q8IXL7-2: MSRB3; NbExp=3; IntAct=EBI-396669, EBI-10699187;
CC       Q9Y3C5; P46934: NEDD4; NbExp=3; IntAct=EBI-396669, EBI-726944;
CC       Q9Y3C5; Q8N5V2: NGEF; NbExp=3; IntAct=EBI-396669, EBI-718372;
CC       Q9Y3C5; Q8NBF2-2: NHLRC2; NbExp=3; IntAct=EBI-396669, EBI-10697320;
CC       Q9Y3C5; Q14995: NR1D2; NbExp=3; IntAct=EBI-396669, EBI-6144053;
CC       Q9Y3C5; Q6X4W1-6: NSMF; NbExp=3; IntAct=EBI-396669, EBI-25842707;
CC       Q9Y3C5; P36639-4: NUDT1; NbExp=3; IntAct=EBI-396669, EBI-25834643;
CC       Q9Y3C5; O15381-5: NVL; NbExp=3; IntAct=EBI-396669, EBI-18577082;
CC       Q9Y3C5; Q5BJF6-2: ODF2; NbExp=3; IntAct=EBI-396669, EBI-9090919;
CC       Q9Y3C5; Q96FW1: OTUB1; NbExp=3; IntAct=EBI-396669, EBI-1058491;
CC       Q9Y3C5; Q6GQQ9-2: OTUD7B; NbExp=3; IntAct=EBI-396669, EBI-25830200;
CC       Q9Y3C5; Q9NR21-5: PARP11; NbExp=3; IntAct=EBI-396669, EBI-17159452;
CC       Q9Y3C5; Q9NV79: PCMTD2; NbExp=3; IntAct=EBI-396669, EBI-6309018;
CC       Q9Y3C5; Q9UF11-2: PLEKHB1; NbExp=3; IntAct=EBI-396669, EBI-12832742;
CC       Q9Y3C5; Q6ZR37: PLEKHG7; NbExp=3; IntAct=EBI-396669, EBI-12891828;
CC       Q9Y3C5; Q8NA72-3: POC5; NbExp=3; IntAct=EBI-396669, EBI-11751537;
CC       Q9Y3C5; P54646: PRKAA2; NbExp=3; IntAct=EBI-396669, EBI-1383852;
CC       Q9Y3C5; O43741: PRKAB2; NbExp=3; IntAct=EBI-396669, EBI-1053424;
CC       Q9Y3C5; O60260-5: PRKN; NbExp=3; IntAct=EBI-396669, EBI-21251460;
CC       Q9Y3C5; P11908: PRPS2; NbExp=3; IntAct=EBI-396669, EBI-4290895;
CC       Q9Y3C5; P40306: PSMB10; NbExp=3; IntAct=EBI-396669, EBI-603329;
CC       Q9Y3C5; P28070: PSMB4; NbExp=3; IntAct=EBI-396669, EBI-603350;
CC       Q9Y3C5; P28062-2: PSMB8; NbExp=3; IntAct=EBI-396669, EBI-372312;
CC       Q9Y3C5; P47897: QARS1; NbExp=10; IntAct=EBI-396669, EBI-347462;
CC       Q9Y3C5; Q9UJ41-4: RABGEF1; NbExp=3; IntAct=EBI-396669, EBI-14093916;
CC       Q9Y3C5; Q9Y5P3: RAI2; NbExp=3; IntAct=EBI-396669, EBI-746228;
CC       Q9Y3C5; Q96PK6: RBM14; NbExp=3; IntAct=EBI-396669, EBI-954272;
CC       Q9Y3C5; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-396669, EBI-17589229;
CC       Q9Y3C5; Q8N5U6: RNF10; NbExp=3; IntAct=EBI-396669, EBI-714023;
CC       Q9Y3C5; Q9ULX5: RNF112; NbExp=3; IntAct=EBI-396669, EBI-25829984;
CC       Q9Y3C5; Q8WVD3: RNF138; NbExp=3; IntAct=EBI-396669, EBI-749039;
CC       Q9Y3C5; Q9UBS8: RNF14; NbExp=3; IntAct=EBI-396669, EBI-2130308;
CC       Q9Y3C5; Q8IYW5: RNF168; NbExp=4; IntAct=EBI-396669, EBI-914207;
CC       Q9Y3C5; Q96D59: RNF183; NbExp=3; IntAct=EBI-396669, EBI-743938;
CC       Q9Y3C5; Q9H0X6: RNF208; NbExp=3; IntAct=EBI-396669, EBI-751555;
CC       Q9Y3C5; P62244: RPS15A; NbExp=3; IntAct=EBI-396669, EBI-347895;
CC       Q9Y3C5; P62979: RPS27A; NbExp=4; IntAct=EBI-396669, EBI-357375;
CC       Q9Y3C5; Q66K80: RUSC1-AS1; NbExp=3; IntAct=EBI-396669, EBI-10248967;
CC       Q9Y3C5; Q8N488: RYBP; NbExp=3; IntAct=EBI-396669, EBI-752324;
CC       Q9Y3C5; Q7Z3H4: SAMD7; NbExp=3; IntAct=EBI-396669, EBI-12148649;
CC       Q9Y3C5; P34741: SDC2; NbExp=3; IntAct=EBI-396669, EBI-1172957;
CC       Q9Y3C5; O00560: SDCBP; NbExp=3; IntAct=EBI-396669, EBI-727004;
CC       Q9Y3C5; Q9NTN9-3: SEMA4G; NbExp=3; IntAct=EBI-396669, EBI-9089805;
CC       Q9Y3C5; Q96B97: SH3KBP1; NbExp=3; IntAct=EBI-396669, EBI-346595;
CC       Q9Y3C5; Q9NUL5-3: SHFL; NbExp=3; IntAct=EBI-396669, EBI-22000547;
CC       Q9Y3C5; O60902-3: SHOX2; NbExp=3; IntAct=EBI-396669, EBI-9092164;
CC       Q9Y3C5; Q9NSD5-3: SLC6A13; NbExp=3; IntAct=EBI-396669, EBI-25831241;
CC       Q9Y3C5; Q9HCE7-2: SMURF1; NbExp=3; IntAct=EBI-396669, EBI-9845742;
CC       Q9Y3C5; Q9HAU4: SMURF2; NbExp=5; IntAct=EBI-396669, EBI-396727;
CC       Q9Y3C5; Q92966: SNAPC3; NbExp=3; IntAct=EBI-396669, EBI-1760638;
CC       Q9Y3C5; Q13573: SNW1; NbExp=3; IntAct=EBI-396669, EBI-632715;
CC       Q9Y3C5; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-396669, EBI-11959123;
CC       Q9Y3C5; A0A024R4B0: SPATA3; NbExp=3; IntAct=EBI-396669, EBI-14123856;
CC       Q9Y3C5; Q6RVD6: SPATA8; NbExp=3; IntAct=EBI-396669, EBI-8635958;
CC       Q9Y3C5; Q8TCT7-2: SPPL2B; NbExp=3; IntAct=EBI-396669, EBI-8345366;
CC       Q9Y3C5; Q7Z698: SPRED2; NbExp=3; IntAct=EBI-396669, EBI-7082156;
CC       Q9Y3C5; Q9C004: SPRY4; NbExp=3; IntAct=EBI-396669, EBI-354861;
CC       Q9Y3C5; Q96BD6: SPSB1; NbExp=3; IntAct=EBI-396669, EBI-2659201;
CC       Q9Y3C5; Q99619: SPSB2; NbExp=3; IntAct=EBI-396669, EBI-2323209;
CC       Q9Y3C5; Q92783-2: STAM; NbExp=3; IntAct=EBI-396669, EBI-12025738;
CC       Q9Y3C5; O75886: STAM2; NbExp=4; IntAct=EBI-396669, EBI-373258;
CC       Q9Y3C5; O95630: STAMBP; NbExp=5; IntAct=EBI-396669, EBI-396676;
CC       Q9Y3C5; Q17RD7-3: SYT16; NbExp=3; IntAct=EBI-396669, EBI-25861603;
CC       Q9Y3C5; Q9BQG1: SYT3; NbExp=3; IntAct=EBI-396669, EBI-17284568;
CC       Q9Y3C5; Q5VWN6: TASOR2; NbExp=3; IntAct=EBI-396669, EBI-745958;
CC       Q9Y3C5; Q86VP1: TAX1BP1; NbExp=2; IntAct=EBI-396669, EBI-529518;
CC       Q9Y3C5; P62380: TBPL1; NbExp=3; IntAct=EBI-396669, EBI-716225;
CC       Q9Y3C5; Q8IYN2: TCEAL8; NbExp=3; IntAct=EBI-396669, EBI-2116184;
CC       Q9Y3C5; Q13569: TDG; NbExp=3; IntAct=EBI-396669, EBI-348333;
CC       Q9Y3C5; P28347-2: TEAD1; NbExp=3; IntAct=EBI-396669, EBI-12151837;
CC       Q9Y3C5; Q96A09: TENT5B; NbExp=3; IntAct=EBI-396669, EBI-752030;
CC       Q9Y3C5; Q8NA77: TEX19; NbExp=3; IntAct=EBI-396669, EBI-13323487;
CC       Q9Y3C5; O60830: TIMM17B; NbExp=3; IntAct=EBI-396669, EBI-2372529;
CC       Q9Y3C5; Q04724: TLE1; NbExp=3; IntAct=EBI-396669, EBI-711424;
CC       Q9Y3C5; Q8N0U2: TMEM61; NbExp=3; IntAct=EBI-396669, EBI-25830583;
CC       Q9Y3C5; Q53NU3: tmp_locus_54; NbExp=3; IntAct=EBI-396669, EBI-10242677;
CC       Q9Y3C5; Q71RG4-4: TMUB2; NbExp=3; IntAct=EBI-396669, EBI-25831574;
CC       Q9Y3C5; P21580: TNFAIP3; NbExp=2; IntAct=EBI-396669, EBI-527670;
CC       Q9Y3C5; Q9H0E2: TOLLIP; NbExp=3; IntAct=EBI-396669, EBI-74615;
CC       Q9Y3C5; P19474: TRIM21; NbExp=3; IntAct=EBI-396669, EBI-81290;
CC       Q9Y3C5; Q9UPQ4-2: TRIM35; NbExp=3; IntAct=EBI-396669, EBI-17716262;
CC       Q9Y3C5; Q9HCM9-2: TRIM39; NbExp=3; IntAct=EBI-396669, EBI-11523450;
CC       Q9Y3C5; Q86WV8: TSC1; NbExp=3; IntAct=EBI-396669, EBI-12806590;
CC       Q9Y3C5; Q9Y3Q8: TSC22D4; NbExp=3; IntAct=EBI-396669, EBI-739485;
CC       Q9Y3C5; Q9UGJ1-2: TUBGCP4; NbExp=3; IntAct=EBI-396669, EBI-10964469;
CC       Q9Y3C5; P62987: UBA52; NbExp=4; IntAct=EBI-396669, EBI-357304;
CC       Q9Y3C5; Q9BSL1: UBAC1; NbExp=3; IntAct=EBI-396669, EBI-749370;
CC       Q9Y3C5; Q8NBM4-4: UBAC2; NbExp=3; IntAct=EBI-396669, EBI-25840976;
CC       Q9Y3C5; P57075-2: UBASH3A; NbExp=3; IntAct=EBI-396669, EBI-7353612;
CC       Q9Y3C5; P0CG47: UBB; NbExp=3; IntAct=EBI-396669, EBI-413034;
CC       Q9Y3C5; P51668: UBE2D1; NbExp=9; IntAct=EBI-396669, EBI-743540;
CC       Q9Y3C5; P62837: UBE2D2; NbExp=10; IntAct=EBI-396669, EBI-347677;
CC       Q9Y3C5; P61077: UBE2D3; NbExp=3; IntAct=EBI-396669, EBI-348268;
CC       Q9Y3C5; Q9Y2X8: UBE2D4; NbExp=10; IntAct=EBI-396669, EBI-745527;
CC       Q9Y3C5; P51965: UBE2E1; NbExp=2; IntAct=EBI-396669, EBI-348546;
CC       Q9Y3C5; Q969T4: UBE2E3; NbExp=4; IntAct=EBI-396669, EBI-348496;
CC       Q9Y3C5; P61088: UBE2N; NbExp=4; IntAct=EBI-396669, EBI-1052908;
CC       Q9Y3C5; Q13404: UBE2V1; NbExp=4; IntAct=EBI-396669, EBI-1050671;
CC       Q9Y3C5; Q9UHD9: UBQLN2; NbExp=4; IntAct=EBI-396669, EBI-947187;
CC       Q9Y3C5; Q04323-2: UBXN1; NbExp=3; IntAct=EBI-396669, EBI-11530712;
CC       Q9Y3C5; Q96RL1-2: UIMC1; NbExp=3; IntAct=EBI-396669, EBI-17761788;
CC       Q9Y3C5; O75604-3: USP2; NbExp=3; IntAct=EBI-396669, EBI-10696113;
CC       Q9Y3C5; P45880: VDAC2; NbExp=3; IntAct=EBI-396669, EBI-354022;
CC       Q9Y3C5; P40337-2: VHL; NbExp=3; IntAct=EBI-396669, EBI-12157263;
CC       Q9Y3C5; Q8NEZ2: VPS37A; NbExp=3; IntAct=EBI-396669, EBI-2850578;
CC       Q9Y3C5; P58304: VSX2; NbExp=3; IntAct=EBI-396669, EBI-6427899;
CC       Q9Y3C5; Q9GZS3: WDR61; NbExp=3; IntAct=EBI-396669, EBI-358545;
CC       Q9Y3C5; Q9BQA1: WDR77; NbExp=3; IntAct=EBI-396669, EBI-1237307;
CC       Q9Y3C5; Q9BRX9: WDR83; NbExp=3; IntAct=EBI-396669, EBI-7705033;
CC       Q9Y3C5; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-396669, EBI-12040603;
CC       Q9Y3C5; O00308: WWP2; NbExp=7; IntAct=EBI-396669, EBI-743923;
CC       Q9Y3C5; P12956: XRCC6; NbExp=3; IntAct=EBI-396669, EBI-353208;
CC       Q9Y3C5; O43167-2: ZBTB24; NbExp=3; IntAct=EBI-396669, EBI-25842419;
CC       Q9Y3C5; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-396669, EBI-14104088;
CC       Q9Y3C5; Q5W0Z9-4: ZDHHC20; NbExp=3; IntAct=EBI-396669, EBI-25840130;
CC       Q9Y3C5; Q15776: ZKSCAN8; NbExp=3; IntAct=EBI-396669, EBI-2602314;
CC       Q9Y3C5; Q9UJW8-4: ZNF180; NbExp=3; IntAct=EBI-396669, EBI-12055755;
CC       Q9Y3C5; Q8WUU4: ZNF296; NbExp=3; IntAct=EBI-396669, EBI-8834821;
CC       Q9Y3C5; Q9NR11-2: ZNF302; NbExp=3; IntAct=EBI-396669, EBI-12988373;
CC       Q9Y3C5; Q8N895: ZNF366; NbExp=3; IntAct=EBI-396669, EBI-2813661;
CC       Q9Y3C5; Q8N0Y2-2: ZNF444; NbExp=3; IntAct=EBI-396669, EBI-12010736;
CC       Q9Y3C5; Q96MN9-2: ZNF488; NbExp=3; IntAct=EBI-396669, EBI-25831733;
CC       Q9Y3C5; Q6ZNH5: ZNF497; NbExp=3; IntAct=EBI-396669, EBI-10486136;
CC       Q9Y3C5; Q96C55: ZNF524; NbExp=3; IntAct=EBI-396669, EBI-10283126;
CC       Q9Y3C5; Q68EA5: ZNF57; NbExp=3; IntAct=EBI-396669, EBI-8490788;
CC       Q9Y3C5; Q96N77-2: ZNF641; NbExp=3; IntAct=EBI-396669, EBI-12939666;
CC       Q9Y3C5; Q9BS34: ZNF670; NbExp=3; IntAct=EBI-396669, EBI-745276;
CC       Q9Y3C5; Q2QGD7: ZXDC; NbExp=3; IntAct=EBI-396669, EBI-1538838;
CC       Q9Y3C5; A0A384ME25; NbExp=3; IntAct=EBI-396669, EBI-10211777;
CC       Q9Y3C5; B7Z3E8; NbExp=3; IntAct=EBI-396669, EBI-25831617;
CC       Q9Y3C5; Q7L8T7; NbExp=3; IntAct=EBI-396669, EBI-25831943;
CC   -!- SUBCELLULAR LOCATION: Early endosome. Recycling endosome. Cytoplasm.
CC       Nucleus. Note=Predominantly cytoplasmic, when unphosphorylated, and
CC       nuclear, when phosphorylated by PKB/AKT1.
CC       {ECO:0000269|PubMed:16123141}.
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in the lung, liver, kidney,
CC       pancreas, spleen, prostate, thymus, ovary, small intestine, colon, and
CC       peripheral blood lymphocytes, and, at intermediate levels, in the
CC       testis, heart, brain and placenta. Highest expression in the skeletal
CC       muscle. In the brain, expressed at different levels in several regions:
CC       high levels in the amygdala, moderate in the hippocampus and thalamus,
CC       low in the caudate and extremely low levels in the corpus callosum (at
CC       protein level). Restricted to neurons, enriched in somatodendritic
CC       compartments and excluded from white matter (at protein level). In
CC       substantia nigra, present in cell bodies and processes of dopaminergic
CC       and nondopaminergic cells (at protein level). In Parkinson disease,
CC       sequestered in Lewy bodies and neurites. Overexpressed in breast cancer
CC       cells, but not detected in the surrounding stroma and weakly, if at
CC       all, in normal breast epithelial cells (at protein level). Also
CC       expressed in several tumor cell lines. {ECO:0000269|PubMed:14559117,
CC       ECO:0000269|PubMed:14562029, ECO:0000269|PubMed:17917589}.
CC   -!- DOMAIN: The PPxY motif mediates interaction with NEDD4. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated in the presence of ITCH, or SMURF2, and UBE2D1, as
CC       well as WWP1. {ECO:0000269|PubMed:14562029,
CC       ECO:0000269|PubMed:20676133}.
CC   -!- PTM: Phosphorylation by PKB/AKT1 may accelerate degradation by the
CC       proteasome. {ECO:0000269|PubMed:16123141}.
CC   -!- PTM: Acylation at both Gly-2 and Cys-4 is required for proper
CC       localization to the endosomes. {ECO:0000269|PubMed:20676133}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB024703; BAA84683.1; -; mRNA.
DR   EMBL; AF151881; AAD34118.1; -; mRNA.
DR   EMBL; AK293047; BAF85736.1; -; mRNA.
DR   EMBL; AK313140; BAG35959.1; -; mRNA.
DR   EMBL; AL162430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06831.1; -; Genomic_DNA.
DR   EMBL; BC020964; AAH20964.1; -; mRNA.
DR   EMBL; BC047654; AAH47654.1; -; mRNA.
DR   CCDS; CCDS556.1; -.
DR   RefSeq; NP_055187.1; NM_014372.4.
DR   AlphaFoldDB; Q9Y3C5; -.
DR   SMR; Q9Y3C5; -.
DR   BioGRID; 117941; 161.
DR   CORUM; Q9Y3C5; -.
DR   IntAct; Q9Y3C5; 272.
DR   MINT; Q9Y3C5; -.
DR   STRING; 9606.ENSP00000242719; -.
DR   iPTMnet; Q9Y3C5; -.
DR   PhosphoSitePlus; Q9Y3C5; -.
DR   SwissPalm; Q9Y3C5; -.
DR   BioMuta; RNF11; -.
DR   DMDM; 21362884; -.
DR   EPD; Q9Y3C5; -.
DR   jPOST; Q9Y3C5; -.
DR   MassIVE; Q9Y3C5; -.
DR   MaxQB; Q9Y3C5; -.
DR   PaxDb; Q9Y3C5; -.
DR   PeptideAtlas; Q9Y3C5; -.
DR   ProteomicsDB; 86014; -.
DR   Antibodypedia; 32937; 181 antibodies from 24 providers.
DR   DNASU; 26994; -.
DR   Ensembl; ENST00000242719.4; ENSP00000242719.3; ENSG00000123091.5.
DR   GeneID; 26994; -.
DR   KEGG; hsa:26994; -.
DR   MANE-Select; ENST00000242719.4; ENSP00000242719.3; NM_014372.5; NP_055187.1.
DR   UCSC; uc001csi.5; human.
DR   AGR; HGNC:10056; -.
DR   CTD; 26994; -.
DR   DisGeNET; 26994; -.
DR   GeneCards; RNF11; -.
DR   HGNC; HGNC:10056; RNF11.
DR   HPA; ENSG00000123091; Low tissue specificity.
DR   MIM; 612598; gene.
DR   neXtProt; NX_Q9Y3C5; -.
DR   OpenTargets; ENSG00000123091; -.
DR   PharmGKB; PA34420; -.
DR   VEuPathDB; HostDB:ENSG00000123091; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   GeneTree; ENSGT00730000110988; -.
DR   HOGENOM; CLU_123539_1_0_1; -.
DR   InParanoid; Q9Y3C5; -.
DR   OMA; HLDCIDN; -.
DR   OrthoDB; 5474929at2759; -.
DR   PhylomeDB; Q9Y3C5; -.
DR   TreeFam; TF318022; -.
DR   PathwayCommons; Q9Y3C5; -.
DR   SignaLink; Q9Y3C5; -.
DR   SIGNOR; Q9Y3C5; -.
DR   BioGRID-ORCS; 26994; 45 hits in 1199 CRISPR screens.
DR   ChiTaRS; RNF11; human.
DR   GeneWiki; RNF11; -.
DR   GenomeRNAi; 26994; -.
DR   Pharos; Q9Y3C5; Tbio.
DR   PRO; PR:Q9Y3C5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9Y3C5; protein.
DR   Bgee; ENSG00000123091; Expressed in lateral nuclear group of thalamus and 211 other tissues.
DR   Genevisible; Q9Y3C5; HS.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:FlyBase.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   CDD; cd16468; RING-H2_RNF11; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR042981; RNF11_RING-H2.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR46359; GEO07743P1; 1.
DR   PANTHER; PTHR46359:SF1; RING FINGER PROTEIN 11; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; Endosome; Lipoprotein; Metal-binding;
KW   Myristate; Nucleus; Palmitate; Phosphoprotein; Reference proteome;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..154
FT                   /note="RING finger protein 11"
FT                   /id="PRO_0000056050"
FT   ZN_FING         99..140
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           37..40
FT                   /note="PPxY motif"
FT   COMPBIAS        1..27
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        32..46
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QYK7"
FT   MOD_RES         135
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:16123141"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:20213681,
FT                   ECO:0000269|PubMed:20676133"
FT   LIPID           4
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   VARIANT         11
FT                   /note="D -> E (in dbSNP:rs12077069)"
FT                   /id="VAR_058272"
FT   MUTAGEN         2
FT                   /note="G->A: Loss of myristoylation. Change in subcellular
FT                   location: Becomes diffused throughout the cytosol. Strong
FT                   reduction of ubiquitination. Reduced efficiency of
FT                   ITCH-binding."
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   MUTAGEN         4
FT                   /note="C->S: Change in subcellular location: Becomes
FT                   partially cytosolic and retained in association with the
FT                   Golgi apparatus. Partial reduction of ubiquitination."
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   MUTAGEN         12
FT                   /note="D->A: Loss of GGA1-binding."
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   MUTAGEN         15
FT                   /note="L->A: Loss of GGA1-binding."
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   MUTAGEN         16
FT                   /note="L->A: Loss of GGA1-binding."
FT                   /evidence="ECO:0000269|PubMed:20676133"
FT   MUTAGEN         40
FT                   /note="Y->A: Loss of ITCH-, SMURF2- and WWP1-binding.
FT                   Partial loss of ubiquitination by ITCH. No effect on
FT                   STAMBP-binding; when associated with S-99 and S-102.
FT                   Persistent TNF-mediated NFKBIA phosphorylation. Loss of
FT                   stimulus-dependent complex formation with TAX1BP1, TNFAIP3
FT                   and RIPK1."
FT                   /evidence="ECO:0000269|PubMed:14559117,
FT                   ECO:0000269|PubMed:14562029, ECO:0000269|PubMed:14755250,
FT                   ECO:0000269|PubMed:18724389, ECO:0000269|PubMed:19131965"
FT   MUTAGEN         99
FT                   /note="C->S: No effect on STAMBP- and SMURF2-binding; when
FT                   associated with S-102. Persistent TNF-mediated NFKBIA
FT                   phosphorylation. No effect on STAMBP-binding; when
FT                   associated with A-40 and S-102. No effect on ubiquitination
FT                   by ITCH; when associated with S-102. Loss of
FT                   stimulus-dependent complex formation with TAX1BP1, TNFAIP3
FT                   and RIPK1."
FT                   /evidence="ECO:0000269|PubMed:14562029,
FT                   ECO:0000269|PubMed:14755250, ECO:0000269|PubMed:19131965,
FT                   ECO:0000269|PubMed:20676133"
FT   MUTAGEN         102
FT                   /note="C->S: No effect on STAMBP- and SMURF2-binding; when
FT                   associated with S-99. No effect on ubiquitination by ITCH;
FT                   when associated with S-102. No effect on STAMBP-binding;
FT                   when associated with A-40 and S-99."
FT                   /evidence="ECO:0000269|PubMed:14562029,
FT                   ECO:0000269|PubMed:14755250, ECO:0000269|PubMed:20676133"
FT   MUTAGEN         103
FT                   /note="M->A,G: Loss of UBE2N-binding. No gain of
FT                   UBE2L3-binding."
FT                   /evidence="ECO:0000269|PubMed:18615712"
FT   MUTAGEN         103
FT                   /note="M->L: No effect on UBE2N-binding. No gain of
FT                   UBE2L3-binding; when associated with L-127 and L-128."
FT                   /evidence="ECO:0000269|PubMed:18615712"
FT   MUTAGEN         103
FT                   /note="M->V: No effect on UBE2N-binding. Gain of
FT                   UBE2L3-binding."
FT                   /evidence="ECO:0000269|PubMed:18615712"
FT   MUTAGEN         127
FT                   /note="D->L: No effect on UBE2N-binding. No gain of
FT                   UBE2L3-binding; when associated with L-128."
FT                   /evidence="ECO:0000269|PubMed:18615712"
FT   MUTAGEN         128
FT                   /note="D->L: No effect on UBE2N-binding. No gain of
FT                   UBE2L3-binding."
FT                   /evidence="ECO:0000269|PubMed:18615712"
FT   MUTAGEN         135
FT                   /note="T->E: Loss of phosphorylation and of
FT                   14-3-3-binding."
FT                   /evidence="ECO:0000269|PubMed:16123141"
FT   CONFLICT        124
FT                   /note="D -> G (in Ref. 3; BAF85736)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   154 AA;  17444 MW;  C368E38148FC1D0D CRC64;
     MGNCLKSPTS DDISLLHESQ SDRASFGEGT EPDQEPPPPY QEQVPVPVYH PTPSQTRLAT
     QLTEEEQIRI AQRIGLIQHL PKGVYDPGRD GSEKKIRECV ICMMDFVYGD PIRFLPCMHI
     YHLDCIDDWL MRSFTCPSCM EPVDAALLSS YETN
//
